archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00011241,1.537,1.2608,1,1
1,GO BLEB ASSEMBLY,7.5427e-07,1.4154,1.3489,1,1
1,GO MEMBRANE RAFT ASSEMBLY,4.4712e-06,1.2358,1.5163,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00021167,1.2056,0.95503,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,9.8628e-07,1.1754,1.0451,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,7.547e-05,1.1571,1.0689,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.3441e-06,1.1242,0.91694,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.2308e-06,1.1203,0.98856,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,1.2308e-06,1.1023,0.88733,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.4268e-07,1.0912,0.96573,1,1
1,GO RESPONSE TO INTERFERON ALPHA,2.7343e-05,1.0659,1.0305,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,1.0451,0.84663,1,1
1,GO NEUTROPHIL HOMEOSTASIS,6.8936e-07,1.0348,0.95632,1,1
1,GO HYALURONAN CATABOLIC PROCESS,8.8325e-08,1.0272,1.0677,1,1
1,GO RESPONSE TO INTERFERON BETA,5.2837e-06,1.0058,0.95522,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,6.8936e-07,1.005,0.97272,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,6.6003e-08,0.99651,0.93643,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,9.0179e-06,0.97374,0.88506,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.0833e-05,0.96933,0.86163,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,5.9841e-06,0.92892,0.81475,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.0184e-05,0.92141,0.85013,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,2.2524e-05,0.9193,0.83878,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.9532e-05,0.91599,0.76443,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.8251e-06,0.90962,0.8913,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,6.8936e-07,0.90337,0.8783,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,8.2505e-07,0.89939,0.9415,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,1.0311e-06,0.89792,0.86043,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0833e-05,0.89618,0.8202,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.4039e-05,0.88685,0.90152,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00017796,0.88164,0.67859,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.1964e-05,0.87587,1.0178,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,1.0311e-06,0.8661,0.79589,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,8.2505e-07,0.86521,0.73738,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.725e-07,0.86182,0.85373,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,5.6999e-08,0.85508,0.86054,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,4.3218e-05,0.84298,0.69293,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,1.906e-06,0.84221,0.79432,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,1.4963e-07,0.83936,0.88264,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,8.628e-07,0.83891,0.79643,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,4.7955e-07,0.83422,0.76919,1,1
1,GO CD40 SIGNALING PATHWAY,2.6322e-07,0.82693,0.75279,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,6.5896e-07,0.82175,0.75757,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,8.628e-07,0.81759,0.9393,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,0.0001547,0.81247,0.80749,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,9.7801e-06,0.80802,0.65228,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.7118e-05,0.80747,0.79519,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,3.7791e-06,0.80446,0.61049,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,4.4712e-06,0.80137,0.63953,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.2366e-07,0.79893,0.77862,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.4609e-05,0.78483,0.71869,1,1
1,GO BONE TRABECULA FORMATION,0.0013872,0.77688,0.68728,1,1
1,GO CYSTEINE METABOLIC PROCESS,9.0179e-06,0.77326,0.70772,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,9.7801e-06,0.77167,0.65368,1,1
1,GO HEMIDESMOSOME ASSEMBLY,8.7323e-05,0.7686,0.96727,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.9263e-05,0.76795,0.76236,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,9.0551e-05,0.76685,0.59459,1,1
1,GO MEMBRANE RAFT ORGANIZATION,3.4728e-06,0.76502,0.90504,1,1
1,GO ENDODERM FORMATION,1.9873e-07,0.76452,0.7813,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,5.0226e-05,0.75597,0.61585,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.3916e-06,0.75467,0.60584,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,1.4039e-05,0.75269,0.81062,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,3.6228e-06,0.74902,0.79816,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,3.3287e-06,0.74535,0.69776,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,6.0198e-07,0.74381,0.73628,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00032948,0.74124,0.68579,1,1
1,GO EPIBOLY,8.2505e-07,0.73565,0.74625,1,1
1,GO FIBRINOLYSIS,4.5813e-07,0.73217,0.84192,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.5774e-06,0.73207,0.72211,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,1.071e-07,0.72741,0.70426,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,6.5896e-07,0.72416,0.70257,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.4728e-06,0.71898,0.62269,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4205e-05,0.71653,0.54698,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,9.3916e-06,0.71488,0.59952,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.1237e-07,0.7087,0.76602,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,4.3763e-07,0.70559,0.65939,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,1.9263e-05,0.7019,0.62981,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,1.1267e-06,0.69998,0.66072,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,2.2879e-07,0.69817,0.63569,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,3.0689e-05,0.69677,0.5846,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.00026903,0.69422,0.59941,1,1
1,GO REGULATION OF FIBRINOLYSIS,2.0833e-05,0.69285,0.65659,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.7578e-07,0.69195,0.65986,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,5.4977e-07,0.6903,0.68842,1,1
1,GO VASCULOGENESIS,2.8891e-07,0.68204,0.60772,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,3.9926e-07,0.67903,0.82883,1,1
1,GO ZYMOGEN INHIBITION,9.8628e-07,0.67684,0.76927,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,4.2876e-06,0.67397,0.58869,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.2876e-06,0.66972,0.61669,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,5.2533e-07,0.66879,0.67063,1,1
1,GO MUCUS SECRETION,0.0010206,0.66378,0.54299,1,1
1,GO LATERAL MESODERM DEVELOPMENT,0.00013433,0.6614,0.51919,1,1
1,GO GAP JUNCTION ASSEMBLY,1.906e-06,0.65852,0.64444,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.906e-06,0.65837,0.64209,1,1
1,GO T CELL EXTRAVASATION,7.9801e-06,0.65778,0.67023,1,1
1,GO CYTIDINE TO URIDINE EDITING,0.00079435,0.65408,0.59279,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,1.4609e-05,0.65247,0.63607,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00021167,0.65225,0.43711,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.3418e-05,0.64875,0.58355,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00019079,0.64754,0.61095,1,1
1,GO APOPTOTIC CELL CLEARANCE,1.9873e-07,0.64512,0.6998,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,2.2658e-06,0.64417,0.57289,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,3.4772e-07,0.64148,0.62079,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,5.2837e-06,0.64011,0.58999,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6015e-06,0.64007,0.63919,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00047456,0.63816,0.57281,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,4.6597e-05,0.63785,0.69186,1,1
1,GO CYTOLYSIS,6.5896e-07,0.63631,0.52563,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00016595,0.6359,0.61335,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,8.3127e-06,0.6355,0.55588,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.00011241,0.63336,0.52638,1,1
1,GO PLASMINOGEN ACTIVATION,0.00012074,0.632,0.59402,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.2658e-06,0.63149,0.72703,1,1
1,GO PIGMENT GRANULE MATURATION,5.8301e-05,0.63062,0.45628,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00016595,0.63061,0.60135,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.7413e-06,0.62864,0.5387,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,5.0683e-06,0.6273,0.62028,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,5.9841e-06,0.62689,0.54878,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,4.5813e-07,0.6261,0.58698,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.00021909,0.62305,0.4791,1,1
1,GO AMYLOID BETA CLEARANCE,8.8325e-08,0.61524,0.54771,1,1
1,GO ENDODERM DEVELOPMENT,5.2533e-07,0.61414,0.62754,1,1
1,GO VAGINA DEVELOPMENT,1.8251e-06,0.61256,0.63281,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,3.3132e-05,0.61217,0.5207,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.0604e-05,0.61142,0.69842,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.0011199,0.60891,0.68414,1,1
1,GO SNRNA PROCESSING,0.0014299,0.60744,0.61019,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,3.9418e-06,0.60598,0.65011,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.1493e-05,0.60518,0.44499,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.0571e-06,0.60394,0.54883,1,1
1,GO DNA DEAMINATION,0.00017796,0.60388,0.54412,1,1
1,GO HIPPO SIGNALING,4.0073e-05,0.60314,0.52158,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,4.1617e-05,0.60059,0.45143,1,1
1,GO COLLAGEN METABOLIC PROCESS,1.6015e-06,0.60033,0.58713,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,4.6623e-06,0.60007,0.60259,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00038934,0.59872,0.59526,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.071e-07,0.59871,0.52846,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0017641,0.59711,0.44239,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,7.3528e-06,0.59621,0.4713,1,1
1,GO LIVER REGENERATION,7.2756e-08,0.59611,0.58887,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.4728e-06,0.59505,0.62581,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0015653,0.59432,0.41219,1,1
1,GO HEME METABOLIC PROCESS,8.628e-07,0.59409,0.5417,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0017123,0.59369,0.71293,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,0.00010092,0.59323,0.52915,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.1493e-05,0.59277,0.52879,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.2111e-07,0.59276,0.57948,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,9.3916e-06,0.59215,0.56794,1,1
1,GO CELLULAR RESPONSE TO IRON ION,2.1663e-05,0.59125,0.52586,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2454e-05,0.59078,0.51763,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,1.104e-05,0.58993,0.54238,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.7791e-06,0.58951,0.60575,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,2.0033e-05,0.5891,0.54928,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.5331e-06,0.58654,0.63837,1,1
1,GO VASCULAR TRANSPORT,0.00040247,0.58499,0.60959,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,3.4728e-06,0.58346,0.51086,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0001165,0.58306,0.53845,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,7.547e-05,0.58261,0.48879,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00044439,0.58163,0.50904,1,1
1,GO NOTOCHORD DEVELOPMENT,4.4712e-06,0.58159,0.62701,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.011904,0.58136,0.47177,1,1
1,GO MACROPHAGE PROLIFERATION,2.9532e-05,0.57999,0.57871,1,1
1,GO GERMINAL CENTER FORMATION,7.8282e-05,0.5783,0.49181,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,8.628e-07,0.57664,0.56484,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.104e-05,0.57606,0.61619,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,7.6603e-06,0.5743,0.4517,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,1.3441e-06,0.57329,0.58982,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,2.9301e-06,0.57042,0.78019,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,3.7145e-05,0.56884,0.44019,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00011241,0.5673,0.55614,1,1
1,GO SALIVARY GLAND DEVELOPMENT,9.3916e-06,0.56562,0.57411,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.4994e-06,0.56519,0.48699,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,7.6603e-06,0.56348,0.58536,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.0001165,0.56287,0.48441,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,2.6322e-07,0.5619,0.60744,1,1
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0073363,0.55977,0.4192,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,2.8077e-06,0.55959,0.50285,1,1
1,GO REGULATION OF PINOCYTOSIS,8.1192e-05,0.55809,0.59329,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.047551,0.55357,0.3317,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.906e-06,0.55258,0.48156,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.00036427,0.5513,0.44875,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,0.00010845,0.5513,0.55142,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.6015e-06,0.55084,0.57227,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00019079,0.5507,0.44553,1,1
1,GO TYPE 2 IMMUNE RESPONSE,1.6455e-05,0.5506,0.52926,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,1.4674e-06,0.5505,0.53454,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00037661,0.54938,0.66246,1,1
1,GO OLIGOPEPTIDE TRANSPORT,4.6597e-05,0.54807,0.58807,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.3287e-06,0.54645,0.50099,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.0027346,0.54596,0.47813,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,1.8521e-05,0.54574,0.57904,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.00017796,0.54443,0.47833,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.00084609,0.54281,0.39211,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0014738,0.54243,0.41268,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,6.2367e-06,0.53952,0.49564,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,4.4878e-05,0.53714,0.47846,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.4609e-05,0.53683,0.50142,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.8891e-07,0.53474,0.5653,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,6.5149e-05,0.53468,0.59405,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,8.3127e-06,0.53405,0.60437,1,1
1,GO COLLAGEN CATABOLIC PROCESS,2.9532e-05,0.53243,0.53651,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.1192e-05,0.53094,0.50812,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.00026903,0.53002,0.4861,1,1
1,GO BLOOD VESSEL REMODELING,1.4039e-05,0.52826,0.45572,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.8301e-05,0.5282,0.56509,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.0311e-06,0.52641,0.5637,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,2.4692e-06,0.52558,0.45121,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00074557,0.52543,0.41595,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.5122e-07,0.52369,0.48616,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.0779e-06,0.52137,0.49501,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.00013917,0.52118,0.45354,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.6307e-05,0.52103,0.45467,1,1
1,GO RESPONSE TO X RAY,1.7474e-06,0.51835,0.48479,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.00022676,0.51653,0.52593,1,1
1,GO RESPONSE TO ANGIOTENSIN,4.5813e-07,0.51612,0.49285,1,1
1,GO CELLULAR RESPONSE TO DSRNA,7.889e-07,0.51519,0.54181,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00044439,0.51399,0.4838,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,2.0784e-06,0.51344,0.44181,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.1904e-06,0.51198,0.61663,1,1
1,GO CERAMIDE CATABOLIC PROCESS,3.0689e-05,0.51182,0.41253,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,8.6584e-06,0.51169,0.42884,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00055855,0.51114,0.39945,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00026903,0.51094,0.41409,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.030383,0.51089,0.27329,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.1617e-05,0.51052,0.48797,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00011241,0.50936,0.49799,1,1
1,GO SKIN MORPHOGENESIS,4.1617e-05,0.50895,0.70181,1,1
1,GO REGULATION OF MYOBLAST FUSION,0.0001547,0.50823,0.52942,1,1
1,GO RESPONSE TO TYPE I INTERFERON,0.00055855,0.50777,0.54666,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,4.1802e-07,0.50775,0.53009,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,2.1831e-07,0.50662,0.58609,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00044439,0.50574,0.46614,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,7.2754e-05,0.5042,0.52851,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.010773,0.50407,0.30699,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,4.5813e-07,0.50241,0.4823,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,5.4977e-07,0.50231,0.48178,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.8084e-07,0.50054,0.48803,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.2505e-07,0.49918,0.49475,1,1
1,GO PEPTIDE CROSS LINKING,0.00010462,0.49844,0.4696,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,1.6452e-07,0.49828,0.50718,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,1.8958e-07,0.49818,0.49215,1,1
1,GO NCRNA 3 END PROCESSING,0.011326,0.49751,0.39701,1,1
1,GO SNRNA METABOLIC PROCESS,0.00050664,0.49715,0.49267,1,1
1,GO LYMPHANGIOGENESIS,4.8612e-06,0.49659,0.46652,1,1
1,GO STORE OPERATED CALCIUM ENTRY,2.6902e-06,0.49539,0.42828,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0010528,0.49536,0.42819,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,4.2876e-06,0.49519,0.53925,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.0033e-05,0.49238,0.43112,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.8077e-06,0.49232,0.55277,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.0184e-05,0.492,0.43273,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,9.389e-05,0.49198,0.43036,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.00063551,0.49094,0.4742,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,2.8891e-07,0.49069,0.48807,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00057693,0.49024,0.43283,1,1
1,GO ENTRY INTO HOST,1.2308e-06,0.4882,0.54455,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,7.9801e-06,0.48819,0.40833,1,1
1,GO AORTIC VALVE DEVELOPMENT,0.00023468,0.48593,0.46465,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0013457,0.48586,0.37887,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,6.5896e-07,0.48568,0.46434,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,5.753e-07,0.48462,0.48376,1,1
1,GO BIOLOGICAL PHASE,0.0016129,0.48375,0.47289,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0001165,0.48285,0.39629,1,1
1,GO PROTEIN OXIDATION,0.0021062,0.48177,0.44301,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,7.5427e-07,0.48147,0.49939,1,1
1,GO TOLERANCE INDUCTION,0.00054072,0.4814,0.44512,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.9841e-06,0.48118,0.49495,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,2.7343e-05,0.48075,0.43882,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.00029782,0.48075,0.46732,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0041716,0.47847,0.34278,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.0028141,0.47736,0.39927,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,7.547e-05,0.47731,0.48538,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.00042998,0.47719,0.58203,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.1237e-07,0.4766,0.42098,1,1
1,GO LEUKOCYTE AGGREGATION,0.0017123,0.47612,0.50773,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0028141,0.47559,0.36338,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,2.1702e-06,0.47554,0.37848,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,2.6902e-06,0.47487,0.4906,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9263e-05,0.47429,0.42041,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00024286,0.47378,0.44706,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.0689e-05,0.47298,0.46362,1,1
1,GO HYALURONAN METABOLIC PROCESS,3.6414e-07,0.47297,0.50332,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,4.2876e-06,0.47292,0.65896,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.1663e-05,0.47181,0.45684,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.3916e-06,0.47118,0.39525,1,1
1,GO REGULATION OF TRANSPOSITION,0.00067758,0.47114,0.4247,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,1.104e-05,0.47006,0.44936,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.001662,0.46949,0.4101,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,5.508e-06,0.4693,0.50794,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,5.2139e-05,0.46878,0.38492,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00090094,0.46854,0.37228,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7145e-05,0.46805,0.43633,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,7.2754e-05,0.46771,0.45471,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,3.9418e-06,0.46564,0.6276,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,1.5201e-05,0.46553,0.47111,1,1
1,GO MATURATION OF LSU RRNA,0.00012512,0.46526,0.43215,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00072223,0.46486,0.42236,1,1
1,GO RESPONSE TO HYPEROXIA,0.00017186,0.4646,0.45097,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,5.7413e-06,0.46434,0.44191,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.7806e-05,0.46419,0.46842,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,2.7343e-05,0.46346,0.49951,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00098941,0.46336,0.4039,1,1
1,GO PROTEIN ACTIVATION CASCADE,2.9301e-06,0.46284,0.48885,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.00013433,0.46245,0.41804,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.011612,0.46232,0.34341,1,1
1,GO VIRAL RNA GENOME REPLICATION,2.4692e-06,0.46228,0.40926,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.4609e-05,0.46103,0.58362,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.9926e-07,0.46054,0.51588,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,1.8521e-05,0.46005,0.47417,1,1
1,GO REGULATION OF MRNA BINDING,5.8301e-05,0.45842,0.3778,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.7343e-05,0.45818,0.47404,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,0.00012512,0.45815,0.40308,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.3132e-05,0.45784,0.49634,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,2.2658e-06,0.45774,0.48419,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.1493e-05,0.45741,0.42755,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.8612e-06,0.45695,0.41531,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,7.0571e-06,0.45694,0.44243,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,9.3916e-06,0.45662,0.40273,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,1.906e-06,0.45594,0.4245,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.8077e-06,0.4558,0.44992,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,3.0576e-06,0.45481,0.38617,1,1
1,GO PROTEASOME ASSEMBLY,3.3132e-05,0.45437,0.34344,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,4.4712e-06,0.45315,0.50815,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.00026903,0.453,0.4399,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,1.0779e-06,0.4525,0.47427,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00018427,0.4524,0.39437,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.2308e-06,0.45234,0.47015,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.389e-05,0.45187,0.34083,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,3.8131e-07,0.4502,0.4325,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.00026003,0.45014,0.41233,1,1
1,GO ZYMOGEN ACTIVATION,6.2786e-05,0.4498,0.46659,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.9904e-06,0.44963,0.37917,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,5.2837e-06,0.44934,0.51209,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.7791e-06,0.44908,0.43108,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,4.3763e-07,0.44889,0.44875,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0073363,0.44839,0.35817,1,1
1,GO CYTOPLASMIC TRANSLATION,0.00014418,0.44817,0.37272,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,1.6455e-05,0.44693,0.39643,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.8521e-05,0.44634,0.33629,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,9.0179e-06,0.44429,0.34274,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0001547,0.4436,0.39892,1,1
1,GO ANIMAL ORGAN REGENERATION,2.8891e-07,0.44352,0.49892,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,9.389e-05,0.44332,0.41742,1,1
1,GO RETINAL METABOLIC PROCESS,0.0062634,0.44287,0.3278,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.001986,0.44264,0.34268,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0779e-06,0.44195,0.47215,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0010859,0.44193,0.32697,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,3.6414e-07,0.44172,0.39394,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00022676,0.44142,0.36744,1,1
1,GO PINOCYTOSIS,2.0833e-05,0.44128,0.55129,1,1
1,GO VIRAL TRANSLATION,1.0184e-05,0.44097,0.43034,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.8418e-05,0.44096,0.43973,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00019079,0.43955,0.53118,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.0833e-05,0.43912,0.40917,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.5896e-07,0.43851,0.39324,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.7806e-05,0.43848,0.39092,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,0.00011241,0.43709,0.44855,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,7.889e-07,0.43604,0.47937,1,1
1,GO CYTOKINE METABOLIC PROCESS,5.7413e-06,0.43528,0.38378,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,1.0311e-06,0.43504,0.59842,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.43425,0.42242,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,2.7343e-05,0.434,0.45995,1,1
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0056288,0.43397,0.30406,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,2.8418e-05,0.4337,0.41835,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00010092,0.43306,0.39178,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.6729e-06,0.43302,0.39028,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.4205e-05,0.43301,0.44875,1,1
1,GO T CELL MEDIATED IMMUNITY,2.3418e-05,0.43294,0.43132,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.43223,0.31898,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0039469,0.43152,0.3404,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00011241,0.43024,0.37407,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,9.7346e-05,0.42954,0.3678,1,1
1,GO REGULATION OF STEROL TRANSPORT,5.4977e-07,0.42921,0.38506,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0010859,0.4288,0.38788,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.7474e-06,0.42879,0.41779,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,0.00057693,0.42801,0.44989,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,3.1888e-05,0.42797,0.31308,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,9.7346e-05,0.42792,0.36368,1,1
1,GO RIBOSOME ASSEMBLY,0.00014935,0.42689,0.38359,1,1
1,GO VIRAL GENOME REPLICATION,9.0551e-05,0.42635,0.38899,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.7955e-07,0.42457,0.53885,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,4.0073e-05,0.42431,0.5105,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,2.6902e-06,0.42352,0.4317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0017641,0.42316,0.36181,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00020448,0.42292,0.41788,1,1
1,GO RESPONSE TO INTERLEUKIN 12,8.2505e-07,0.42189,0.42007,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,5.4121e-05,0.42162,0.37435,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,7.0571e-06,0.42144,0.40671,1,1
1,GO IMMATURE T CELL PROLIFERATION,2.6307e-05,0.42026,0.49836,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.5813e-07,0.41976,0.37619,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,4.6623e-06,0.41936,0.45435,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0018173,0.41897,0.34452,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00081984,0.41897,0.41049,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,9.3916e-06,0.4188,0.38159,1,1
1,GO DETECTION OF BIOTIC STIMULUS,2.9532e-05,0.41854,0.43909,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00017796,0.41852,0.35019,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,6.0504e-05,0.41844,0.38278,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0006154,0.41814,0.3531,1,1
1,GO ARGININE METABOLIC PROCESS,0.00010462,0.4181,0.41107,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00074557,0.41809,0.42156,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00063551,0.41768,0.5798,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,9.0179e-06,0.41632,0.42222,1,1
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.024288,0.41519,0.26605,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,3.9926e-07,0.41452,0.41836,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,4.8379e-05,0.41433,0.45873,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0011199,0.41409,0.46453,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00081984,0.41356,0.41999,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.02268,0.41255,0.42416,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.5759e-05,0.41234,0.37726,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.0264e-07,0.41168,0.36706,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,9.0221e-07,0.41158,0.35183,1,1
1,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.02166,0.41127,0.47968,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0022992,0.41106,0.33093,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,4.1617e-05,0.41104,0.37512,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.7806e-05,0.41091,0.55035,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,2.8077e-06,0.41089,0.55163,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,7.6603e-06,0.41081,0.45724,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00040247,0.41069,0.35544,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0015653,0.41068,0.31208,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.104e-05,0.41012,0.39364,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.00042998,0.41007,0.58424,1,1
1,GO BONE GROWTH,1.7806e-05,0.40957,0.49196,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,2.9301e-06,0.40911,0.47525,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00081984,0.40881,0.33209,1,1
1,GO PLATELET AGGREGATION,9.7801e-06,0.40867,0.35177,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00022676,0.40834,0.34613,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00016023,0.40829,0.42981,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,4.6623e-06,0.40786,0.36784,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.40756,0.40881,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,3.1888e-05,0.40731,0.41164,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.9904e-06,0.40661,0.45923,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00028792,0.4064,0.45695,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.7801e-06,0.40615,0.40005,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.2837e-06,0.40585,0.37506,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0056288,0.40564,0.29879,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.6455e-05,0.40522,0.47059,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00059588,0.4051,0.34899,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.40466,0.35495,1,1
1,GO I KAPPAB PHOSPHORYLATION,0.00069957,0.40407,0.25504,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,3.7791e-06,0.40407,0.4811,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,4.2876e-06,0.40378,0.46616,1,1
1,GO EMBRYO IMPLANTATION,1.8251e-06,0.40352,0.49936,1,1
1,GO RESPONSE TO SALT STRESS,3.6228e-06,0.40292,0.36979,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,7.2754e-05,0.40291,0.3783,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,6.2985e-07,0.40182,0.39726,1,1
1,GO TRANSLATIONAL INITIATION,0.00012512,0.40113,0.34676,1,1
1,GO COPPER ION HOMEOSTASIS,7.013e-05,0.40065,0.43269,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.0039469,0.40052,0.40235,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.5331e-06,0.40003,0.35478,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,8.4205e-05,0.39932,0.38771,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00353,0.39848,0.28745,1,1
1,GO RECEPTOR CATABOLIC PROCESS,5.0683e-06,0.39806,0.41105,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,2.6307e-05,0.3978,0.43566,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.00054072,0.39738,0.56699,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,5.8301e-05,0.39652,0.36412,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,1.2308e-06,0.39626,0.42411,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.00012512,0.39596,0.32744,1,1
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0050528,0.39577,0.44972,1,1
1,GO ENAMEL MINERALIZATION,0.0060989,0.3951,0.35062,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,1.4609e-05,0.39508,0.47439,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.001662,0.39493,0.31427,1,1
1,GO MATURATION OF SSU RRNA,0.00018427,0.39468,0.35995,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00063551,0.39437,0.35727,1,1
1,GO PHAGOCYTOSIS RECOGNITION,9.0551e-05,0.39416,0.53215,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.001662,0.39414,0.30097,1,1
1,GO MUSCLE CELL FATE COMMITMENT,0.004408,0.39382,0.34936,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7806e-05,0.39375,0.36255,1,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.001872,0.39327,0.39788,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.00025131,0.39326,0.38694,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,1.2862e-06,0.3928,0.36984,1,1
1,GO PLATELET DEGRANULATION,6.2367e-06,0.39201,0.44332,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,1.1493e-05,0.39129,0.34242,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.6015e-06,0.39081,0.39597,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,8.6584e-06,0.38981,0.33762,1,1
1,GO PULMONARY VALVE DEVELOPMENT,0.00092958,0.3896,0.43877,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0016129,0.38956,0.44264,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,3.4772e-07,0.38928,0.36477,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,8.1192e-05,0.38855,0.34552,1,1
1,GO NIK NF KAPPAB SIGNALING,2.8077e-06,0.38828,0.37791,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,7.3528e-06,0.38815,0.34372,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00027832,0.38806,0.33187,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.8521e-05,0.38784,0.37162,1,1
1,GO INTERLEUKIN 1 PRODUCTION,2.6307e-05,0.38763,0.42949,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,2.6307e-05,0.38715,0.40294,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.4609e-05,0.38665,0.37361,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.007729,0.38663,0.26781,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,2.2658e-06,0.38657,0.36238,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0042883,0.38622,0.2631,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,6.5896e-07,0.38616,0.36261,1,1
1,GO RESPONSE TO ESTROGEN,1.8251e-06,0.38605,0.38527,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.7118e-05,0.38565,0.34917,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.001191,0.38558,0.39717,1,1
1,GO INTERACTION WITH SYMBIONT,1.4609e-05,0.38551,0.3132,1,1
1,GO MUSCLE FILAMENT SLIDING,8.3127e-06,0.38506,0.38801,1,1
1,GO REGULATION OF GASTRULATION,3.8131e-07,0.38483,0.3985,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0019282,0.38462,0.3193,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00040247,0.38394,0.35213,1,1
1,GO ERAD PATHWAY,4.3763e-07,0.3822,0.3356,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00050664,0.3818,0.35294,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.01282,0.38142,0.44127,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0016129,0.3813,0.34476,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.3132e-05,0.38085,0.37999,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.38048,0.33666,1,1
1,GO MATURATION OF 5 8S RRNA,0.00054072,0.38036,0.29417,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0022332,0.38035,0.39456,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,5.4121e-05,0.38004,0.3727,1,1
1,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,0.011612,0.37971,0.31224,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.0037331,0.37968,0.29113,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.00032948,0.37959,0.40143,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,3.7145e-05,0.37932,0.35011,1,1
1,GO MRNA TRANSCRIPTION,1.7806e-05,0.37828,0.37027,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,4.8612e-06,0.37824,0.32762,1,1
1,GO TRACHEA MORPHOGENESIS,0.001228,0.37823,0.28537,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,1.2454e-05,0.37795,0.32154,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.2658e-06,0.37791,0.45673,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,9.7801e-06,0.37751,0.41373,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.5308e-05,0.37681,0.39881,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.4334e-07,0.37668,0.41834,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,0.00017186,0.37616,0.39524,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00023468,0.37615,0.3754,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.00098941,0.37609,0.31495,1,1
1,GO VIRAL LIFE CYCLE,4.1112e-06,0.37592,0.37706,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00052342,0.37505,0.28395,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,6.7596e-05,0.37455,0.40034,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,8.6584e-06,0.37454,0.30846,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.1112e-06,0.37434,0.3106,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,2.9532e-05,0.37424,0.32414,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0062634,0.37378,0.29908,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.37329,0.28967,1,1
1,GO B CELL MEDIATED IMMUNITY,3.6228e-06,0.37314,0.34566,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,5.2139e-05,0.37214,0.32511,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0022992,0.3718,0.31992,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.2366e-07,0.37145,0.36907,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.7145e-05,0.37105,0.57021,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.038561,0.37062,0.21752,1,1
1,GO INTERLEUKIN 17 PRODUCTION,5.2837e-06,0.37025,0.45293,1,1
1,GO PROTEIN DEGLYCOSYLATION,6.2786e-05,0.36992,0.36676,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4039e-05,0.36944,0.40058,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,4.3218e-05,0.36943,0.34803,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00037661,0.36934,0.42686,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,3.3287e-06,0.36899,0.44836,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0022332,0.36879,0.2984,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0010859,0.36839,0.3766,1,1
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0031536,0.36793,0.27519,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,3.7145e-05,0.3679,0.31367,1,1
1,GO FOREGUT MORPHOGENESIS,2.1663e-05,0.36774,0.42836,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00026903,0.36747,0.32269,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0013054,0.36729,0.45634,1,1
1,GO MEMBRANE INVAGINATION,2.7578e-07,0.36711,0.3797,1,1
1,GO VIRAL GENE EXPRESSION,5.6174e-05,0.36689,0.35832,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.36683,0.4031,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00031859,0.36675,0.29582,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00012964,0.36654,0.36218,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0012662,0.36646,0.31732,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00049035,0.36612,0.34316,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,9.3916e-06,0.36579,0.41093,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,6.0504e-05,0.36524,0.34463,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00047456,0.36523,0.35379,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,7.547e-05,0.36486,0.36554,1,1
1,GO REGULATION OF COAGULATION,2.2524e-05,0.3648,0.41692,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.014138,0.36446,0.24899,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,0.00011241,0.36424,0.42569,1,1
1,GO INTERFERON BETA PRODUCTION,0.00098941,0.36403,0.25876,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,2.0033e-05,0.36381,0.41762,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,2.4346e-05,0.3636,0.31759,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,7.8282e-05,0.3634,0.46777,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,4.6623e-06,0.36329,0.47993,1,1
1,GO EOSINOPHIL MIGRATION,0.0020453,0.36287,0.39334,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00057693,0.36221,0.29613,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,6.5149e-05,0.36169,0.35785,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,3.4421e-05,0.36163,0.32911,1,1
1,GO IMMUNOGLOBULIN SECRETION,0.00030804,0.36159,0.33424,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00040247,0.36122,0.45759,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00010462,0.36098,0.35786,1,1
1,GO MEMBRANE DISASSEMBLY,0.00081984,0.36097,0.28046,1,1
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.011326,0.36038,0.22668,1,1
1,GO RRNA PSEUDOURIDINE SYNTHESIS,0.0050528,0.36023,0.28442,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013433,0.36021,0.3424,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00098941,0.36016,0.33777,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00045924,0.35941,0.28838,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0012662,0.35931,0.44728,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00035231,0.3591,0.33544,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,6.0504e-05,0.35868,0.31711,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.35858,0.35493,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,0.0028141,0.35804,0.30273,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00038934,0.35803,0.39665,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00024286,0.35799,0.26362,1,1
1,GO COMPLEMENT ACTIVATION,1.9904e-06,0.35716,0.33147,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,4.6597e-05,0.35696,0.29767,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,6.4994e-06,0.35555,0.36526,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0059384,0.35551,0.38726,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,3.7791e-06,0.35539,0.37605,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,0.0001547,0.35531,0.33966,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,8.4205e-05,0.35492,0.38537,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0029794,0.3548,0.43176,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.8418e-05,0.35458,0.29481,1,1
1,GO CELL REDOX HOMEOSTASIS,7.0571e-06,0.35446,0.31273,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.7806e-05,0.35382,0.38829,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,4.4878e-05,0.35382,0.36658,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.5816e-05,0.35343,0.33267,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.0504e-05,0.35295,0.32595,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,5.9841e-06,0.35225,0.31952,1,1
1,GO INTERACTION WITH HOST,3.4728e-06,0.35211,0.38531,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0014299,0.35206,0.3438,1,1
1,GO INTERLEUKIN 2 PRODUCTION,5.2837e-06,0.35194,0.40041,1,1
1,GO PEPTIDE CATABOLIC PROCESS,2.2658e-06,0.3514,0.33042,1,1
1,GO PIGMENT ACCUMULATION,0.00017186,0.35138,0.30007,1,1
1,GO RESPONSE TO MANGANESE ION,5.6174e-05,0.35094,0.31756,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.00040247,0.35092,0.32178,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0013457,0.35078,0.26783,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,8.3127e-06,0.35072,0.35452,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.1964e-05,0.35064,0.3842,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.001662,0.35002,0.3871,1,1
1,GO STEROL IMPORT,0.00014935,0.34946,0.48474,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,0.00040247,0.3493,0.35453,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,5.4121e-05,0.34914,0.42489,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00016023,0.34882,0.31859,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.8521e-05,0.34857,0.45195,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,5.2139e-05,0.34844,0.37431,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,7.8282e-05,0.34756,0.27125,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.033894,0.34753,0.24139,1,1
1,GO DEFENSE RESPONSE TO VIRUS,0.00018427,0.34722,0.3618,1,1
1,GO ERBB2 SIGNALING PATHWAY,0.00049035,0.34701,0.26388,1,1
1,GO LENS FIBER CELL DEVELOPMENT,0.0017641,0.34645,0.37603,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00030804,0.34625,0.32705,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00092958,0.346,0.32294,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.027188,0.34586,0.26881,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00041602,0.34569,0.3965,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0001165,0.34546,0.3106,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.014138,0.34523,0.26141,1,1
1,GO FIBROBLAST PROLIFERATION,7.2754e-05,0.34473,0.31209,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.029719,0.34465,0.38839,1,1
1,GO T CELL APOPTOTIC PROCESS,1.349e-05,0.34464,0.32233,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.104e-05,0.34461,0.36997,1,1
1,GO NCRNA PROCESSING,8.4205e-05,0.34461,0.28622,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0034322,0.34434,0.25027,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00079435,0.34412,0.31669,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,5.6174e-05,0.34369,0.36476,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,6.5149e-05,0.34364,0.31605,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0014299,0.34361,0.32341,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.7118e-05,0.34358,0.3233,1,1
1,GO INTERLEUKIN 8 PRODUCTION,4.8379e-05,0.34287,0.34114,1,1
1,GO L GLUTAMATE IMPORT,0.00069957,0.34248,0.34083,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0015189,0.3422,0.26861,1,1
1,GO NUCLEOSIDE SALVAGE,0.0075304,0.34187,0.39781,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0013872,0.34158,0.35852,1,1
1,GO GASTRULATION,5.753e-07,0.34155,0.35375,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.00069957,0.34141,0.25457,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00047456,0.34091,0.43601,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.001662,0.34048,0.60189,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.2862e-06,0.34036,0.42252,1,1
1,GO TYPE I INTERFERON PRODUCTION,0.00012964,0.34016,0.29242,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00069957,0.33985,0.28992,1,1
1,GO PENTOSE METABOLIC PROCESS,0.0012662,0.33969,0.24122,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0071468,0.33959,0.27577,1,1
1,GO STEROID ESTERIFICATION,0.015574,0.3394,0.26258,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,9.0551e-05,0.33819,0.41442,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0012662,0.33799,0.29857,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,4.6597e-05,0.33793,0.30707,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00079435,0.33769,0.27747,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.001872,0.33762,0.34175,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.8583e-05,0.33751,0.2902,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,1.4609e-05,0.33744,0.28317,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00047456,0.3374,0.29433,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0031536,0.33719,0.29311,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0013054,0.33709,0.29155,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.00042998,0.33702,0.37908,1,1
1,GO REGULATION OF LIPASE ACTIVITY,2.0033e-05,0.33699,0.27071,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,2.6307e-05,0.33693,0.31502,1,1
1,GO FIBROBLAST MIGRATION,6.2786e-05,0.33648,0.36292,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.00026903,0.33586,0.42069,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.8077e-06,0.33562,0.37146,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.00090094,0.33556,0.32385,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.3287e-06,0.33541,0.30406,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,2.1831e-07,0.33511,0.3177,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,7.2754e-05,0.33476,0.28537,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,2.9301e-06,0.33466,0.4082,1,1
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.027803,0.33462,0.21742,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,0.00021167,0.33426,0.38879,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.0576e-06,0.3341,0.41314,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,2.0033e-05,0.33349,0.40429,1,1
1,GO CYCLOOXYGENASE PATHWAY,0.046579,0.33342,0.29811,1,1
1,GO DECIDUALIZATION,0.0042883,0.33303,0.39013,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,0.00019753,0.33299,0.34253,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.02068,0.33282,0.33429,1,1
1,GO CELL SUBSTRATE ADHESION,8.3127e-06,0.33236,0.36747,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,9.7801e-06,0.33194,0.38149,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00065623,0.33181,0.3048,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00052342,0.3317,0.37624,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00029782,0.33169,0.31674,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00057693,0.33142,0.24826,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.6307e-05,0.33137,0.44931,1,1
1,GO CHYLOMICRON ASSEMBLY,0.0085714,0.33093,0.24478,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,3.8583e-05,0.33059,0.28725,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00019753,0.33016,0.31645,1,1
1,GO SPROUTING ANGIOGENESIS,5.6174e-05,0.3294,0.32542,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,3.5759e-05,0.32917,0.29849,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.2658e-06,0.3284,0.3232,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.016339,0.32801,0.42791,1,1
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0031536,0.32797,0.30753,1,1
1,GO MESODERM MORPHOGENESIS,4.4712e-06,0.32796,0.33244,1,1
1,GO PIGMENT METABOLIC PROCESS,5.2837e-06,0.32794,0.31617,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0022992,0.32768,0.27284,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.32752,0.30053,1,1
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.046579,0.3275,0.24827,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,1.7806e-05,0.32725,0.37807,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.0226e-05,0.3271,0.37941,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00012074,0.32695,0.25945,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0021062,0.32691,0.34883,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.349e-05,0.32683,0.35903,1,1
1,GO GLIAL CELL ACTIVATION,8.7323e-05,0.32655,0.33759,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,3.6228e-06,0.32641,0.36147,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00032948,0.32625,0.25598,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00079435,0.32567,0.2931,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00028792,0.32549,0.36101,1,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.035393,0.32506,0.18889,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,0.00038934,0.32476,0.27149,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.036164,0.32433,0.2982,1,1
1,GO PSEUDOURIDINE SYNTHESIS,0.0075304,0.32422,0.24519,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00017186,0.32402,0.28187,1,1
1,GO XENOBIOTIC TRANSPORT,0.00012964,0.32348,0.34371,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00024286,0.32296,0.34319,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,1.1964e-05,0.3221,0.35049,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.025994,0.32175,0.1945,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.001986,0.32125,0.27967,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0001547,0.32093,0.38266,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.2862e-06,0.32031,0.31402,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.104e-05,0.32021,0.3217,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00032948,0.32,0.40818,1,1
1,GO STEROL TRANSPORT,1.5816e-05,0.3199,0.27835,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.1617e-05,0.31989,0.27908,1,1
1,GO REGENERATION,2.4692e-06,0.31985,0.29033,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,9.7801e-06,0.31928,0.25774,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.0040578,0.31924,0.19311,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.7118e-05,0.31917,0.37203,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,5.6174e-05,0.31903,0.35121,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00019753,0.31827,0.28433,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,9.3916e-06,0.31788,0.29115,1,1
1,GO PROTEIN TARGETING TO VACUOLE,1.4609e-05,0.31767,0.28005,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.00022676,0.3167,0.26454,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010859,0.31639,0.2379,1,1
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.011612,0.31575,0.28647,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00038934,0.3152,0.26446,1,1
1,GO LIPOPROTEIN LOCALIZATION,1.5201e-05,0.31491,0.42758,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.5816e-05,0.31482,0.3313,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,1.6455e-05,0.31461,0.34434,1,1
1,GO ASTROCYTE ACTIVATION,0.0040578,0.3141,0.2812,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00069957,0.31353,0.32601,1,1
1,GO FOCAL ADHESION ASSEMBLY,4.3218e-05,0.3134,0.3458,1,1
1,GO REGULATION OF PROTEIN MATURATION,1.9263e-05,0.31318,0.31931,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.8521e-05,0.31282,0.2931,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9532e-05,0.31274,0.31394,1,1
1,GO MULTI ORGANISM LOCALIZATION,9.2696e-08,0.31267,0.39481,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.035393,0.31188,0.22418,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0057817,0.31176,0.24307,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.1493e-05,0.31173,0.29015,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,7.8282e-05,0.31172,0.29648,1,1
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.034637,0.31141,0.24022,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.508e-06,0.31138,0.32949,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,1.5816e-05,0.31079,0.30918,1,1
1,GO VESICLE CARGO LOADING,0.00012074,0.31075,0.28228,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0028957,0.31042,0.28734,1,1
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0038387,0.31041,0.2579,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,7.6603e-06,0.30986,0.38895,1,1
1,GO MUSCLE CELL PROLIFERATION,8.3127e-06,0.30978,0.30248,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,6.2786e-05,0.30967,0.28478,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00026003,0.30939,0.29388,1,1
1,GO RESPONSE TO PROGESTERONE,0.0028957,0.30884,0.28714,1,1
1,GO RRNA METABOLIC PROCESS,0.00059588,0.30865,0.2759,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,4.4878e-05,0.30839,0.32298,1,1
1,GO TRNA 5 LEADER REMOVAL,7.547e-05,0.30833,0.32904,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.020205,0.30809,0.25944,1,1
1,GO VASCULATURE DEVELOPMENT,2.1663e-05,0.30803,0.27843,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0025083,0.30794,0.24473,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,2.6307e-05,0.30763,0.2608,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.5816e-05,0.30761,0.31313,1,1
1,GO SYNCYTIUM FORMATION,0.00014935,0.30751,0.30735,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,3.4421e-05,0.30748,0.24653,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00014935,0.30748,0.25314,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,1.906e-06,0.30743,0.27574,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.7806e-05,0.30724,0.27564,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00029782,0.30683,0.26034,1,1
1,GO RNA 5 END PROCESSING,0.0006154,0.30678,0.27477,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.017137,0.30664,0.45029,1,1
1,GO CHOLESTEROL EFFLUX,2.9301e-06,0.30658,0.32701,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00055855,0.30656,0.36215,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,2.0833e-05,0.30651,0.34083,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,4.8379e-05,0.30647,0.33515,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,3.7791e-06,0.30577,0.46217,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,3.8583e-05,0.30552,0.28185,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0025817,0.30549,0.25958,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,9.7346e-05,0.30525,0.25152,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,1.8521e-05,0.30497,0.34962,1,1
1,GO NCRNA METABOLIC PROCESS,0.00020448,0.30479,0.25039,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.02166,0.30457,0.291,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00047456,0.3043,0.20931,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00017186,0.30383,0.29238,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0006154,0.3038,0.28275,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,0.0007696,0.30362,0.27073,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00040247,0.30354,0.27221,1,1
1,GO REPLICATIVE SENESCENCE,0.0056288,0.3035,0.35725,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0053338,0.30343,0.34291,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.8583e-05,0.30314,0.26005,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,7.6603e-06,0.30281,0.3271,1,1
1,GO POSITIVE REGULATION OF ACTION POTENTIAL,0.0019282,0.3027,0.30538,1,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.013798,0.30232,0.32532,1,1
1,GO TRANSLATIONAL TERMINATION,0.00020448,0.30227,0.26005,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.1267e-06,0.30227,0.39455,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.4692e-06,0.30181,0.34719,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00026003,0.30164,0.27295,1,1
1,GO SELECTIVE AUTOPHAGY,5.753e-07,0.30121,0.31157,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,4.4878e-05,0.30117,0.29564,1,1
1,GO IRON ION HOMEOSTASIS,3.9418e-06,0.30112,0.2716,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,4.8379e-05,0.30087,0.3547,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.4346e-05,0.30077,0.32689,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00023468,0.3006,0.27651,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.5816e-05,0.30054,0.30942,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00065623,0.30023,0.30066,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.00040247,0.30018,0.32099,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0022332,0.30016,0.28472,1,1
1,GO T CELL CYTOKINE PRODUCTION,1.1964e-05,0.29996,0.40171,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.033166,0.29984,0.18303,1,1
1,GO SPERM EGG RECOGNITION,7.0571e-06,0.29954,0.26285,1,1
1,GO ETHANOL OXIDATION,0.025994,0.2994,0.34528,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.024846,0.29933,0.17885,1,1
1,GO COAGULATION,9.3916e-06,0.29928,0.29345,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,7.0571e-06,0.29871,0.33008,1,1
1,GO FOAM CELL DIFFERENTIATION,0.00021909,0.29858,0.32187,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00037661,0.29845,0.3388,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.9801e-06,0.29839,0.31096,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00044439,0.29837,0.24867,1,1
1,GO ENDOTHELIAL CELL MIGRATION,3.8583e-05,0.29833,0.32035,1,1
1,GO HISTONE PHOSPHORYLATION,7.013e-05,0.29794,0.26461,1,1
1,GO GENITALIA MORPHOGENESIS,0.0051916,0.29794,0.26145,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.6902e-06,0.29785,0.37812,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,9.0179e-06,0.29783,0.28229,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0022332,0.29761,0.28685,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,2.5308e-05,0.29729,0.30696,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.014841,0.29695,0.33142,1,1
1,GO RIBOSOME BIOGENESIS,0.00022676,0.29663,0.30191,1,1
1,GO RESPONSE TO INTERLEUKIN 1,6.2367e-06,0.29659,0.32397,1,1
1,GO RRNA MODIFICATION,0.0064317,0.29658,0.20815,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0059384,0.2965,0.28176,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,4.3218e-05,0.29604,0.33321,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0025083,0.29562,0.2379,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.9301e-06,0.2948,0.27844,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,1.349e-05,0.2947,0.2881,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,8.4205e-05,0.29465,0.46101,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,2.7343e-05,0.29455,0.31929,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,0.00044439,0.2945,0.41243,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,2.1702e-06,0.29382,0.32347,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,9.7346e-05,0.29352,0.30949,1,1
1,GO RNA CATABOLIC PROCESS,1.0604e-05,0.29348,0.25048,1,1
1,GO GLAND MORPHOGENESIS,0.00025131,0.29338,0.34541,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,0.001872,0.29263,0.22975,1,1
1,GO NUCLEOTIDE SALVAGE,0.0085714,0.29261,0.35796,1,1
1,GO REGULATION OF PROTEIN IMPORT,1.7806e-05,0.29254,0.33553,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,7.0571e-06,0.29254,0.29431,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,5.2139e-05,0.29231,0.25315,1,1
1,GO CYTOKINETIC PROCESS,0.00059588,0.29205,0.24649,1,1
1,GO ACUTE PHASE RESPONSE,0.0081404,0.29174,0.26684,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,8.4205e-05,0.29144,0.28589,1,1
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0022332,0.29141,0.23291,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.0025083,0.29091,0.26861,1,1
1,GO HYPOTONIC RESPONSE,0.001872,0.29084,0.27435,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00021167,0.29074,0.33648,1,1
1,GO NATURAL KILLER CELL ACTIVATION,3.0689e-05,0.29073,0.29608,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.015203,0.29056,0.27687,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00095906,0.29044,0.34307,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,9.0179e-06,0.2904,0.2884,1,1
1,GO MYOBLAST DIFFERENTIATION,2.8418e-05,0.29037,0.29657,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,6.2786e-05,0.29035,0.25548,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.5201e-05,0.29034,0.28593,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,2.0833e-05,0.29014,0.25417,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001228,0.29011,0.30343,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.2454e-05,0.28985,0.24381,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00014418,0.28974,0.29344,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,6.5149e-05,0.28965,0.42812,1,1
1,GO REGULATION OF CELL AGING,7.9801e-06,0.28901,0.29885,1,1
1,GO TRNA 5 END PROCESSING,0.00019753,0.28894,0.29483,1,1
1,GO FATTY ACID BETA OXIDATION,0.0001547,0.28883,0.26101,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0011199,0.28817,0.28423,1,1
1,GO AMYLOID FIBRIL FORMATION,0.041093,0.28798,0.23184,1,1
1,GO PLASMA MEMBRANE TUBULATION,8.3127e-06,0.28789,0.32541,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00037661,0.28779,0.28148,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9263e-05,0.28753,0.28626,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,5.8301e-05,0.2875,0.30316,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00081984,0.28737,0.29265,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0049174,0.28678,0.1505,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0001165,0.28677,0.2568,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0037331,0.28653,0.26852,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00022676,0.28627,0.27082,1,1
1,GO TISSUE REGENERATION,0.00028792,0.286,0.27952,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0075304,0.28584,0.43039,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0001547,0.28566,0.28832,1,1
1,GO TRNA WOBBLE BASE MODIFICATION,0.001228,0.2856,0.20845,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.28493,0.20442,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00059588,0.28472,0.29144,1,1
1,GO REGULATION OF RNA BINDING,9.7346e-05,0.28465,0.27196,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.0010206,0.28428,0.36524,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,0.00012512,0.2842,0.23611,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,6.2367e-06,0.28364,0.22215,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.0073e-05,0.28352,0.26008,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0024367,0.28352,0.25791,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00010845,0.28284,0.27477,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,4.6623e-06,0.28283,0.30362,1,1
1,GO MACROPHAGE MIGRATION,7.2754e-05,0.2827,0.31274,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,3.7791e-06,0.28258,0.23106,1,1
1,GO RESPONSE TO REDOX STATE,0.014138,0.28225,0.22447,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,3.7145e-05,0.28186,0.2801,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.0053338,0.28167,0.30166,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00042998,0.28105,0.26236,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00038934,0.2808,0.21745,1,1
1,GO RESPONSE TO VIRUS,0.00011241,0.28059,0.31142,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.035393,0.28043,0.22074,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.0037331,0.28031,0.32364,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00014418,0.2802,0.30751,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00079435,0.28011,0.28781,1,1
1,GO CELL CELL RECOGNITION,2.3654e-06,0.27998,0.27849,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00074557,0.27998,0.2521,1,1
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0039469,0.27995,0.27049,1,1
1,GO CARTILAGE DEVELOPMENT,0.00010462,0.27982,0.26426,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00074557,0.27969,0.24075,1,1
1,GO CERAMIDE TRANSPORT,0.00072223,0.27968,0.28907,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0022332,0.27913,0.22429,1,1
1,GO TISSUE REMODELING,0.00027832,0.27882,0.26003,1,1
1,GO RIG I SIGNALING PATHWAY,0.00022676,0.2788,0.32239,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.8251e-06,0.27864,0.27152,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0019282,0.27833,0.23393,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,7.6603e-06,0.27832,0.25706,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.015203,0.27828,0.25675,1,1
1,GO NECROTIC CELL DEATH,0.00032948,0.27799,0.36252,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0040578,0.27774,0.23828,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,8.4205e-05,0.27769,0.2571,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,0.0017123,0.27753,0.27471,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00027832,0.27752,0.33925,1,1
1,GO RESPONSE TO THYROID HORMONE,0.00010092,0.27749,0.33802,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.00016595,0.27727,0.27958,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0013872,0.2772,0.282,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,7.3528e-06,0.27713,0.27992,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,0.00035231,0.27707,0.31298,1,1
1,GO FATTY ACID HOMEOSTASIS,0.02068,0.27702,0.19798,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0010528,0.2769,0.22858,1,1
1,GO PROTEIN FOLDING,4.6623e-06,0.27687,0.25493,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,6.7596e-05,0.27685,0.27706,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0029794,0.27677,0.23845,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.1904e-06,0.27661,0.43311,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,2.2524e-05,0.27631,0.25036,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,8.1192e-05,0.27628,0.25984,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,7.013e-05,0.27611,0.31835,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0011549,0.27596,0.26297,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00072223,0.27573,0.2931,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0017641,0.27462,0.24484,1,1
1,GO T CELL MIGRATION,0.00013433,0.27459,0.28752,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00040247,0.27412,0.28372,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.0179e-06,0.27378,0.23665,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00024286,0.27365,0.25213,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00353,0.27355,0.26567,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.00057693,0.27264,0.29138,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.1964e-05,0.27254,0.24116,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0022332,0.27247,0.30455,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.27242,0.24876,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00090094,0.27235,0.33254,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00065623,0.27225,0.27178,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0031536,0.27215,0.24825,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00023468,0.27167,0.29317,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,4.4878e-05,0.27138,0.24915,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0025083,0.27045,0.20339,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,1.1493e-05,0.27039,0.24042,1,1
1,GO AUTOPHAGOSOME MATURATION,2.0033e-05,0.27008,0.27774,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,3.1888e-05,0.26991,0.24044,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,3.3287e-06,0.26972,0.35679,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0017123,0.26948,0.22757,1,1
1,GO WOUND HEALING,1.7118e-05,0.26848,0.31277,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5201e-05,0.26843,0.30732,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0097392,0.26835,0.25864,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00041602,0.26831,0.24864,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00040247,0.26828,0.25305,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0028141,0.26827,0.39803,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00040247,0.26823,0.22811,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0046564,0.26799,0.21459,1,1
1,GO RESPONSE TO IONIZING RADIATION,3.0689e-05,0.26769,0.21093,1,1
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.00059588,0.26756,0.22398,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.007729,0.26744,0.20208,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,9.0551e-05,0.26705,0.2558,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.6623e-06,0.26683,0.33035,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.001191,0.26681,0.22061,1,1
1,GO RESPONSE TO WOUNDING,2.5308e-05,0.26666,0.26625,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0012662,0.26639,0.25762,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0042883,0.26596,0.26721,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.033894,0.26595,0.17465,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00059588,0.2659,0.32457,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00010092,0.2657,0.36794,1,1
1,GO EOSINOPHIL CHEMOTAXIS,0.020205,0.26561,0.36374,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0012662,0.26553,0.2286,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0011199,0.26549,0.24274,1,1
1,GO KERATINOCYTE MIGRATION,0.0010859,0.26548,0.30483,1,1
1,GO ERK1 AND ERK2 CASCADE,1.6455e-05,0.26541,0.24267,1,1
1,GO CHONDROCYTE DEVELOPMENT,0.0017123,0.26522,0.34044,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00047456,0.26516,0.23725,1,1
1,GO SEQUESTERING OF METAL ION,0.0022992,0.265,0.26248,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0028957,0.26489,0.26142,1,1
1,GO ASTROCYTE DEVELOPMENT,0.00092958,0.26471,0.27358,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.104e-05,0.26463,0.27783,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.00035231,0.26455,0.21453,1,1
1,GO TRANSPOSITION,0.033166,0.26424,0.2001,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0013872,0.26397,0.22525,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.001986,0.26389,0.22297,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00087311,0.26365,0.25668,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00047456,0.2636,0.23742,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00047456,0.26352,0.4075,1,1
1,GO OSTEOBLAST DIFFERENTIATION,4.3218e-05,0.26351,0.27413,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.050569,0.26345,0.26964,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.00019753,0.2633,0.29087,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.01282,0.26327,0.24,1,1
1,GO RESPONSE TO DSRNA,4.4712e-06,0.26311,0.35276,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00038934,0.26306,0.35165,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00018427,0.26292,0.20817,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00040247,0.2628,0.23588,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00030804,0.26219,0.24028,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.2139e-05,0.2621,0.3582,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.1702e-06,0.26207,0.26085,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0081404,0.26201,0.33709,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.00084609,0.26192,0.27023,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0010859,0.26192,0.20667,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.021165,0.26173,0.2186,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.00059588,0.26168,0.25116,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00098941,0.2616,0.2968,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.4044e-06,0.26143,0.32046,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.3418e-05,0.26141,0.30087,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,5.4121e-05,0.261,0.21045,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.0033e-05,0.26079,0.25306,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.042857,0.26057,0.16455,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.9418e-06,0.26056,0.30914,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,3.3287e-06,0.26052,0.21318,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00026903,0.26035,0.29849,1,1
1,GO REGULATION OF GENE SILENCING,4.8612e-06,0.25966,0.23508,1,1
1,GO RNA DESTABILIZATION,2.9532e-05,0.25959,0.2442,1,1
1,GO TRANSLATIONAL ELONGATION,0.00023468,0.25944,0.22865,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00026903,0.2593,0.27559,1,1
1,GO GTP METABOLIC PROCESS,0.0011199,0.25925,0.28396,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.0013457,0.25898,0.21123,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,7.8282e-05,0.25867,0.27227,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,1.0604e-05,0.25854,0.26951,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.3218e-05,0.25835,0.24482,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00049035,0.25819,0.23027,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00059588,0.25753,0.28494,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00069957,0.25728,0.24972,1,1
1,GO CELL MATRIX ADHESION,6.2786e-05,0.25728,0.30955,1,1
1,GO COPPER ION TRANSPORT,0.00012964,0.25727,0.26811,1,1
1,GO HYPEROSMOTIC RESPONSE,0.00063551,0.25712,0.24306,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00012964,0.25682,0.28251,1,1
1,GO VIRAL RELEASE FROM HOST CELL,0.0011199,0.25661,0.23054,1,1
1,GO PEROXISOMAL TRANSPORT,0.0010859,0.25657,0.20495,1,1
1,GO DE NOVO PROTEIN FOLDING,0.00040247,0.25653,0.20866,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00020448,0.25642,0.25059,1,1
1,GO PROTEIN DENEDDYLATION,0.00037661,0.25587,0.21676,1,1
1,GO PEPTIDE METABOLIC PROCESS,3.7791e-06,0.25568,0.22655,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0006154,0.25555,0.22148,1,1
1,GO REGULATION OF VASOCONSTRICTION,8.1192e-05,0.25539,0.26592,1,1
1,GO P38MAPK CASCADE,5.0226e-05,0.25495,0.32666,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.014841,0.25492,0.22429,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.001986,0.25489,0.23494,1,1
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.024846,0.25432,0.2084,1,1
1,GO PROTEIN KINASE B SIGNALING,2.7343e-05,0.25431,0.21321,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.8583e-05,0.25405,0.24707,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0006154,0.25399,0.29968,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,0.0022332,0.25386,0.21283,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.001662,0.25378,0.30928,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,5.508e-06,0.25366,0.23089,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,7.547e-05,0.25329,0.23484,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.0051916,0.25309,0.15727,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,9.7346e-05,0.25285,0.24654,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013872,0.25269,0.28184,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0012662,0.25267,0.2615,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,4.3218e-05,0.25241,0.29873,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.4346e-05,0.25239,0.36995,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.001228,0.2522,0.21407,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0017123,0.25203,0.25859,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,3.7145e-05,0.25203,0.28064,1,1
1,GO REGULATION OF HEART GROWTH,0.00012512,0.25195,0.253,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,5.4121e-05,0.25174,0.27464,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0062634,0.25169,0.30384,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,7.547e-05,0.25155,0.27506,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,2.9532e-05,0.25146,0.20936,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,7.547e-05,0.25138,0.31439,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0015653,0.25053,0.22678,1,1
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00047456,0.25046,0.2385,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00031859,0.25006,0.26585,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0069616,0.24987,0.1668,1,1
1,GO FIBROBLAST ACTIVATION,0.0017123,0.24974,0.31119,1,1
1,GO INNATE IMMUNE RESPONSE,7.8282e-05,0.24955,0.24117,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.0024367,0.24951,0.25624,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,9.0179e-06,0.24942,0.20866,1,1
1,GO LYMPHOCYTE MIGRATION,0.00044439,0.24937,0.20977,1,1
1,GO CARDIOLIPIN METABOLIC PROCESS,0.0066042,0.24934,0.18346,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,2.7343e-05,0.24926,0.27419,1,1
1,GO SYMBIOTIC PROCESS,2.1702e-06,0.24921,0.25465,1,1
1,GO REGULATION OF ORGAN GROWTH,1.7474e-06,0.24884,0.2961,1,1
1,GO DETECTION OF OTHER ORGANISM,0.014138,0.24871,0.25884,1,1
1,GO LIPID IMPORT INTO CELL,0.010506,0.24871,0.21907,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,8.1192e-05,0.24866,0.18607,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.1112e-06,0.24865,0.27965,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0001165,0.24857,0.22413,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.9904e-06,0.2484,0.24239,1,1
1,GO AMINO SUGAR CATABOLIC PROCESS,0.00013917,0.24825,0.29861,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.6584e-06,0.24795,0.24763,1,1
1,GO TOXIN TRANSPORT,0.00353,0.24783,0.16488,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,1.2454e-05,0.24769,0.22989,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,7.6603e-06,0.2467,0.33632,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0075304,0.24667,0.24946,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.033166,0.24652,0.307,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00029782,0.24651,0.29361,1,1
1,GO UV PROTECTION,0.035393,0.24647,0.21394,1,1
1,GO RESPONSE TO CYTOKINE,3.4421e-05,0.24614,0.27416,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,3.7145e-05,0.24599,0.25647,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.00095906,0.24564,0.18294,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.0022332,0.24528,0.22393,1,1
1,GO PHAGOCYTOSIS,3.7791e-06,0.2452,0.30331,1,1
1,GO LUNG MORPHOGENESIS,0.0087944,0.24487,0.18886,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,7.0571e-06,0.24477,0.2447,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,4.3218e-05,0.24469,0.25139,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.029068,0.24469,0.12373,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00059588,0.2446,0.18566,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037747,0.24452,0.15409,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.0033e-05,0.24432,0.23734,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00074557,0.244,0.22176,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,0.00063551,0.24394,0.21521,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0010859,0.24364,0.25578,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,7.013e-05,0.24311,0.20688,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0025083,0.24281,0.36934,1,1
1,GO REGULATION OF MITOPHAGY,0.015203,0.24256,0.19602,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0060989,0.24249,0.24991,1,1
1,GO LIPID STORAGE,0.00032948,0.24203,0.24591,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0016129,0.242,0.18816,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.0038387,0.24167,0.18055,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.9532e-05,0.24101,0.27936,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026903,0.2409,0.20714,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0050528,0.24076,0.20615,1,1
1,GO RESPONSE TO TESTOSTERONE,0.00038934,0.24076,0.23237,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00042998,0.2407,0.2695,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,4.6597e-05,0.24051,0.19471,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00021167,0.24023,0.22143,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00031859,0.24011,0.32537,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,3.8583e-05,0.24009,0.25335,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0006154,0.24005,0.20228,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.7801e-06,0.24005,0.2344,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,1.0311e-06,0.23991,0.25795,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.0049174,0.23945,0.20956,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,9.0551e-05,0.23943,0.21103,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.0015189,0.23939,0.17646,1,1
1,GO RESPONSE TO OSMOTIC STRESS,0.00019079,0.23932,0.20562,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0087944,0.23915,0.28976,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0010528,0.23891,0.24992,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.9532e-05,0.23874,0.36917,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0097392,0.23864,0.20217,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,3.1888e-05,0.23845,0.29123,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.02068,0.23809,0.23026,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0010528,0.23799,0.25792,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0087944,0.23785,0.27543,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,0.00010092,0.23777,0.27645,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.2376,0.22836,1,1
1,GO PLATELET ACTIVATION,0.00084609,0.23675,0.21716,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.00052342,0.23659,0.30264,1,1
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.001872,0.23651,0.26648,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00021167,0.23563,0.22252,1,1
1,GO MACROPHAGE CHEMOTAXIS,0.00010462,0.2356,0.31174,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.0033e-05,0.23525,0.28973,1,1
1,GO DNA LIGATION,0.0011199,0.23519,0.24137,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.4346e-05,0.23499,0.27588,1,1
1,GO AMINE CATABOLIC PROCESS,0.00063551,0.23447,0.26221,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.001662,0.23439,0.1937,1,1
1,GO PROTEIN TARGETING,2.8418e-05,0.2342,0.20124,1,1
1,GO TRNA PROCESSING,0.00098941,0.23411,0.1781,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.0032441,0.23404,0.28693,1,1
1,GO PEPTIDYL ARGININE N METHYLATION,0.033166,0.23352,0.15885,1,1
1,GO MITOCHONDRIAL TRANSLATION,0.00065623,0.23347,0.21636,1,1
1,GO MESODERM DEVELOPMENT,0.00037661,0.23329,0.17728,1,1
1,GO SULFUR COMPOUND TRANSPORT,4.4712e-06,0.23329,0.26602,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.00028792,0.23319,0.28166,1,1
1,GO RESPONSE TO PH,0.00041602,0.23317,0.26305,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,1.7474e-06,0.23313,0.26392,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0036303,0.23311,0.17998,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,4.1112e-06,0.2331,0.26075,1,1
1,GO MEMBRANE BIOGENESIS,0.035393,0.23287,0.1775,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,7.2754e-05,0.23272,0.23448,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.031748,0.23255,0.18525,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.00030804,0.23253,0.30301,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.0034322,0.23194,0.18264,1,1
1,GO CRISTAE FORMATION,0.012203,0.23155,0.20042,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0019282,0.23144,0.21763,1,1
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.017969,0.23124,0.16584,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.0025083,0.2312,0.18091,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.026586,0.23105,0.16121,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.4878e-05,0.23071,0.28204,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00084609,0.2307,0.33682,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,1.5816e-05,0.23069,0.22498,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.023205,0.23068,0.1924,1,1
1,GO TRNA METHYLATION,0.0010206,0.23037,0.19904,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.012203,0.23012,0.34967,1,1
1,GO MITOPHAGY,5.8301e-05,0.2301,0.25019,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.029719,0.22985,0.3475,1,1
1,GO HISTONE H4 DEACETYLATION,0.0090226,0.22953,0.20996,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0019282,0.22952,0.2642,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.027803,0.2295,0.17556,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,8.1192e-05,0.22948,0.22999,1,1
1,GO RRNA METHYLATION,0.014486,0.22941,0.17624,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,3.3287e-06,0.22929,0.23198,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00079435,0.22915,0.17578,1,1
1,GO PODOSOME ASSEMBLY,0.0011199,0.22897,0.30391,1,1
1,GO PEROXISOME ORGANIZATION,0.00065623,0.22882,0.19624,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.017137,0.22833,0.34774,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.5759e-05,0.22807,0.23393,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.0097392,0.22804,0.36295,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00020448,0.22771,0.19873,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00074557,0.2277,0.24524,1,1
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0029794,0.22763,0.23455,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0085714,0.22756,0.2165,1,1
1,GO MYOBLAST FUSION,0.00092958,0.22732,0.29882,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.0001547,0.22729,0.32015,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0066042,0.22693,0.17165,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00072223,0.22633,0.20584,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.023741,0.22623,0.1912,1,1
1,GO SUPEROXIDE ANION GENERATION,0.0028957,0.22601,0.25458,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,8.4205e-05,0.22582,0.21601,1,1
1,GO RNA 3 END PROCESSING,0.0029794,0.22577,0.17401,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.00353,0.22558,0.17691,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,4.3218e-05,0.22528,0.21702,1,1
1,GO CELL PROLIFERATION IN HINDBRAIN,0.023741,0.22489,0.18009,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.00012512,0.22483,0.22143,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0007696,0.22451,0.29784,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.00021167,0.2244,0.21491,1,1
1,GO VIRION ASSEMBLY,0.0031536,0.22433,0.15878,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.8521e-05,0.22396,0.33896,1,1
1,GO RESPONSE TO RETINOIC ACID,0.00026003,0.22393,0.2271,1,1
1,GO T CELL CHEMOTAXIS,0.00010092,0.22383,0.24521,1,1
1,GO RESPONSE TO BACTERIUM,3.5759e-05,0.22374,0.25043,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00014418,0.22367,0.24554,1,1
1,GO MITOCHONDRIAL GENE EXPRESSION,0.0011549,0.22232,0.2016,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.001228,0.22224,0.23928,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,0.0014299,0.22224,0.23157,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.010506,0.22222,0.17829,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,5.6174e-05,0.22182,0.20397,1,1
1,GO OSTEOCLAST DIFFERENTIATION,0.00050664,0.22122,0.18974,1,1
1,GO TISSUE MIGRATION,0.00012964,0.22101,0.27629,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.00074557,0.22086,0.2022,1,1
1,GO INTEGRIN ACTIVATION,0.0087944,0.22079,0.19335,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,1.8521e-05,0.22065,0.27193,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0007696,0.22058,0.18725,1,1
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0054795,0.22049,0.15573,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0011549,0.22031,0.37458,1,1
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.0060989,0.22025,0.18127,1,1
1,GO IMMUNE EFFECTOR PROCESS,2.7343e-05,0.21949,0.25781,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00034072,0.21924,0.21958,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.349e-05,0.21904,0.23556,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0071468,0.21884,0.15974,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.00042998,0.21848,0.19938,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.001228,0.21844,0.18741,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.014841,0.21837,0.26201,1,1
1,GO REGULATION OF VASCULOGENESIS,0.025994,0.2178,0.27389,1,1
1,GO DNA DEALKYLATION,0.010506,0.21762,0.18777,1,1
1,GO RESPONSE TO INTERLEUKIN 15,0.00079435,0.21761,0.32068,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,9.0551e-05,0.2176,0.18842,1,1
1,GO TRNA METABOLIC PROCESS,0.0022332,0.21758,0.16383,1,1
1,GO URETER DEVELOPMENT,0.019283,0.21691,0.2134,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.0689e-05,0.2169,0.24889,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0056288,0.21662,0.26556,1,1
1,GO RNA MODIFICATION,0.00019753,0.21654,0.1872,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0056288,0.21653,0.1954,1,1
1,GO REGULATION OF URINE VOLUME,0.00026003,0.21647,0.24333,1,1
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.0051916,0.2164,0.37149,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,7.547e-05,0.21637,0.2547,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.00067758,0.21617,0.17887,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.0016129,0.21614,0.24424,1,1
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.030383,0.21604,0.17602,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.216,0.18635,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0097392,0.21594,0.14677,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.009256,0.21593,0.21181,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6597e-05,0.21583,0.21554,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.010773,0.2155,0.18745,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0025817,0.21477,0.20658,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.001191,0.21465,0.2486,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,4.6597e-05,0.21463,0.18851,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00052342,0.21436,0.21518,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0026572,0.21412,0.21996,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0017641,0.21411,0.26717,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00038934,0.21398,0.1916,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00044439,0.21394,0.24524,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.011612,0.21359,0.19559,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00057693,0.21325,0.23537,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,7.5427e-07,0.21325,0.2127,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0021062,0.21323,0.18102,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0017123,0.21315,0.22164,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,3.7145e-05,0.21259,0.26038,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.7323e-05,0.21252,0.23964,1,1
1,GO TRNA MODIFICATION,0.0013872,0.21222,0.18275,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.00041602,0.21162,0.27415,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.00057693,0.21094,0.21144,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0006154,0.2109,0.21137,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,4.3218e-05,0.21076,0.19207,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0042883,0.21057,0.20764,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.001872,0.21035,0.23326,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.0025083,0.21008,0.2039,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,2.1663e-05,0.21005,0.23867,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00025131,0.21005,0.20279,1,1
1,GO HEAD MORPHOGENESIS,0.0016129,0.21003,0.23744,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0066042,0.20969,0.15718,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,7.013e-05,0.20964,0.22466,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00024286,0.20959,0.19367,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00063551,0.20948,0.19846,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,6.7596e-05,0.20944,0.19811,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.015203,0.20934,0.20268,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.026586,0.20931,0.15378,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0030654,0.20929,0.17862,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.029068,0.20847,0.22748,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.027803,0.20823,0.23139,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,0.014841,0.20819,0.15681,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0099891,0.20806,0.1628,1,1
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0081404,0.20762,0.22912,1,1
1,GO REGULATION OF CELLULAR RESPIRATION,0.04854,0.20735,0.13198,1,1
1,GO RESPONSE TO KETONE,0.0037331,0.2073,0.15105,1,1
1,GO REGULATION OF LIPID STORAGE,0.00090094,0.20727,0.23765,1,1
1,GO BLASTOCYST GROWTH,0.001662,0.20725,0.23881,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.00034072,0.20696,0.18331,1,1
1,GO CYTOKINE PRODUCTION,6.7596e-05,0.20687,0.24059,1,1
1,GO PLATELET MORPHOGENESIS,0.0027346,0.2068,0.18649,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.050569,0.20646,0.13341,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,7.547e-05,0.20632,0.19292,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00063551,0.20625,0.22606,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0015653,0.2057,0.19745,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,4.8379e-05,0.20569,0.22161,1,1
1,GO COENZYME A METABOLIC PROCESS,0.0056288,0.20558,0.18203,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00072223,0.20538,0.18739,1,1
1,GO CELLULAR RESPONSE TO ATP,6.2786e-05,0.2048,0.22956,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.1904e-06,0.20451,0.19158,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00045924,0.20436,0.16143,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,5.4121e-05,0.20401,0.26813,1,1
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.015203,0.20391,0.14333,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0053338,0.20333,0.21691,1,1
1,GO REGULATION OF BODY FLUID LEVELS,0.00027832,0.20285,0.19223,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.0039469,0.20285,0.23706,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,1.0184e-05,0.2026,0.18584,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00016595,0.20259,0.22825,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0050528,0.20253,0.1806,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0046564,0.2023,0.21458,1,1
1,GO REGULATION OF PROTEOLYSIS,4.4878e-05,0.20227,0.18819,1,1
1,GO RESPONSE TO VITAMIN A,0.029068,0.2018,0.20832,1,1
1,GO MYELOID CELL HOMEOSTASIS,5.8301e-05,0.2016,0.19613,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.043763,0.20151,0.17615,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00041602,0.20144,0.23486,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,1.7118e-05,0.20137,0.20491,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00353,0.20123,0.22492,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,7.5427e-07,0.20121,0.16593,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.0015189,0.20117,0.18085,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0029794,0.20055,0.15339,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00038934,0.20037,0.21244,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00054072,0.20027,0.21725,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.9904e-06,0.20027,0.18311,1,1
1,GO ETHANOL METABOLIC PROCESS,0.010773,0.19997,0.21652,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00044439,0.19975,0.21679,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00072223,0.19966,0.19195,1,1
1,GO PROTEIN REFOLDING,0.033166,0.19938,0.16315,1,1
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.029719,0.19893,0.14399,1,1
1,GO NUCLEAR EXPORT,2.5308e-05,0.19868,0.17592,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.049546,0.19839,0.1668,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.011326,0.19838,0.18058,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,4.4878e-05,0.19829,0.22937,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00084609,0.19824,0.25885,1,1
1,GO PROTEIN N LINKED GLYCOSYLATION,0.00050664,0.19783,0.17903,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.011904,0.19754,0.14355,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.013465,0.19748,0.18192,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0027346,0.19748,0.20325,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.001191,0.19739,0.17131,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0060989,0.19738,0.22686,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00026903,0.19711,0.22214,1,1
1,GO CELL AGING,6.5149e-05,0.19708,0.19676,1,1
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.031059,0.19694,0.099016,1,1
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.043763,0.1968,0.22342,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00017186,0.19663,0.24126,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,2.9532e-05,0.19651,0.20253,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.041093,0.19618,0.19627,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001191,0.19604,0.21682,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.011612,0.19602,0.27393,1,1
1,GO INTERFERON GAMMA PRODUCTION,0.00029782,0.196,0.24369,1,1
1,GO VESICLE TARGETING,0.00019753,0.19585,0.21512,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.050569,0.19568,0.13477,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0015189,0.19561,0.17211,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.00040247,0.1955,0.18762,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0013054,0.1954,0.20548,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.024288,0.19506,0.16905,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00036427,0.19487,0.2301,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.02166,0.19479,0.26578,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.050569,0.19444,0.17051,1,1
1,GO OXALATE TRANSPORT,0.0024367,0.19428,0.17281,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0015653,0.19376,0.20578,1,1
1,GO REGULATION OF HEMOPOIESIS,0.00017796,0.19367,0.17188,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.0029794,0.19352,0.17088,1,1
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00054072,0.19346,0.1934,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.033166,0.19313,0.13798,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.0037331,0.19292,0.17585,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.015203,0.19275,0.1257,1,1
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00095906,0.19266,0.17756,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.0784e-06,0.19244,0.18052,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.025414,0.19226,0.12251,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0028957,0.19214,0.20358,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0046564,0.19172,0.2187,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0083534,0.19166,0.32409,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,0.00012074,0.19156,0.19386,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.017969,0.19106,0.13369,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.0015653,0.19097,0.15238,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00021167,0.19085,0.18422,1,1
1,GO BODY FLUID SECRETION,0.00030804,0.1905,0.20494,1,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.02068,0.1905,0.14566,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,0.0013872,0.19043,0.20103,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.2524e-05,0.19027,0.19624,1,1
1,GO SECRETION BY TISSUE,0.025994,0.18996,0.16438,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.9904e-06,0.18985,0.1755,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0017641,0.18973,0.19389,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00011241,0.18966,0.19656,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00036427,0.18966,0.14411,1,1
1,GO INFLAMMATORY RESPONSE,0.00013433,0.18964,0.23165,1,1
1,GO BONE REMODELING,0.001228,0.18964,0.1998,1,1
1,GO MITOTIC CYTOKINESIS,0.015203,0.18938,0.14429,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.0022992,0.18912,0.2938,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.00041602,0.1887,0.23182,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00042998,0.18864,0.15948,1,1
1,GO BODY MORPHOGENESIS,0.0069616,0.18856,0.16146,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.011612,0.18844,0.17893,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.18839,0.14197,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00020448,0.1883,0.19676,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,5.2139e-05,0.1879,0.1827,1,1
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.015574,0.18789,0.20187,1,1
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.0049174,0.18748,0.18559,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,4.5813e-07,0.18718,0.1775,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.017969,0.18713,0.16553,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.3132e-05,0.18678,0.21959,1,1
1,GO RESPONSE TO TUMOR CELL,0.034637,0.18641,0.15849,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,6.4994e-06,0.18634,0.22356,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,0.0013872,0.18605,0.14893,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,0.0010859,0.18591,0.18684,1,1
1,GO DEFENSE RESPONSE,0.0001547,0.1859,0.20176,1,1
1,GO DRUG METABOLIC PROCESS,0.0032441,0.18571,0.15716,1,1
1,GO CELLULAR RESPONSE TO LIPID,0.00020448,0.18567,0.18437,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,5.0226e-05,0.18534,0.19726,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.018398,0.1848,0.14923,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.0071468,0.18468,0.27192,1,1
1,GO CELLULAR RESPONSE TO PH,0.02268,0.18423,0.13389,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00016595,0.18421,0.17208,1,1
1,GO FACE DEVELOPMENT,0.00054072,0.18399,0.22677,1,1
1,GO TUBE MORPHOGENESIS,0.00042998,0.18388,0.18362,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.009256,0.18374,0.13591,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.00013433,0.18355,0.19307,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5813e-07,0.18352,0.17865,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0090226,0.18339,0.21099,1,1
1,GO RNA METHYLATION,0.00092958,0.18327,0.17456,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00032948,0.18319,0.15661,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00010845,0.18318,0.15641,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.027188,0.18316,0.14589,1,1
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.034637,0.18268,0.12608,1,1
1,GO PEPTIDYL ARGININE METHYLATION,0.010773,0.18262,0.14353,1,1
1,GO MESENCHYME DEVELOPMENT,0.0022992,0.18252,0.18625,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00092958,0.18244,0.27006,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.9841e-06,0.18241,0.20403,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.0013872,0.18194,0.16516,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00012964,0.18187,0.17916,1,1
1,GO OVULATION,0.033894,0.18151,0.2627,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0018173,0.18071,0.14682,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,0.00069957,0.18018,0.23089,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,2.6902e-06,0.18013,0.18546,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0041716,0.18,0.1462,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0022332,0.17979,0.15832,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0029794,0.17969,0.14267,1,1
1,GO T CELL PROLIFERATION,0.0018173,0.17934,0.17807,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00011241,0.1793,0.19226,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.033166,0.17914,0.19029,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00084609,0.17888,0.16935,1,1
1,GO PROTEIN KINASE A SIGNALING,0.0001547,0.17858,0.21538,1,1
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.03939,0.17852,0.10462,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.0018173,0.17844,0.35723,1,1
1,GO ANION HOMEOSTASIS,0.0067808,0.17785,0.17167,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.011612,0.1778,0.13423,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024286,0.17718,0.23667,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.8521e-05,0.17676,0.19562,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00014935,0.17673,0.20373,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00092958,0.17672,0.16669,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.0059384,0.17666,0.17945,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.0029794,0.17648,0.18655,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00054072,0.1761,0.23454,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.004408,0.17602,0.13656,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.041967,0.17592,0.20342,1,1
1,GO CELL ACTIVATION,5.8301e-05,0.17569,0.21438,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00026003,0.17564,0.14802,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00014935,0.17562,0.18547,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0028957,0.1756,0.13733,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00040247,0.17514,0.18312,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.027803,0.17493,0.20602,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.17487,0.16646,1,1
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.015953,0.17475,0.14728,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.036948,0.17454,0.14395,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0029794,0.17445,0.16573,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0047853,0.17402,0.14301,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.052669,0.17397,0.15423,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.0079323,0.17384,0.14892,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.02268,0.17357,0.12989,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.00063551,0.17353,0.15789,1,1
1,GO HISTONE H2B UBIQUITINATION,0.047551,0.17351,0.11235,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,4.3218e-05,0.17328,0.16006,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0045306,0.17324,0.14326,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00019753,0.17295,0.19293,1,1
1,GO AGING,0.0001165,0.17285,0.17198,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.0027346,0.17279,0.13282,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.17276,0.21929,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0311e-06,0.17273,0.16812,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00031859,0.17247,0.17471,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00063551,0.17242,0.16713,1,1
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0015653,0.17233,0.17409,1,1
1,GO RESPONSE TO CHEMOKINE,0.010506,0.17226,0.1937,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.004408,0.17219,0.15038,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0053338,0.17213,0.14796,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.012203,0.17202,0.12345,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,6.0504e-05,0.17194,0.18266,1,1
1,GO LYSOSOMAL TRANSPORT,0.00016023,0.17172,0.17593,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.00041602,0.1715,0.23614,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.035393,0.17149,0.17172,1,1
1,GO GOLGI VESICLE TRANSPORT,1.7118e-05,0.17119,0.16327,1,1
1,GO REGULATION OF CELL ACTIVATION,0.00049035,0.17119,0.16844,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00090094,0.17104,0.14414,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,0.00026903,0.17057,0.18771,1,1
1,GO VACUOLAR TRANSPORT,0.00050664,0.17011,0.14489,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,0.00025131,0.16984,0.15981,1,1
1,GO REGULATION OF IMMUNE RESPONSE,9.389e-05,0.16961,0.19226,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.9263e-05,0.16941,0.17695,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0031536,0.16934,0.16578,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,0.00041602,0.16914,0.18842,1,1
1,GO NEURAL TUBE PATTERNING,0.029068,0.16812,0.14849,1,1
1,GO AEROBIC RESPIRATION,0.025994,0.1676,0.10393,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,5.0683e-06,0.16748,0.15451,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.011612,0.16736,0.25925,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.014841,0.16732,0.17006,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00059588,0.16683,0.16525,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0069616,0.16679,0.13913,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.026586,0.16599,0.18423,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0047853,0.16556,0.12184,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,7.889e-07,0.16539,0.18005,1,1
1,GO SPINDLE LOCALIZATION,0.00034072,0.16534,0.16821,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.0040578,0.16529,0.13787,1,1
1,GO RNA CAPPING,0.00028792,0.16511,0.16155,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0053338,0.16487,0.17361,1,1
1,GO FATTY ACID METABOLIC PROCESS,0.0013457,0.16474,0.13468,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0017641,0.16429,0.12938,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,0.0019282,0.16417,0.1501,1,1
1,GO REGULATION OF RESPONSE TO STRESS,8.4205e-05,0.16413,0.14832,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.014138,0.16405,0.13503,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0015653,0.1638,0.14961,1,1
1,GO VACUOLE ORGANIZATION,8.1192e-05,0.16375,0.15449,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,7.547e-05,0.16367,0.15474,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0014299,0.16351,0.14179,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,5.7413e-06,0.16349,0.24456,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00067758,0.16347,0.20729,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.017549,0.16333,0.17875,1,1
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.05161,0.16328,0.21767,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00019753,0.16327,0.18155,1,1
1,GO RNA DECAPPING,0.00079435,0.16313,0.16857,1,1
1,GO REGULATION OF ERAD PATHWAY,5.508e-06,0.16299,0.19997,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,0.00019079,0.16282,0.17744,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,7.2111e-07,0.16273,0.16007,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00017186,0.16272,0.23239,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0033369,0.16251,0.17216,1,1
1,GO SULFATE TRANSPORT,3.1888e-05,0.16227,0.18152,1,1
1,GO ORGANELLE INHERITANCE,0.0027346,0.16215,0.16437,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.001191,0.16207,0.14492,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0017123,0.16205,0.21821,1,1
1,GO MYELOID CELL DIFFERENTIATION,0.00016023,0.16177,0.15119,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0036303,0.16174,0.11042,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.026586,0.16173,0.1307,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,2.4346e-05,0.16168,0.1835,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.0017123,0.16122,0.20934,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00034072,0.16094,0.1535,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00353,0.1607,0.12855,1,1
1,GO TRANSLESION SYNTHESIS,0.023741,0.16065,0.11507,1,1
1,GO MUSCLE ADAPTATION,0.015953,0.1606,0.11035,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.010506,0.16022,0.13772,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.0050528,0.16009,0.22129,1,1
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00026903,0.159,0.1453,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0021689,0.1587,0.28981,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0010206,0.15852,0.17217,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,7.889e-07,0.15824,0.17142,1,1
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00098941,0.15804,0.1463,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0016129,0.15767,0.19632,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00059588,0.15752,0.11977,1,1
1,GO ORGANIC ACID METABOLIC PROCESS,0.00021167,0.15735,0.13349,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.014841,0.1573,0.13989,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0056288,0.15718,0.15719,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.02843,0.15712,0.17911,1,1
1,GO LIPID CATABOLIC PROCESS,0.0017123,0.15687,0.12025,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00025131,0.15682,0.15007,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0017641,0.15647,0.18786,1,1
1,GO LYMPHOCYTE ACTIVATION,0.00041602,0.15622,0.16288,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.014486,0.15558,0.11678,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.012508,0.15539,0.16851,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.015574,0.15529,0.16438,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00020448,0.15474,0.1697,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.046579,0.15454,0.19197,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0023671,0.15449,0.20261,1,1
1,GO RRNA 3 END PROCESSING,0.011326,0.15438,0.16464,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.024846,0.15429,0.1288,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.029719,0.15399,0.13957,1,1
1,GO PROTEIN IMPORT,0.00017796,0.15338,0.14214,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.033894,0.1531,0.11471,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,9.4334e-07,0.15283,0.16324,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,4.6597e-05,0.15261,0.16028,1,1
1,GO TELOMERE ORGANIZATION,0.0030654,0.15251,0.10648,1,1
1,GO MAINTENANCE OF LOCATION,5.8301e-05,0.15245,0.16646,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0064317,0.15232,0.15718,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.017969,0.15217,0.18717,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0021062,0.15197,0.14681,1,1
1,GO PROTEIN STABILIZATION,0.00012512,0.15163,0.14007,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.040234,0.15162,0.10915,1,1
1,GO HEART GROWTH,0.0071468,0.15054,0.15243,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00036427,0.15054,0.13107,1,1
1,GO HUMORAL IMMUNE RESPONSE,0.0081404,0.15051,0.12033,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0073363,0.15048,0.15646,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,3.3287e-06,0.15033,0.14399,1,1
1,GO MACROPHAGE ACTIVATION,0.016339,0.14995,0.15586,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.013139,0.14992,0.12982,1,1
1,GO CELL KILLING,0.013798,0.14984,0.1285,1,1
1,GO GOLGI VESICLE BUDDING,0.0010528,0.14979,0.17832,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0015189,0.14968,0.12168,1,1
1,GO VACUOLAR ACIDIFICATION,0.0024367,0.14956,0.17,1,1
1,GO PROTEIN CATABOLIC PROCESS,2.4692e-06,0.14928,0.14378,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.00010092,0.1492,0.12053,1,1
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00013917,0.14841,0.13167,1,1
1,GO NEUTROPHIL MIGRATION,0.0036303,0.1484,0.22611,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00024286,0.14825,0.12998,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,0.00031859,0.14819,0.12762,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0081404,0.1481,0.15544,1,1
1,GO RESPONSE TO LIPID,0.0010528,0.148,0.15452,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.014841,0.1479,0.13304,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.013798,0.14695,0.23566,1,1
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0099891,0.14694,0.11183,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.04854,0.1468,0.096196,1,1
1,GO REGULATION OF CATABOLIC PROCESS,1.8251e-06,0.14674,0.1534,1,1
1,GO PROTEOLYSIS,3.3132e-05,0.14668,0.13285,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.024846,0.14664,0.11223,1,1
1,GO RESPONSE TO LEPTIN,0.040234,0.14618,0.16901,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.0090226,0.14538,0.11596,1,1
1,GO MITOTIC RECOMBINATION,0.021165,0.14529,0.14765,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0059384,0.14525,0.10739,1,1
1,GO POSITIVE REGULATION OF BINDING,0.00092958,0.14507,0.13924,1,1
1,GO CELLULAR RESPONSE TO UV,0.0022332,0.14497,0.1358,1,1
1,GO NUCLEAR TRANSPORT,9.389e-05,0.14458,0.12429,1,1
1,GO RNA LOCALIZATION,0.00072223,0.14429,0.16848,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0037331,0.14414,0.14374,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00010092,0.14377,0.13671,1,1
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.0022992,0.14338,0.12807,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.001191,0.14326,0.13364,1,1
1,GO ELECTRON TRANSPORT CHAIN,0.004408,0.14311,0.11693,1,1
1,GO TRNA TRANSPORT,0.016734,0.14284,0.13769,1,1
1,GO RESPONSE TO UV,0.001228,0.14281,0.13018,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,0.00029782,0.1427,0.15963,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.012508,0.14261,0.13551,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0010206,0.14239,0.14346,1,1
1,GO COPII COATED VESICLE BUDDING,0.0027346,0.14234,0.17351,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00016023,0.14229,0.14699,1,1
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.029068,0.14156,0.083702,1,1
1,GO HISTONE DEACETYLATION,0.0032441,0.14151,0.11148,1,1
1,GO REGULATION OF NUCLEAR DIVISION,0.0017641,0.14151,0.10732,1,1
1,GO RNA PROCESSING,0.00081984,0.14111,0.14663,1,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0040578,0.14109,0.11285,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00042998,0.14103,0.15178,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.00081984,0.14087,0.16713,1,1
1,GO GOLGI ORGANIZATION,0.00079435,0.14082,0.12747,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.012508,0.14055,0.098786,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.034637,0.14052,0.13358,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,9.0221e-07,0.14045,0.16487,1,1
1,GO PROTEIN NEDDYLATION,0.0079323,0.14027,0.16006,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.00021909,0.14025,0.18092,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0010859,0.14011,0.12621,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00041602,0.13999,0.13417,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,8.1192e-05,0.13975,0.16103,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,0.0047853,0.13958,0.12705,1,1
1,GO DNA BIOSYNTHETIC PROCESS,5.0683e-06,0.13951,0.14674,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.0015653,0.13918,0.13088,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0024367,0.13907,0.15564,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00054072,0.13896,0.16604,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,4.4712e-06,0.13892,0.16024,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.01282,0.13823,0.11367,1,1
1,GO REGULATION OF MAPK CASCADE,0.00037661,0.13812,0.15013,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.050569,0.13794,0.12028,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00074557,0.13775,0.1546,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0057817,0.13752,0.14792,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00019079,0.13733,0.1878,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0050528,0.13659,0.13214,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.045624,0.13656,0.19835,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0024367,0.13656,0.18657,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.0060989,0.13651,0.11176,1,1
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.009256,0.13643,0.12188,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.040234,0.13629,0.10284,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.037747,0.13625,0.10553,1,1
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.030383,0.13559,0.13415,1,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00021167,0.1353,0.15152,1,1
1,GO POSTREPLICATION REPAIR,0.019283,0.13502,0.093146,1,1
1,GO CELLULAR RESPIRATION,0.0079323,0.13492,0.11775,1,1
1,GO RECEPTOR RECYCLING,0.011047,0.13488,0.1176,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00081984,0.13462,0.14953,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0021689,0.13435,0.14069,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.040234,0.1342,0.20488,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0054795,0.13398,0.15623,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,0.00055855,0.13374,0.15661,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0006154,0.13345,0.13871,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.011326,0.13339,0.10542,1,1
1,GO REGULATION OF TUBE SIZE,0.0028957,0.13331,0.15857,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0062634,0.1333,0.10197,1,1
1,GO REGULATION OF CHEMOTAXIS,0.0087944,0.13307,0.12612,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0037331,0.13234,0.12712,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.012203,0.13223,0.096783,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.0099891,0.13161,0.11896,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00098941,0.13161,0.11007,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0046564,0.13123,0.083306,1,1
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.0056288,0.13122,0.095844,1,1
1,GO ESTROGEN METABOLIC PROCESS,0.0045306,0.1312,0.21379,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.033166,0.13109,0.1099,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.04854,0.13023,0.12712,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.00074557,0.13009,0.14656,1,1
1,GO STEM CELL DIFFERENTIATION,0.00074557,0.13003,0.14406,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.00063551,0.12983,0.14221,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,9.7346e-05,0.12978,0.15804,1,1
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001872,0.12972,0.16018,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00021909,0.12951,0.16883,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.023205,0.1295,0.1359,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.0054795,0.12937,0.15265,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00034072,0.12898,0.14932,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.00036427,0.12896,0.11852,1,1
1,GO LIPID HOMEOSTASIS,0.0075304,0.12884,0.11767,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00020448,0.12869,0.15823,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00016595,0.12868,0.12138,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.013798,0.12798,0.14332,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0039469,0.12772,0.11019,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0032441,0.12766,0.11237,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.015203,0.12687,0.11635,1,1
1,GO SPHINGOID METABOLIC PROCESS,0.038561,0.12687,0.091166,1,1
1,GO EXOCYTOSIS,0.0011549,0.12645,0.1365,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00079435,0.12642,0.11659,1,1
1,GO MRNA METABOLIC PROCESS,0.00063551,0.12576,0.13509,1,1
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.045624,0.12563,0.088238,1,1
1,GO RESPONSE TO HORMONE,0.0013872,0.12561,0.11326,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.013465,0.12488,0.11042,1,1
1,GO MRNA CLEAVAGE,0.0038387,0.12463,0.11476,1,1
1,GO BLASTOCYST FORMATION,0.0069616,0.12461,0.14698,1,1
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0014738,0.1243,0.12751,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00069957,0.1236,0.1215,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,7.9801e-06,0.12358,0.12318,1,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.016734,0.12307,0.10088,1,1
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0045306,0.12232,0.095736,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00065623,0.12208,0.12198,1,1
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.036164,0.12201,0.094771,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00013433,0.12199,0.13636,1,1
1,GO MODIFIED AMINO ACID TRANSPORT,0.0049174,0.12174,0.22391,1,1
1,GO APOPTOTIC PROCESS,0.00049035,0.12164,0.1131,1,1
1,GO RUFFLE ORGANIZATION,0.033166,0.12151,0.11262,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.033894,0.12121,0.10027,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.015574,0.12119,0.23406,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.010245,0.12118,0.082715,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0011199,0.12107,0.095532,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.0024367,0.12088,0.099654,1,1
1,GO B CELL ACTIVATION,0.0041716,0.12078,0.11358,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.00095906,0.12045,0.091814,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.019283,0.12031,0.095259,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.024288,0.11968,0.071051,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.0036303,0.11961,0.098563,1,1
1,GO GENE SILENCING,0.00047456,0.11959,0.1052,1,1
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.052669,0.11952,0.10832,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.0036303,0.11934,0.088891,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.021165,0.11915,0.086832,1,1
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0066042,0.1189,0.084199,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0039469,0.11889,0.10019,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.018836,0.11866,0.12005,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00057693,0.11806,0.12714,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00098941,0.11784,0.12546,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.04854,0.11724,0.12419,1,1
1,GO RESPONSE TO PEPTIDE,0.00095906,0.11713,0.10566,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0012662,0.11674,0.12603,1,1
1,GO ORGANELLE DISASSEMBLY,6.7596e-05,0.11624,0.13366,1,1
1,GO CELL DIVISION,0.033166,0.11603,0.064421,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.001872,0.1157,0.098597,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.001872,0.11558,0.10881,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0029794,0.11529,0.11674,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0013457,0.11487,0.1161,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.009256,0.11482,0.12054,1,1
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0017123,0.11406,0.10015,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.041093,0.114,0.082113,1,1
1,GO NUCLEUS ORGANIZATION,0.0022332,0.11397,0.11021,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00014418,0.11372,0.12071,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.015203,0.11346,0.08548,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,5.6174e-05,0.1134,0.12098,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0031536,0.11331,0.11122,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,9.7346e-05,0.11317,0.13437,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.009256,0.1119,0.084189,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00084609,0.11173,0.16788,1,1
1,GO RNA SURVEILLANCE,0.0025817,0.11171,0.18862,1,1
1,GO MEMBRANE ORGANIZATION,0.0019282,0.11121,0.10019,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.046579,0.1108,0.085237,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.0021689,0.11067,0.091016,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,9.3916e-06,0.11022,0.12181,1,1
1,GO ALCOHOL METABOLIC PROCESS,0.017969,0.10979,0.09155,1,1
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.049546,0.10976,0.1203,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.010773,0.10955,0.073269,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.038561,0.10947,0.10366,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.0010859,0.10897,0.12139,1,1
1,GO MRNA TRANSPORT,0.0023671,0.10885,0.14504,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00045924,0.10882,0.20137,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.015203,0.10828,0.081241,1,1
1,GO REGULATION OF AUTOPHAGY,0.00020448,0.10801,0.12626,1,1
1,GO REGULATION OF BINDING,0.004408,0.10774,0.11089,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.031059,0.10726,0.060164,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.037747,0.10726,0.12695,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.0041716,0.10665,0.097192,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.0018173,0.10649,0.10604,1,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.026586,0.10637,0.079326,1,1
1,GO ENDOSOME ORGANIZATION,0.0067808,0.10635,0.11225,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.0032441,0.10498,0.15251,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.026586,0.10408,0.10074,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.052669,0.10386,0.12376,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012512,0.10295,0.14151,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0023671,0.10227,0.11742,1,1
1,GO MACROAUTOPHAGY,3.3132e-05,0.10204,0.13102,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.0026572,0.10156,0.10504,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.022165,0.10081,0.098573,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.031059,0.10072,0.064933,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.016734,0.099295,0.08854,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.052669,0.099202,0.085092,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.0020453,0.099168,0.1049,1,1
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.013465,0.098844,0.10236,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.02068,0.098714,0.090272,1,1
1,GO MITOTIC CELL CYCLE,0.017137,0.097865,0.073566,1,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.041967,0.097753,0.11532,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.010506,0.097647,0.067536,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.007729,0.097529,0.17094,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0020453,0.096464,0.089919,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.05161,0.095704,0.11133,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.024846,0.095113,0.072107,1,1
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.0090226,0.094927,0.079496,1,1
1,GO REGULATION OF PROTEIN TARGETING,0.033894,0.094425,0.076724,1,1
1,GO IRON ION TRANSPORT,0.0059384,0.094137,0.092237,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.0012662,0.093582,0.073772,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.01282,0.093459,0.09369,1,1
1,GO FEMALE GAMETE GENERATION,0.010506,0.092027,0.081161,1,1
1,GO ORGANELLE FISSION,0.041967,0.09179,0.064505,1,1
1,GO RESPONSE TO ACID CHEMICAL,0.029068,0.091766,0.12058,1,1
1,GO CELL CYCLE PROCESS,0.016734,0.091379,0.061397,1,1
1,GO POLYOL BIOSYNTHETIC PROCESS,0.0060989,0.091314,0.1095,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0050528,0.091064,0.10055,1,1
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0013054,0.090818,0.090659,1,1
1,GO ENDOCYTOSIS,0.00052342,0.090729,0.13266,1,1
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.017137,0.090032,0.084838,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.025994,0.089848,0.086138,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,0.0011199,0.089732,0.10857,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0039469,0.089576,0.094815,1,1
1,GO MACROMOLECULE DEACYLATION,0.019283,0.089207,0.073475,1,1
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0090226,0.089186,0.12063,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0036303,0.089055,0.098192,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0033369,0.087693,0.092003,1,1
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.012508,0.087675,0.13449,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0062634,0.08754,0.062304,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0062634,0.087472,0.11474,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.0045306,0.087284,0.087382,1,1
1,GO VESICLE ORGANIZATION,0.02166,0.087253,0.078672,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0051916,0.086983,0.11228,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.0001165,0.086551,0.095347,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.00090094,0.086383,0.07513,1,1
1,GO REGULATION OF CELL CYCLE,0.021165,0.086329,0.051161,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0036303,0.085498,0.090485,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.033894,0.085489,0.088794,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.015203,0.085441,0.081388,1,1
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.014486,0.084745,0.13555,1,1
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.024288,0.083651,0.079901,1,1
1,GO CELL CELL SIGNALING BY WNT,0.049546,0.083516,0.079892,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0021062,0.083293,0.077974,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.0079323,0.082353,0.074466,1,1
1,GO PROTEIN TETRAMERIZATION,0.0032441,0.081875,0.10924,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.052669,0.081689,0.067064,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.081321,0.081777,1,1
1,GO POLYOL METABOLIC PROCESS,0.015953,0.081257,0.072481,1,1
1,GO MULTI ORGANISM PROCESS,0.0051916,0.081029,0.063897,1,1
1,GO CHROMOSOME CONDENSATION,0.012508,0.080985,0.10983,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.047551,0.080774,0.074369,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0027346,0.080359,0.073048,1,1
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.05161,0.07979,0.094005,1,1
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.011047,0.079508,0.066618,1,1
1,GO AMMONIUM TRANSPORT,0.038561,0.079287,0.16962,1,1
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.016734,0.077648,0.11198,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.02843,0.07644,0.075022,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00065623,0.075665,0.074404,1,1
1,GO DNA METABOLIC PROCESS,0.004408,0.07527,0.065823,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.02843,0.075054,0.074653,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00090094,0.07495,0.073843,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0062634,0.074384,0.070916,1,1
1,GO MITOCHONDRION ORGANIZATION,0.0021062,0.073405,0.080775,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.049546,0.071957,0.067535,1,1
1,GO CELL CYCLE,0.02166,0.071665,0.048243,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.052669,0.06974,0.055211,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.047551,0.068365,0.07433,1,1
1,GO SNRNA TRANSCRIPTION,0.0054795,0.066311,0.081546,1,1
1,GO REGULATION OF DNA REPLICATION,0.0087944,0.065776,0.079769,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.038561,0.064163,0.069412,1,1
1,GO RNA EXPORT FROM NUCLEUS,0.040234,0.063539,0.089051,1,1
1,GO INTRACELLULAR TRANSPORT,0.0015653,0.063527,0.06897,1,1
1,GO RESPONSE TO NITROGEN COMPOUND,0.05161,0.062695,0.054534,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0027346,0.060104,0.11703,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0032441,0.054613,0.064768,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,7.889e-07,1.2188,0.9552,1,1
2,GO ETHANOL OXIDATION,2.9301e-06,0.97262,0.82318,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00016023,0.96721,0.73654,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,7.8282e-05,0.82445,0.70794,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.6015e-06,0.82265,0.75691,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.1192e-05,0.799,0.54757,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0014738,0.78829,0.58927,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.2879e-07,0.77703,0.70378,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,1.1493e-05,0.764,0.68603,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00034072,0.75365,0.63141,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0027346,0.72299,0.44713,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.00034072,0.71623,0.56991,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.4609e-05,0.70935,0.69537,1,1
2,GO RESPONSE TO INTERFERON ALPHA,0.007729,0.70136,0.32585,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.025414,0.69156,0.74252,1,1
2,GO RESPONSE TO INTERLEUKIN 18,9.7346e-05,0.68969,0.68465,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.8612e-06,0.68144,0.51343,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.6414e-07,0.68021,0.52869,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,5.4977e-07,0.67989,0.6221,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,4.8612e-06,0.67581,0.64131,1,1
2,GO BIOLOGICAL PHASE,2.1663e-05,0.67252,0.67402,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00027832,0.65953,0.46611,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00020448,0.65356,0.53952,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00087311,0.65048,0.49737,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0021689,0.64671,0.48034,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00041602,0.63924,0.58755,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,9.389e-05,0.62672,0.52091,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00024286,0.62238,0.48207,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,1.6455e-05,0.61743,0.5325,1,1
2,GO MYOBLAST MIGRATION,0.0037331,0.61589,0.53006,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0025083,0.6153,0.40231,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.3287e-06,0.61141,0.56732,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00067758,0.60615,0.38948,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00055855,0.59988,0.47251,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,1.4674e-06,0.59842,0.5472,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0027346,0.59403,0.44583,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00013433,0.59147,0.46613,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019079,0.58885,0.54153,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0026572,0.58809,0.44817,1,1
2,GO PROSTATE GLAND GROWTH,1.0604e-05,0.58277,0.62851,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00052342,0.5746,0.4175,1,1
2,GO HAIR FOLLICLE MATURATION,4.2876e-06,0.57317,0.50929,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,3.7791e-06,0.5727,0.42028,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0226e-05,0.5693,0.54481,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.3218e-05,0.56446,0.57641,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,5.4121e-05,0.5639,0.51084,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0040578,0.56154,0.40596,1,1
2,GO MUCUS SECRETION,0.0015189,0.5613,0.54353,1,1
2,GO ETHER METABOLIC PROCESS,1.1493e-05,0.55969,0.49063,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00055855,0.55842,0.37715,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0010206,0.55619,0.51876,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0087944,0.54879,0.39014,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,0.00011241,0.54863,0.55457,1,1
2,GO OTIC VESICLE DEVELOPMENT,5.0226e-05,0.54762,0.49616,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.0028957,0.54436,0.38993,1,1
2,GO LYSINE METABOLIC PROCESS,0.00047456,0.54427,0.49105,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,2.1702e-06,0.53953,0.52154,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0025083,0.539,0.417,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0032441,0.53516,0.40135,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00014935,0.53459,0.46176,1,1
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0013054,0.53424,0.38285,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,7.0571e-06,0.53315,0.46472,1,1
2,GO ACTIN FILAMENT SEVERING,0.0067808,0.53247,0.37707,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0030654,0.53143,0.35165,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0024367,0.52756,0.50617,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.906e-06,0.52628,0.49368,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.0001547,0.52516,0.43691,1,1
2,GO PROSTANOID METABOLIC PROCESS,3.8583e-05,0.51843,0.45281,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00024286,0.51167,0.45479,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.4044e-06,0.50989,0.45644,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00028792,0.5091,0.38389,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,5.0226e-05,0.50824,0.40987,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,3.3132e-05,0.50532,0.55247,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,7.547e-05,0.50048,0.46764,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0016129,0.49837,0.42673,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,7.547e-05,0.49801,0.3979,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0057817,0.49763,0.39211,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0013054,0.49496,0.35703,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00041602,0.48942,0.43739,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0016129,0.48346,0.35981,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.015574,0.48307,0.39056,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00044439,0.48059,0.46447,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.4728e-06,0.47901,0.42254,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00030804,0.47764,0.40799,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00050664,0.47722,0.42927,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0049174,0.47674,0.42337,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,8.1192e-05,0.4752,0.43373,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.2962e-05,0.47187,0.43418,1,1
2,GO RESPONSE TO INTERFERON BETA,0.0099891,0.46842,0.35115,1,1
2,GO REGULATION OF HIPPO SIGNALING,0.020205,0.46834,0.2461,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,1.7118e-05,0.46809,0.41513,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.2862e-06,0.46665,0.48481,1,1
2,GO NEURAL CREST FORMATION,0.00025131,0.46561,0.36549,1,1
2,GO MUSCLE ATROPHY,0.023741,0.4645,0.3159,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.46238,0.34531,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.046579,0.46191,0.30855,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,7.2754e-05,0.45356,0.33365,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,9.3916e-06,0.45162,0.42813,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0022992,0.45013,0.36154,1,1
2,GO NEPHRON TUBULE FORMATION,0.0027346,0.44818,0.31656,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.0010859,0.44741,0.4971,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,3.3132e-05,0.44716,0.41667,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.104e-05,0.44531,0.3719,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00057693,0.44499,0.4096,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,6.7596e-05,0.44416,0.38692,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.7145e-05,0.44402,0.44577,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.013798,0.44249,0.40489,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.001872,0.44144,0.2784,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00044439,0.43886,0.41696,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00010092,0.43707,0.36734,1,1
2,GO DENDRITIC CELL MIGRATION,2.0833e-05,0.43567,0.3916,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0030654,0.43454,0.36715,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0038387,0.43358,0.35544,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00021909,0.43184,0.44266,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00017796,0.43045,0.36444,1,1
2,GO REGULATION OF PROTEIN IMPORT,7.8282e-05,0.42768,0.30988,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0049174,0.42459,0.33675,1,1
2,GO REGULATION OF GLOMERULAR FILTRATION,0.012508,0.42068,0.36337,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3654e-06,0.41888,0.40362,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.00035231,0.41597,0.3914,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0045306,0.41386,0.36477,1,1
2,GO ETHANOL METABOLIC PROCESS,1.2454e-05,0.41328,0.49637,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,2.2524e-05,0.41126,0.32599,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0045306,0.40954,0.36044,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.001986,0.40915,0.33747,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00017186,0.40752,0.45169,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00036427,0.40309,0.33092,1,1
2,GO OXYGEN TRANSPORT,0.017137,0.40266,0.41156,1,1
2,GO CELLULAR RESPONSE TO COPPER ION,0.031059,0.40254,0.42595,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.031748,0.39751,0.26461,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00028792,0.39535,0.3855,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00063551,0.39496,0.38613,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.012203,0.39338,0.27462,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.7806e-05,0.39275,0.35727,1,1
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0060989,0.39196,0.34619,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.050569,0.39146,0.18448,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0032441,0.39103,0.35845,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00014935,0.391,0.30692,1,1
2,GO PORE COMPLEX ASSEMBLY,5.0683e-06,0.39017,0.37634,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00024286,0.38945,0.35612,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0032441,0.38886,0.36542,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0050528,0.38886,0.24038,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0085714,0.38851,0.33522,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.001986,0.38839,0.31981,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,2.5308e-05,0.38812,0.33751,1,1
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.035393,0.38807,0.22265,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,2.8891e-07,0.38804,0.4015,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00095906,0.38802,0.35929,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.021165,0.38378,0.33778,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00040247,0.38307,0.29639,1,1
2,GO HEME METABOLIC PROCESS,0.00019079,0.38291,0.3461,1,1
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.013798,0.38097,0.2391,1,1
2,GO PENTOSE METABOLIC PROCESS,7.2754e-05,0.37984,0.3666,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00025131,0.379,0.32135,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0011549,0.3771,0.33166,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00098941,0.37689,0.34472,1,1
2,GO LIMB BUD FORMATION,0.0025817,0.37637,0.47345,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,4.2876e-06,0.37556,0.34868,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00054072,0.3738,0.32363,1,1
2,GO RESPONSE TO CADMIUM ION,0.0041716,0.37301,0.26983,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00017186,0.37234,0.31354,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0010859,0.37187,0.23635,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,5.9841e-06,0.3715,0.34682,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0034322,0.37143,0.23402,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.001872,0.36948,0.28068,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,7.2754e-05,0.36599,0.30981,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.5759e-05,0.36571,0.30245,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.007729,0.36497,0.25223,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.027188,0.36279,0.2515,1,1
2,GO CYSTEINE METABOLIC PROCESS,0.001872,0.35924,0.35908,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,7.547e-05,0.35899,0.34698,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.0054795,0.35869,0.25094,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.8418e-05,0.35784,0.31859,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.001228,0.3574,0.22918,1,1
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00019753,0.35727,0.30906,1,1
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.034637,0.35712,0.28081,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00041602,0.3557,0.31329,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,7.013e-05,0.35549,0.3547,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00017186,0.35413,0.28419,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00016595,0.35355,0.29327,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,7.6603e-06,0.35275,0.38288,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.05161,0.35217,0.2133,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,0.00023468,0.35038,0.32538,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00042998,0.34998,0.26846,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,6.7728e-06,0.3499,0.31293,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0033369,0.34927,0.26525,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00063551,0.34843,0.35516,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00029782,0.34839,0.3119,1,1
2,GO FATTY ACID HOMEOSTASIS,0.014138,0.34829,0.20772,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00052342,0.34769,0.30775,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00019079,0.34747,0.26544,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00022676,0.34744,0.29864,1,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.023741,0.34735,0.27251,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0019282,0.34718,0.37952,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,6.7728e-06,0.34683,0.3541,1,1
2,GO RETINAL METABOLIC PROCESS,0.035393,0.34646,0.2657,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.017969,0.34269,0.24991,1,1
2,GO PRE MIRNA PROCESSING,0.001872,0.34144,0.22852,1,1
2,GO REGULATION OF DNA METHYLATION,4.6597e-05,0.34129,0.2736,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0011199,0.33906,0.29875,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0039469,0.33816,0.24768,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0007696,0.33813,0.29412,1,1
2,GO TONGUE MORPHOGENESIS,0.0060989,0.33749,0.34097,1,1
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.029068,0.33733,0.20486,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0041716,0.33607,0.30784,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.0010528,0.33547,0.32311,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.00013433,0.33505,0.4769,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0079323,0.33474,0.24572,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.029068,0.33405,0.20609,1,1
2,GO RNA DECAPPING,3.8583e-05,0.33388,0.23697,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0025083,0.3337,0.44137,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,5.2139e-05,0.33295,0.36286,1,1
2,GO MICROVILLUS ASSEMBLY,0.0019282,0.3326,0.35386,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0022992,0.33239,0.23539,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.024288,0.33166,0.34474,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.0012662,0.33092,0.24905,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,8.6584e-06,0.33032,0.36231,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.001986,0.32972,0.32609,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00017796,0.3288,0.27356,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0081404,0.32827,0.20526,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00067758,0.32825,0.28442,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.00019079,0.3282,0.32944,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00074557,0.32799,0.25551,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.014138,0.32789,0.29309,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00079435,0.32675,0.31189,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0087944,0.32616,0.20662,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.001986,0.32514,0.35791,1,1
2,GO ZINC ION HOMEOSTASIS,0.013798,0.32435,0.32015,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0025817,0.32427,0.21957,1,1
2,GO IMP METABOLIC PROCESS,0.034637,0.3242,0.27509,1,1
2,GO EPIBOLY,0.034637,0.32415,0.18403,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,0.0022992,0.32379,0.22993,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00059588,0.32312,0.25202,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0062634,0.32299,0.25842,1,1
2,GO RETINOL METABOLIC PROCESS,0.00069957,0.32205,0.24299,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.007729,0.3201,0.28802,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0081404,0.3199,0.30841,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00016595,0.31908,0.42139,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0007696,0.31892,0.26076,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0032441,0.31862,0.3256,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,1.906e-06,0.31751,0.2648,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00052342,0.3174,0.48821,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.5149e-05,0.31702,0.28095,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0028141,0.31633,0.26712,1,1
2,GO RESPONSE TO NITROSATIVE STRESS,0.030383,0.31618,0.20965,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0014299,0.31594,0.27115,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00028792,0.31551,0.28241,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0045306,0.31534,0.19096,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.013798,0.31389,0.23237,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0083534,0.31384,0.29439,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0099891,0.31381,0.28726,1,1
2,GO GAS TRANSPORT,0.0064317,0.31363,0.35374,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0050528,0.31333,0.32658,1,1
2,GO PIGMENT GRANULE MATURATION,0.012203,0.31312,0.25517,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0034322,0.31298,0.38202,1,1
2,GO CARNITINE SHUTTLE,5.6174e-05,0.31298,0.31693,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022332,0.31212,0.25561,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0036303,0.31111,0.21981,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.8418e-05,0.31107,0.251,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0056288,0.31092,0.29792,1,1
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0007696,0.3107,0.28635,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0021062,0.31043,0.26669,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00063551,0.30986,0.21016,1,1
2,GO DETOXIFICATION,0.00019079,0.3095,0.26205,1,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.021165,0.30928,0.24237,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0069616,0.3082,0.24922,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,9.7801e-06,0.30811,0.31182,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0032441,0.30795,0.23311,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00010845,0.3076,0.28209,1,1
2,GO AMP METABOLIC PROCESS,0.016734,0.30722,0.2298,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00019753,0.30708,0.39671,1,1
2,GO DNA LIGATION,0.0014738,0.30662,0.22878,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0023671,0.30655,0.37875,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0016129,0.30612,0.26385,1,1
2,GO THYMOCYTE APOPTOTIC PROCESS,0.0090226,0.30593,0.24352,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00055855,0.30575,0.26379,1,1
2,GO MONONUCLEAR CELL MIGRATION,9.7346e-05,0.3057,0.27038,1,1
2,GO INTERLEUKIN 2 PRODUCTION,3.8583e-05,0.30565,0.2651,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.043763,0.30557,0.18349,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.004408,0.30532,0.29172,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00081984,0.30438,0.22969,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00020448,0.3038,0.31849,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0083534,0.30363,0.18841,1,1
2,GO RESPIRATORY BURST,0.0025083,0.30358,0.237,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00036427,0.30352,0.26929,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0021062,0.30294,0.24919,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0007696,0.30237,0.24679,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0028141,0.30198,0.23833,1,1
2,GO ENTRY INTO HOST,0.0019282,0.30169,0.22172,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.04854,0.30114,0.21181,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,9.7346e-05,0.3008,0.29486,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,7.013e-05,0.30064,0.32568,1,1
2,GO KERATINOCYTE PROLIFERATION,0.02843,0.30059,0.28596,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.04854,0.30058,0.16851,1,1
2,GO FOREGUT MORPHOGENESIS,0.0025817,0.29939,0.34239,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00014418,0.29938,0.33314,1,1
2,GO OVULATION,0.0013872,0.29899,0.25418,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0017641,0.29864,0.28391,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,2.7343e-05,0.29814,0.29384,1,1
2,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.01282,0.29792,0.19036,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00057693,0.29755,0.24186,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0015189,0.29678,0.24938,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00072223,0.29601,0.2591,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0017123,0.29582,0.19052,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001191,0.29556,0.20799,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0013457,0.29527,0.29306,1,1
2,GO NUCLEAR PORE ORGANIZATION,1.4039e-05,0.29527,0.34743,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,5.4121e-05,0.29466,0.25256,1,1
2,GO VIRAL TRANSLATION,0.00012512,0.29435,0.33713,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,3.3202e-07,0.29425,0.27593,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0017123,0.29374,0.26928,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0030654,0.2937,0.27438,1,1
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00057693,0.29317,0.31209,1,1
2,GO PODOSOME ASSEMBLY,0.0010528,0.29268,0.27419,1,1
2,GO RESPONSE TO TUMOR CELL,0.0067808,0.29259,0.22318,1,1
2,GO GASTRIC ACID SECRETION,0.001228,0.29234,0.24359,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00049035,0.29142,0.25472,1,1
2,GO MATURATION OF LSU RRNA,0.0013457,0.29137,0.32786,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0038387,0.29041,0.22133,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.012203,0.28901,0.20823,1,1
2,GO RESPONSE TO COPPER ION,0.033894,0.28891,0.27089,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0050528,0.28853,0.2686,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.001228,0.28853,0.22133,1,1
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.011904,0.28848,0.22255,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00028792,0.28845,0.28614,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00026903,0.28826,0.26289,1,1
2,GO RIG I SIGNALING PATHWAY,4.0073e-05,0.2881,0.26385,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00065623,0.28801,0.27519,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0015189,0.28773,0.26772,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.00054072,0.2875,0.29619,1,1
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.016734,0.28737,0.23287,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.00030804,0.28722,0.23232,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,0.00025131,0.28659,0.44109,1,1
2,GO BLASTODERM SEGMENTATION,0.019283,0.28649,0.2911,1,1
2,GO FIBROBLAST ACTIVATION,0.00081984,0.28636,0.32039,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00045924,0.28599,0.28621,1,1
2,GO T CELL CHEMOTAXIS,0.00011241,0.28576,0.25846,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.037747,0.28563,0.14697,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00081984,0.28519,0.26861,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.28494,0.26199,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0073363,0.2848,0.21557,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00022676,0.28472,0.21443,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.7343e-05,0.28428,0.28317,1,1
2,GO MATURATION OF 5 8S RRNA,0.00040247,0.28384,0.29683,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00016023,0.28381,0.25682,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0025817,0.28291,0.34626,1,1
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.022165,0.28275,0.37956,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.027803,0.28248,0.18709,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,4.0073e-05,0.28207,0.27596,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0027346,0.28166,0.22208,1,1
2,GO REGULATION OF LIPASE ACTIVITY,5.2139e-05,0.2814,0.22573,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010773,0.2812,0.21009,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00026903,0.28082,0.31561,1,1
2,GO HYPEROSMOTIC RESPONSE,0.00095906,0.28062,0.27633,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.3418e-05,0.28029,0.31852,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0066042,0.28016,0.20091,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.001191,0.2798,0.23862,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.00029782,0.27925,0.22482,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.0034322,0.27907,0.17663,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.0011549,0.27896,0.44222,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.27855,0.27879,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0007696,0.27849,0.21344,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00032948,0.27777,0.28294,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0019282,0.27752,0.24763,1,1
2,GO HIPPO SIGNALING,0.0006154,0.27723,0.34983,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,3.1888e-05,0.27718,0.24309,1,1
2,GO CHROMATIN DISASSEMBLY,0.00055855,0.2771,0.22681,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.0028957,0.27671,0.21457,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0028141,0.27646,0.18976,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00065623,0.27632,0.25228,1,1
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.021165,0.27533,0.19528,1,1
2,GO VIRAL GENE EXPRESSION,0.00054072,0.27526,0.25999,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0019282,0.27515,0.24374,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.001228,0.27447,0.18005,1,1
2,GO ARACHIDONIC ACID SECRETION,7.8282e-05,0.274,0.28469,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00059588,0.27392,0.28376,1,1
2,GO MIRNA METABOLIC PROCESS,3.6228e-06,0.27377,0.23931,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.024288,0.2733,0.26082,1,1
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.035393,0.27318,0.23067,1,1
2,GO VESICLE CARGO LOADING,5.6174e-05,0.27306,0.27992,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.033894,0.27298,0.24783,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,0.00041602,0.2726,0.39181,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0028957,0.27225,0.18841,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0013054,0.27208,0.20445,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0011549,0.27153,0.25688,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00095906,0.2714,0.25086,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.014138,0.27083,0.30597,1,1
2,GO REGULATION OF CELL KILLING,0.0060989,0.27078,0.18864,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00017186,0.27047,0.35446,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0012662,0.26947,0.21521,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0099891,0.2692,0.17031,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00055855,0.26874,0.25877,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,9.0551e-05,0.26805,0.24172,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0027346,0.26734,0.24392,1,1
2,GO GTP METABOLIC PROCESS,0.00084609,0.26711,0.28782,1,1
2,GO MRNA MODIFICATION,0.001986,0.26692,0.2032,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00010092,0.26647,0.25791,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017549,0.26631,0.32264,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00037661,0.26616,0.3567,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00016023,0.26608,0.21856,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.0054795,0.26545,0.20872,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0056288,0.26544,0.31048,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.8418e-05,0.26504,0.24453,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0039469,0.26433,0.26018,1,1
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0025083,0.26382,0.25223,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.02166,0.26376,0.19274,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0025817,0.26369,0.21768,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0017123,0.26309,0.23199,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.021165,0.263,0.22577,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.001986,0.26282,0.18957,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00052342,0.26278,0.24923,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00017186,0.26265,0.23069,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0054795,0.26253,0.2678,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,1.6455e-05,0.26201,0.24882,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.0015653,0.26198,0.20012,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.00016595,0.26186,0.22582,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0040578,0.26155,0.19656,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.00026003,0.26047,0.26666,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0051916,0.2603,0.2011,1,1
2,GO FOREBRAIN MORPHOGENESIS,0.033166,0.25902,0.17177,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00032948,0.25894,0.24645,1,1
2,GO RNA 5 END PROCESSING,0.00054072,0.25877,0.24139,1,1
2,GO OSTEOBLAST DEVELOPMENT,0.00057693,0.25867,0.30394,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0011549,0.25857,0.20856,1,1
2,GO NUCLEAR MIGRATION,0.0032441,0.25854,0.19574,1,1
2,GO LAMELLIPODIUM ORGANIZATION,7.0571e-06,0.25798,0.27198,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0017123,0.25764,0.23167,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0018173,0.25744,0.20467,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.02268,0.25722,0.21145,1,1
2,GO MATURATION OF SSU RRNA,0.00063551,0.25673,0.29897,1,1
2,GO AMINE CATABOLIC PROCESS,0.0039469,0.25667,0.28814,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00017186,0.25637,0.25222,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0067808,0.25616,0.18758,1,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.043763,0.25595,0.16439,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010773,0.25504,0.31234,1,1
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0014299,0.25469,0.29201,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00067758,0.25468,0.25147,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.011326,0.25458,0.16623,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,2.8418e-05,0.2542,0.27233,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.7118e-05,0.25402,0.24833,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.001228,0.25355,0.22522,1,1
2,GO MICROVILLUS ORGANIZATION,0.010506,0.25289,0.29662,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0034322,0.25283,0.28348,1,1
2,GO HISTONE H3 K9 ACETYLATION,1.1964e-05,0.2527,0.25829,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.041967,0.25241,0.12555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.020205,0.2524,0.21537,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0097392,0.25117,0.25537,1,1
2,GO PLATELET MORPHOGENESIS,0.00010092,0.2509,0.24738,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001872,0.25044,0.24803,1,1
2,GO TRNA METHYLATION,0.00018427,0.25004,0.2326,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,2.7343e-05,0.24997,0.21133,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00049035,0.249,0.21458,1,1
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.00045924,0.24878,0.22397,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0050528,0.24796,0.25006,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00072223,0.24791,0.29233,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00084609,0.24754,0.28323,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00037661,0.2471,0.24016,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.041093,0.247,0.21567,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.033894,0.24699,0.21548,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0015189,0.2469,0.20119,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.004408,0.24683,0.17847,1,1
2,GO PEPTIDE CROSS LINKING,0.02166,0.2463,0.19565,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.037747,0.24593,0.30436,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.00021909,0.24535,0.22389,1,1
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.013139,0.24511,0.21954,1,1
2,GO GLUTATHIONE METABOLIC PROCESS,6.0504e-05,0.24489,0.27913,1,1
2,GO AMINO ACID ACTIVATION,0.00016023,0.2448,0.2837,1,1
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.00353,0.24479,0.37055,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00090094,0.24478,0.22728,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,7.547e-05,0.24431,0.20645,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.013465,0.24397,0.22501,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.001191,0.24303,0.17099,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.016339,0.24257,0.14627,1,1
2,GO CYTOPLASM ORGANIZATION,0.0016129,0.24231,0.29117,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0011549,0.2422,0.18878,1,1
2,GO NADP METABOLIC PROCESS,0.0047853,0.24197,0.2056,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.01282,0.24172,0.22703,1,1
2,GO LAMELLIPODIUM ASSEMBLY,3.3132e-05,0.24152,0.23922,1,1
2,GO RESPONSE TO X RAY,0.00024286,0.24149,0.32402,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.02068,0.24086,0.17471,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.2401,0.22733,1,1
2,GO HISTONE H4 DEACETYLATION,0.00050664,0.2399,0.29464,1,1
2,GO ERYTHROCYTE MATURATION,0.0045306,0.2397,0.30878,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.00090094,0.23959,0.18272,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00092958,0.23909,0.23647,1,1
2,GO CHONDROCYTE PROLIFERATION,0.013139,0.23834,0.3206,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.036948,0.2383,0.17781,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.0037331,0.23817,0.23767,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00020448,0.23789,0.22389,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0017123,0.23779,0.23085,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00021167,0.23774,0.2392,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0028141,0.23771,0.20837,1,1
2,GO PROTEASOME ASSEMBLY,0.0054795,0.23755,0.169,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.0021689,0.23742,0.21593,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0024367,0.23698,0.18731,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0006154,0.23666,0.24345,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.0007696,0.23604,0.227,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00013917,0.23598,0.20923,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,4.8379e-05,0.23583,0.20121,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0019282,0.23438,0.21695,1,1
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.024288,0.23399,0.24526,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0032441,0.23371,0.23687,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.031059,0.23369,0.18083,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0056288,0.23315,0.20294,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.00042998,0.2324,0.1869,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.027188,0.232,0.22664,1,1
2,GO RESPONSE TO MANGANESE ION,0.0013872,0.23176,0.22346,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00037661,0.23138,0.19719,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.0504e-05,0.23121,0.20817,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.00098941,0.23059,0.21719,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.009256,0.23053,0.29304,1,1
2,GO RNA STABILIZATION,0.00044439,0.23037,0.16942,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00057693,0.22963,0.21305,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,1.0604e-05,0.22963,0.20316,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0028141,0.22959,0.23036,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00055855,0.22916,0.2428,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.011326,0.22907,0.19088,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0056288,0.22855,0.13906,1,1
2,GO ZYMOGEN INHIBITION,0.024288,0.22834,0.21583,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00087311,0.22811,0.15602,1,1
2,GO PEPTIDYL PROLINE MODIFICATION,0.0016129,0.22811,0.17565,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00022676,0.22791,0.28044,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.016734,0.22789,0.18534,1,1
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.02268,0.22781,0.17166,1,1
2,GO REGULATION OF HAIR CYCLE,0.001872,0.22735,0.25656,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.024288,0.22724,0.20338,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0045306,0.22699,0.1506,1,1
2,GO THYMUS DEVELOPMENT,0.00019753,0.22665,0.2155,1,1
2,GO PIGMENT METABOLIC PROCESS,0.0015653,0.22658,0.20479,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.001191,0.22652,0.17774,1,1
2,GO SECRETION BY TISSUE,0.0024367,0.22636,0.22809,1,1
2,GO KERATAN SULFATE METABOLIC PROCESS,0.038561,0.2261,0.14064,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00035231,0.22558,0.23081,1,1
2,GO RIBOSOME BIOGENESIS,0.00016595,0.22553,0.26312,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001872,0.22512,0.16017,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0021062,0.22422,0.20102,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.010245,0.22405,0.18815,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0010206,0.22342,0.23372,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.049546,0.22297,0.12435,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001662,0.22269,0.16027,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0049174,0.22256,0.21257,1,1
2,GO NUCLEUS LOCALIZATION,0.00079435,0.22255,0.1868,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.010773,0.22243,0.19285,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0022332,0.22167,0.19115,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00079435,0.22102,0.23142,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.2454e-05,0.22099,0.22174,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00040247,0.22049,0.21836,1,1
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0014299,0.21939,0.26816,1,1
2,GO MAINTENANCE OF CELL NUMBER,2.6307e-05,0.21917,0.21794,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,7.8282e-05,0.21882,0.18569,1,1
2,GO ENAMEL MINERALIZATION,0.033166,0.21831,0.30052,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0038387,0.2183,0.23292,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,5.6174e-05,0.21796,0.18633,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.0028957,0.2176,0.18385,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.00081984,0.2173,0.24259,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.027188,0.21718,0.23403,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00049035,0.21673,0.19453,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00041602,0.21655,0.15771,1,1
2,GO INTERFERON ALPHA PRODUCTION,0.019739,0.21655,0.20314,1,1
2,GO REGULATION OF NEURON MATURATION,0.04854,0.21638,0.20985,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00021167,0.21578,0.24325,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.016339,0.21563,0.18642,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00036427,0.21554,0.23995,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00041602,0.21534,0.22117,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0085714,0.21529,0.22025,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.0015189,0.21507,0.15272,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0022992,0.21502,0.20257,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0064317,0.21476,0.17098,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0040578,0.21452,0.15301,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0023671,0.21432,0.1737,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.023741,0.21428,0.15194,1,1
2,GO B CELL HOMEOSTASIS,0.018836,0.21403,0.12761,1,1
2,GO INTESTINAL ABSORPTION,0.015574,0.2139,0.161,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.016339,0.21382,0.17499,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0013457,0.21381,0.18279,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,2.3418e-05,0.21369,0.19953,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00049035,0.2133,0.218,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00026903,0.21311,0.18568,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00024286,0.21304,0.22839,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00092958,0.2129,0.17685,1,1
2,GO LIPID OXIDATION,0.0042883,0.21207,0.1526,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0087944,0.21191,0.20875,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0010528,0.21185,0.20067,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0001547,0.21182,0.22917,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0057817,0.2118,0.19447,1,1
2,GO B CELL APOPTOTIC PROCESS,0.016339,0.21164,0.13949,1,1
2,GO INTERACTION WITH HOST,0.0010206,0.21138,0.18325,1,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.047551,0.21123,0.13068,1,1
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0011549,0.21117,0.32387,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.0184e-05,0.21036,0.20298,1,1
2,GO RNA POLYADENYLATION,0.00031859,0.21025,0.16167,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00069957,0.21022,0.19874,1,1
2,GO RRNA TRANSCRIPTION,0.00047456,0.21018,0.23609,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.033166,0.21012,0.178,1,1
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0028957,0.20965,0.15391,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.027803,0.20962,0.21634,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0012662,0.20928,0.2034,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.012203,0.2092,0.17019,1,1
2,GO REGULATION OF CELL MATURATION,0.016339,0.20845,0.15292,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00040247,0.2083,0.16718,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.036164,0.20821,0.13773,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.018398,0.20819,0.13833,1,1
2,GO PIGMENT ACCUMULATION,0.0042883,0.20811,0.21453,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.1964e-05,0.20772,0.1959,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.0006154,0.2075,0.27214,1,1
2,GO RRNA MODIFICATION,0.0022992,0.20725,0.22037,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.00041602,0.20714,0.26655,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0041716,0.20711,0.17516,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.012203,0.20661,0.20024,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0066042,0.20642,0.153,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0032441,0.20625,0.17197,1,1
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0097392,0.20598,0.21145,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0032441,0.20555,0.21581,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.022165,0.20545,0.23801,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00020448,0.20513,0.18087,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.013139,0.20513,0.18246,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0062634,0.20473,0.27546,1,1
2,GO GOLGI LOCALIZATION,0.041967,0.20466,0.15169,1,1
2,GO BLASTOCYST FORMATION,0.00028792,0.20426,0.19953,1,1
2,GO NCRNA PROCESSING,0.00021167,0.20423,0.22567,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,1.1493e-05,0.20398,0.2503,1,1
2,GO CORNIFICATION,0.0033369,0.20373,0.26876,1,1
2,GO COPPER ION TRANSPORT,0.0083534,0.2032,0.18904,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.0025083,0.20275,0.16388,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0039469,0.20256,0.21596,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0083534,0.2022,0.17764,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0081404,0.20207,0.20708,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.014841,0.202,0.14098,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.017137,0.20196,0.15114,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0097392,0.2018,0.24301,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00044439,0.2018,0.19348,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00054072,0.20151,0.18924,1,1
2,GO TRNA 5 LEADER REMOVAL,0.00092958,0.20129,0.22494,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.010245,0.20114,0.14867,1,1
2,GO CELL CELL JUNCTION MAINTENANCE,0.0071468,0.20095,0.26426,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.007729,0.20066,0.20563,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.037747,0.20016,0.12294,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0053338,0.2001,0.20011,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.024846,0.19993,0.16812,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.0001547,0.19988,0.19481,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.0087944,0.19964,0.18318,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.042857,0.19931,0.12085,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.014138,0.19921,0.13185,1,1
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.001191,0.19911,0.25754,1,1
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.023205,0.1984,0.22334,1,1
2,GO RNA DESTABILIZATION,0.0081404,0.19819,0.13718,1,1
2,GO RNA METHYLATION,0.0013872,0.19798,0.15871,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.001872,0.19782,0.18255,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017796,0.1976,0.21277,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0059384,0.19753,0.20271,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.001662,0.19743,0.16348,1,1
2,GO HISTONE DEUBIQUITINATION,8.4205e-05,0.19705,0.18145,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.03939,0.19613,0.12527,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0056288,0.19613,0.20436,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00036427,0.19609,0.16007,1,1
2,GO RESPONSE TO SALT STRESS,0.017549,0.19588,0.20532,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0064317,0.19572,0.156,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0053338,0.19557,0.25304,1,1
2,GO FATTY ACID BETA OXIDATION,0.016339,0.19511,0.11874,1,1
2,GO RRNA METABOLIC PROCESS,0.00017796,0.1949,0.2428,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,2.8418e-05,0.19463,0.22081,1,1
2,GO REGULATION OF GENE SILENCING,7.3528e-06,0.19462,0.19869,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.011904,0.19456,0.13933,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011612,0.19441,0.16649,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.029719,0.19381,0.17445,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.012508,0.19358,0.15932,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.0034322,0.19339,0.19301,1,1
2,GO PINOCYTOSIS,0.0032441,0.19334,0.14961,1,1
2,GO TRANSLATIONAL TERMINATION,0.0020453,0.19306,0.21297,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00084609,0.19286,0.19104,1,1
2,GO POSITIVE REGULATION OF CELL AGING,0.036948,0.19285,0.13854,1,1
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.026586,0.19272,0.14154,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.0067808,0.19259,0.20547,1,1
2,GO INTERACTION WITH SYMBIONT,0.00026003,0.19257,0.21133,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.043763,0.19232,0.11543,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0031536,0.19195,0.14251,1,1
2,GO V D J RECOMBINATION,0.011047,0.19192,0.22247,1,1
2,GO AEROBIC RESPIRATION,0.0015189,0.19184,0.19142,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0062634,0.19174,0.23677,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00040247,0.19153,0.23328,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.035393,0.19144,0.12765,1,1
2,GO TRNA TRANSPORT,1.2454e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.00044439,0.19126,0.21118,1,1
2,GO AMYLOID BETA CLEARANCE,0.016339,0.19123,0.15252,1,1
2,GO B CELL PROLIFERATION,0.0022332,0.19115,0.15619,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.040234,0.19099,0.15912,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.036948,0.19088,0.1628,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.015953,0.19062,0.1778,1,1
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.001986,0.19051,0.18065,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0085714,0.19047,0.13959,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.0099891,0.19038,0.176,1,1
2,GO TRNA METABOLIC PROCESS,0.00011241,0.19017,0.19466,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.6902e-06,0.18902,0.20025,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00069957,0.18899,0.15451,1,1
2,GO TRANSLATIONAL INITIATION,0.019283,0.18881,0.19098,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.037747,0.18875,0.11938,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.015574,0.18871,0.14948,1,1
2,GO NCRNA METABOLIC PROCESS,0.00021167,0.18855,0.20332,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00063551,0.18838,0.1691,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.0067808,0.18827,0.1506,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.018836,0.18819,0.18593,1,1
2,GO RESPONSE TO ZINC ION,0.047551,0.18803,0.20233,1,1
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0041716,0.18801,0.17313,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.00017796,0.18795,0.20671,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.015203,0.18787,0.16961,1,1
2,GO NEGATIVE T CELL SELECTION,0.036164,0.18694,0.091995,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.0023671,0.18686,0.17654,1,1
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.05161,0.18685,0.29973,1,1
2,GO LIVER REGENERATION,0.037747,0.18645,0.13785,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00063551,0.18622,0.24136,1,1
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.02843,0.18611,0.11896,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0060989,0.18602,0.17283,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.00012964,0.18602,0.19013,1,1
2,GO RNA INTERFERENCE,0.009256,0.18581,0.17558,1,1
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.024288,0.18579,0.17767,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0007696,0.18571,0.1903,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00016595,0.18563,0.20033,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.0022332,0.18543,0.12667,1,1
2,GO PIGMENT GRANULE ORGANIZATION,0.00012512,0.18527,0.22399,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.023741,0.18466,0.12192,1,1
2,GO AXIS ELONGATION,0.011904,0.18446,0.27909,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.00017186,0.18423,0.20917,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.02268,0.18404,0.13676,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.013139,0.18333,0.1907,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0090226,0.18317,0.1929,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.00079435,0.18306,0.15624,1,1
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.021165,0.18281,0.18305,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0030654,0.18176,0.16886,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00050664,0.18169,0.17714,1,1
2,GO TRNA MODIFICATION,0.00065623,0.18139,0.17772,1,1
2,GO CELL CELL JUNCTION ASSEMBLY,0.036164,0.18061,0.11407,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.00016595,0.18052,0.19441,1,1
2,GO CELL CELL JUNCTION ORGANIZATION,0.018836,0.1805,0.13101,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.029719,0.18044,0.13715,1,1
2,GO FEVER GENERATION,0.029068,0.18031,0.17002,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.0045306,0.18021,0.192,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0011199,0.18012,0.1781,1,1
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.018836,0.18006,0.12433,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.020205,0.18005,0.26963,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0046564,0.17973,0.17011,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.031059,0.17946,0.13126,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0036303,0.1791,0.23964,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.036164,0.17876,0.19281,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00013433,0.17868,0.18281,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0067808,0.17854,0.13156,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0011199,0.17842,0.16062,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00026903,0.17836,0.22362,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0006154,0.17821,0.18389,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0087944,0.17817,0.17025,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0024367,0.17801,0.21298,1,1
2,GO TRICARBOXYLIC ACID CYCLE,0.0039469,0.17768,0.22167,1,1
2,GO RNA MODIFICATION,0.00034072,0.17762,0.16128,1,1
2,GO SYMBIOTIC PROCESS,8.7323e-05,0.17731,0.16324,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00087311,0.17713,0.17085,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010245,0.1771,0.14983,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00034072,0.17669,0.1801,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00010845,0.17655,0.16698,1,1
2,GO ALDITOL METABOLIC PROCESS,0.0056288,0.17624,0.24067,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.0571e-06,0.17621,0.16539,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0017641,0.17617,0.18807,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00057693,0.17616,0.15202,1,1
2,GO FATTY ACID TRANSPORT,0.00074557,0.17603,0.14663,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00038934,0.17601,0.17811,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00024286,0.17577,0.17109,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00026003,0.1756,0.21319,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0056288,0.17553,0.14183,1,1
2,GO TRANSLATIONAL ELONGATION,0.013465,0.17542,0.16158,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.027188,0.17509,0.13759,1,1
2,GO RESPONSE TO IRON ION,0.033894,0.17507,0.16452,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.034637,0.17498,0.13349,1,1
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.025414,0.17464,0.13194,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.010773,0.17429,0.13354,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,7.013e-05,0.1737,0.18929,1,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.011326,0.17337,0.18942,1,1
2,GO VIRAL LIFE CYCLE,0.0014299,0.17329,0.16852,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.001191,0.17325,0.2014,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.029719,0.17318,0.10427,1,1
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.0059384,0.17227,0.16833,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0011549,0.1718,0.17388,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.0014299,0.17143,0.14822,1,1
2,GO PROGRAMMED NECROTIC CELL DEATH,0.018398,0.17105,0.15897,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.023741,0.17074,0.14362,1,1
2,GO TRNA PROCESSING,0.00028792,0.17067,0.18298,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00047456,0.1704,0.19324,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.0047853,0.17033,0.16739,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.00065623,0.17018,0.18945,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00067758,0.17004,0.16651,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.024288,0.16959,0.17512,1,1
2,GO HISTONE H3 K14 ACETYLATION,3.8583e-05,0.16925,0.19803,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.01282,0.16906,0.18254,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0011549,0.16896,0.19383,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.015574,0.16886,0.20077,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00020448,0.16832,0.15555,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0037331,0.16819,0.1292,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.012203,0.16811,0.14494,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.001986,0.16732,0.14286,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.02068,0.16725,0.14061,1,1
2,GO IRON ION HOMEOSTASIS,0.0062634,0.16724,0.14771,1,1
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.016339,0.16622,0.20905,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0029794,0.16586,0.1598,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.010245,0.16534,0.17512,1,1
2,GO PROTEIN IMPORT,0.0012662,0.1648,0.13747,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0046564,0.16474,0.13857,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0010528,0.16474,0.14218,1,1
2,GO RNA CATABOLIC PROCESS,0.00014935,0.16465,0.1721,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.011612,0.16398,0.15501,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.001228,0.16389,0.17584,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.013139,0.16388,0.12266,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0017123,0.1636,0.14697,1,1
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0014299,0.16358,0.1406,1,1
2,GO RRNA 3 END PROCESSING,0.0099891,0.16344,0.16479,1,1
2,GO LIPID MODIFICATION,0.0041716,0.16339,0.11393,1,1
2,GO PEPTIDE METABOLIC PROCESS,0.0011199,0.16319,0.14502,1,1
2,GO PHOTOPERIODISM,0.03939,0.163,0.10823,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.012203,0.16294,0.15343,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.011326,0.16221,0.10233,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0087944,0.16216,0.15047,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.00055855,0.16207,0.19833,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0034322,0.16194,0.18439,1,1
2,GO TRNA 5 END PROCESSING,0.0014738,0.16194,0.20031,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.043763,0.16185,0.15047,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.029068,0.16183,0.088742,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0039469,0.16178,0.15564,1,1
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.0071468,0.16149,0.16946,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.018836,0.1614,0.1086,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00038934,0.16111,0.20516,1,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.04854,0.16062,0.10231,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.040234,0.16054,0.14725,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0067808,0.16039,0.12688,1,1
2,GO TERPENOID METABOLIC PROCESS,0.026586,0.16011,0.13546,1,1
2,GO P BODY ASSEMBLY,0.00063551,0.1601,0.14729,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.0025817,0.16009,0.18119,1,1
2,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00054072,0.15975,0.16627,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0045306,0.1597,0.14624,1,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.011904,0.15959,0.14195,1,1
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.0026572,0.15939,0.14108,1,1
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.031059,0.15928,0.13353,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.0030654,0.15912,0.17973,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0015189,0.15906,0.17625,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0071468,0.15846,0.22047,1,1
2,GO EPIDERMIS DEVELOPMENT,0.010506,0.1582,0.17522,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0034322,0.15803,0.21994,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0079323,0.15797,0.16325,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0099891,0.15793,0.13075,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0050528,0.15741,0.17989,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.0041716,0.15723,0.15216,1,1
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00019753,0.15679,0.19295,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.0025083,0.15635,0.15286,1,1
2,GO ERBB SIGNALING PATHWAY,0.0057817,0.1556,0.12517,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00081984,0.15548,0.15897,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.043763,0.15543,0.098774,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.0017123,0.15536,0.13833,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0042883,0.1552,0.11266,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.02843,0.155,0.15954,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0071468,0.15475,0.14191,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.013465,0.15451,0.13066,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.037747,0.15387,0.10327,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.00054072,0.15353,0.19197,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00045924,0.15322,0.17236,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0028957,0.15321,0.20756,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.0011549,0.15296,0.11773,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00042998,0.15295,0.15057,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.00079435,0.15283,0.1899,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0014299,0.15279,0.2028,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,2.5308e-05,0.15277,0.15972,1,1
2,GO CHYLOMICRON ASSEMBLY,0.020205,0.15267,0.10948,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.001986,0.15244,0.17054,1,1
2,GO TOXIN TRANSPORT,0.011612,0.15187,0.13264,1,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.049546,0.15186,0.11553,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0042883,0.15178,0.16581,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.15147,0.13985,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,2.3418e-05,0.15134,0.17493,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0081404,0.15133,0.23203,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,8.7323e-05,0.15103,0.14832,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.013798,0.15094,0.11287,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.0042883,0.15077,0.14092,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.0066042,0.15075,0.12867,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0012662,0.14967,0.14197,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0021689,0.14943,0.18399,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0053338,0.14932,0.14643,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.025414,0.14926,0.12859,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00069957,0.14889,0.11609,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.009256,0.14849,0.15098,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.018836,0.14834,0.12912,1,1
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.0025083,0.14824,0.13442,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0045306,0.14791,0.18977,1,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0059384,0.14788,0.20213,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.0025083,0.14771,0.16408,1,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.019283,0.14744,0.13175,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,3.8583e-05,0.14657,0.14386,1,1
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.045624,0.14632,0.19152,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0085714,0.14602,0.11719,1,1
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.027803,0.14583,0.10977,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.0083534,0.14582,0.18035,1,1
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00052342,0.1457,0.15615,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.0013457,0.14555,0.13664,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0013054,0.14554,0.15599,1,1
2,GO IMPORT INTO NUCLEUS,0.022165,0.14532,0.11197,1,1
2,GO RECEPTOR CATABOLIC PROCESS,0.03245,0.14522,0.14506,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00092958,0.14511,0.13625,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.0059384,0.1451,0.11218,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0069616,0.1451,0.1561,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.017137,0.14507,0.13089,1,1
2,GO GMP METABOLIC PROCESS,0.024846,0.14505,0.16515,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0054795,0.14496,0.15685,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0033369,0.14488,0.1124,1,1
2,GO HISTONE PHOSPHORYLATION,0.00081984,0.14481,0.13203,1,1
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0059384,0.14475,0.14674,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.011047,0.1447,0.20577,1,1
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.00072223,0.14451,0.13866,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.017969,0.1445,0.20887,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0030654,0.14404,0.12769,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0025083,0.14395,0.22883,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.014486,0.14348,0.10733,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.035393,0.1434,0.13458,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.001872,0.14324,0.14252,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.0025817,0.14295,0.14807,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0026572,0.1428,0.16588,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.012203,0.14273,0.10797,1,1
2,GO GOLGI RIBBON FORMATION,0.031059,0.14271,0.13085,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0083534,0.14243,0.20176,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,4.1617e-05,0.14217,0.19552,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0025083,0.14206,0.18039,1,1
2,GO HISTONE H2B UBIQUITINATION,0.014138,0.14186,0.13774,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.013139,0.14184,0.12243,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,9.0551e-05,0.14169,0.15154,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0006154,0.14149,0.121,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.14111,0.1198,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.0604e-05,0.14079,0.16829,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0019282,0.14069,0.1252,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.041093,0.14062,0.15157,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012508,0.14059,0.14893,1,1
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.025994,0.14045,0.14335,1,1
2,GO MALE SEX DIFFERENTIATION,0.015574,0.14021,0.13832,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.016734,0.14017,0.15993,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00353,0.13959,0.11711,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.001986,0.13931,0.16377,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0040578,0.13911,0.16199,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0014299,0.13901,0.11734,1,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.047551,0.13859,0.13394,1,1
2,GO REGULATION OF ORGAN GROWTH,0.033894,0.13834,0.12596,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.0022992,0.13778,0.12507,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.037747,0.13743,0.093374,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.015953,0.13733,0.11238,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.001872,0.13732,0.14293,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,5.4121e-05,0.13709,0.13758,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0053338,0.13708,0.19361,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.001986,0.13672,0.12658,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.018398,0.13665,0.13636,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0057817,0.13629,0.12634,1,1
2,GO BASE EXCISION REPAIR,0.0010206,0.13621,0.13639,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,8.1192e-05,0.13601,0.12954,1,1
2,GO KERATINOCYTE MIGRATION,0.026586,0.13589,0.14024,1,1
2,GO AMIDE BIOSYNTHETIC PROCESS,0.00052342,0.13545,0.15553,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.041093,0.13541,0.098591,1,1
2,GO TISSUE HOMEOSTASIS,0.013139,0.1354,0.092127,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.025994,0.13531,0.16907,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00049035,0.13527,0.14849,1,1
2,GO NUCLEAR EXPORT,5.0226e-05,0.13523,0.16528,1,1
2,GO DNA GEOMETRIC CHANGE,1.6455e-05,0.13397,0.16783,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0050528,0.13364,0.15621,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0020453,0.13316,0.17094,1,1
2,GO TELOMERE ORGANIZATION,0.00029782,0.13287,0.13882,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0022332,0.13282,0.11892,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.037747,0.13276,0.12785,1,1
2,GO MRNA 3 END PROCESSING,8.1192e-05,0.13165,0.15532,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0075304,0.13125,0.14154,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.030383,0.13121,0.15578,1,1
2,GO MRNA TRANSCRIPTION,0.014138,0.13119,0.14171,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00012964,0.13118,0.13134,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.022165,0.13007,0.098426,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00353,0.12974,0.12888,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0014299,0.12965,0.13797,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0033369,0.12951,0.12847,1,1
2,GO HISTONE UBIQUITINATION,0.031059,0.12923,0.081861,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.025994,0.12906,0.10994,1,1
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.036948,0.12901,0.12515,1,1
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.017549,0.12876,0.14172,1,1
2,GO RUFFLE ORGANIZATION,0.041093,0.12865,0.085359,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.0037331,0.12848,0.13599,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0097392,0.12848,0.14773,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.014138,0.12839,0.10456,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0045306,0.128,0.13562,1,1
2,GO EXIT FROM MITOSIS,0.01282,0.1279,0.098681,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.018836,0.12784,0.17201,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00017186,0.12781,0.12316,1,1
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0037331,0.12779,0.18489,1,1
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.046579,0.12769,0.12112,1,1
2,GO OXIDATIVE DEMETHYLATION,0.025994,0.12765,0.090446,1,1
2,GO TELOMERIC LOOP DISASSEMBLY,0.038561,0.1275,0.1283,1,1
2,GO CELL CELL RECOGNITION,0.026586,0.12718,0.098306,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.011904,0.12678,0.18035,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0024367,0.12657,0.10739,1,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.041967,0.12579,0.12027,1,1
2,GO RNA PROCESSING,3.4421e-05,0.12572,0.16152,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00079435,0.12562,0.1332,1,1
2,GO KERATINIZATION,0.025994,0.12552,0.18132,1,1
2,GO POLYOL METABOLIC PROCESS,0.001191,0.12529,0.14861,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0010206,0.12506,0.15564,1,1
2,GO RESPONSE TO ESTROGEN,0.023205,0.12488,0.13343,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,7.547e-05,0.12488,0.11946,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.021165,0.12444,0.083458,1,1
2,GO HISTONE H3 DEACETYLATION,0.011904,0.12442,0.12474,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0007696,0.12418,0.16681,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0041716,0.12386,0.11172,1,1
2,GO GENE SILENCING,5.508e-06,0.12385,0.13907,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.023741,0.12359,0.09924,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.00087311,0.12353,0.16414,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0015189,0.12331,0.12039,1,1
2,GO RESPONSE TO PEPTIDOGLYCAN,0.015574,0.12307,0.12466,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0045306,0.12301,0.11022,1,1
2,GO PROTEIN SUMOYLATION,3.4421e-05,0.12271,0.13421,1,1
2,GO MRNA METABOLIC PROCESS,1.7118e-05,0.12248,0.14894,1,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0094949,0.12242,0.13812,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0047853,0.12222,0.13145,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0021689,0.12218,0.18815,1,1
2,GO MRNA CLEAVAGE,0.00021167,0.12208,0.14874,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00074557,0.12201,0.15557,1,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.047551,0.12194,0.12688,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.018836,0.12185,0.11987,1,1
2,GO MRNA TRANSPORT,0.00022676,0.1215,0.14785,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.001986,0.12111,0.11249,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0010206,0.1211,0.11727,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0021062,0.12089,0.12252,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0038387,0.12049,0.10945,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.012203,0.1204,0.099253,1,1
2,GO LIPID METABOLIC PROCESS,0.0029794,0.12016,0.093843,1,1
2,GO LIPID CATABOLIC PROCESS,0.027188,0.12006,0.07731,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.016734,0.11975,0.17436,1,1
2,GO ACTIN NUCLEATION,0.0085714,0.11917,0.12397,1,1
2,GO BODY FLUID SECRETION,0.0049174,0.11914,0.1296,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.02843,0.11904,0.11588,1,1
2,GO PROTEIN NEDDYLATION,0.02166,0.11873,0.10961,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.023205,0.11866,0.086651,1,1
2,GO REGULATION OF MYELINATION,0.026586,0.11862,0.11447,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.00019079,0.11822,0.14927,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.00057693,0.11795,0.14871,1,1
2,GO NUCLEAR TRANSPORT,0.0012662,0.11762,0.12208,1,1
2,GO EPITHELIAL TUBE FORMATION,0.0071468,0.1167,0.14776,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0025083,0.11639,0.10776,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.020205,0.11613,0.12997,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.0013457,0.11565,0.096928,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0028141,0.11562,0.11311,1,1
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0014299,0.11549,0.11659,1,1
2,GO RESPONSE TO UV,0.001662,0.11535,0.13673,1,1
2,GO RNA CAPPING,0.0075304,0.11512,0.09999,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022332,0.11423,0.12333,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.011612,0.11377,0.095786,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.041967,0.11371,0.11386,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0025083,0.11348,0.12878,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0022992,0.1134,0.11392,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0029794,0.11337,0.14379,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.023205,0.11295,0.092148,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.0094949,0.11289,0.10223,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00084609,0.11254,0.13447,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.011047,0.11244,0.094214,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.0067808,0.11242,0.089633,1,1
2,GO RESPONSE TO ALCOHOL,0.042857,0.11204,0.084471,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00016595,0.11197,0.12128,1,1
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.0006154,0.11191,0.13088,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.029068,0.11173,0.09598,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.043763,0.11167,0.076771,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0075304,0.11163,0.084019,1,1
2,GO POLYAMINE METABOLIC PROCESS,0.027188,0.11154,0.12868,1,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0075304,0.11133,0.097153,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.038561,0.11132,0.070021,1,1
2,GO CRISTAE FORMATION,0.050569,0.1113,0.13952,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00084609,0.11121,0.13329,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.0073363,0.11097,0.086476,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.018836,0.11092,0.14196,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.011612,0.11083,0.080932,1,1
2,GO RNA EXPORT FROM NUCLEUS,9.0551e-05,0.11068,0.17069,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.001228,0.11053,0.14689,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0034322,0.11001,0.12959,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.014841,0.10997,0.11472,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.007729,0.10989,0.13571,1,1
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.020205,0.10979,0.11394,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.026586,0.10972,0.11891,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0001165,0.10956,0.14472,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.040234,0.10911,0.093241,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.0069616,0.10818,0.12496,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0090226,0.10781,0.10079,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.004408,0.10774,0.080633,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.016734,0.107,0.10545,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.0007696,0.10681,0.11294,1,1
2,GO MRNA PROCESSING,0.00013433,0.10673,0.12377,1,1
2,GO MITOCHONDRIAL TRANSPORT,0.0033369,0.10672,0.10286,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0067808,0.1067,0.10033,1,1
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.052669,0.1067,0.057698,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00035231,0.10664,0.11339,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00016023,0.10552,0.11528,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,4.1617e-05,0.10498,0.11054,1,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0037331,0.10495,0.13495,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.045624,0.10488,0.10611,1,1
2,GO TUBE FORMATION,0.0087944,0.10442,0.13705,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0066042,0.10376,0.16795,1,1
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.034637,0.1036,0.1171,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0028957,0.10273,0.087268,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.011326,0.1026,0.090222,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.022165,0.10246,0.078972,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0033369,0.10225,0.12672,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.001872,0.10198,0.11746,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00084609,0.10158,0.11675,1,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.036948,0.1012,0.071555,1,1
2,GO RNA 3 END PROCESSING,0.0010859,0.10116,0.13378,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0085714,0.10065,0.1843,1,1
2,GO HISTONE H3 ACETYLATION,0.00038934,0.10023,0.10638,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.00024286,0.099617,0.12281,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00016023,0.099248,0.10584,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0013872,0.098422,0.13266,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.050569,0.098371,0.092757,1,1
2,GO RNA LOCALIZATION,9.0551e-05,0.098195,0.15685,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.025414,0.097938,0.092131,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0025083,0.097412,0.15343,1,1
2,GO DNA METHYLATION,0.001191,0.097405,0.11385,1,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.036164,0.097182,0.078226,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.00032948,0.097151,0.15323,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.031748,0.097136,0.0924,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.018836,0.096858,0.064618,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0060989,0.096121,0.072845,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0087944,0.096056,0.10869,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.010506,0.095767,0.11516,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0017123,0.09529,0.11351,1,1
2,GO REGULATION OF DNA REPAIR,0.027803,0.095058,0.072378,1,1
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.029068,0.094905,0.1139,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0057817,0.094424,0.14149,1,1
2,GO STEM CELL DIFFERENTIATION,0.010773,0.094058,0.12095,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00353,0.093801,0.099404,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.049546,0.093738,0.097834,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00072223,0.093578,0.089556,1,1
2,GO SNRNA PROCESSING,0.009256,0.093359,0.096868,1,1
2,GO RESPONSE TO HEAT,0.02268,0.093356,0.097181,1,1
2,GO RNA SPLICING,0.00032948,0.093084,0.12073,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.0094949,0.092643,0.08035,1,1
2,GO DNA CONFORMATION CHANGE,0.0022992,0.092533,0.094702,1,1
2,GO CHROMATIN REMODELING,0.00029782,0.092448,0.11632,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.009256,0.092202,0.098224,1,1
2,GO CELL AGING,0.012203,0.092119,0.088626,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.4346e-05,0.090771,0.1302,1,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.0051916,0.090737,0.078205,1,1
2,GO REGULATION OF NUCLEASE ACTIVITY,0.042857,0.090515,0.12173,1,1
2,GO REGULATION OF PROTEIN STABILITY,0.011612,0.090253,0.072783,1,1
2,GO NEURAL TUBE FORMATION,0.023205,0.09019,0.14562,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.023741,0.089775,0.1034,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.011904,0.08948,0.086803,1,1
2,GO NCRNA CATABOLIC PROCESS,0.017137,0.088972,0.13617,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00047456,0.088858,0.12069,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0075304,0.088757,0.10111,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.02843,0.087968,0.060325,1,1
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.001228,0.087903,0.084858,1,1
2,GO CELLULAR RESPONSE TO UV,0.0060989,0.087743,0.11549,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.02843,0.08723,0.082009,1,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.041093,0.086364,0.078517,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.0073363,0.086257,0.08139,1,1
2,GO PEROXISOMAL TRANSPORT,0.014486,0.085778,0.11286,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.041967,0.085751,0.082296,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0057817,0.085542,0.083036,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0051916,0.085516,0.089922,1,1
2,GO SNRNA METABOLIC PROCESS,0.0022992,0.085496,0.10364,1,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.0038387,0.084422,0.077762,1,1
2,GO CELLULAR RESPONSE TO HEAT,0.03939,0.08426,0.099183,1,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.017969,0.083117,0.075529,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00072223,0.0828,0.098703,1,1
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.007729,0.082147,0.11327,1,1
2,GO RRNA METHYLATION,0.02843,0.081485,0.1597,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0019282,0.08097,0.10037,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.041967,0.080511,0.07287,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.018398,0.080462,0.053569,1,1
2,GO NCRNA TRANSCRIPTION,0.0079323,0.080268,0.098014,1,1
2,GO HISTONE DEACETYLATION,0.0062634,0.079882,0.090372,1,1
2,GO SELECTIVE AUTOPHAGY,0.017969,0.079739,0.093905,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0016129,0.079692,0.10174,1,1
2,GO CHROMOSOME SEPARATION,0.026586,0.078615,0.076513,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.015203,0.078474,0.089141,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001986,0.078376,0.089469,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.025414,0.077301,0.065926,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.018836,0.07674,0.095021,1,1
2,GO PEROXISOME ORGANIZATION,0.018398,0.075617,0.098051,1,1
2,GO CELLULAR COMPONENT DISASSEMBLY,0.034637,0.075331,0.060103,1,1
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.014138,0.075052,0.091265,1,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.019283,0.073885,0.068889,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.049546,0.072709,0.099896,1,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0051916,0.072273,0.070045,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0090226,0.071385,0.10286,1,1
2,GO REGULATION OF RNA SPLICING,0.017137,0.071372,0.089751,1,1
2,GO RESPONSE TO RADIATION,0.0075304,0.071316,0.071314,1,1
2,GO DNA METABOLIC PROCESS,0.00065623,0.069042,0.076051,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.0085714,0.06879,0.068234,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0029794,0.068134,0.078725,1,1
2,GO DNA DEPENDENT DNA REPLICATION,0.041967,0.067885,0.086184,1,1
2,GO DNA MODIFICATION,0.0015653,0.06723,0.078711,1,1
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.009256,0.067219,0.079738,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.046579,0.066806,0.11709,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.050569,0.066325,0.045383,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.014138,0.066172,0.087766,1,1
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.02843,0.065806,0.083378,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.029068,0.065549,0.081761,1,1
2,GO MACROAUTOPHAGY,0.027803,0.065165,0.054319,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.0020453,0.063603,0.10135,1,1
2,GO MITOTIC NUCLEAR DIVISION,0.03939,0.06225,0.069712,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.0083534,0.061894,0.11858,1,1
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.041967,0.060539,0.091235,1,1
2,GO DNA REPAIR,0.0016129,0.060215,0.077932,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.004408,0.058792,0.059091,1,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.037747,0.057915,0.083609,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.036164,0.057595,0.041506,1,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.042857,0.057435,0.049978,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.02068,0.056633,0.048629,1,1
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.023741,0.053938,0.075505,1,1
2,GO RESPONSE TO LIGHT STIMULUS,0.027188,0.053593,0.06027,1,1
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.05161,0.05213,0.06606,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.03245,0.051571,0.06987,1,1
2,GO SNRNA TRANSCRIPTION,0.0090226,0.05122,0.078967,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.0085714,0.049786,0.06961,1,1
2,GO DNA METHYLATION OR DEMETHYLATION,0.033894,0.048029,0.064391,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.024288,0.047121,0.047038,1,1
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.05161,0.045971,0.15185,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.04854,0.045496,0.091348,1,1
2,GO METHYLATION,0.004408,0.04502,0.072683,1,1
2,GO MITOCHONDRION ORGANIZATION,0.038561,0.044294,0.060444,1,1
2,GO CHROMOSOME ORGANIZATION,0.0099891,0.040902,0.062854,1,1
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.020205,0.040675,0.04923,1,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.04854,0.03906,0.059534,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.02268,0.036689,0.053422,1,1
2,GO COVALENT CHROMATIN MODIFICATION,0.033894,0.036669,0.05146,1,1
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.046579,0.035657,0.049754,1,1
2,GO PEPTIDYL LYSINE MODIFICATION,0.034637,0.02977,0.046309,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0027346,0.38146,0.25967,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.03939,0.33738,0.25131,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.037747,0.30237,0.18672,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0064317,0.27528,0.21508,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.0011199,0.26595,0.24764,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.020205,0.24009,0.14035,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.037747,0.23697,0.22179,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.025994,0.23302,0.20211,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.031059,0.20867,0.18668,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.0046564,0.20437,0.16281,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO REGULATION OF TUBULIN DEACETYLATION,0.027188,0.20276,0.20538,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.047551,0.19713,0.17411,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.0062634,0.19677,0.19911,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.052669,0.1941,0.096069,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.0060989,0.1887,0.20607,1,1
3,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.05161,0.1833,0.11631,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.049546,0.18136,0.15569,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.014841,0.17909,0.14522,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.0083534,0.16904,0.19259,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0041716,0.16648,0.13209,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO THYROID GLAND DEVELOPMENT,0.022165,0.15356,0.18117,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO PROTEIN DEMETHYLATION,0.037747,0.15217,0.11321,1,1
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.042857,0.15178,0.12137,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.013798,0.14497,0.14402,1,1
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.007729,0.14423,0.10342,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0047853,0.11257,0.11194,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.016734,0.11143,0.084827,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.009256,0.1067,0.12313,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO METAL ION TRANSPORT,0.031059,0.098552,0.068972,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO SODIUM ION TRANSPORT,0.04854,0.090093,0.07834,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
3,GO DNA DEPENDENT DNA REPLICATION,0.020205,0.089143,0.079149,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.033894,0.086043,0.089639,1,1
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO NUCLEAR EXPORT,0.024846,0.070434,0.06326,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.047551,0.068477,0.092842,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NUCLEOTIDE EXCISION REPAIR,0.05161,0.059969,0.059967,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
4,GO PROGESTERONE METABOLIC PROCESS,5.4121e-05,1.0766,0.99758,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.0042883,1.0527,0.75898,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.0011549,1.0302,0.94087,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.6455e-05,0.9558,0.99005,1,1
4,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.00021909,0.91669,0.70731,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.349e-05,0.88751,0.64558,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.017137,0.88237,0.5785,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,1.0604e-05,0.87073,0.84821,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,4.8379e-05,0.84853,0.6048,1,1
4,GO MUCUS SECRETION,9.0551e-05,0.81178,0.68051,1,1
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.025414,0.81089,0.4475,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,1.5201e-05,0.76213,0.68204,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,6.5149e-05,0.75763,0.60614,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,5.2837e-06,0.75103,0.65666,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.00049035,0.7507,0.6438,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,8.628e-07,0.74473,0.65624,1,1
4,GO RETINAL METABOLIC PROCESS,0.0007696,0.73513,0.63253,1,1
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.013798,0.72591,0.49786,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,2.1663e-05,0.72476,0.69115,1,1
4,GO GERMINAL CENTER FORMATION,3.8583e-05,0.71939,0.56938,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,7.013e-05,0.71562,0.62404,1,1
4,GO QUINONE METABOLIC PROCESS,5.0226e-05,0.71406,0.70729,1,1
4,GO HISTAMINE SECRETION,2.3654e-06,0.70834,0.66515,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00030804,0.70799,0.60806,1,1
4,GO RENAL ABSORPTION,1.7806e-05,0.70322,0.66983,1,1
4,GO INTESTINAL LIPID ABSORPTION,3.1904e-06,0.7002,0.72989,1,1
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0013457,0.69911,0.4898,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.2139e-05,0.69389,0.63014,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0001547,0.69215,0.5979,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,3.8583e-05,0.67914,0.67037,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,3.4421e-05,0.66382,0.54357,1,1
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.00098941,0.65675,0.44475,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.013798,0.641,0.31424,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00021167,0.63568,0.47259,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,1.2454e-05,0.63089,0.62182,1,1
4,GO CYTIDINE TO URIDINE EDITING,0.00025131,0.63072,0.63263,1,1
4,GO CYSTEINE METABOLIC PROCESS,0.00037661,0.62705,0.59367,1,1
4,GO HISTAMINE TRANSPORT,8.628e-07,0.62544,0.65145,1,1
4,GO ACTIN FILAMENT SEVERING,0.00031859,0.62538,0.48457,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00012512,0.6186,0.50755,1,1
4,GO RESPONSE TO INTERFERON BETA,0.0017641,0.61321,0.41224,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.00067758,0.61181,0.50161,1,1
4,GO LIPID DROPLET FORMATION,2.7343e-05,0.60532,0.60929,1,1
4,GO T CELL EXTRAVASATION,0.00090094,0.60292,0.53314,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0032441,0.60162,0.40122,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.0001165,0.601,0.61103,1,1
4,GO BASIC AMINO ACID TRANSPORT,0.0032441,0.5917,0.46336,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,1.4044e-06,0.5899,0.59145,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,1.8521e-05,0.58705,0.64446,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00013433,0.5786,0.45865,1,1
4,GO REGULATION OF FIBRINOLYSIS,6.5149e-05,0.57454,0.52685,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00057693,0.57231,0.46911,1,1
4,GO LIPID DIGESTION,2.0033e-05,0.57141,0.64062,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,5.4121e-05,0.57014,0.42529,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00059588,0.5664,0.60161,1,1
4,GO RESPONSE TO TYPE I INTERFERON,0.00063551,0.56463,0.46943,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,1.1964e-05,0.56344,0.55926,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,8.3127e-06,0.56256,0.52594,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,1.7806e-05,0.5582,0.54047,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,0.00016023,0.55657,0.66666,1,1
4,GO CYCLOOXYGENASE PATHWAY,0.00079435,0.55619,0.53226,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00019753,0.55601,0.55299,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00353,0.55132,0.49825,1,1
4,GO TOXIN METABOLIC PROCESS,2.1702e-06,0.55021,0.53436,1,1
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.00019079,0.54933,0.43993,1,1
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0010528,0.54933,0.37246,1,1
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0017641,0.54557,0.42245,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.013465,0.54461,0.62294,1,1
4,GO TOLERANCE INDUCTION,0.012203,0.54289,0.42092,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,6.4994e-06,0.54156,0.51079,1,1
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,9.0551e-05,0.53559,0.42019,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00081984,0.53518,0.38783,1,1
4,GO MATURE B CELL DIFFERENTIATION,4.8379e-05,0.53457,0.42688,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.014486,0.53226,0.35464,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.00042998,0.52928,0.48236,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.00079435,0.52894,0.445,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.00034072,0.52569,0.47529,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,1.8521e-05,0.52558,0.46711,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,7.547e-05,0.52462,0.50156,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,5.4121e-05,0.5233,0.47333,1,1
4,GO INTESTINAL ABSORPTION,5.2837e-06,0.51996,0.60292,1,1
4,GO VASCULAR TRANSPORT,0.00028792,0.51844,0.45818,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,2.5308e-05,0.51562,0.49146,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.001191,0.51271,0.37178,1,1
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0011199,0.51266,0.43322,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00016023,0.51213,0.44221,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00018427,0.51147,0.50187,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0094949,0.51096,0.41353,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,0.00059588,0.50912,0.4394,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.5774e-06,0.50785,0.52562,1,1
4,GO SUPEROXIDE ANION GENERATION,2.9532e-05,0.50745,0.49204,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,6.0504e-05,0.50211,0.51045,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,5.6174e-05,0.50118,0.63979,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.00026003,0.49977,0.38453,1,1
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.007729,0.49719,0.30305,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0013457,0.49532,0.46117,1,1
4,GO NADP METABOLIC PROCESS,0.00010845,0.49437,0.38077,1,1
4,GO STEROID ESTERIFICATION,4.3218e-05,0.49283,0.59599,1,1
4,GO KETONE CATABOLIC PROCESS,0.0013872,0.4921,0.39973,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00353,0.48961,0.39653,1,1
4,GO RESPONSE TO PAIN,2.7343e-05,0.4882,0.43468,1,1
4,GO GALACTOSE METABOLIC PROCESS,2.3418e-05,0.48813,0.59205,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.1493e-05,0.4835,0.44747,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,4.1802e-07,0.48196,0.52734,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,0.00013917,0.47665,0.37921,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.2454e-05,0.47648,0.45514,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,0.00050664,0.47607,0.43532,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,6.2786e-05,0.47307,0.38419,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00037661,0.4726,0.37508,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.0833e-05,0.46857,0.45773,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,2.7343e-05,0.46805,0.45317,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00013917,0.46618,0.4055,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0013054,0.46587,0.41268,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00028792,0.46584,0.40163,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00353,0.46513,0.44244,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.1112e-06,0.46333,0.47226,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0022332,0.4612,0.34199,1,1
4,GO RESPONSE TO COLD,2.4692e-06,0.46013,0.40903,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.0689e-05,0.45982,0.41015,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00024286,0.45845,0.40863,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00017796,0.45845,0.41421,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.0049174,0.45378,0.32094,1,1
4,GO GLUTATHIONE METABOLIC PROCESS,0.0016129,0.44945,0.34848,1,1
4,GO RESPONSE TO DIETARY EXCESS,4.0073e-05,0.44852,0.44137,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.013e-05,0.44718,0.41195,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.2524e-05,0.44543,0.38772,1,1
4,GO NADPH REGENERATION,0.001872,0.44404,0.30138,1,1
4,GO PROTEIN DEGLYCOSYLATION,1.1493e-05,0.44129,0.43773,1,1
4,GO REGULATION OF ANOIKIS,0.00023468,0.44121,0.3963,1,1
4,GO CERAMIDE TRANSPORT,0.0026572,0.44065,0.37948,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00030804,0.44011,0.34377,1,1
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.0054795,0.43959,0.376,1,1
4,GO LYSINE METABOLIC PROCESS,0.0071468,0.43942,0.291,1,1
4,GO O GLYCAN PROCESSING,0.00081984,0.43918,0.32492,1,1
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.016734,0.43832,0.29995,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00013917,0.43628,0.42324,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0042883,0.43576,0.35565,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.3528e-06,0.43573,0.34939,1,1
4,GO REGULATION OF NEURON MATURATION,0.0050528,0.43491,0.28041,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0015653,0.43486,0.2987,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00041602,0.43274,0.40089,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,0.0083534,0.43267,0.33233,1,1
4,GO LEYDIG CELL DIFFERENTIATION,0.00044439,0.43195,0.48513,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.0083534,0.43157,0.24445,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,2.9532e-05,0.43137,0.58615,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00040247,0.4312,0.36762,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.00074557,0.43108,0.52275,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.00090094,0.42834,0.41759,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00353,0.42828,0.31754,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00010845,0.42632,0.4089,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0032441,0.42625,0.30794,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00012964,0.42471,0.40044,1,1
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00081984,0.42434,0.44237,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.027803,0.42401,0.33904,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.1192e-05,0.42246,0.44907,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,9.0551e-05,0.42099,0.38828,1,1
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,4.1617e-05,0.4207,0.36794,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00067758,0.42022,0.38484,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0026572,0.42002,0.3087,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00050664,0.41991,0.41526,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5816e-05,0.41896,0.41547,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00035231,0.41893,0.45952,1,1
4,GO PLASMINOGEN ACTIVATION,0.0015653,0.41852,0.44699,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,3.8583e-05,0.4183,0.37075,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.00353,0.41821,0.30933,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00042998,0.41676,0.35432,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00014935,0.41522,0.3823,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0019282,0.41361,0.34656,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0011199,0.41277,0.38325,1,1
4,GO DETECTION OF OTHER ORGANISM,0.001986,0.41201,0.36097,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.547e-05,0.41091,0.43544,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,5.2139e-05,0.41074,0.45627,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.00012512,0.40855,0.37651,1,1
4,GO KETONE BODY METABOLIC PROCESS,0.0034322,0.40625,0.32925,1,1
4,GO NUCLEOTIDE SALVAGE,0.00036427,0.40564,0.37051,1,1
4,GO EOSINOPHIL MIGRATION,0.001191,0.40498,0.36055,1,1
4,GO CELLULAR DEFENSE RESPONSE,1.104e-05,0.40399,0.40383,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00035231,0.40398,0.3917,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,9.3916e-06,0.40394,0.38174,1,1
4,GO VASODILATION,0.00010462,0.40384,0.53233,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,5.6174e-05,0.40303,0.30251,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0037331,0.40153,0.34936,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.00028792,0.4011,0.33973,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,9.7346e-05,0.40106,0.505,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.6902e-06,0.40096,0.41884,1,1
4,GO RESPONSE TO ACIDIC PH,0.00074557,0.40059,0.32079,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00023468,0.40049,0.3971,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,3.3132e-05,0.40016,0.38112,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00074557,0.39982,0.34096,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,3.1888e-05,0.39978,0.34873,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.0010528,0.39724,0.40167,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00016595,0.39639,0.34106,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,9.7801e-06,0.39533,0.39725,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.00050664,0.39433,0.37232,1,1
4,GO B CELL APOPTOTIC PROCESS,3.1888e-05,0.39426,0.34616,1,1
4,GO HEPARIN METABOLIC PROCESS,0.018836,0.39269,0.27091,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0069616,0.39113,0.41551,1,1
4,GO PHAGOSOME ACIDIFICATION,8.3127e-06,0.39112,0.37326,1,1
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.00017796,0.39099,0.30116,1,1
4,GO GAP JUNCTION ASSEMBLY,0.01282,0.39086,0.27062,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.4878e-05,0.3906,0.45474,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.026586,0.39015,0.25954,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00029782,0.39011,0.43828,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0012662,0.38964,0.31964,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,0.00090094,0.38932,0.29075,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.00067758,0.38744,0.39518,1,1
4,GO BLOOD VESSEL REMODELING,0.00020448,0.38715,0.32102,1,1
4,GO STEROL TRANSPORT,7.8282e-05,0.38704,0.28547,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,5.6174e-05,0.38703,0.34046,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.00021909,0.38681,0.40938,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,2.4346e-05,0.38602,0.32666,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00012512,0.38503,0.39148,1,1
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.00025131,0.38482,0.39089,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.041093,0.3848,0.30698,1,1
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.0064317,0.3847,0.29385,1,1
4,GO PROTEIN AUTOPROCESSING,4.2876e-06,0.38415,0.45527,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,5.508e-06,0.38413,0.37233,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00072223,0.38413,0.37912,1,1
4,GO REGULATION OF MYOBLAST FUSION,7.013e-05,0.38326,0.37136,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.00024286,0.38308,0.28032,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,0.00013917,0.38207,0.41644,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,3.7145e-05,0.38187,0.30517,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.0018173,0.3814,0.35344,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00017186,0.38137,0.35398,1,1
4,GO ZYMOGEN ACTIVATION,0.00049035,0.38087,0.36621,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00030804,0.38006,0.35593,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00037661,0.37976,0.32877,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,2.1663e-05,0.37755,0.39291,1,1
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0019282,0.37723,0.31947,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0017641,0.37665,0.25551,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0010528,0.37594,0.33488,1,1
4,GO PROTEIN DEMANNOSYLATION,3.1888e-05,0.37576,0.42793,1,1
4,GO ETHANOL METABOLIC PROCESS,0.00047456,0.3754,0.3273,1,1
4,GO RESPONSE TO INTERFERON ALPHA,0.03939,0.37464,0.20678,1,1
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0030654,0.37339,0.29903,1,1
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00013917,0.37339,0.36662,1,1
4,GO THYMOCYTE APOPTOTIC PROCESS,0.00098941,0.37179,0.30369,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00021167,0.3715,0.4816,1,1
4,GO FOAM CELL DIFFERENTIATION,6.0504e-05,0.3705,0.31824,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.0033e-05,0.36967,0.33134,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00025131,0.36898,0.34908,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00014418,0.36734,0.29183,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0022992,0.3669,0.28298,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,0.011326,0.36681,0.31542,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0081404,0.3659,0.49934,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.017137,0.3657,0.23338,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.00047456,0.36393,0.33072,1,1
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.02068,0.3638,0.20036,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00021909,0.36376,0.29526,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00042998,0.36356,0.38212,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,4.6597e-05,0.36241,0.3277,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.011326,0.36184,0.40844,1,1
4,GO REGULATION OF TISSUE REMODELING,6.4994e-06,0.36148,0.37909,1,1
4,GO REGULATION OF COAGULATION,0.00038934,0.36136,0.30815,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND,0.0049174,0.36097,0.27501,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.00063551,0.35881,0.28548,1,1
4,GO DIGESTION,7.8282e-05,0.35871,0.30516,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,1.8521e-05,0.35864,0.36278,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00026003,0.35842,0.38442,1,1
4,GO REGULATION OF BONE REMODELING,4.4712e-06,0.35805,0.42285,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.3132e-05,0.35803,0.33868,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00021167,0.3579,0.29037,1,1
4,GO INTEGRIN ACTIVATION,4.4712e-06,0.35733,0.37786,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.0083534,0.35706,0.29146,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.018836,0.35476,0.2575,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.02068,0.35402,0.27824,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00030804,0.35327,0.30523,1,1
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0057817,0.35205,0.30478,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,0.0022332,0.35145,0.29562,1,1
4,GO VACUOLAR ACIDIFICATION,5.2533e-07,0.3506,0.40566,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,7.013e-05,0.35055,0.40742,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.010245,0.35033,0.24235,1,1
4,GO BONE RESORPTION,2.6902e-06,0.35023,0.41345,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.9301e-06,0.34938,0.3454,1,1
4,GO RESPONSE TO STEROL DEPLETION,0.00047456,0.34928,0.40715,1,1
4,GO SIGNAL PEPTIDE PROCESSING,3.7145e-05,0.34923,0.41607,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,2.9532e-05,0.34885,0.40124,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00014418,0.34883,0.29542,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00028792,0.34882,0.34411,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.0024367,0.34813,0.28525,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0047853,0.34798,0.3718,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00065623,0.34735,0.25255,1,1
4,GO ICOSANOID METABOLIC PROCESS,4.8379e-05,0.34705,0.34109,1,1
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00049035,0.34678,0.34573,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.010245,0.34579,0.18962,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0011199,0.34493,0.30868,1,1
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0028957,0.34492,0.30476,1,1
4,GO ANOIKIS,0.00014935,0.34435,0.27716,1,1
4,GO BILE ACID METABOLIC PROCESS,3.1888e-05,0.34411,0.39911,1,1
4,GO ETHER METABOLIC PROCESS,0.0030654,0.34374,0.22748,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.00052342,0.34348,0.27496,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0034322,0.34308,0.26133,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00050664,0.34296,0.27267,1,1
4,GO INSEMINATION,0.00050664,0.3424,0.33374,1,1
4,GO CARNITINE METABOLIC PROCESS,0.00092958,0.3422,0.2881,1,1
4,GO RESPONSE TO GROWTH HORMONE,2.1663e-05,0.34148,0.369,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00011241,0.34106,0.27892,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.0504e-05,0.34043,0.31883,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,9.7801e-06,0.33964,0.29784,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0023671,0.33916,0.29345,1,1
4,GO FATTY ACID CATABOLIC PROCESS,6.2985e-07,0.33907,0.34003,1,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0031536,0.33861,0.25782,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0006154,0.3373,0.27987,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00081984,0.33721,0.25694,1,1
4,GO RETINOL METABOLIC PROCESS,0.00038934,0.3372,0.45943,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.013465,0.33719,0.33888,1,1
4,GO MITOCHONDRIAL RNA PROCESSING,0.0021689,0.33718,0.2651,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0012662,0.33696,0.32205,1,1
4,GO RESPONSE TO LITHIUM ION,6.2786e-05,0.33664,0.42317,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00010462,0.33641,0.33369,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00055855,0.33635,0.28534,1,1
4,GO RESPONSE TO THYROID HORMONE,0.001872,0.33591,0.26146,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00026903,0.33577,0.30864,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.00098941,0.33551,0.37142,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,5.6174e-05,0.3352,0.42938,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.009256,0.33444,0.30852,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00012074,0.33408,0.30568,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.001228,0.33386,0.28511,1,1
4,GO N GLYCAN PROCESSING,0.010245,0.33327,0.23618,1,1
4,GO TRICARBOXYLIC ACID CYCLE,0.0028957,0.33322,0.25928,1,1
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.0075304,0.333,0.32007,1,1
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0011549,0.33297,0.28356,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,0.00036427,0.33275,0.32285,1,1
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0017641,0.33261,0.28243,1,1
4,GO CELL REDOX HOMEOSTASIS,8.7323e-05,0.33226,0.31179,1,1
4,GO LIVER MORPHOGENESIS,0.001662,0.33211,0.28029,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0022332,0.33175,0.31872,1,1
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.00065623,0.33111,0.34881,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,7.6603e-06,0.33045,0.33273,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00065623,0.33032,0.28226,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00067758,0.33028,0.43389,1,1
4,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.00074557,0.33017,0.31955,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0064317,0.33003,0.25951,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.038561,0.32991,0.24444,1,1
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,1.9263e-05,0.32925,0.32987,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.00098941,0.32839,0.30448,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0075304,0.32829,0.27656,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.00063551,0.32801,0.36072,1,1
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0079323,0.32764,0.32594,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0025817,0.32733,0.1948,1,1
4,GO TISSUE REMODELING,6.5149e-05,0.32706,0.28763,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0046564,0.32594,0.31692,1,1
4,GO UBIQUINONE METABOLIC PROCESS,6.7728e-06,0.32536,0.33387,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.32519,0.28492,1,1
4,GO MACROPHAGE PROLIFERATION,0.014841,0.32415,0.25394,1,1
4,GO RESPONSE TO MUSCLE ACTIVITY,0.01282,0.32367,0.22524,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.2962e-05,0.32365,0.28873,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.0060989,0.32338,0.20684,1,1
4,GO RESPONSE TO ANGIOTENSIN,0.0023671,0.32334,0.28619,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.013465,0.32331,0.20694,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.7596e-05,0.32302,0.28533,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.007729,0.32247,0.32537,1,1
4,GO FATTY ACID BETA OXIDATION,1.1493e-05,0.32141,0.29366,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0010528,0.32139,0.24096,1,1
4,GO STEROID HORMONE SECRETION,0.00353,0.32121,0.26633,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.7413e-06,0.32106,0.35467,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001986,0.32062,0.26987,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.2754e-05,0.32053,0.25484,1,1
4,GO ACUTE PHASE RESPONSE,0.00024286,0.32048,0.30135,1,1
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.014138,0.32027,0.22053,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.00037661,0.32014,0.34434,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00014418,0.32001,0.30972,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.0099891,0.31961,0.35702,1,1
4,GO STEROID METABOLIC PROCESS,1.2454e-05,0.31933,0.30719,1,1
4,GO PENTOSE METABOLIC PROCESS,0.014486,0.31912,0.21401,1,1
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0012662,0.31891,0.31971,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00031859,0.31834,0.36362,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.017549,0.31679,0.24182,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.00087311,0.31544,0.3235,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0006154,0.31542,0.26646,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00018427,0.31542,0.2603,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,1.3441e-06,0.31519,0.30812,1,1
4,GO TETRAPYRROLE METABOLIC PROCESS,0.00090094,0.31492,0.27329,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.00065623,0.31483,0.23155,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.00023468,0.31452,0.30658,1,1
4,GO RESPONSE TO FATTY ACID,0.00036427,0.3143,0.24179,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.0057817,0.3141,0.18979,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0036303,0.31386,0.27569,1,1
4,GO REGULATION OF CHLORIDE TRANSPORT,0.001986,0.31314,0.35843,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.0011549,0.31276,0.2873,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.023205,0.31249,0.26461,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0069616,0.31214,0.23013,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0028957,0.31191,0.33151,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0083534,0.31157,0.40063,1,1
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.024846,0.31143,0.23731,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,2.5774e-06,0.31088,0.36689,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00034072,0.3106,0.30619,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00032948,0.30927,0.27765,1,1
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0042883,0.30921,0.20836,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00040247,0.30908,0.27267,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0066042,0.30891,0.36583,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.012508,0.30856,0.21168,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00079435,0.30802,0.26062,1,1
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.011612,0.30768,0.23033,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013872,0.30658,0.22241,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,0.001662,0.30655,0.27198,1,1
4,GO INOSITOL METABOLIC PROCESS,7.0571e-06,0.30602,0.33514,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.02268,0.30547,0.24675,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.8282e-05,0.30531,0.24442,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0034322,0.30522,0.26136,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00092958,0.30445,0.25072,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.30368,0.2836,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.013139,0.30354,0.19407,1,1
4,GO MICROVILLUS ORGANIZATION,0.012508,0.30268,0.28067,1,1
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.001228,0.30255,0.20251,1,1
4,GO PHOSPHOLIPID EFFLUX,0.0017641,0.30176,0.33809,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,2.6307e-05,0.30166,0.26195,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00042998,0.30156,0.34337,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00017186,0.30155,0.272,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00063551,0.30078,0.3238,1,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.025994,0.30001,0.23565,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0071468,0.29945,0.24986,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0034322,0.29938,0.27965,1,1
4,GO TRANSCYTOSIS,0.00021909,0.29937,0.28932,1,1
4,GO PLATELET DEGRANULATION,0.0015653,0.29931,0.2366,1,1
4,GO POSITIVE REGULATION OF CELL SIZE,0.00084609,0.2982,0.29265,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.011326,0.2982,0.28043,1,1
4,GO METHIONINE METABOLIC PROCESS,0.00057693,0.29794,0.28716,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.016734,0.29722,0.31071,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00035231,0.29661,0.21228,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0010528,0.29643,0.30828,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.7791e-06,0.29637,0.2804,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0001165,0.29628,0.29522,1,1
4,GO ZYMOGEN INHIBITION,0.0066042,0.29614,0.20035,1,1
4,GO DIGESTIVE SYSTEM PROCESS,0.00030804,0.29564,0.26324,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,0.00057693,0.29535,0.2235,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0030654,0.2948,0.23506,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.0046564,0.2948,0.27239,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0028141,0.29479,0.26795,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00034072,0.29466,0.21516,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00098941,0.29453,0.24481,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0097392,0.29429,0.16286,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0021689,0.29421,0.20718,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.02268,0.29334,0.24768,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0026572,0.29326,0.38366,1,1
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.00084609,0.29262,0.24053,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0010528,0.29201,0.2711,1,1
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,5.4121e-05,0.29165,0.27039,1,1
4,GO AMINE METABOLIC PROCESS,6.5896e-07,0.29138,0.30438,1,1
4,GO CHYLOMICRON ASSEMBLY,0.017969,0.29125,0.29123,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00024286,0.29116,0.24478,1,1
4,GO REGULATION OF WOUND HEALING,0.00044439,0.29114,0.26314,1,1
4,GO STEROL METABOLIC PROCESS,0.00023468,0.291,0.2456,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.001191,0.29099,0.30055,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,0.00055855,0.29073,0.34881,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00016595,0.29067,0.36056,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.037747,0.29062,0.21557,1,1
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.0037331,0.29028,0.25124,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0010859,0.29026,0.25369,1,1
4,GO BONE REMODELING,3.8583e-05,0.29001,0.32403,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.016339,0.28952,0.26258,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0046564,0.28936,0.2878,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.0023671,0.28932,0.23341,1,1
4,GO ENDOCRINE PROCESS,0.00050664,0.28882,0.24419,1,1
4,GO ANIMAL ORGAN REGENERATION,0.0010859,0.28873,0.2043,1,1
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,6.0504e-05,0.28871,0.28823,1,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.00087311,0.28864,0.25606,1,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0041716,0.28854,0.34246,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0060989,0.28831,0.29277,1,1
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.016339,0.28801,0.3361,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0010528,0.2873,0.20827,1,1
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.015574,0.28706,0.22736,1,1
4,GO REGULATION OF ICOSANOID SECRETION,0.0029794,0.287,0.26984,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.00040247,0.28649,0.2888,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0015653,0.28638,0.27445,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,3.0689e-05,0.28622,0.29224,1,1
4,GO OXALATE TRANSPORT,0.00024286,0.28604,0.26582,1,1
4,GO LIPID LOCALIZATION,4.2876e-06,0.28593,0.27614,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.0073e-05,0.28554,0.28524,1,1
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.02843,0.28542,0.1678,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.0017123,0.28533,0.23935,1,1
4,GO HYALURONAN CATABOLIC PROCESS,0.014486,0.28521,0.14724,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,2.8418e-05,0.28511,0.25292,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0041716,0.28498,0.21552,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00067758,0.28467,0.22649,1,1
4,GO LYTIC VACUOLE ORGANIZATION,1.9904e-06,0.28465,0.31027,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0045306,0.28436,0.18323,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,8.1192e-05,0.28429,0.24131,1,1
4,GO RESPONSE TO LEUCINE,0.036164,0.28405,0.21408,1,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.0064317,0.28403,0.29061,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.023205,0.28402,0.30278,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0062634,0.28385,0.22425,1,1
4,GO AMYLOID BETA CLEARANCE,0.0026572,0.2837,0.20228,1,1
4,GO RESPONSE TO GONADOTROPIN,0.00055855,0.2834,0.26368,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0024367,0.28325,0.24578,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1.6455e-05,0.28309,0.24785,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.017137,0.28297,0.21347,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.009256,0.28291,0.20846,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.0059384,0.28275,0.20902,1,1
4,GO B CELL MEDIATED IMMUNITY,0.00059588,0.28272,0.22605,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0006154,0.28262,0.26759,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.004408,0.28246,0.21387,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00030804,0.28236,0.31508,1,1
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0049174,0.28167,0.25414,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,2.0833e-05,0.28156,0.24713,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0038387,0.28149,0.21728,1,1
4,GO REGULATION OF RESPIRATORY BURST,0.00035231,0.28142,0.29904,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.001662,0.28072,0.2279,1,1
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.0057817,0.28064,0.22271,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,0.00021909,0.28032,0.27987,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.0024367,0.28025,0.30527,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.8521e-05,0.28012,0.29595,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00027832,0.27972,0.3107,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00084609,0.27944,0.20534,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0056288,0.27909,0.1936,1,1
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.0054795,0.27901,0.30837,1,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0028141,0.27896,0.2912,1,1
4,GO AEROBIC RESPIRATION,0.00026003,0.2788,0.25757,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,0.00041602,0.27872,0.30744,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.0073e-05,0.27835,0.26923,1,1
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.03939,0.27823,0.16371,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.042857,0.27815,0.20769,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.014138,0.27807,0.2052,1,1
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0081404,0.27789,0.23076,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.00044439,0.27774,0.27033,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.2454e-05,0.27772,0.25772,1,1
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.052669,0.27758,0.23438,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0014299,0.27733,0.20531,1,1
4,GO REGULATION OF B CELL PROLIFERATION,8.7323e-05,0.27594,0.23512,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00014935,0.27587,0.28694,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00030804,0.27561,0.18838,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,4.8379e-05,0.27488,0.30251,1,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.010773,0.27487,0.20328,1,1
4,GO PH REDUCTION,0.00010845,0.27416,0.23855,1,1
4,GO MAST CELL ACTIVATION,0.00020448,0.27415,0.25458,1,1
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00047456,0.27406,0.2368,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00021909,0.27301,0.34337,1,1
4,GO STEROL HOMEOSTASIS,0.0006154,0.27301,0.31018,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.004408,0.27289,0.25838,1,1
4,GO HEME METABOLIC PROCESS,0.0056288,0.27255,0.30069,1,1
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0051916,0.27238,0.18099,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00092958,0.27238,0.29334,1,1
4,GO HORMONE METABOLIC PROCESS,0.00010462,0.2723,0.30607,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0034322,0.27228,0.2947,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00065623,0.27219,0.31927,1,1
4,GO FLUID TRANSPORT,2.2524e-05,0.27208,0.25777,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0057817,0.27199,0.25423,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0017123,0.2714,0.19425,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.001662,0.27139,0.21813,1,1
4,GO RESPONSE TO PROTOZOAN,0.00034072,0.2711,0.23699,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.026586,0.27089,0.21698,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0032441,0.27088,0.18119,1,1
4,GO PHAGOSOME MATURATION,5.8301e-05,0.27027,0.29524,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00095906,0.27022,0.24025,1,1
4,GO FUCOSE METABOLIC PROCESS,0.031059,0.27019,0.26478,1,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.0041716,0.27005,0.25808,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,0.0013457,0.27002,0.22902,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0012662,0.26983,0.19161,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0022992,0.26971,0.30301,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.6597e-05,0.26955,0.25269,1,1
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00041602,0.26941,0.33044,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.001872,0.26865,0.17649,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0036303,0.26864,0.22213,1,1
4,GO HEMOGLOBIN METABOLIC PROCESS,0.0094949,0.26843,0.23705,1,1
4,GO APICAL JUNCTION ASSEMBLY,0.004408,0.26816,0.26412,1,1
4,GO PEROXISOMAL TRANSPORT,2.6307e-05,0.2679,0.26189,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,8.7323e-05,0.26752,0.23489,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.00026903,0.26751,0.27578,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010206,0.26721,0.20107,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00019753,0.26714,0.2851,1,1
4,GO ALCOHOL METABOLIC PROCESS,5.2139e-05,0.26687,0.24783,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.0039469,0.26647,0.23069,1,1
4,GO VIRAL GENOME REPLICATION,0.018398,0.26645,0.14544,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00081984,0.26614,0.19023,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.0021689,0.26571,0.29517,1,1
4,GO REGULATION OF CELL KILLING,0.0022992,0.26546,0.20179,1,1
4,GO LIPID DROPLET ORGANIZATION,0.00034072,0.2654,0.26652,1,1
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0067808,0.26497,0.19314,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,2.0833e-05,0.26495,0.25284,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.010506,0.26485,0.38572,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00021167,0.26484,0.20995,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00050664,0.26475,0.2578,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.02843,0.26472,0.17475,1,1
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.00037661,0.26467,0.25772,1,1
4,GO MUSCLE CELL MIGRATION,0.0081404,0.26447,0.19244,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0042883,0.26425,0.20304,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.043763,0.26406,0.19093,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.013e-05,0.26379,0.25506,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0032441,0.26343,0.19768,1,1
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00065623,0.26321,0.28268,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0038387,0.26311,0.20415,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00035231,0.2631,0.33202,1,1
4,GO GRANULOCYTE DIFFERENTIATION,0.049546,0.26308,0.17498,1,1
4,GO CELL KILLING,0.00030804,0.2628,0.20557,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00031859,0.26275,0.25529,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,2.9301e-06,0.26249,0.31965,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.0050528,0.26244,0.18916,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0039469,0.26218,0.21074,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.0012662,0.26181,0.18031,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00092958,0.26131,0.20694,1,1
4,GO XENOBIOTIC TRANSPORT,9.7346e-05,0.26099,0.41078,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.00023468,0.26098,0.21782,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,2.9532e-05,0.26097,0.33661,1,1
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0090226,0.26086,0.25224,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.0551e-05,0.2608,0.23647,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0041716,0.26055,0.2516,1,1
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.031059,0.2604,0.2377,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.012508,0.26036,0.28197,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0015189,0.2603,0.16815,1,1
4,GO LIPID OXIDATION,2.9532e-05,0.26008,0.24921,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.7801e-06,0.25938,0.30587,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00013433,0.25894,0.25543,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,0.025414,0.25879,0.1975,1,1
4,GO ARACHIDONIC ACID SECRETION,0.00067758,0.25861,0.2386,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0023671,0.2584,0.18831,1,1
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.02843,0.258,0.18143,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0024367,0.25764,0.19668,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.001228,0.2573,0.19091,1,1
4,GO AMINO ACID ACTIVATION,0.0053338,0.25714,0.21174,1,1
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,6.2786e-05,0.2569,0.23571,1,1
4,GO SECRETION BY TISSUE,0.0011199,0.25686,0.24608,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00074557,0.25645,0.26196,1,1
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0047853,0.25628,0.37898,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.001986,0.25606,0.24268,1,1
4,GO ER OVERLOAD RESPONSE,0.0015653,0.25601,0.29676,1,1
4,GO FIBROBLAST PROLIFERATION,0.025994,0.25593,0.13823,1,1
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.030383,0.25577,0.19,1,1
4,GO ELECTRON TRANSPORT CHAIN,6.7596e-05,0.2555,0.2644,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.031059,0.25542,0.18585,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,8.7323e-05,0.25501,0.2535,1,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00050664,0.25482,0.33374,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.0012662,0.25455,0.29706,1,1
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.00054072,0.25431,0.22231,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.025414,0.25431,0.25577,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0013457,0.25408,0.22291,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00063551,0.25376,0.2836,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.044685,0.25332,0.2077,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.00018427,0.25325,0.27636,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.001986,0.25308,0.24735,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00017796,0.25304,0.24437,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.0011549,0.253,0.24483,1,1
4,GO ARGININE METABOLIC PROCESS,0.0075304,0.25293,0.36045,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0090226,0.25262,0.18772,1,1
4,GO NEUTROPHIL MIGRATION,1.349e-05,0.25238,0.2195,1,1
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.0010206,0.25224,0.26206,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00052342,0.25207,0.22505,1,1
4,GO MAST CELL MEDIATED IMMUNITY,0.00084609,0.25195,0.23359,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0020453,0.25169,0.23778,1,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0031536,0.25122,0.21939,1,1
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00021909,0.25115,0.25679,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0007696,0.25033,0.23534,1,1
4,GO PROTEIN HYDROXYLATION,0.0056288,0.25019,0.24195,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.00084609,0.25009,0.25118,1,1
4,GO B CELL PROLIFERATION,0.00018427,0.25002,0.19386,1,1
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0064317,0.24988,0.25063,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.040234,0.24984,0.1393,1,1
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.041093,0.24961,0.19353,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0038387,0.24935,0.17221,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00027832,0.24878,0.28043,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0049174,0.24844,0.20782,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0017123,0.2484,0.2252,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00012964,0.24838,0.2199,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.013798,0.24835,0.21032,1,1
4,GO RESPONSE TO PH,0.001191,0.24827,0.20553,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.0037331,0.24821,0.25472,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0057817,0.24811,0.16228,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.03939,0.24781,0.23416,1,1
4,GO MUSCLE HYPERTROPHY,0.00040247,0.24771,0.20815,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00050664,0.24766,0.26949,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0012662,0.2475,0.1806,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.00032948,0.24744,0.23125,1,1
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.029719,0.24742,0.15926,1,1
4,GO CARNITINE SHUTTLE,0.00098941,0.24728,0.25693,1,1
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.033166,0.24704,0.18347,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0007696,0.24692,0.26238,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0050528,0.24692,0.20309,1,1
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.016339,0.24691,0.14906,1,1
4,GO OSTEOBLAST PROLIFERATION,0.0019282,0.24683,0.26323,1,1
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.036164,0.24671,0.16294,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.029068,0.24669,0.17826,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.0016129,0.24666,0.30152,1,1
4,GO TRANSFERRIN TRANSPORT,6.7596e-05,0.2466,0.29838,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.034637,0.24658,0.13168,1,1
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.019739,0.24649,0.17668,1,1
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.0015189,0.24642,0.23125,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0029794,0.2464,0.20373,1,1
4,GO GOLGI VESICLE BUDDING,9.0551e-05,0.24615,0.23647,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.24553,0.23532,1,1
4,GO RENAL SODIUM EXCRETION,0.0024367,0.24542,0.20412,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.0028957,0.24525,0.36847,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.00079435,0.24504,0.17968,1,1
4,GO RESPONSE TO INSECTICIDE,0.018398,0.24477,0.31181,1,1
4,GO AMINO ACID IMPORT,0.015953,0.24465,0.18768,1,1
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0069616,0.24444,0.26446,1,1
4,GO PEPTIDE CATABOLIC PROCESS,0.0021062,0.24438,0.25031,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0045306,0.24436,0.19719,1,1
4,GO ENTRY INTO HOST,0.0039469,0.24429,0.19834,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.021165,0.24415,0.1449,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.001662,0.24402,0.18037,1,1
4,GO DOPAMINE TRANSPORT,0.013798,0.24398,0.26966,1,1
4,GO NOREPINEPHRINE SECRETION,0.0090226,0.24374,0.23448,1,1
4,GO COPII COATED VESICLE BUDDING,0.00017796,0.24364,0.22438,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,1.2962e-05,0.24358,0.23066,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001547,0.24346,0.20156,1,1
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.0046564,0.24306,0.23582,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0028141,0.24301,0.21421,1,1
4,GO RESPONSE TO PROGESTERONE,0.0050528,0.24299,0.1946,1,1
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0010528,0.24286,0.23467,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0057817,0.2423,0.20015,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0064317,0.24212,0.1836,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,0.00010845,0.24192,0.23108,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.00054072,0.24172,0.23618,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00032948,0.24133,0.24276,1,1
4,GO AUTOPHAGOSOME MATURATION,0.0006154,0.24116,0.22136,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.0032441,0.24101,0.36002,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.0099891,0.2409,0.36562,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.00021909,0.24016,0.28682,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0053338,0.23979,0.20247,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0032441,0.23958,0.17941,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.0021689,0.23954,0.24741,1,1
4,GO REGULATION OF ACTIN NUCLEATION,0.0022992,0.23936,0.26143,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0010859,0.23924,0.20086,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00047456,0.2392,0.225,1,1
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.036948,0.239,0.17368,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,0.00059588,0.23895,0.25348,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.052669,0.2389,0.30166,1,1
4,GO ALANINE TRANSPORT,0.0014299,0.23867,0.31602,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,9.0551e-05,0.23867,0.23354,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00013433,0.23853,0.21063,1,1
4,GO LOCOMOTOR RHYTHM,0.010773,0.23835,0.20083,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00021909,0.23796,0.21813,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00029782,0.23791,0.27511,1,1
4,GO MITOCHONDRIAL GENE EXPRESSION,0.010245,0.23777,0.16465,1,1
4,GO SPERM CAPACITATION,0.00098941,0.23735,0.23419,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,5.4121e-05,0.23725,0.25978,1,1
4,GO RESPONSE TO NUTRIENT,0.0047853,0.23701,0.16319,1,1
4,GO COPULATION,0.0030654,0.23662,0.21508,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.00021167,0.23659,0.2281,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.00014418,0.23656,0.4418,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.050569,0.23651,0.18163,1,1
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00010845,0.23602,0.22552,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00038934,0.23598,0.19106,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.013139,0.23577,0.18794,1,1
4,GO REGULATION OF B CELL ACTIVATION,7.013e-05,0.23559,0.21174,1,1
4,GO GOLGI TO VACUOLE TRANSPORT,0.0049174,0.23542,0.18282,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0010859,0.2354,0.27165,1,1
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.0079323,0.23539,0.17416,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0034322,0.23534,0.26414,1,1
4,GO P38MAPK CASCADE,0.0046564,0.23502,0.17546,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0015189,0.235,0.17041,1,1
4,GO TYPE 2 IMMUNE RESPONSE,0.01282,0.23488,0.17323,1,1
4,GO MAGNESIUM ION TRANSPORT,0.0014738,0.23468,0.23281,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0013054,0.2344,0.19923,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0022992,0.23432,0.19216,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00055855,0.23418,0.19897,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,8.3127e-06,0.23406,0.27612,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.00029782,0.23404,0.20259,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00032948,0.23404,0.24946,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.045624,0.23392,0.13912,1,1
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0025083,0.23391,0.18632,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.0045306,0.23371,0.18348,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.040234,0.23366,0.20853,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0071468,0.23362,0.17712,1,1
4,GO RESPONSE TO ACTIVITY,0.00084609,0.23348,0.21281,1,1
4,GO PEROXISOME ORGANIZATION,3.1888e-05,0.23344,0.24321,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00065623,0.23342,0.20885,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00021167,0.2334,0.23838,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00021909,0.23326,0.3007,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0040578,0.23294,0.19625,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.0028141,0.23258,0.42134,1,1
4,GO MITOCHONDRIAL TRANSLATION,0.024846,0.23245,0.1526,1,1
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.0010528,0.23238,0.1883,1,1
4,GO IMMUNE EFFECTOR PROCESS,0.00021909,0.23227,0.20821,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.015574,0.2321,0.15896,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.03939,0.23188,0.26514,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,8.1192e-05,0.23135,0.2316,1,1
4,GO VESICLE TARGETING,0.0015653,0.23129,0.21625,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.0013054,0.231,0.23423,1,1
4,GO REGULATION OF FERTILIZATION,0.0021689,0.23082,0.28783,1,1
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.030383,0.23066,0.16566,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0024367,0.23037,0.20199,1,1
4,GO GRANULOCYTE MIGRATION,5.2139e-05,0.23028,0.21917,1,1
4,GO LEUKOCYTE MIGRATION,0.0010528,0.23017,0.16697,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0022332,0.23011,0.18591,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,4.6623e-06,0.22966,0.23985,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0039469,0.22947,0.24512,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,1.0604e-05,0.22941,0.23547,1,1
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.00084609,0.22933,0.21927,1,1
4,GO MITOCHONDRIAL TRANSCRIPTION,0.013465,0.22929,0.19861,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0056288,0.22897,0.2084,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00010845,0.22897,0.29419,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.001986,0.22894,0.24921,1,1
4,GO MANNOSYLATION,1.7806e-05,0.22889,0.25401,1,1
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0066042,0.22865,0.16407,1,1
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.0032441,0.22864,0.18806,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00013433,0.22852,0.22679,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.00012074,0.22833,0.21037,1,1
4,GO MITOCHONDRIAL TRNA PROCESSING,0.0060989,0.22822,0.23762,1,1
4,GO PHOSPHOLIPID TRANSPORT,3.5759e-05,0.2282,0.22214,1,1
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0025817,0.22806,0.15918,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.0021062,0.22784,0.17472,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0014299,0.22777,0.19584,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0087944,0.22744,0.25516,1,1
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0066042,0.2273,0.20787,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0012662,0.22725,0.19253,1,1
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0081404,0.22701,0.18331,1,1
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.038561,0.22696,0.15334,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.0039469,0.22665,0.14767,1,1
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0023671,0.22659,0.18119,1,1
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0041716,0.22598,0.20894,1,1
4,GO RESPONSE TO ISCHEMIA,0.0011549,0.22554,0.22015,1,1
4,GO COMPLEMENT ACTIVATION,0.0081404,0.2255,0.18098,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00023468,0.22549,0.19206,1,1
4,GO LIPID STORAGE,0.0012662,0.22532,0.22454,1,1
4,GO AMELOGENESIS,0.02843,0.22513,0.19336,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0067808,0.22509,0.16136,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00021909,0.22496,0.23722,1,1
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.0049174,0.2249,0.21525,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.013798,0.22464,0.16289,1,1
4,GO LIPID EXPORT FROM CELL,0.001872,0.22463,0.25883,1,1
4,GO SELECTIVE AUTOPHAGY,3.5759e-05,0.2246,0.24307,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.00353,0.22415,0.18448,1,1
4,GO LIPID HOMEOSTASIS,0.00087311,0.22409,0.23868,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0036303,0.2237,0.2034,1,1
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.024288,0.2235,0.15366,1,1
4,GO INNATE IMMUNE RESPONSE,0.00027832,0.22343,0.19633,1,1
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0010206,0.22338,0.22187,1,1
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.0006154,0.22326,0.19154,1,1
4,GO CELL CHEMOTAXIS,0.00054072,0.22302,0.175,1,1
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.037747,0.223,0.13317,1,1
4,GO MITOPHAGY,0.001191,0.22291,0.19361,1,1
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.041967,0.22276,0.15002,1,1
4,GO ACETYL COA METABOLIC PROCESS,0.0022332,0.22264,0.20508,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00017796,0.22246,0.18186,1,1
4,GO CHEMOKINE PRODUCTION,0.011047,0.2224,0.14259,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.0020453,0.22235,0.22122,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00050664,0.22197,0.17626,1,1
4,GO RESPONSE TO CYTOKINE,0.00049035,0.22196,0.16877,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,6.5149e-05,0.22162,0.24349,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00098941,0.22162,0.21457,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,4.8379e-05,0.22122,0.22735,1,1
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.033894,0.2212,0.16639,1,1
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0083534,0.22082,0.21389,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0059384,0.22075,0.21178,1,1
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.020205,0.22058,0.15145,1,1
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.013465,0.22041,0.14707,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.00087311,0.22038,0.21053,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00028792,0.22037,0.17507,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.012508,0.22035,0.17705,1,1
4,GO CD40 SIGNALING PATHWAY,0.0033369,0.22024,0.16743,1,1
4,GO T CELL MEDIATED IMMUNITY,0.017969,0.21989,0.18456,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.03939,0.21966,0.14452,1,1
4,GO COAGULATION,0.0017123,0.21938,0.16313,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.0028141,0.21936,0.16932,1,1
4,GO WOUND HEALING,0.0067808,0.21933,0.14088,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.00014935,0.21902,0.21841,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.026586,0.21894,0.13569,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00012964,0.21881,0.21557,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00074557,0.21876,0.18665,1,1
4,GO HYALURONAN METABOLIC PROCESS,0.0026572,0.21868,0.14977,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0050528,0.21861,0.18319,1,1
4,GO VITAMIN TRANSPORT,0.0081404,0.21861,0.2239,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0010859,0.21835,0.21687,1,1
4,GO CORNIFICATION,0.0021689,0.21827,0.24425,1,1
4,GO REGULATION OF PH,0.00012074,0.21811,0.19975,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.020205,0.21803,0.14643,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.030383,0.21748,0.237,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00065623,0.21737,0.2433,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.029068,0.21723,0.13517,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.031748,0.21719,0.19435,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00012964,0.21674,0.2025,1,1
4,GO REGULATION OF CELLULAR PH,0.00012074,0.21672,0.20037,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,8.6584e-06,0.21645,0.2367,1,1
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0026572,0.21629,0.19272,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0021062,0.21625,0.18652,1,1
4,GO MYOBLAST FUSION,0.0034322,0.21617,0.20007,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00034072,0.21605,0.21385,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.00074557,0.21585,0.19911,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0054795,0.21561,0.17097,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.0047853,0.21548,0.17874,1,1
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.02843,0.21512,0.20223,1,1
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00026003,0.21504,0.24242,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.013465,0.21442,0.14528,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.041093,0.21416,0.1732,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.037747,0.21415,0.15777,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.02268,0.21414,0.20872,1,1
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0006154,0.21412,0.24571,1,1
4,GO GLYCOSYLATION,0.00016595,0.21392,0.22016,1,1
4,GO NUCLEOTIDE TRANSPORT,0.00026003,0.21385,0.21154,1,1
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0010206,0.21372,0.22737,1,1
4,GO ERK1 AND ERK2 CASCADE,0.015574,0.21353,0.12753,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.013798,0.21307,0.15014,1,1
4,GO INTERLEUKIN 12 PRODUCTION,0.00069957,0.21299,0.19345,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.6455e-05,0.21277,0.22058,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0017123,0.21257,0.16991,1,1
4,GO SPLEEN DEVELOPMENT,0.0056288,0.21229,0.15921,1,1
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.00028792,0.21206,0.19074,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.0026572,0.21205,0.16474,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0028141,0.21198,0.19229,1,1
4,GO REGULATION OF EXCRETION,0.03939,0.21196,0.15348,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.017549,0.2118,0.15417,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.0013457,0.21176,0.19283,1,1
4,GO OXIDATION REDUCTION PROCESS,2.5308e-05,0.21174,0.22039,1,1
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.017137,0.21167,0.15841,1,1
4,GO HORMONE CATABOLIC PROCESS,0.0040578,0.21165,0.41009,1,1
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.030383,0.21161,0.12726,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.0097392,0.21154,0.16443,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00092958,0.21149,0.15191,1,1
4,GO DEFENSE RESPONSE,0.00019079,0.2113,0.18629,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00052342,0.21085,0.21969,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.010245,0.21073,0.13822,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.041967,0.21067,0.211,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0033369,0.21064,0.14557,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.0099891,0.21063,0.23548,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.015574,0.21063,0.20218,1,1
4,GO REGULATION OF STEROL TRANSPORT,0.0081404,0.21061,0.17106,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0025817,0.21043,0.25331,1,1
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0060989,0.21039,0.23524,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.5201e-05,0.21036,0.22656,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.001872,0.21025,0.15888,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00353,0.21018,0.1622,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.4039e-05,0.21014,0.23317,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,1.5816e-05,0.2098,0.23506,1,1
4,GO LYMPHOCYTE MIGRATION,0.0024367,0.20978,0.16305,1,1
4,GO KERATINIZATION,0.0027346,0.2097,0.2022,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0036303,0.20962,0.15979,1,1
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0028957,0.20951,0.20859,1,1
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.036948,0.20943,0.16374,1,1
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0073363,0.20941,0.17826,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.037747,0.20936,0.12821,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.010506,0.20913,0.14953,1,1
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.0012662,0.20883,0.18909,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0049174,0.20881,0.18459,1,1
4,GO FATTY ACID TRANSPORT,3.5759e-05,0.20874,0.23105,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.0036303,0.20873,0.26461,1,1
4,GO AMINE CATABOLIC PROCESS,0.001986,0.2087,0.31683,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0013872,0.20807,0.16184,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0025817,0.20797,0.15325,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0001165,0.20785,0.18996,1,1
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0024367,0.20773,0.19757,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,2.6307e-05,0.20767,0.2128,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.00010092,0.20761,0.21528,1,1
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.010773,0.20754,0.17821,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.00018427,0.20754,0.19433,1,1
4,GO RESPONSE TO INTERLEUKIN 1,0.00025131,0.20754,0.17645,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0047853,0.2075,0.16387,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0033369,0.20748,0.18989,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.010773,0.20709,0.14447,1,1
4,GO CELLULAR RESPIRATION,0.00055855,0.207,0.21546,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.019283,0.20699,0.12514,1,1
4,GO PLATELET MORPHOGENESIS,0.001872,0.20679,0.22124,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00034072,0.20674,0.19063,1,1
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.0025817,0.20672,0.18095,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0047853,0.2067,0.20693,1,1
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.013465,0.20667,0.17975,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.00026003,0.20657,0.22324,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.010773,0.20656,0.21288,1,1
4,GO REGULATION OF TUBE SIZE,0.00049035,0.2061,0.20925,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0031536,0.20602,0.16054,1,1
4,GO MUSCLE ADAPTATION,0.00353,0.20553,0.15203,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.0013457,0.20522,0.15565,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00020448,0.20509,0.2656,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0045306,0.20502,0.27174,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0017641,0.20475,0.19192,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.010773,0.20462,0.21348,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.0054795,0.20455,0.27801,1,1
4,GO RESPONSE TO CHEMOKINE,0.00013917,0.20447,0.19817,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0036303,0.20416,0.24509,1,1
4,GO FATTY ACID METABOLIC PROCESS,7.2754e-05,0.20344,0.2327,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0047853,0.20342,0.17383,1,1
4,GO PROTEIN KINASE B SIGNALING,0.0064317,0.20342,0.13327,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.009256,0.20341,0.15832,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0067808,0.20335,0.24362,1,1
4,GO RESPONSE TO KETONE,0.001986,0.20303,0.16719,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0029794,0.20301,0.167,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.01282,0.20295,0.1676,1,1
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0027346,0.20287,0.18094,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0015189,0.20268,0.21263,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,0.00035231,0.20252,0.19769,1,1
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.034637,0.20246,0.10893,1,1
4,GO REGULATION OF LIPID STORAGE,0.0021689,0.20219,0.18497,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,0.0032441,0.20211,0.26645,1,1
4,GO ERAD PATHWAY,0.0075304,0.20208,0.15612,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.001662,0.20198,0.19026,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00057693,0.20192,0.16297,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.0027346,0.20173,0.19888,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0056288,0.20171,0.16382,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00018427,0.20155,0.16871,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.7346e-05,0.20149,0.21548,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00063551,0.20149,0.24128,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.0020453,0.20146,0.19408,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0038387,0.20129,0.13687,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.017969,0.20112,0.23397,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,3.7145e-05,0.20102,0.22256,1,1
4,GO REGULATION OF ISOTYPE SWITCHING,0.013139,0.20079,0.10642,1,1
4,GO T CELL MIGRATION,0.018398,0.2005,0.14443,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0079323,0.20039,0.15348,1,1
4,GO REGULATION OF LIPID LOCALIZATION,0.00052342,0.20012,0.2057,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,0.00081984,0.2,0.17423,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.05161,0.19989,0.13864,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0014299,0.19989,0.18971,1,1
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0049174,0.19942,0.23417,1,1
4,GO DETECTION OF BIOTIC STIMULUS,0.00353,0.19924,0.24534,1,1
4,GO TRNA 5 LEADER REMOVAL,0.01282,0.19922,0.16476,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.00038934,0.19914,0.17444,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0056288,0.19889,0.20907,1,1
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.035393,0.19876,0.24657,1,1
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.00027832,0.19871,0.23288,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.00079435,0.19868,0.21394,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.0047853,0.19852,0.16187,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00014418,0.19848,0.22972,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.00353,0.19832,0.18227,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.016734,0.19821,0.19299,1,1
4,GO MANGANESE ION TRANSPORT,0.00074557,0.19811,0.2143,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.0097392,0.1981,0.19978,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.001191,0.19785,0.23327,1,1
4,GO REGULATION OF MITOPHAGY,0.0030654,0.19772,0.18235,1,1
4,GO SYNCYTIUM FORMATION,0.0067808,0.1977,0.14886,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.004408,0.1975,0.15799,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.015574,0.19738,0.12651,1,1
4,GO INFLAMMATORY RESPONSE,0.00019079,0.19724,0.18489,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0032441,0.19717,0.15555,1,1
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.021165,0.19711,0.10918,1,1
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.013465,0.19697,0.14859,1,1
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.018836,0.19689,0.15282,1,1
4,GO PROTEASOME ASSEMBLY,0.0028141,0.19671,0.19793,1,1
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.020205,0.19654,0.28122,1,1
4,GO CARDIOLIPIN METABOLIC PROCESS,0.050569,0.19647,0.095083,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.011612,0.19623,0.12435,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.033166,0.19602,0.12085,1,1
4,GO CYTOKINE PRODUCTION,0.00087311,0.19565,0.16771,1,1
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.0007696,0.19541,0.20527,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00025131,0.19521,0.22547,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,0.00022676,0.19511,0.1768,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.023741,0.19508,0.19439,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.011904,0.1948,0.17543,1,1
4,GO WATER HOMEOSTASIS,0.0081404,0.19471,0.18846,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.023205,0.19444,0.1161,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.01282,0.19436,0.16561,1,1
4,GO DRUG METABOLIC PROCESS,0.0011199,0.19428,0.27799,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.010245,0.19428,0.1622,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.015953,0.19415,0.14316,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.017549,0.19393,0.13001,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0047853,0.19372,0.12832,1,1
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.014138,0.19351,0.20818,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.014486,0.1933,0.14431,1,1
4,GO TERPENOID METABOLIC PROCESS,0.018836,0.19326,0.17796,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.049546,0.19317,0.14242,1,1
4,GO HUMORAL IMMUNE RESPONSE,4.6597e-05,0.19299,0.19256,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.011047,0.19296,0.21273,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0011199,0.19278,0.15013,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0079323,0.19265,0.13132,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.00079435,0.19188,0.19461,1,1
4,GO PIGMENT METABOLIC PROCESS,0.007729,0.19185,0.18545,1,1
4,GO RESPONSE TO ETHER,0.00095906,0.19157,0.20592,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00050664,0.19147,0.16809,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0020453,0.19134,0.18798,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.014138,0.19134,0.19544,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0034322,0.19097,0.20177,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.00049035,0.19094,0.23477,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00010845,0.19054,0.21089,1,1
4,GO REGULATION OF HORMONE LEVELS,3.5759e-05,0.19042,0.20901,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00012964,0.19037,0.17474,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.0062634,0.19021,0.18416,1,1
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0023671,0.1902,0.18858,1,1
4,GO POLYAMINE METABOLIC PROCESS,0.0027346,0.19004,0.19984,1,1
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0021689,0.19001,0.18871,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00013917,0.18951,0.19902,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.029068,0.18934,0.12182,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0067808,0.1892,0.1824,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.00049035,0.18917,0.16872,1,1
4,GO PLATELET AGGREGATION,0.019283,0.18909,0.13658,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.012203,0.18909,0.17243,1,1
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0028957,0.18908,0.26736,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0031536,0.18905,0.17228,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00013917,0.18898,0.18319,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.5816e-05,0.18893,0.24587,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.03939,0.18832,0.18897,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0029794,0.1883,0.15909,1,1
4,GO OSTEOBLAST DEVELOPMENT,0.031748,0.18828,0.089506,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,9.0551e-05,0.18818,0.20162,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.0010528,0.1879,0.16899,1,1
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.046579,0.18786,0.21381,1,1
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0083534,0.18773,0.12449,1,1
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.035393,0.18697,0.15899,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.001228,0.18693,0.15815,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.001872,0.1869,0.14404,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.00021909,0.18685,0.19643,1,1
4,GO REGULATION OF ANION TRANSPORT,0.00057693,0.1867,0.21464,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0041716,0.18669,0.15903,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.001228,0.18663,0.20154,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.045624,0.1866,0.1292,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0015653,0.18629,0.15117,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00054072,0.18627,0.17049,1,1
4,GO RESPONSE TO VIRUS,0.0045306,0.18597,0.15919,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,0.00022676,0.18595,0.17305,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.013139,0.1859,0.14055,1,1
4,GO ESTROGEN METABOLIC PROCESS,0.0071468,0.1857,0.21192,1,1
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.031748,0.18569,0.16577,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0059384,0.18513,0.2103,1,1
4,GO RESPONSE TO INTERLEUKIN 4,0.0019282,0.18513,0.16761,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.0021689,0.18499,0.15808,1,1
4,GO RESPONSE TO STARVATION,3.5759e-05,0.18491,0.21878,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0054795,0.18475,0.12944,1,1
4,GO B CELL DIFFERENTIATION,0.0001165,0.18459,0.18928,1,1
4,GO POSITIVE CHEMOTAXIS,0.017549,0.18439,0.13029,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.004408,0.18427,0.13681,1,1
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0062634,0.18414,0.19338,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.0036303,0.18397,0.23881,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.00030804,0.18369,0.18054,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.013465,0.18361,0.1706,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0038387,0.18331,0.13355,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.00026903,0.18307,0.14785,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.049546,0.183,0.18669,1,1
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.016734,0.18298,0.22473,1,1
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00063551,0.18295,0.21703,1,1
4,GO NOREPINEPHRINE TRANSPORT,0.0062634,0.18291,0.21471,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.00069957,0.18262,0.15361,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0021062,0.18247,0.14707,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.023205,0.18246,0.1714,1,1
4,GO CELL ACTIVATION,0.00057693,0.18211,0.1595,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00044439,0.18196,0.16018,1,1
4,GO RESPONSE TO BACTERIUM,0.00045924,0.18173,0.17318,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0017641,0.18149,0.17743,1,1
4,GO FUCOSYLATION,0.041093,0.18136,0.21705,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00028792,0.18134,0.19414,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.017137,0.18125,0.19486,1,1
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.0042883,0.18082,0.17884,1,1
4,GO NIK NF KAPPAB SIGNALING,0.0014299,0.18082,0.14288,1,1
4,GO RESPONSE TO TESTOSTERONE,0.027803,0.18072,0.13746,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0085714,0.18067,0.17083,1,1
4,GO RESPONSE TO WOUNDING,0.015574,0.18059,0.11337,1,1
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.024846,0.18016,0.15656,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.0073e-05,0.17983,0.24354,1,1
4,GO LIPID CATABOLIC PROCESS,1.0184e-05,0.17976,0.24028,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0045306,0.17969,0.15962,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.0032441,0.17965,0.13049,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.00014418,0.17957,0.18409,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0017641,0.17949,0.23369,1,1
4,GO REGULATION OF PEPTIDE SECRETION,0.00016023,0.17892,0.15827,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00037661,0.17888,0.18217,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00040247,0.17885,0.16308,1,1
4,GO MEMBRANE FUSION,0.00079435,0.17876,0.17356,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.5308e-05,0.17864,0.24447,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.010245,0.17859,0.12224,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.001662,0.1785,0.17607,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.0010528,0.17846,0.16798,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.00023468,0.17801,0.21005,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.0090226,0.17789,0.14569,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.0013054,0.17788,0.16604,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.0025083,0.17785,0.15009,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.018836,0.17773,0.14918,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.017549,0.17767,0.12557,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0013054,0.17766,0.17514,1,1
4,GO HORMONE BIOSYNTHETIC PROCESS,0.012508,0.17762,0.19551,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00079435,0.17761,0.17858,1,1
4,GO LIPID METABOLIC PROCESS,0.00016023,0.17747,0.1807,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,0.00038934,0.17747,0.19372,1,1
4,GO VACUOLE ORGANIZATION,1.8521e-05,0.17745,0.21304,1,1
4,GO ORGANELLE FUSION,0.00021909,0.17736,0.17887,1,1
4,GO RENAL SYSTEM PROCESS,0.0021689,0.17733,0.18061,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0037331,0.17727,0.14498,1,1
4,GO ENERGY HOMEOSTASIS,0.025414,0.17708,0.15722,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.0045306,0.17687,0.14023,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0075304,0.17678,0.17709,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.023741,0.17675,0.14516,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,7.547e-05,0.17675,0.13733,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.015953,0.17651,0.16154,1,1
4,GO ORGANIC ANION TRANSPORT,1.7806e-05,0.17644,0.20965,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,3.5759e-05,0.17641,0.23236,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0010859,0.17636,0.1743,1,1
4,GO RESPONSE TO ALCOHOL,0.001191,0.17624,0.1402,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.017549,0.17598,0.15528,1,1
4,GO PEPTIDE SECRETION,9.7346e-05,0.17589,0.1671,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.009256,0.17583,0.17463,1,1
4,GO LEUKOCYTE PROLIFERATION,0.0016129,0.17577,0.15584,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0001547,0.17571,0.16165,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00072223,0.17517,0.16713,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.0037331,0.17516,0.18604,1,1
4,GO B CELL ACTIVATION,0.00027832,0.17504,0.16499,1,1
4,GO EXOCYTOSIS,0.00012074,0.17491,0.18353,1,1
4,GO PLATELET ACTIVATION,0.013465,0.17477,0.12695,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0010206,0.17457,0.16856,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0069616,0.17385,0.14535,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.033894,0.17365,0.12819,1,1
4,GO VIRION ASSEMBLY,0.0025817,0.17347,0.14134,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.001191,0.17331,0.14115,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.011047,0.17324,0.17601,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0046564,0.17318,0.13945,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00047456,0.17302,0.16891,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.001228,0.17297,0.20139,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00036427,0.17293,0.14985,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00030804,0.17291,0.15023,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.0024367,0.17248,0.14971,1,1
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.02166,0.17242,0.14316,1,1
4,GO CARBOHYDRATE TRANSPORT,0.00024286,0.17239,0.20128,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0032441,0.17181,0.18379,1,1
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.0075304,0.17159,0.17769,1,1
4,GO IMMUNOGLOBULIN PRODUCTION,0.00040247,0.17159,0.14518,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0028957,0.17144,0.14546,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.030383,0.17127,0.17314,1,1
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.017969,0.171,0.16618,1,1
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.040234,0.1706,0.16048,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.00072223,0.1706,0.15048,1,1
4,GO VASCULAR WOUND HEALING,0.046579,0.17059,0.23192,1,1
4,GO DIOL METABOLIC PROCESS,0.010506,0.17035,0.24148,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.011904,0.16994,0.1853,1,1
4,GO TOXIN TRANSPORT,0.0047853,0.16989,0.18854,1,1
4,GO REGULATION OF HORMONE SECRETION,0.0013872,0.16963,0.1507,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.00032948,0.16955,0.18449,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.00027832,0.16918,0.15644,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00018427,0.16902,0.17565,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0012662,0.16879,0.14875,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0028957,0.16865,0.16542,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.030383,0.16859,0.14867,1,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.011047,0.16841,0.1535,1,1
4,GO EXCRETION,0.0015653,0.16788,0.17518,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.014841,0.16771,0.16743,1,1
4,GO B CELL HOMEOSTASIS,0.011326,0.16762,0.16865,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0050528,0.16756,0.15549,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.011612,0.16734,0.14521,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00026903,0.16702,0.21833,1,1
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.03245,0.167,0.17792,1,1
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.007729,0.16658,0.1423,1,1
4,GO THIOESTER METABOLIC PROCESS,0.0010859,0.16634,0.18927,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,8.1192e-05,0.16633,0.19926,1,1
4,GO CELLULAR PIGMENTATION,0.0049174,0.16632,0.14625,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,0.0030654,0.16629,0.17599,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0025083,0.16609,0.15411,1,1
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.02843,0.16579,0.12343,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00010462,0.16578,0.16918,1,1
4,GO PROTEIN PROCESSING,5.4121e-05,0.16573,0.23066,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.00049035,0.16564,0.18998,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.00040247,0.16525,0.18376,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.018398,0.16508,0.1562,1,1
4,GO PROTEIN REFOLDING,0.014841,0.165,0.19134,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0015189,0.16482,0.14957,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0034322,0.16447,0.14753,1,1
4,GO GLUCOSE METABOLIC PROCESS,5.508e-06,0.1641,0.22733,1,1
4,GO VIRAL LIFE CYCLE,0.0045306,0.16388,0.12551,1,1
4,GO NECROTIC CELL DEATH,0.0046564,0.16388,0.17365,1,1
4,GO COPPER ION TRANSPORT,0.018398,0.16378,0.16067,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0057817,0.16375,0.12666,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.012203,0.16342,0.12493,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0031536,0.16291,0.12113,1,1
4,GO CHOLESTEROL STORAGE,0.03245,0.16267,0.17254,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.014138,0.16255,0.11044,1,1
4,GO RESPONSE TO STEROL,0.0071468,0.16225,0.21831,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00055855,0.1618,0.19192,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0014738,0.16174,0.20209,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.042857,0.16168,0.13837,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,0.001191,0.16164,0.12877,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.8379e-05,0.16151,0.20132,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00019753,0.16134,0.15323,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.014138,0.16131,0.12988,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0026572,0.1612,0.12887,1,1
4,GO T CELL DIFFERENTIATION,0.0019282,0.16118,0.12167,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0071468,0.16089,0.1847,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.02166,0.16088,0.10679,1,1
4,GO ADAPTIVE THERMOGENESIS,0.00069957,0.1607,0.15225,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00095906,0.16063,0.16609,1,1
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0067808,0.16061,0.166,1,1
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.010506,0.16045,0.1947,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.014138,0.16045,0.12972,1,1
4,GO ATP TRANSPORT,0.043763,0.16036,0.098806,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.00017796,0.16032,0.22778,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.018836,0.15986,0.095919,1,1
4,GO TISSUE HOMEOSTASIS,0.0045306,0.15979,0.14965,1,1
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0067808,0.1596,0.10437,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.011326,0.1591,0.10549,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0087944,0.15904,0.11582,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0014299,0.15841,0.13061,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00036427,0.15824,0.15548,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0024367,0.15822,0.12242,1,1
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.024288,0.15818,0.12924,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.0054795,0.15804,0.11689,1,1
4,GO REGULATION OF PROTEIN FOLDING,0.038561,0.15789,0.11019,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.013465,0.15766,0.12558,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0085714,0.15715,0.15956,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.010773,0.15714,0.1416,1,1
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0046564,0.15678,0.167,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00021909,0.15676,0.19117,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0013872,0.15648,0.18602,1,1
4,GO REGULATION OF VASOCONSTRICTION,0.0016129,0.15646,0.19814,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.018398,0.15626,0.1213,1,1
4,GO PROTEIN MANNOSYLATION,0.0028141,0.15617,0.16445,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.00047456,0.15615,0.20418,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.011612,0.15605,0.13044,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.043763,0.15591,0.12368,1,1
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.0054795,0.15489,0.14951,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.013465,0.15486,0.15658,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.025994,0.15484,0.13765,1,1
4,GO PROTEIN MATURATION,0.00016023,0.15424,0.19098,1,1
4,GO REGULATION OF BLOOD PRESSURE,0.00022676,0.15391,0.18422,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0066042,0.15388,0.15998,1,1
4,GO SODIUM ION HOMEOSTASIS,0.03939,0.15376,0.13046,1,1
4,GO KERATINOCYTE DIFFERENTIATION,0.0031536,0.15372,0.18175,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0012662,0.15368,0.19699,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0049174,0.15366,0.15593,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00072223,0.15361,0.17365,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.001228,0.15356,0.16085,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0054795,0.15346,0.11423,1,1
4,GO RESPONSE TO DSRNA,0.0037331,0.15297,0.13685,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0031536,0.15273,0.1308,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.042857,0.15263,0.1325,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0007696,0.15259,0.16304,1,1
4,GO T CELL APOPTOTIC PROCESS,0.020205,0.15249,0.13354,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.025414,0.15243,0.13378,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0064317,0.15223,0.15137,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.050569,0.15216,0.15286,1,1
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.0041716,0.15193,0.15829,1,1
4,GO DE NOVO PROTEIN FOLDING,0.00353,0.15189,0.16804,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.00022676,0.15184,0.18554,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.0025817,0.15184,0.10719,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.0045306,0.15178,0.11347,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.010245,0.15153,0.1496,1,1
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0032441,0.15122,0.20075,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00044439,0.15116,0.15244,1,1
4,GO GOLGI ORGANIZATION,4.8379e-05,0.15093,0.18175,1,1
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0018173,0.1508,0.25606,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00012964,0.15078,0.18979,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0040578,0.15074,0.1606,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0012662,0.15061,0.13623,1,1
4,GO MACROPHAGE ACTIVATION,0.0011549,0.15041,0.14348,1,1
4,GO ANION TRANSPORT,4.4878e-05,0.1504,0.18256,1,1
4,GO MITOCHONDRIAL FISSION,0.021165,0.15028,0.17224,1,1
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.033894,0.14984,0.12826,1,1
4,GO BICARBONATE TRANSPORT,0.0067808,0.14928,0.17816,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.007729,0.14925,0.14809,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0066042,0.14912,0.15971,1,1
4,GO CHOLESTEROL EFFLUX,0.0094949,0.14909,0.1785,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0066042,0.14818,0.14413,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.013139,0.14814,0.121,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00081984,0.148,0.17444,1,1
4,GO AGING,0.0013457,0.14787,0.12882,1,1
4,GO RESPONSE TO GAMMA RADIATION,0.007729,0.1477,0.11618,1,1
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0083534,0.14756,0.14887,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.052669,0.14749,0.10156,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0021689,0.14748,0.16734,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.047551,0.14744,0.093164,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.030383,0.14743,0.11604,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0026572,0.14741,0.16723,1,1
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.0019282,0.14738,0.16024,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00035231,0.14722,0.16301,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00079435,0.14654,0.13758,1,1
4,GO ORGANELLE DISASSEMBLY,0.00014935,0.14649,0.16851,1,1
4,GO DEFENSE RESPONSE TO FUNGUS,0.017137,0.14645,0.11059,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.024288,0.14638,0.13723,1,1
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.014486,0.14622,0.18376,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0056288,0.14595,0.14513,1,1
4,GO CERAMIDE METABOLIC PROCESS,0.00095906,0.14555,0.18044,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0051916,0.14538,0.11311,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.038561,0.14495,0.20164,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.011047,0.14484,0.097693,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00095906,0.14478,0.13272,1,1
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.00067758,0.14459,0.16162,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00014935,0.14454,0.1665,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.036164,0.1443,0.13224,1,1
4,GO REPLICATIVE SENESCENCE,0.015574,0.14421,0.18991,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.015574,0.14402,0.13986,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.0087944,0.14379,0.12479,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0045306,0.14338,0.15357,1,1
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.02166,0.14321,0.16438,1,1
4,GO ORGANIC ACID TRANSPORT,5.4121e-05,0.14295,0.21312,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.0060989,0.1424,0.1758,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.023741,0.14236,0.14159,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.011326,0.14219,0.16105,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.010245,0.14191,0.11189,1,1
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.015574,0.14141,0.12195,1,1
4,GO T CELL ACTIVATION,0.0071468,0.14124,0.11801,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.0015653,0.14104,0.14243,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0014738,0.14097,0.16492,1,1
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.012203,0.14094,0.14471,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.0010528,0.14084,0.15859,1,1
4,GO CHEMICAL HOMEOSTASIS,0.00050664,0.14063,0.13659,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00021167,0.14039,0.17915,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0085714,0.14038,0.10249,1,1
4,GO RESPONSE TO STEROID HORMONE,0.0027346,0.14029,0.14521,1,1
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.029719,0.14025,0.17597,1,1
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.034637,0.14023,0.20955,1,1
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.021165,0.14023,0.086235,1,1
4,GO RESPONSE TO HORMONE,0.0015653,0.13995,0.13183,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.009256,0.13994,0.1309,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.015953,0.13962,0.12957,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00041602,0.13943,0.1488,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00044439,0.13923,0.1258,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,0.0023671,0.13911,0.15636,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00095906,0.13905,0.12694,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0085714,0.13899,0.10646,1,1
4,GO VITAMIN METABOLIC PROCESS,0.013465,0.1389,0.1773,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00092958,0.13888,0.14623,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0028141,0.13884,0.14626,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0071468,0.13865,0.14147,1,1
4,GO IRON ION TRANSPORT,0.00026003,0.13853,0.21441,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0025083,0.13846,0.13199,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.00084609,0.13806,0.16915,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.015203,0.13789,0.089584,1,1
4,GO PHAGOCYTOSIS,0.024846,0.13778,0.10361,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,0.00019079,0.1375,0.14775,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0053338,0.13734,0.16139,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0030654,0.13718,0.12704,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.020205,0.13701,0.13156,1,1
4,GO RESPONSE TO DRUG,0.007729,0.13693,0.12666,1,1
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.033894,0.13668,0.11844,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.019283,0.13658,0.13296,1,1
4,GO VESICLE ORGANIZATION,0.001228,0.13599,0.14859,1,1
4,GO SECRETION,0.00028792,0.13587,0.15079,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.019283,0.13585,0.15675,1,1
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.015953,0.13578,0.19212,1,1
4,GO RESPONSE TO LIPID,0.0042883,0.13571,0.11749,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0041716,0.13551,0.12509,1,1
4,GO WATER TRANSPORT,0.026586,0.1355,0.10024,1,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.037747,0.13514,0.13909,1,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.036164,0.13511,0.12198,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00087311,0.1351,0.15115,1,1
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.001662,0.13499,0.14318,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.007729,0.13493,0.10025,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.0049174,0.13467,0.15487,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,9.7346e-05,0.13467,0.18052,1,1
4,GO LYSOSOME LOCALIZATION,0.0067808,0.13462,0.13117,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0049174,0.13427,0.11797,1,1
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.052669,0.13386,0.11288,1,1
4,GO T CELL PROLIFERATION,0.012508,0.13374,0.12469,1,1
4,GO GOLGI RIBBON FORMATION,0.021165,0.13356,0.15571,1,1
4,GO LIPID MODIFICATION,0.00055855,0.13355,0.16072,1,1
4,GO PROTEIN FOLDING,0.010245,0.1333,0.12876,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0022992,0.13273,0.16455,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00353,0.1326,0.11266,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0081404,0.13238,0.13701,1,1
4,GO REGULATION OF APPETITE,0.047551,0.13186,0.092237,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0097392,0.13134,0.11755,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.0024367,0.13128,0.20244,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00032948,0.13125,0.1447,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.001191,0.13104,0.14043,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.01282,0.13057,0.16101,1,1
4,GO RESPONSE TO UV C,0.041093,0.13043,0.14477,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.020205,0.12975,0.12065,1,1
4,GO VIRAL BUDDING,0.0073363,0.12945,0.13853,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0037331,0.12927,0.1198,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.021165,0.12881,0.13004,1,1
4,GO REGULATION OF HEMOPOIESIS,0.0033369,0.12816,0.10881,1,1
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.041093,0.12809,0.096513,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.0014299,0.12777,0.15001,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00079435,0.12753,0.17929,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0030654,0.12745,0.11409,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.00084609,0.12717,0.16575,1,1
4,GO INORGANIC ANION TRANSPORT,0.0006154,0.12715,0.13338,1,1
4,GO MUSCLE CELL PROLIFERATION,0.050569,0.12713,0.080805,1,1
4,GO METAL ION HOMEOSTASIS,0.012508,0.12698,0.1005,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0007696,0.12692,0.14627,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.019283,0.12683,0.091322,1,1
4,GO BODY FLUID SECRETION,0.023741,0.12667,0.098303,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0039469,0.12645,0.12756,1,1
4,GO REGULATION OF CELL ADHESION,0.017969,0.12625,0.10705,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.0025083,0.12615,0.1169,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.0066042,0.12604,0.12082,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0016129,0.12601,0.11356,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.033166,0.12595,0.13095,1,1
4,GO ION HOMEOSTASIS,0.0040578,0.12579,0.1143,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.050569,0.12546,0.10784,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.0038387,0.12447,0.1291,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.014486,0.1243,0.11433,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.023741,0.12421,0.1292,1,1
4,GO CYTOKINE SECRETION,0.011047,0.12417,0.12603,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00353,0.12416,0.13233,1,1
4,GO RESPONSE TO FUNGUS,0.013465,0.12399,0.10503,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0045306,0.12395,0.12912,1,1
4,GO LYMPHOCYTE ACTIVATION,0.0067808,0.12379,0.10376,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.041093,0.12369,0.097727,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.004408,0.12313,0.1307,1,1
4,GO STEROL IMPORT,0.009256,0.12309,0.28995,1,1
4,GO SYMBIOTIC PROCESS,0.010245,0.12303,0.092802,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0041716,0.12298,0.09939,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00031859,0.12289,0.14778,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.011612,0.12274,0.12337,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0013054,0.12252,0.12831,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0050528,0.12182,0.12835,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.026586,0.12162,0.11154,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00045924,0.12157,0.19705,1,1
4,GO RESPONSE TO INSULIN,0.001191,0.12157,0.14092,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0010859,0.12102,0.12546,1,1
4,GO PROTEOLYSIS,0.00050664,0.12012,0.12381,1,1
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.02268,0.12008,0.12086,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0042883,0.11998,0.12181,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.041093,0.11988,0.10679,1,1
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.001191,0.11974,0.15894,1,1
4,GO PEPTIDE METABOLIC PROCESS,0.037747,0.11972,0.089605,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00026903,0.11963,0.15804,1,1
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.0071468,0.11942,0.139,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0099891,0.11906,0.09211,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0028957,0.11851,0.12109,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.025414,0.11829,0.1058,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0025817,0.11754,0.13418,1,1
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0099891,0.11741,0.11588,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.00092958,0.11709,0.11867,1,1
4,GO PYRUVATE METABOLIC PROCESS,0.024846,0.11695,0.1099,1,1
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.017969,0.11645,0.14456,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.034637,0.11608,0.090024,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.0017123,0.11598,0.17431,1,1
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.031059,0.11587,0.072181,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.001872,0.11579,0.10093,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00013433,0.11574,0.16257,1,1
4,GO PROTEIN DESTABILIZATION,0.014138,0.11572,0.10118,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.045624,0.1155,0.11867,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0023671,0.11541,0.11905,1,1
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.012203,0.11519,0.10875,1,1
4,GO URONIC ACID METABOLIC PROCESS,0.0067808,0.1145,0.19911,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.009256,0.11436,0.12076,1,1
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036948,0.11393,0.095372,1,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.010506,0.11389,0.11113,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0045306,0.11332,0.099897,1,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.02268,0.1133,0.091653,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.010506,0.11328,0.10974,1,1
4,GO ATP METABOLIC PROCESS,0.0045306,0.11301,0.13321,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,0.00072223,0.1127,0.11168,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0047853,0.11261,0.1176,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0039469,0.11251,0.10167,1,1
4,GO ENDOSOME ORGANIZATION,0.0046564,0.11243,0.14184,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0054795,0.11237,0.11392,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0075304,0.11217,0.13546,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.00032948,0.11163,0.14537,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.012508,0.11038,0.09534,1,1
4,GO POSITIVE REGULATION OF SECRETION,0.00034072,0.11032,0.14784,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.013798,0.11017,0.14044,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0028141,0.1101,0.11619,1,1
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.03245,0.10962,0.13103,1,1
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.043763,0.10961,0.11069,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0064317,0.10942,0.1056,1,1
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.018836,0.10927,0.097589,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0047853,0.10918,0.10888,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.010773,0.10916,0.096674,1,1
4,GO BLASTOCYST FORMATION,0.031748,0.1089,0.14096,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.013798,0.10884,0.099417,1,1
4,GO REGULATION OF PROTEIN BINDING,0.014138,0.10817,0.10933,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0015653,0.10805,0.13702,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.047551,0.10803,0.091949,1,1
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.017137,0.10788,0.12353,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0012662,0.10764,0.11934,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.029719,0.10723,0.093752,1,1
4,GO DETECTION OF STIMULUS,0.0046564,0.10718,0.088749,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.015203,0.10713,0.10042,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.00353,0.10712,0.15427,1,1
4,GO TISSUE MIGRATION,0.017969,0.10698,0.12031,1,1
4,GO EPITHELIUM DEVELOPMENT,0.013798,0.10633,0.087919,1,1
4,GO RESPONSE TO PEPTIDE,0.0064317,0.10601,0.094036,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.019283,0.1056,0.11492,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.03939,0.10518,0.095703,1,1
4,GO GLAND DEVELOPMENT,0.045624,0.1051,0.067318,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0069616,0.10485,0.11043,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.030383,0.10478,0.10545,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0067808,0.10463,0.1897,1,1
4,GO SOMITOGENESIS,0.013139,0.10429,0.10753,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.045624,0.10425,0.094761,1,1
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.013139,0.10336,0.13466,1,1
4,GO REGULATION OF CELL DEATH,0.010773,0.10288,0.083823,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0029794,0.10287,0.10305,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.004408,0.10284,0.10222,1,1
4,GO NEGATIVE REGULATION OF CELL DEATH,0.010506,0.10276,0.088639,1,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.027803,0.10271,0.073213,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.014138,0.10267,0.10256,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00074557,0.10244,0.14583,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.0081404,0.10216,0.10865,1,1
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.0097392,0.10175,0.10913,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.017549,0.10129,0.10299,1,1
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.029719,0.10095,0.086133,1,1
4,GO LYMPH NODE DEVELOPMENT,0.02843,0.10033,0.16296,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0071468,0.1003,0.10717,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.0099891,0.10006,0.10944,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.009256,0.1,0.093125,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0067808,0.09997,0.084744,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.019739,0.099872,0.083354,1,1
4,GO RESPONSE TO ESTRADIOL,0.04854,0.099803,0.079487,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0049174,0.099753,0.12591,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.019283,0.099523,0.096254,1,1
4,GO HOMEOSTATIC PROCESS,0.00049035,0.099521,0.11233,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.022165,0.099191,0.10324,1,1
4,GO FEEDING BEHAVIOR,0.041967,0.098187,0.11078,1,1
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.046579,0.097672,0.065138,1,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.0046564,0.09737,0.11058,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0029794,0.097107,0.11889,1,1
4,GO TOR SIGNALING,0.0057817,0.096753,0.078851,1,1
4,GO CELL MATURATION,0.017137,0.096314,0.089084,1,1
4,GO PROTEIN STABILIZATION,0.011904,0.096232,0.092506,1,1
4,GO MACROPHAGE DIFFERENTIATION,0.047551,0.095982,0.14833,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.033166,0.095842,0.085118,1,1
4,GO APOPTOTIC PROCESS,0.012203,0.09514,0.082211,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.012508,0.094713,0.10858,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0028141,0.09466,0.10723,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.025414,0.094041,0.08104,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.0057817,0.093853,0.093783,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.041967,0.09381,0.12731,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0017123,0.093756,0.12428,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.02268,0.093405,0.096739,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.033166,0.093283,0.088096,1,1
4,GO CYTOSOLIC TRANSPORT,0.001986,0.093246,0.11173,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0097392,0.092608,0.10815,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.023741,0.092141,0.069123,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.0034322,0.091686,0.10408,1,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.015574,0.091644,0.084057,1,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.034637,0.091122,0.1066,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.040234,0.090071,0.06737,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0037331,0.089758,0.089863,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0040578,0.089419,0.10312,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.031059,0.088809,0.078274,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0017123,0.088711,0.096205,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.01282,0.088358,0.076629,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.015574,0.08809,0.10185,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.043763,0.087755,0.064542,1,1
4,GO REGULATION OF MAPK CASCADE,0.016339,0.087654,0.09578,1,1
4,GO MYELOID CELL HOMEOSTASIS,0.022165,0.086761,0.095737,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.0085714,0.086685,0.10582,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.025994,0.084637,0.10024,1,1
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.027803,0.084144,0.13174,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.044685,0.083502,0.09586,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.019739,0.083293,0.073606,1,1
4,GO MACROMOLECULE CATABOLIC PROCESS,0.015953,0.083107,0.063505,1,1
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.025414,0.082442,0.11383,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.010773,0.081256,0.081288,1,1
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.042857,0.079932,0.09102,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.01282,0.079797,0.095366,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0057817,0.079525,0.080926,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0081404,0.078815,0.081126,1,1
4,GO SPERM EGG RECOGNITION,0.037747,0.078581,0.10102,1,1
4,GO VESICLE LOCALIZATION,0.030383,0.078508,0.089721,1,1
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.021165,0.077873,0.060323,1,1
4,GO REGULATION OF TOR SIGNALING,0.011326,0.077455,0.085733,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.037747,0.076461,0.070279,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0075304,0.075877,0.1138,1,1
4,GO CELLULAR HOMEOSTASIS,0.007729,0.074895,0.10047,1,1
4,GO MITOCHONDRION ORGANIZATION,0.0030654,0.074121,0.11021,1,1
4,GO GOLGI VESICLE TRANSPORT,0.0083534,0.07412,0.10844,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.013798,0.072705,0.094551,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0042883,0.071136,0.11831,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.013798,0.069171,0.079692,1,1
4,GO DNA CATABOLIC PROCESS,0.017969,0.067745,0.076268,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.025414,0.067342,0.075306,1,1
4,GO POLYOL METABOLIC PROCESS,0.033894,0.066985,0.10431,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.023205,0.065624,0.090241,1,1
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.05161,0.064423,0.065301,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.02843,0.064105,0.066887,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.035393,0.063795,0.070517,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.024846,0.06336,0.078795,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.024846,0.062854,0.071982,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.021165,0.058308,0.074103,1,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.013798,0.05541,0.092012,1,1
4,GO INTRACELLULAR TRANSPORT,0.0051916,0.054562,0.070717,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.02068,0.054076,0.068106,1,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.016339,0.053053,0.056536,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.018398,0.051948,0.067328,1,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.015953,0.047617,0.074138,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0097392,0.046732,0.071514,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.046579,0.045235,0.062255,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.00020448,1.4705,1.1646,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,7.8282e-05,1.3173,1.0222,1,1
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,3.3132e-05,1.2543,1.1181,1,1
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,2.5774e-06,1.0832,1.0892,1,1
5,GO CYTIDINE TO URIDINE EDITING,5.2837e-06,0.93805,0.83425,1,1
5,GO RESPONSE TO INTERFERON ALPHA,8.1192e-05,0.92742,0.68837,1,1
5,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.2786e-05,0.8948,0.77637,1,1
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00032948,0.88604,0.64996,1,1
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,1.349e-05,0.84157,0.6488,1,1
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,1.5816e-05,0.82332,0.66799,1,1
5,GO TOLERANCE INDUCTION,3.3132e-05,0.81912,0.67817,1,1
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00044439,0.80821,0.53176,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00047456,0.77503,0.55048,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.5308e-05,0.76102,0.62228,1,1
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,2.0833e-05,0.74274,0.72212,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00010462,0.70658,0.49538,1,1
5,GO EOSINOPHIL CHEMOTAXIS,2.5308e-05,0.69579,0.61334,1,1
5,GO T CELL MEDIATED CYTOTOXICITY,0.00026003,0.69462,0.47661,1,1
5,GO LIVER MORPHOGENESIS,5.0683e-06,0.69023,0.54822,1,1
5,GO REGULATION OF TOLERANCE INDUCTION,7.9801e-06,0.68781,0.60753,1,1
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,5.0226e-05,0.68182,0.48411,1,1
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,2.0784e-06,0.66579,0.69104,1,1
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,2.1702e-06,0.66507,0.66652,1,1
5,GO HISTAMINE SECRETION,6.2786e-05,0.66461,0.59162,1,1
5,GO RESPONSE TO TYPE I INTERFERON,3.3287e-06,0.66205,0.69163,1,1
5,GO NEGATIVE REGULATION OF CELL KILLING,0.0014299,0.65871,0.439,1,1
5,GO REGULATION OF PLASMINOGEN ACTIVATION,0.05161,0.65647,0.395,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00063551,0.64697,0.51244,1,1
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,3.1888e-05,0.64213,0.53944,1,1
5,GO EOSINOPHIL MIGRATION,2.3418e-05,0.64069,0.58485,1,1
5,GO RESPONSE TO INTERFERON BETA,0.00021167,0.64055,0.58417,1,1
5,GO REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00065623,0.63915,0.49305,1,1
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00026903,0.63881,0.47549,1,1
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,2.3654e-06,0.63785,0.56909,1,1
5,GO LIPID DROPLET FORMATION,4.8612e-06,0.62311,0.65657,1,1
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,1.0604e-05,0.62058,0.6632,1,1
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.8583e-05,0.61642,0.61357,1,1
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0056288,0.60684,0.41438,1,1
5,GO GERMINAL CENTER FORMATION,0.00017186,0.60366,0.56319,1,1
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.00010462,0.60081,0.43707,1,1
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,5.8301e-05,0.59918,0.43524,1,1
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,5.508e-06,0.59859,0.5251,1,1
5,GO SEROTONIN METABOLIC PROCESS,1.349e-05,0.59785,0.63979,1,1
5,GO GLIAL CELL FATE COMMITMENT,9.7346e-05,0.5951,0.53258,1,1
5,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,4.0073e-05,0.58946,0.59411,1,1
5,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.3528e-06,0.58839,0.55535,1,1
5,GO TYPE B PANCREATIC CELL PROLIFERATION,5.2837e-06,0.58824,0.60024,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00063551,0.58527,0.62323,1,1
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,4.8612e-06,0.58259,0.57817,1,1
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00013917,0.57923,0.45995,1,1
5,GO DETECTION OF OTHER ORGANISM,5.8301e-05,0.57735,0.49828,1,1
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.6307e-05,0.57247,0.55676,1,1
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,2.9301e-06,0.56821,0.56148,1,1
5,GO REGULATION OF TRANSPOSITION,5.0226e-05,0.56742,0.44872,1,1
5,GO HISTAMINE TRANSPORT,8.7323e-05,0.56624,0.51612,1,1
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00013433,0.56445,0.51594,1,1
5,GO REGULATION OF PLATELET AGGREGATION,2.0833e-05,0.56407,0.47336,1,1
5,GO MATURE B CELL DIFFERENTIATION,0.0045306,0.56288,0.35026,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.0033e-05,0.56174,0.45506,1,1
5,GO DNA DEAMINATION,0.00011241,0.55903,0.48017,1,1
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,6.2786e-05,0.55839,0.44717,1,1
5,GO REVERSE CHOLESTEROL TRANSPORT,6.2786e-05,0.55828,0.4071,1,1
5,GO REGULATION OF VASCULOGENESIS,3.8583e-05,0.5562,0.51185,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.2786e-05,0.55472,0.4257,1,1
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0060989,0.55281,0.40849,1,1
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.00024286,0.55168,0.45587,1,1
5,GO REGULATORY T CELL DIFFERENTIATION,2.8891e-07,0.5512,0.52409,1,1
5,GO MUCUS SECRETION,0.0031536,0.5498,0.4776,1,1
5,GO RESPONSE TO IMMOBILIZATION STRESS,7.2754e-05,0.54918,0.44933,1,1
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00010092,0.54651,0.46933,1,1
5,GO NEGATIVE REGULATION OF ANOIKIS,7.0571e-06,0.54616,0.66086,1,1
5,GO LABYRINTHINE LAYER MORPHOGENESIS,3.8583e-05,0.53865,0.58562,1,1
5,GO IMMUNOGLOBULIN SECRETION,0.00017796,0.53794,0.40043,1,1
5,GO KERATINOCYTE DEVELOPMENT,0.00016595,0.53753,0.45122,1,1
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0028957,0.53733,0.38053,1,1
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00045924,0.53687,0.46362,1,1
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00012074,0.53431,0.42373,1,1
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00035231,0.53367,0.55881,1,1
5,GO REGULATION OF VIRAL GENOME REPLICATION,9.389e-05,0.53187,0.37543,1,1
5,GO POSITIVE REGULATION OF CELL MATURATION,0.0001547,0.53139,0.41084,1,1
5,GO INDOLALKYLAMINE METABOLIC PROCESS,6.0504e-05,0.52981,0.4535,1,1
5,GO TRANSPOSITION,7.0571e-06,0.5296,0.45051,1,1
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,5.0226e-05,0.52958,0.41531,1,1
5,GO MICROVILLUS ASSEMBLY,0.00024286,0.5295,0.43184,1,1
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00011241,0.5291,0.4758,1,1
5,GO LIPOXYGENASE PATHWAY,0.00012964,0.52719,0.46051,1,1
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,1.906e-06,0.52674,0.63948,1,1
5,GO O GLYCAN PROCESSING,2.0833e-05,0.52388,0.43156,1,1
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00031859,0.52338,0.42528,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.7801e-06,0.52306,0.40584,1,1
5,GO LUNG CELL DIFFERENTIATION,5.8301e-05,0.52117,0.51601,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00057693,0.52093,0.43612,1,1
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0037331,0.52027,0.49247,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0015189,0.51997,0.59087,1,1
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.6174e-05,0.51735,0.48249,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.1493e-05,0.51607,0.44416,1,1
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,7.0571e-06,0.51605,0.45958,1,1
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.9418e-06,0.51411,0.47357,1,1
5,GO SYNAPTIC GROWTH AT NEUROMUSCULAR JUNCTION,7.0571e-06,0.51396,0.53785,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00021909,0.5121,0.45443,1,1
5,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,7.547e-05,0.51207,0.51624,1,1
5,GO KETONE CATABOLIC PROCESS,0.00054072,0.51108,0.42908,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00090094,0.51022,0.38369,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0028957,0.50993,0.40691,1,1
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,7.2754e-05,0.50976,0.51268,1,1
5,GO ENDOTHELIAL CELL CHEMOTAXIS,9.0179e-06,0.50735,0.45892,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.001662,0.50731,0.32139,1,1
5,GO REFLEX,0.0090226,0.50357,0.42062,1,1
5,GO RESPONSE TO WATER,2.3418e-05,0.49941,0.45953,1,1
5,GO REGULATION OF RECEPTOR CLUSTERING,6.5149e-05,0.49909,0.47741,1,1
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00041602,0.49783,0.47044,1,1
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,1.2962e-05,0.4975,0.47154,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.389e-05,0.49717,0.41019,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,7.8282e-05,0.49695,0.36213,1,1
5,GO RENAL ABSORPTION,0.00035231,0.49553,0.50615,1,1
5,GO RESPONSE TO INTERLEUKIN 18,0.0025817,0.49506,0.36324,1,1
5,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.0007696,0.4949,0.42787,1,1
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.007729,0.49465,0.44519,1,1
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.7343e-05,0.49178,0.44831,1,1
5,GO CERAMIDE CATABOLIC PROCESS,0.00010462,0.4909,0.34519,1,1
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.4039e-05,0.48935,0.4351,1,1
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.9263e-05,0.48716,0.42443,1,1
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,7.2754e-05,0.48692,0.41376,1,1
5,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0015189,0.48588,0.40432,1,1
5,GO MEMBRANE RAFT ORGANIZATION,0.0021062,0.48411,0.34255,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0015189,0.48066,0.34248,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.5201e-05,0.47748,0.49463,1,1
5,GO ALPHA BETA T CELL PROLIFERATION,9.3916e-06,0.47624,0.40944,1,1
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00041602,0.4757,0.32122,1,1
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00084609,0.47316,0.35297,1,1
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.7118e-05,0.47206,0.37362,1,1
5,GO REGULATION OF WATER LOSS VIA SKIN,0.00012512,0.47008,0.43399,1,1
5,GO RESPONSE TO MUSCLE STRETCH,0.00087311,0.46911,0.37171,1,1
5,GO MITOCHONDRIAL DEPOLARIZATION,2.6902e-06,0.4678,0.40391,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.1112e-06,0.46666,0.44692,1,1
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00032948,0.46535,0.5202,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,2.6307e-05,0.46387,0.43858,1,1
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00047456,0.46382,0.40868,1,1
5,GO T CELL MEDIATED IMMUNITY,0.0001165,0.46362,0.32062,1,1
5,GO MICROVILLUS ORGANIZATION,0.00045924,0.46335,0.35166,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,5.4121e-05,0.46294,0.50303,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.6228e-06,0.46176,0.351,1,1
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00010462,0.46015,0.44402,1,1
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,4.4878e-05,0.46011,0.3607,1,1
5,GO CORTICOSTEROID HORMONE SECRETION,0.00074557,0.45903,0.37312,1,1
5,GO REGULATION OF VIRAL LIFE CYCLE,0.00013917,0.45863,0.34599,1,1
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,8.1192e-05,0.45684,0.54596,1,1
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.0018173,0.45627,0.44335,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,1.349e-05,0.45591,0.56484,1,1
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00055855,0.45548,0.35291,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00034072,0.45449,0.43271,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.0057817,0.45205,0.29791,1,1
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,4.8379e-05,0.45171,0.32474,1,1
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,3.4728e-06,0.45137,0.40583,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00079435,0.45053,0.28846,1,1
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.4609e-05,0.44943,0.51287,1,1
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00098941,0.44924,0.34454,1,1
5,GO GLYCOLIPID CATABOLIC PROCESS,0.00029782,0.44801,0.33793,1,1
5,GO EPITHELIAL CELL MORPHOGENESIS,0.00029782,0.44739,0.41009,1,1
5,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.00014418,0.44695,0.50002,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00029782,0.44668,0.29941,1,1
5,GO RESPONSE TO PAIN,0.00027832,0.44636,0.32956,1,1
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00049035,0.44613,0.42497,1,1
5,GO MYOBLAST FUSION,1.1493e-05,0.44564,0.3898,1,1
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.011047,0.44548,0.3046,1,1
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00353,0.44519,0.37133,1,1
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00012964,0.44458,0.34978,1,1
5,GO REGULATION OF MYOBLAST FUSION,0.00029782,0.44424,0.36219,1,1
5,GO B CELL APOPTOTIC PROCESS,0.00028792,0.44408,0.3946,1,1
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013917,0.44103,0.40557,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00014418,0.44097,0.32791,1,1
5,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0017123,0.43951,0.33613,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0007696,0.43929,0.33409,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,7.013e-05,0.4389,0.37842,1,1
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00016595,0.43886,0.29047,1,1
5,GO VIRAL GENOME REPLICATION,6.0504e-05,0.43809,0.33322,1,1
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,6.0504e-05,0.43739,0.44521,1,1
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0022332,0.43715,0.35139,1,1
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.0014299,0.4364,0.39016,1,1
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.2754e-05,0.43627,0.35208,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00016023,0.43568,0.35659,1,1
5,GO POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0054795,0.43523,0.38319,1,1
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.00092958,0.43506,0.38465,1,1
5,GO RESPONSE TO INTERFERON GAMMA,1.5201e-05,0.43426,0.43393,1,1
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.104e-05,0.43194,0.37554,1,1
5,GO T CELL EXTRAVASATION,0.00081984,0.43177,0.41252,1,1
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,7.8282e-05,0.42941,0.36127,1,1
5,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.001662,0.42938,0.37316,1,1
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,8.1192e-05,0.42933,0.38006,1,1
5,GO REGULATION OF EXOSOMAL SECRETION,6.5149e-05,0.42821,0.31458,1,1
5,GO RESPONSE TO DIETARY EXCESS,9.389e-05,0.42755,0.42521,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.0021062,0.42692,0.34849,1,1
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.00047456,0.42617,0.32307,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0016129,0.42562,0.28944,1,1
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.011326,0.42553,0.33005,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00055855,0.42536,0.4127,1,1
5,GO MYELIN MAINTENANCE,7.547e-05,0.42535,0.407,1,1
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.00022676,0.42506,0.43014,1,1
5,GO ZYMOGEN ACTIVATION,0.00047456,0.42489,0.37159,1,1
5,GO REGULATION OF PLATELET ACTIVATION,3.3132e-05,0.42458,0.38877,1,1
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,3.6228e-06,0.4241,0.31863,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00017186,0.42355,0.35299,1,1
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.00040247,0.42349,0.41969,1,1
5,GO FUCOSE METABOLIC PROCESS,2.8418e-05,0.4229,0.34072,1,1
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.007729,0.42223,0.28647,1,1
5,GO DENDRITIC CELL APOPTOTIC PROCESS,0.001191,0.42188,0.39526,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME,0.00037661,0.42156,0.35675,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0030654,0.42131,0.3105,1,1
5,GO N GLYCAN PROCESSING,8.1192e-05,0.42099,0.41949,1,1
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.6623e-06,0.4208,0.44657,1,1
5,GO DEFENSE RESPONSE TO VIRUS,3.3132e-05,0.42044,0.32573,1,1
5,GO ENTRY INTO HOST,0.00028792,0.41968,0.27426,1,1
5,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00030804,0.41966,0.34162,1,1
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,1.7806e-05,0.41959,0.40941,1,1
5,GO REGULATION OF B CELL PROLIFERATION,2.1663e-05,0.41947,0.34596,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,1.4609e-05,0.41938,0.31907,1,1
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.1702e-06,0.41852,0.36644,1,1
5,GO CELLULAR DEFENSE RESPONSE,0.00057693,0.41847,0.27642,1,1
5,GO GLIAL CELL APOPTOTIC PROCESS,0.00030804,0.41763,0.46665,1,1
5,GO TOXIN METABOLIC PROCESS,4.1617e-05,0.41639,0.41758,1,1
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00090094,0.41623,0.55203,1,1
5,GO REGULATION OF ANOIKIS,4.0073e-05,0.41545,0.47975,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00013433,0.41481,0.29637,1,1
5,GO CAMP BIOSYNTHETIC PROCESS,0.00019753,0.41468,0.36325,1,1
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,2.1702e-06,0.41434,0.34574,1,1
5,GO RESPONSE TO COLD,2.5308e-05,0.4143,0.37095,1,1
5,GO RADIAL GLIAL CELL DIFFERENTIATION,0.001191,0.41418,0.38333,1,1
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0015653,0.41363,0.35775,1,1
5,GO DENDRITIC CELL DIFFERENTIATION,6.4994e-06,0.41302,0.44398,1,1
5,GO INTERLEUKIN 10 PRODUCTION,2.6307e-05,0.41222,0.30304,1,1
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.0013872,0.41221,0.31801,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.009256,0.4122,0.32726,1,1
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0024367,0.41089,0.43306,1,1
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.2786e-05,0.41075,0.31333,1,1
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00016023,0.41072,0.32207,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,9.389e-05,0.41019,0.47285,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.4205e-05,0.40996,0.43091,1,1
5,GO MYELIN ASSEMBLY,0.00042998,0.40967,0.31313,1,1
5,GO REGULATION OF TISSUE REMODELING,2.1663e-05,0.40913,0.32461,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.7323e-05,0.40906,0.28569,1,1
5,GO IMMUNOLOGICAL MEMORY PROCESS,5.9841e-06,0.40798,0.40553,1,1
5,GO PROTEIN O LINKED GLYCOSYLATION,7.6603e-06,0.40782,0.31054,1,1
5,GO GALACTOSE METABOLIC PROCESS,0.0050528,0.40761,0.27911,1,1
5,GO DETECTION OF TEMPERATURE STIMULUS,0.00065623,0.40694,0.38303,1,1
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00052342,0.40669,0.43381,1,1
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,2.0833e-05,0.40657,0.3586,1,1
5,GO AMINE BIOSYNTHETIC PROCESS,7.3528e-06,0.40629,0.40937,1,1
5,GO LUNG ALVEOLUS DEVELOPMENT,1.3441e-06,0.40589,0.39082,1,1
5,GO SMOOTH MUSCLE CELL MIGRATION,5.6174e-05,0.40486,0.34708,1,1
5,GO REGULATION OF BONE REMODELING,2.0033e-05,0.40482,0.34605,1,1
5,GO MINERALOCORTICOID METABOLIC PROCESS,0.026586,0.40471,0.29763,1,1
5,GO REGULATION OF GLIAL CELL PROLIFERATION,3.1888e-05,0.40396,0.34513,1,1
5,GO STEROID ESTERIFICATION,6.5149e-05,0.40268,0.4744,1,1
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00055855,0.40176,0.29175,1,1
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.7323e-05,0.40012,0.37348,1,1
5,GO STEROID HORMONE SECRETION,0.00098941,0.39896,0.30407,1,1
5,GO AMYLOID FIBRIL FORMATION,0.0006154,0.39882,0.33744,1,1
5,GO RELAXATION OF CARDIAC MUSCLE,0.001662,0.39857,0.34998,1,1
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,8.1192e-05,0.39846,0.39691,1,1
5,GO MAGNESIUM ION TRANSPORT,6.0504e-05,0.39815,0.30021,1,1
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.5774e-06,0.39744,0.51238,1,1
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.00014935,0.3966,0.32364,1,1
5,GO PARAXIAL MESODERM MORPHOGENESIS,0.00024286,0.39646,0.45538,1,1
5,GO MEMBRANE LIPID CATABOLIC PROCESS,1.0604e-05,0.39593,0.34578,1,1
5,GO PHOSPHOLIPID EFFLUX,0.0011199,0.39561,0.25794,1,1
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,1.5816e-05,0.39544,0.32901,1,1
5,GO RESPONSE TO THYROID HORMONE,0.00065623,0.39334,0.33894,1,1
5,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,6.2786e-05,0.39232,0.39519,1,1
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,6.5149e-05,0.39207,0.46675,1,1
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,4.4878e-05,0.39184,0.31043,1,1
5,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0032441,0.39143,0.29691,1,1
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.0012662,0.39101,0.31068,1,1
5,GO NEURONAL ION CHANNEL CLUSTERING,0.001872,0.39059,0.37452,1,1
5,GO ESTROUS CYCLE,7.8282e-05,0.39026,0.36873,1,1
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00025131,0.39006,0.31332,1,1
5,GO VASCULAR WOUND HEALING,4.8379e-05,0.38848,0.42409,1,1
5,GO SERTOLI CELL DIFFERENTIATION,0.00047456,0.38803,0.38321,1,1
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.001872,0.38731,0.37847,1,1
5,GO BONE RESORPTION,3.5759e-05,0.38696,0.3022,1,1
5,GO NEGATIVE REGULATION OF LIPID STORAGE,3.8583e-05,0.38675,0.3268,1,1
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.001228,0.38669,0.30927,1,1
5,GO RESPONSE TO AUDITORY STIMULUS,0.00031859,0.38622,0.37494,1,1
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.0015189,0.38615,0.36034,1,1
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,7.2754e-05,0.38574,0.38218,1,1
5,GO TYPE 2 IMMUNE RESPONSE,0.00012074,0.38474,0.43451,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.8521e-05,0.38462,0.3828,1,1
5,GO POSITIVE REGULATION OF CELL KILLING,0.0001165,0.38431,0.30561,1,1
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0006154,0.38428,0.43877,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,7.8282e-05,0.38399,0.32618,1,1
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0067808,0.38357,0.28798,1,1
5,GO LABYRINTHINE LAYER DEVELOPMENT,2.4346e-05,0.38324,0.35723,1,1
5,GO PROTEIN KINASE C SIGNALING,0.00050664,0.38308,0.3205,1,1
5,GO LINOLEIC ACID METABOLIC PROCESS,0.00034072,0.38267,0.32053,1,1
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00012512,0.38258,0.32374,1,1
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00031859,0.38205,0.29404,1,1
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,2.5308e-05,0.38173,0.3651,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.508e-06,0.38154,0.32863,1,1
5,GO POSITIVE REGULATION OF WOUND HEALING,2.7343e-05,0.38152,0.37966,1,1
5,GO PROSTATE GLAND MORPHOGENESIS,0.033166,0.38108,0.24795,1,1
5,GO LUNG EPITHELIUM DEVELOPMENT,5.6174e-05,0.38034,0.37719,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00013433,0.37983,0.30344,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00012512,0.37938,0.3138,1,1
5,GO SIALYLATION,0.02268,0.37902,0.23042,1,1
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.00018427,0.37876,0.36756,1,1
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00012964,0.37853,0.27539,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.1964e-05,0.37815,0.31398,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.001191,0.37814,0.318,1,1
5,GO VITAMIN D METABOLIC PROCESS,1.6455e-05,0.37792,0.37024,1,1
5,GO ADRENAL GLAND DEVELOPMENT,2.7343e-05,0.37729,0.43447,1,1
5,GO IMMUNE RESPONSE TO TUMOR CELL,0.0016129,0.3767,0.34279,1,1
5,GO RESPONSE TO COPPER ION,0.00026003,0.37641,0.39671,1,1
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.011047,0.37563,0.26629,1,1
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00025131,0.37548,0.37974,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.036948,0.37544,0.2133,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,9.7801e-06,0.37531,0.38627,1,1
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,9.0551e-05,0.37478,0.31514,1,1
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00021909,0.3746,0.36507,1,1
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00010462,0.37378,0.38348,1,1
5,GO LIPID DROPLET ORGANIZATION,7.0571e-06,0.37349,0.34146,1,1
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0010528,0.37307,0.33598,1,1
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.0054795,0.37286,0.3244,1,1
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.036948,0.37205,0.19452,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.0018173,0.37194,0.32597,1,1
5,GO MECHANOSENSORY BEHAVIOR,0.020205,0.37174,0.3536,1,1
5,GO ASYMMETRIC CELL DIVISION,0.0036303,0.3715,0.27367,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.001191,0.37108,0.39204,1,1
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0037331,0.37076,0.32775,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,8.1192e-05,0.37039,0.25088,1,1
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,2.8418e-05,0.36895,0.36279,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,3.5759e-05,0.36894,0.34606,1,1
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00037661,0.3688,0.2786,1,1
5,GO TISSUE REMODELING,4.1617e-05,0.36879,0.29407,1,1
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,5.6174e-05,0.36853,0.25107,1,1
5,GO VASODILATION,0.001662,0.36823,0.27577,1,1
5,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0029794,0.36744,0.26651,1,1
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00032948,0.36739,0.24994,1,1
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.7145e-05,0.36709,0.36206,1,1
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.0047853,0.36648,0.31203,1,1
5,GO OSTEOBLAST PROLIFERATION,6.0504e-05,0.36629,0.35166,1,1
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.0031536,0.36577,0.36607,1,1
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00026903,0.365,0.24527,1,1
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00040247,0.36482,0.31082,1,1
5,GO OPTIC NERVE DEVELOPMENT,0.00054072,0.36464,0.39031,1,1
5,GO MAST CELL MEDIATED IMMUNITY,3.1888e-05,0.36463,0.31671,1,1
5,GO GLYCINE TRANSPORT,0.049546,0.3641,0.23209,1,1
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.00027832,0.36389,0.31511,1,1
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00018427,0.36338,0.26661,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.013e-05,0.36334,0.31219,1,1
5,GO NERVE DEVELOPMENT,1.7806e-05,0.36274,0.31883,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00044439,0.36126,0.32713,1,1
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.0017641,0.36091,0.3219,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00026003,0.36075,0.26912,1,1
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00081984,0.36048,0.29595,1,1
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0062634,0.36024,0.25847,1,1
5,GO SEQUESTERING OF ACTIN MONOMERS,7.013e-05,0.36018,0.46403,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.01282,0.36004,0.29753,1,1
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00010092,0.35925,0.47633,1,1
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.029068,0.35916,0.26856,1,1
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00041602,0.35913,0.31496,1,1
5,GO EPOXYGENASE P450 PATHWAY,0.0046564,0.3591,0.31586,1,1
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00012074,0.35876,0.27798,1,1
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0025817,0.35876,0.33179,1,1
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0010859,0.35871,0.40011,1,1
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00074557,0.35866,0.33736,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.7791e-06,0.35756,0.30481,1,1
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.026586,0.35734,0.26631,1,1
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00030804,0.35675,0.31176,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,1.4609e-05,0.35669,0.38597,1,1
5,GO OLIGODENDROCYTE DEVELOPMENT,3.9418e-06,0.35627,0.3233,1,1
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0025817,0.35625,0.32461,1,1
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00010845,0.35614,0.28258,1,1
5,GO LYMPHOCYTE MEDIATED IMMUNITY,4.6597e-05,0.35571,0.29605,1,1
5,GO B CELL MEDIATED IMMUNITY,9.389e-05,0.35547,0.34664,1,1
5,GO ACUTE INFLAMMATORY RESPONSE,2.6307e-05,0.35545,0.32362,1,1
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00017796,0.35516,0.25002,1,1
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,9.7801e-06,0.35503,0.32231,1,1
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,6.4994e-06,0.35485,0.27688,1,1
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.010245,0.35482,0.28184,1,1
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00014418,0.3546,0.24452,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,1.4609e-05,0.35444,0.33018,1,1
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,8.1192e-05,0.35413,0.25324,1,1
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,2.3418e-05,0.35358,0.29624,1,1
5,GO MAST CELL ACTIVATION,1.104e-05,0.35331,0.30876,1,1
5,GO BONE REMODELING,2.4346e-05,0.35275,0.32373,1,1
5,GO CELL MIGRATION IN HINDBRAIN,0.0017641,0.35252,0.34587,1,1
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,6.0504e-05,0.35237,0.3038,1,1
5,GO AMMONIUM TRANSPORT,0.00014418,0.35196,0.32534,1,1
5,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00012512,0.35166,0.29467,1,1
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.5331e-06,0.35151,0.34321,1,1
5,GO RESPONSE TO VIRUS,4.8379e-05,0.35135,0.27013,1,1
5,GO REGULATION OF GTP BINDING,0.0085714,0.35129,0.25864,1,1
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0018173,0.35102,0.23539,1,1
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00036427,0.35074,0.26347,1,1
5,GO GLAND MORPHOGENESIS,0.00025131,0.35039,0.30211,1,1
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,3.5759e-05,0.35001,0.36427,1,1
5,GO FOAM CELL DIFFERENTIATION,0.00012074,0.34981,0.35988,1,1
5,GO NEGATIVE REGULATION OF COAGULATION,0.0057817,0.34936,0.22486,1,1
5,GO BILE ACID AND BILE SALT TRANSPORT,0.0015653,0.34897,0.26954,1,1
5,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00026003,0.34881,0.35653,1,1
5,GO INTERLEUKIN 13 PRODUCTION,0.0022332,0.34861,0.3125,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,5.6174e-05,0.34846,0.33604,1,1
5,GO SYNCYTIUM FORMATION,4.8379e-05,0.34846,0.28918,1,1
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0030654,0.34787,0.23691,1,1
5,GO MOVEMENT IN HOST ENVIRONMENT,0.00034072,0.34776,0.23917,1,1
5,GO T CELL CYTOKINE PRODUCTION,0.00010462,0.34742,0.24742,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.004408,0.34741,0.28213,1,1
5,GO RESPONSE TO MAGNESIUM ION,0.0026572,0.34739,0.28717,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00026903,0.34731,0.26608,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00024286,0.3473,0.32384,1,1
5,GO ANOIKIS,1.349e-05,0.34697,0.38408,1,1
5,GO LEUKOTRIENE METABOLIC PROCESS,0.00042998,0.34563,0.27625,1,1
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.5816e-05,0.34544,0.27779,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00017186,0.3454,0.27505,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1.8521e-05,0.34534,0.3041,1,1
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,6.7596e-05,0.34508,0.24994,1,1
5,GO SYNAPSE MATURATION,0.0081404,0.34483,0.36337,1,1
5,GO REGULATION OF HORMONE METABOLIC PROCESS,0.014138,0.34444,0.23873,1,1
5,GO BASEMENT MEMBRANE ORGANIZATION,0.0047853,0.34443,0.31085,1,1
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.0099891,0.34402,0.35636,1,1
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,9.7346e-05,0.34346,0.39373,1,1
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0046564,0.34341,0.27936,1,1
5,GO BLOOD VESSEL REMODELING,0.0016129,0.34341,0.22928,1,1
5,GO THALAMUS DEVELOPMENT,0.0033369,0.34325,0.31347,1,1
5,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00036427,0.34286,0.27365,1,1
5,GO B CELL PROLIFERATION,6.2786e-05,0.34254,0.2585,1,1
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00049035,0.34246,0.28378,1,1
5,GO ADHESION OF SYMBIONT TO HOST,0.00029782,0.34218,0.39991,1,1
5,GO LEUKOCYTE PROLIFERATION,1.2454e-05,0.34201,0.25792,1,1
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00042998,0.3418,0.33636,1,1
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.00026903,0.34169,0.27608,1,1
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00037661,0.3416,0.22281,1,1
5,GO ENGULFMENT OF APOPTOTIC CELL,3.8583e-05,0.34149,0.35138,1,1
5,GO PLASMINOGEN ACTIVATION,0.050569,0.34098,0.22065,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0090226,0.34024,0.26882,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00041602,0.34012,0.3268,1,1
5,GO REGULATION OF B CELL ACTIVATION,3.1904e-06,0.33997,0.29317,1,1
5,GO ANTIBACTERIAL HUMORAL RESPONSE,1.104e-05,0.33996,0.335,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.00055855,0.33994,0.25193,1,1
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,9.389e-05,0.3398,0.34518,1,1
5,GO EMBRYONIC PLACENTA DEVELOPMENT,9.3916e-06,0.33976,0.33437,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,5.2139e-05,0.33969,0.26785,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,6.5149e-05,0.33913,0.35296,1,1
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.00040247,0.33883,0.3232,1,1
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,7.8282e-05,0.33866,0.27981,1,1
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,7.547e-05,0.33839,0.3111,1,1
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00049035,0.33835,0.28126,1,1
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00019753,0.3381,0.28572,1,1
5,GO RESPONSE TO INTERLEUKIN 2,0.00018427,0.33808,0.28229,1,1
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.3132e-05,0.33749,0.42261,1,1
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00021167,0.33742,0.275,1,1
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0047853,0.33737,0.24423,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.8282e-05,0.33721,0.23645,1,1
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00021167,0.33664,0.27947,1,1
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.4121e-05,0.33593,0.33948,1,1
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,7.2754e-05,0.3359,0.28173,1,1
5,GO PROTEIN DEMANNOSYLATION,0.00017796,0.33557,0.27775,1,1
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0054795,0.33466,0.25262,1,1
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0018173,0.33445,0.28628,1,1
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,5.6174e-05,0.33428,0.25642,1,1
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0071468,0.33413,0.24615,1,1
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,7.9801e-06,0.33386,0.26288,1,1
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00063551,0.33383,0.28719,1,1
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.3127e-06,0.33381,0.31059,1,1
5,GO CRANIAL NERVE DEVELOPMENT,1.4609e-05,0.33355,0.3158,1,1
5,GO SUPEROXIDE ANION GENERATION,0.00032948,0.33345,0.32688,1,1
5,GO POSITIVE REGULATION OF FERTILIZATION,0.0090226,0.33335,0.254,1,1
5,GO LIPID TRANSLOCATION,1.1267e-06,0.33301,0.34664,1,1
5,GO EPITHELIAL CELL MATURATION,0.0011199,0.33298,0.31592,1,1
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00023468,0.33209,0.28499,1,1
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00081984,0.3319,0.29263,1,1
5,GO REGULATION OF FAT CELL DIFFERENTIATION,9.3916e-06,0.33144,0.27422,1,1
5,GO INTERLEUKIN 8 PRODUCTION,0.001986,0.33093,0.2275,1,1
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00036427,0.33057,0.43282,1,1
5,GO MONOCYTE CHEMOTAXIS,0.00098941,0.33054,0.22285,1,1
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,3.7145e-05,0.33027,0.37626,1,1
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0028957,0.33008,0.24472,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION,7.3528e-06,0.32978,0.27713,1,1
5,GO AMINOGLYCAN CATABOLIC PROCESS,0.0014738,0.32944,0.26738,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.0042883,0.32912,0.23487,1,1
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021062,0.32903,0.27379,1,1
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00026903,0.32884,0.22112,1,1
5,GO IMMUNE EFFECTOR PROCESS,8.1192e-05,0.3288,0.23537,1,1
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0024367,0.32863,0.2271,1,1
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.038561,0.32855,0.25559,1,1
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.9532e-05,0.32825,0.27189,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.0081404,0.32806,0.26961,1,1
5,GO RESPONSE TO LITHIUM ION,0.00031859,0.32768,0.35829,1,1
5,GO RESPONSE TO INTERLEUKIN 15,0.0022992,0.32716,0.26869,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.2139e-05,0.32663,0.26583,1,1
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00037661,0.32629,0.22541,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00040247,0.32618,0.26817,1,1
5,GO APICAL JUNCTION ASSEMBLY,6.4994e-06,0.32562,0.33969,1,1
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00095906,0.32557,0.34352,1,1
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,1.2962e-05,0.3254,0.3224,1,1
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00019753,0.32511,0.23874,1,1
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0010528,0.32507,0.22515,1,1
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00035231,0.3249,0.33778,1,1
5,GO INNATE IMMUNE RESPONSE,4.0073e-05,0.32418,0.24791,1,1
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00035231,0.32399,0.3621,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00018427,0.32382,0.28696,1,1
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.00057693,0.32351,0.29617,1,1
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00021909,0.32341,0.30178,1,1
5,GO INTESTINAL ABSORPTION,0.00036427,0.32303,0.32993,1,1
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,1.0184e-05,0.32288,0.34002,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00087311,0.32206,0.2005,1,1
5,GO PRO B CELL DIFFERENTIATION,0.0054795,0.32193,0.25494,1,1
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00016023,0.32157,0.26503,1,1
5,GO GLIAL CELL PROLIFERATION,0.00081984,0.32141,0.25512,1,1
5,GO ENDOTHELIAL CELL DEVELOPMENT,4.8379e-05,0.32134,0.26878,1,1
5,GO MEMBRANE DEPOLARIZATION,0.00013433,0.32132,0.27888,1,1
5,GO ENDOCARDIUM DEVELOPMENT,0.0017641,0.32105,0.32818,1,1
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0014738,0.32105,0.30875,1,1
5,GO T CELL PROLIFERATION,1.8521e-05,0.32094,0.25857,1,1
5,GO POSITIVE REGULATION OF CHEMOTAXIS,6.7728e-06,0.32082,0.28128,1,1
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00040247,0.32066,0.31305,1,1
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,3.0689e-05,0.32064,0.31184,1,1
5,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.0006154,0.32049,0.30621,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,2.8418e-05,0.32033,0.34289,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION,0.00017186,0.32028,0.25954,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,8.3127e-06,0.32021,0.3019,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.0018173,0.3202,0.29864,1,1
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.023205,0.31938,0.29737,1,1
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.0226e-05,0.31937,0.26061,1,1
5,GO GAMMA DELTA T CELL ACTIVATION,0.00081984,0.31911,0.3373,1,1
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0060989,0.3185,0.34766,1,1
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.4878e-05,0.31759,0.28082,1,1
5,GO REGULATION OF COAGULATION,0.0025083,0.31742,0.23515,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0018173,0.31716,0.1925,1,1
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0017641,0.31711,0.24638,1,1
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.00353,0.31694,0.27217,1,1
5,GO ACTIN FILAMENT NETWORK FORMATION,0.04854,0.3169,0.27609,1,1
5,GO REGULATION OF AMYLOID BETA FORMATION,8.7323e-05,0.31668,0.35667,1,1
5,GO AMYLOID BETA METABOLIC PROCESS,7.3528e-06,0.31656,0.31106,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,5.8301e-05,0.31653,0.27101,1,1
5,GO PLATELET DEGRANULATION,0.0007696,0.31645,0.25598,1,1
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.0833e-05,0.31625,0.28375,1,1
5,GO EPITHELIAL CELL DEVELOPMENT,9.3916e-06,0.31623,0.25664,1,1
5,GO STRIATED MUSCLE ADAPTATION,0.00034072,0.31611,0.24351,1,1
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00010092,0.31611,0.29579,1,1
5,GO AMYLOID BETA FORMATION,1.5816e-05,0.31609,0.337,1,1
5,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00019079,0.31559,0.27312,1,1
5,GO BRANCH ELONGATION OF AN EPITHELIUM,0.015203,0.31545,0.3365,1,1
5,GO REGULATION OF T CELL ACTIVATION,9.7801e-06,0.31544,0.24328,1,1
5,GO REGULATION OF CELL KILLING,0.00032948,0.3154,0.25767,1,1
5,GO INTERFERON ALPHA PRODUCTION,1.1493e-05,0.31481,0.32786,1,1
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,2.8418e-05,0.31476,0.26692,1,1
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,8.2505e-07,0.31474,0.33009,1,1
5,GO INTERLEUKIN 4 PRODUCTION,2.9532e-05,0.31439,0.29089,1,1
5,GO REGULATION OF WOUND HEALING,0.00074557,0.31428,0.24835,1,1
5,GO ENDOTHELIUM DEVELOPMENT,9.7801e-06,0.31412,0.26749,1,1
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.0007696,0.31411,0.29519,1,1
5,GO MECHANORECEPTOR DIFFERENTIATION,9.0179e-06,0.31405,0.26619,1,1
5,GO REGULATION OF RESPIRATORY BURST,0.00065623,0.31345,0.31743,1,1
5,GO INTERFERON BETA PRODUCTION,9.0551e-05,0.31276,0.25191,1,1
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.001228,0.31261,0.25177,1,1
5,GO MUSCLE CELL MIGRATION,0.00021167,0.31245,0.28585,1,1
5,GO LEUKOCYTE MEDIATED IMMUNITY,0.0001165,0.31236,0.2286,1,1
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,1.2862e-06,0.3121,0.29548,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.2962e-05,0.31206,0.26252,1,1
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,2.2524e-05,0.31171,0.25455,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.00025131,0.31122,0.32714,1,1
5,GO METANEPHROS MORPHOGENESIS,0.0001165,0.31058,0.28647,1,1
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.010506,0.31024,0.16747,1,1
5,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0019282,0.31006,0.36052,1,1
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.00027832,0.31005,0.2617,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0006154,0.31001,0.27856,1,1
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,2.8418e-05,0.30983,0.32296,1,1
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.00028792,0.30955,0.23464,1,1
5,GO RESPONSE TO PROTOZOAN,0.00059588,0.30944,0.27616,1,1
5,GO ALPHA BETA T CELL ACTIVATION,5.0226e-05,0.30899,0.25003,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00095906,0.30882,0.27757,1,1
5,GO MACROPHAGE CYTOKINE PRODUCTION,0.0011199,0.30864,0.40348,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0025817,0.3079,0.20124,1,1
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.6455e-05,0.30783,0.26052,1,1
5,GO REGULATION OF CARDIAC CONDUCTION,1.7118e-05,0.30762,0.27367,1,1
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0014738,0.30746,0.32822,1,1
5,GO LIPID STORAGE,9.389e-05,0.30741,0.2404,1,1
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00017186,0.30735,0.32237,1,1
5,GO SKELETAL MUSCLE ADAPTATION,0.00011241,0.30721,0.29189,1,1
5,GO POSITIVE REGULATION OF CILIUM MOVEMENT,0.00050664,0.30721,0.26662,1,1
5,GO KERATAN SULFATE METABOLIC PROCESS,0.0022332,0.30718,0.21766,1,1
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0010859,0.30716,0.27843,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0067808,0.3066,0.22296,1,1
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00092958,0.30659,0.19701,1,1
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.00090094,0.30645,0.25989,1,1
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.00090094,0.30638,0.36884,1,1
5,GO GLIAL CELL DEVELOPMENT,9.3916e-06,0.30637,0.27045,1,1
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,5.2139e-05,0.30625,0.22909,1,1
5,GO REGULATION OF CELL CELL ADHESION,3.4728e-06,0.30604,0.26887,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,3.5759e-05,0.30589,0.32304,1,1
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,7.2754e-05,0.30588,0.23361,1,1
5,GO REGULATION OF SYMBIOTIC PROCESS,0.00028792,0.30585,0.235,1,1
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,6.2985e-07,0.3056,0.30183,1,1
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,7.2754e-05,0.30545,0.24775,1,1
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00024286,0.30495,0.23721,1,1
5,GO MYOTUBE DIFFERENTIATION,5.9841e-06,0.30438,0.26659,1,1
5,GO MEMBRANE LIPID METABOLIC PROCESS,1.8251e-06,0.30365,0.25262,1,1
5,GO REGULATION OF ERBB SIGNALING PATHWAY,1.4039e-05,0.30354,0.26223,1,1
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.8251e-06,0.30331,0.30241,1,1
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00010845,0.30319,0.26171,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.7118e-05,0.30314,0.28602,1,1
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0025817,0.30313,0.27755,1,1
5,GO INTERLEUKIN 12 PRODUCTION,1.2962e-05,0.30274,0.28117,1,1
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00014935,0.30271,0.27284,1,1
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0031536,0.30268,0.23583,1,1
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00052342,0.30257,0.19837,1,1
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0075304,0.30253,0.24362,1,1
5,GO SPHINGOID METABOLIC PROCESS,7.6603e-06,0.30251,0.30966,1,1
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00069957,0.30211,0.34376,1,1
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.2454e-05,0.30211,0.28007,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0024367,0.30165,0.2399,1,1
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00024286,0.30104,0.27665,1,1
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,9.7346e-05,0.30103,0.46113,1,1
5,GO ASTROCYTE DIFFERENTIATION,0.00057693,0.30083,0.25339,1,1
5,GO MACROPHAGE DIFFERENTIATION,0.00013917,0.30058,0.22728,1,1
5,GO ADAPTIVE IMMUNE RESPONSE,4.0073e-05,0.30053,0.30262,1,1
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00065623,0.3005,0.28822,1,1
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00095906,0.30046,0.20683,1,1
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,9.3916e-06,0.30042,0.27129,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0083534,0.30037,0.26492,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.5759e-05,0.30004,0.24334,1,1
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00038934,0.3,0.35605,1,1
5,GO NEGATIVE REGULATION OF BONE REMODELING,0.0011199,0.29994,0.35414,1,1
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,5.753e-07,0.29935,0.30462,1,1
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.9263e-05,0.29926,0.26843,1,1
5,GO LUNG MORPHOGENESIS,0.0036303,0.29921,0.21329,1,1
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.00011241,0.29919,0.30381,1,1
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,1.7118e-05,0.29907,0.27046,1,1
5,GO REGULATION OF STEROID METABOLIC PROCESS,0.00012964,0.29897,0.23971,1,1
5,GO MALE SEX DETERMINATION,0.014138,0.29888,0.22679,1,1
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,6.5149e-05,0.29869,0.28049,1,1
5,GO DETECTION OF CALCIUM ION,0.0075304,0.29858,0.29724,1,1
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,1.2962e-05,0.29848,0.24615,1,1
5,GO RENAL TUBULE DEVELOPMENT,0.00031859,0.29778,0.21901,1,1
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0031536,0.29767,0.23664,1,1
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00020448,0.29757,0.23916,1,1
5,GO RESPONSE TO IRON ION,0.00017796,0.29709,0.24951,1,1
5,GO REGULATION OF ORGANIC ACID TRANSPORT,8.7323e-05,0.29697,0.26007,1,1
5,GO TYPE I INTERFERON PRODUCTION,0.00012964,0.2969,0.2433,1,1
5,GO REGULATION OF RESPONSE TO TUMOR CELL,0.0051916,0.29661,0.22364,1,1
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.8583e-05,0.29639,0.2689,1,1
5,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.0016129,0.29621,0.4199,1,1
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00055855,0.29603,0.21049,1,1
5,GO INTERLEUKIN 5 PRODUCTION,0.011612,0.29598,0.23039,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0007696,0.29591,0.23059,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00084609,0.29582,0.26327,1,1
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00047456,0.29566,0.30095,1,1
5,GO CHEMOKINE PRODUCTION,7.013e-05,0.29549,0.27912,1,1
5,GO POSITIVE REGULATION OF CELL ADHESION,7.8282e-05,0.29544,0.23909,1,1
5,GO REGULATION OF SODIUM ION TRANSPORT,3.4421e-05,0.29541,0.25822,1,1
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,6.5149e-05,0.29537,0.21292,1,1
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0085714,0.29531,0.27858,1,1
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.026586,0.29514,0.24891,1,1
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00020448,0.29498,0.21442,1,1
5,GO PROTEIN TARGETING TO LYSOSOME,0.0017123,0.29493,0.27078,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,6.7596e-05,0.29483,0.30564,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00050664,0.29439,0.23383,1,1
5,GO REGULATION OF MAST CELL ACTIVATION,0.00034072,0.29426,0.24479,1,1
5,GO RESPONSE TO MECHANICAL STIMULUS,4.2876e-06,0.29414,0.27502,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.007729,0.29407,0.24775,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.001228,0.29397,0.21469,1,1
5,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00044439,0.29396,0.23041,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0021689,0.29381,0.25894,1,1
5,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0011199,0.29381,0.23857,1,1
5,GO ASTROCYTE ACTIVATION,0.00012964,0.29368,0.33651,1,1
5,GO BROWN FAT CELL DIFFERENTIATION,5.2139e-05,0.29316,0.30463,1,1
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00049035,0.29309,0.25184,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,7.8282e-05,0.29292,0.32508,1,1
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0017123,0.2929,0.25698,1,1
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,5.8301e-05,0.29288,0.22586,1,1
5,GO CELLULAR RESPONSE TO NUTRIENT,0.0022992,0.2926,0.25293,1,1
5,GO RESPONSE TO AMPHETAMINE,0.0030654,0.29257,0.24773,1,1
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.29245,0.18387,1,1
5,GO ICOSANOID METABOLIC PROCESS,0.00013917,0.29238,0.2685,1,1
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.0017641,0.29215,0.2934,1,1
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,7.3528e-06,0.29178,0.27049,1,1
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00040247,0.29173,0.26609,1,1
5,GO REGULATION OF NEURON MATURATION,0.0022332,0.29163,0.27721,1,1
5,GO LEUKOCYTE CELL CELL ADHESION,3.5759e-05,0.29157,0.23904,1,1
5,GO REGULATION OF CELL MATRIX ADHESION,6.7596e-05,0.29156,0.27179,1,1
5,GO DETECTION OF BIOTIC STIMULUS,0.00084609,0.29146,0.32463,1,1
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,1.5201e-05,0.29136,0.2476,1,1
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.018836,0.29124,0.19045,1,1
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0014299,0.29118,0.24766,1,1
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.0011199,0.29106,0.25608,1,1
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,8.1192e-05,0.29104,0.36029,1,1
5,GO LEUKOCYTE MIGRATION,1.7118e-05,0.29077,0.24479,1,1
5,GO EXOCRINE SYSTEM DEVELOPMENT,0.00065623,0.29069,0.28088,1,1
5,GO ALPHA BETA T CELL DIFFERENTIATION,6.0504e-05,0.29057,0.24811,1,1
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00011241,0.29025,0.24088,1,1
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0075304,0.29018,0.28479,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.5308e-05,0.29011,0.25191,1,1
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0029794,0.2899,0.24147,1,1
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00023468,0.2895,0.30091,1,1
5,GO REGULATION OF CARTILAGE DEVELOPMENT,5.8301e-05,0.28946,0.28676,1,1
5,GO TISSUE REGENERATION,0.0050528,0.28932,0.20576,1,1
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0010206,0.28931,0.38194,1,1
5,GO REGULATION OF ACROSOME REACTION,0.0019282,0.2893,0.2596,1,1
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.0833e-05,0.2891,0.26182,1,1
5,GO NEURON CELL CELL ADHESION,0.018836,0.28893,0.37372,1,1
5,GO PARAXIAL MESODERM DEVELOPMENT,0.0027346,0.28883,0.28268,1,1
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00063551,0.28874,0.33731,1,1
5,GO GLYCOSYLATION,1.6015e-06,0.28817,0.26351,1,1
5,GO BEHAVIORAL RESPONSE TO PAIN,0.0060989,0.28794,0.28792,1,1
5,GO HEART TRABECULA FORMATION,0.0036303,0.28756,0.28626,1,1
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.014841,0.28755,0.22097,1,1
5,GO T CELL ACTIVATION,2.8418e-05,0.28749,0.22834,1,1
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00019079,0.28746,0.24327,1,1
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0031536,0.28744,0.22848,1,1
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0001547,0.28741,0.28292,1,1
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,7.2754e-05,0.2874,0.27917,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0017641,0.28734,0.23228,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00065623,0.28678,0.21144,1,1
5,GO PLATELET ACTIVATION,0.00018427,0.28675,0.20993,1,1
5,GO STEROID METABOLIC PROCESS,2.5308e-05,0.28671,0.22419,1,1
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0049174,0.28669,0.18161,1,1
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00050664,0.28666,0.28334,1,1
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0067808,0.2866,0.291,1,1
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00019079,0.28645,0.21487,1,1
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,5.9841e-06,0.28642,0.26079,1,1
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,5.753e-07,0.28622,0.28512,1,1
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0028141,0.28618,0.59781,1,1
5,GO PROTEIN DEGLYCOSYLATION,0.0010528,0.28611,0.24247,1,1
5,GO PLASMA MEMBRANE FUSION,0.00074557,0.28596,0.26398,1,1
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.00018427,0.28584,0.2737,1,1
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,7.013e-05,0.28578,0.31386,1,1
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,9.389e-05,0.2856,0.28242,1,1
5,GO VIRAL LIFE CYCLE,0.00045924,0.28548,0.20097,1,1
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0049174,0.28528,0.23261,1,1
5,GO RESPONSE TO ACIDIC PH,0.00084609,0.28467,0.27708,1,1
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.044685,0.28456,0.15818,1,1
5,GO TOOTH MINERALIZATION,0.0040578,0.28423,0.25656,1,1
5,GO POLYSACCHARIDE METABOLIC PROCESS,1.8251e-06,0.28414,0.2642,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.0689e-05,0.28397,0.23313,1,1
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0087944,0.28396,0.22588,1,1
5,GO EPITHELIAL CELL PROLIFERATION,8.1192e-05,0.28389,0.22681,1,1
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00044439,0.28357,0.1903,1,1
5,GO REGULATION OF RESPONSE TO WOUNDING,0.00055855,0.28339,0.23213,1,1
5,GO MYELOID LEUKOCYTE ACTIVATION,0.00019753,0.28318,0.21098,1,1
5,GO SPHINGOLIPID METABOLIC PROCESS,2.9301e-06,0.28316,0.24636,1,1
5,GO OLIGODENDROCYTE DIFFERENTIATION,6.7728e-06,0.28291,0.26223,1,1
5,GO POSITIVE REGULATION OF OSSIFICATION,0.00030804,0.28287,0.29956,1,1
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.013465,0.28287,0.21983,1,1
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00020448,0.28242,0.2199,1,1
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00030804,0.28227,0.24732,1,1
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,1.5816e-05,0.28224,0.22995,1,1
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00067758,0.28204,0.20081,1,1
5,GO FAT CELL DIFFERENTIATION,5.9841e-06,0.28199,0.25933,1,1
5,GO REGULATION OF CELL ADHESION,4.1617e-05,0.28193,0.23188,1,1
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.8521e-05,0.28153,0.25507,1,1
5,GO REGULATION OF CELL ACTIVATION,2.0833e-05,0.28133,0.214,1,1
5,GO B CELL ACTIVATION,2.6307e-05,0.28122,0.2206,1,1
5,GO DIOL METABOLIC PROCESS,5.508e-06,0.28118,0.30561,1,1
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00019753,0.28116,0.25282,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.019739,0.28065,0.21359,1,1
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0019282,0.2805,0.20078,1,1
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,4.1617e-05,0.28048,0.24643,1,1
5,GO RESPONSE TO GROWTH HORMONE,0.00017796,0.28047,0.27006,1,1
5,GO LEUKOCYTE APOPTOTIC PROCESS,0.00063551,0.2803,0.22514,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00090094,0.28025,0.25912,1,1
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00012074,0.28021,0.2187,1,1
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0013457,0.28004,0.25268,1,1
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,1.8251e-06,0.28,0.25431,1,1
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,1.7806e-05,0.27982,0.34968,1,1
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0059384,0.27961,0.24165,1,1
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00031859,0.27959,0.20858,1,1
5,GO B CELL HOMEOSTASIS,0.00044439,0.27951,0.26466,1,1
5,GO CERAMIDE BIOSYNTHETIC PROCESS,8.3127e-06,0.27891,0.25571,1,1
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.025994,0.27888,0.20356,1,1
5,GO RESPONSE TO STEROL DEPLETION,0.0030654,0.27882,0.23348,1,1
5,GO ADIPOSE TISSUE DEVELOPMENT,3.3132e-05,0.27878,0.2572,1,1
5,GO GLIAL CELL DIFFERENTIATION,4.6597e-05,0.27872,0.22012,1,1
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,2.2658e-06,0.27849,0.27258,1,1
5,GO STEROL HOMEOSTASIS,3.7145e-05,0.27832,0.237,1,1
5,GO FUCOSYLATION,2.7343e-05,0.27821,0.27374,1,1
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00013433,0.27816,0.24774,1,1
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0073363,0.27789,0.2483,1,1
5,GO INTERLEUKIN 1 PRODUCTION,0.00079435,0.27785,0.23437,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.6307e-05,0.27784,0.24841,1,1
5,GO LIPOSACCHARIDE METABOLIC PROCESS,2.2658e-06,0.27782,0.24244,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00016595,0.27741,0.20514,1,1
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0024367,0.2774,0.26578,1,1
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,1.9263e-05,0.27696,0.2569,1,1
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.2454e-05,0.27683,0.24178,1,1
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,6.0504e-05,0.27677,0.25232,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.0085714,0.27677,0.21297,1,1
5,GO DEFENSE RESPONSE,2.2524e-05,0.27676,0.22489,1,1
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0017123,0.27673,0.2222,1,1
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0018173,0.27668,0.2818,1,1
5,GO RESPIRATORY SYSTEM DEVELOPMENT,0.00017186,0.27668,0.21562,1,1
5,GO CAMP METABOLIC PROCESS,0.0026572,0.27652,0.19789,1,1
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00090094,0.27647,0.22431,1,1
5,GO EPITHELIAL CELL FATE COMMITMENT,0.0066042,0.27646,0.26205,1,1
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00040247,0.27634,0.27875,1,1
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00045924,0.27601,0.24327,1,1
5,GO STEROL METABOLIC PROCESS,8.4205e-05,0.27594,0.21867,1,1
5,GO INTERACTION WITH HOST,0.00049035,0.27573,0.19586,1,1
5,GO CERAMIDE METABOLIC PROCESS,2.9301e-06,0.27549,0.24481,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.00037661,0.27548,0.23411,1,1
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0040578,0.27527,0.28506,1,1
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00034072,0.2749,0.25813,1,1
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.0021062,0.27488,0.25662,1,1
5,GO HOMOTYPIC CELL CELL ADHESION,0.00010092,0.27488,0.27971,1,1
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00050664,0.27475,0.30078,1,1
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00021909,0.27462,0.24873,1,1
5,GO DEVELOPMENTAL INDUCTION,1.4039e-05,0.2744,0.27523,1,1
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00014935,0.2744,0.22903,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.015203,0.27434,0.16558,1,1
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0053338,0.27414,0.18438,1,1
5,GO MEMBRANE REPOLARIZATION,0.00063551,0.2738,0.2449,1,1
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0013457,0.27348,0.22603,1,1
5,GO SECONDARY PALATE DEVELOPMENT,0.00010092,0.27344,0.3003,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,3.8583e-05,0.27337,0.25807,1,1
5,GO CELL CHEMOTAXIS,1.4609e-05,0.27325,0.25438,1,1
5,GO REGULATION OF AMINO ACID TRANSPORT,0.00044439,0.27318,0.27764,1,1
5,GO OVARIAN FOLLICLE DEVELOPMENT,0.00032948,0.27312,0.20241,1,1
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,5.4121e-05,0.27282,0.29657,1,1
5,GO KERATINOCYTE PROLIFERATION,0.02268,0.27233,0.17122,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0073363,0.27227,0.21969,1,1
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00057693,0.27221,0.21995,1,1
5,GO REGULATION OF MUSCLE HYPERTROPHY,0.00049035,0.27202,0.23644,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.9532e-05,0.27163,0.21337,1,1
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.1964e-05,0.2713,0.22172,1,1
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0038387,0.27107,0.27611,1,1
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.7806e-05,0.27102,0.25362,1,1
5,GO CYTOKINE PRODUCTION,5.8301e-05,0.27086,0.22334,1,1
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.040234,0.27073,0.20072,1,1
5,GO EMBRYONIC BODY MORPHOGENESIS,0.025994,0.27073,0.21528,1,1
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0025083,0.27061,0.20793,1,1
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.8521e-05,0.27042,0.24416,1,1
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.0016129,0.27041,0.23123,1,1
5,GO DNA DEMETHYLATION,0.00013433,0.27039,0.25812,1,1
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.00067758,0.27033,0.2243,1,1
5,GO ANTIMICROBIAL HUMORAL RESPONSE,4.4878e-05,0.2703,0.2111,1,1
5,GO CYTOKINE SECRETION,6.5149e-05,0.27029,0.22671,1,1
5,GO EXTRACELLULAR VESICLE BIOGENESIS,0.00030804,0.27027,0.21262,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0032441,0.27026,0.22207,1,1
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.05161,0.27026,0.26094,1,1
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.0057817,0.2701,0.234,1,1
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0081404,0.26997,0.37179,1,1
5,GO HAIR CELL DIFFERENTIATION,6.2786e-05,0.26977,0.25201,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.009256,0.26961,0.18983,1,1
5,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00087311,0.26943,0.18786,1,1
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00012964,0.2694,0.21399,1,1
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.015203,0.26937,0.20361,1,1
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.014486,0.26932,0.31546,1,1
5,GO AMINO SUGAR CATABOLIC PROCESS,0.0038387,0.26928,0.21731,1,1
5,GO CELL KILLING,8.4205e-05,0.26923,0.22218,1,1
5,GO METANEPHROS DEVELOPMENT,0.00059588,0.26921,0.20432,1,1
5,GO REGULATION OF MUSCLE ADAPTATION,0.00024286,0.26921,0.21417,1,1
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.029068,0.26912,0.21286,1,1
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0017123,0.26908,0.29308,1,1
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0026572,0.26887,0.29564,1,1
5,GO LONG TERM SYNAPTIC POTENTIATION,0.0021689,0.26851,0.20704,1,1
5,GO CELL ACTIVATION,8.4205e-05,0.26831,0.1977,1,1
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00010845,0.26829,0.19694,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.0069616,0.26821,0.31804,1,1
5,GO REGULATION OF RUFFLE ASSEMBLY,0.0013872,0.26815,0.24972,1,1
5,GO MAMMARY GLAND MORPHOGENESIS,0.0019282,0.26772,0.23235,1,1
5,GO LEUKOCYTE CHEMOTAXIS,4.6597e-05,0.26764,0.22406,1,1
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00016023,0.26749,0.29174,1,1
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0075304,0.26749,0.16876,1,1
5,GO REGULATION OF CELL SUBSTRATE ADHESION,0.00084609,0.26744,0.2195,1,1
5,GO REGULATION OF FLAGELLATED SPERM MOTILITY,6.5149e-05,0.26735,0.22517,1,1
5,GO WATER HOMEOSTASIS,2.0033e-05,0.26729,0.27494,1,1
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0099891,0.26708,0.26454,1,1
5,GO AXIS ELONGATION,0.017969,0.26665,0.16978,1,1
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,5.4121e-05,0.26637,0.25987,1,1
5,GO DORSAL AORTA DEVELOPMENT,0.02843,0.26632,0.21634,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,8.7323e-05,0.26631,0.21393,1,1
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00065623,0.26628,0.20797,1,1
5,GO RESPONSE TO CYTOKINE,8.1192e-05,0.26609,0.20586,1,1
5,GO CRANIAL NERVE MORPHOGENESIS,0.0049174,0.26608,0.22942,1,1
5,GO POSITIVE REGULATION OF CELL ACTIVATION,4.4878e-05,0.26594,0.21819,1,1
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00074557,0.26576,0.20611,1,1
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.0053338,0.26567,0.27867,1,1
5,GO FATTY ACID HOMEOSTASIS,0.013139,0.26557,0.26618,1,1
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1.7118e-05,0.2654,0.25686,1,1
5,GO SODIUM ION TRANSPORT,1.5816e-05,0.26528,0.21911,1,1
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.7145e-05,0.26525,0.24536,1,1
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.9418e-06,0.26518,0.23515,1,1
5,GO RESPONSE TO PEPTIDOGLYCAN,0.00098941,0.26515,0.20682,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00081984,0.26497,0.18886,1,1
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0057817,0.26458,0.21777,1,1
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.00087311,0.26456,0.31396,1,1
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,9.0221e-07,0.26455,0.25646,1,1
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0033369,0.26451,0.14642,1,1
5,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0067808,0.26437,0.1924,1,1
5,GO RESPONSE TO TUMOR CELL,0.0013457,0.26424,0.27992,1,1
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.6597e-05,0.26408,0.262,1,1
5,GO REGULATION OF NEUTROPHIL MIGRATION,0.00013917,0.26399,0.22032,1,1
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.050569,0.26399,0.13728,1,1
5,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00024286,0.26387,0.25936,1,1
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0037331,0.26378,0.21494,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0025083,0.26373,0.22807,1,1
5,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.007729,0.26332,0.29663,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0021689,0.26307,0.21106,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.0689e-05,0.26298,0.19668,1,1
5,GO ENDOTHELIAL CELL PROLIFERATION,0.00026903,0.26298,0.22439,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.025994,0.26288,0.20492,1,1
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,2.6307e-05,0.26288,0.23368,1,1
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00054072,0.26284,0.27611,1,1
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.029719,0.26252,0.2041,1,1
5,GO MULTICELLULAR ORGANISM AGING,3.3132e-05,0.26244,0.22318,1,1
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00012964,0.26228,0.22688,1,1
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0007696,0.26209,0.32007,1,1
5,GO REGULATION OF LEUKOCYTE MIGRATION,8.7323e-05,0.26193,0.216,1,1
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.025414,0.26191,0.29179,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0024367,0.26176,0.26777,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0042883,0.26133,0.17633,1,1
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.4994e-06,0.26096,0.2362,1,1
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.0026572,0.26094,0.24105,1,1
5,GO LIPOPROTEIN METABOLIC PROCESS,1.0779e-06,0.26066,0.25918,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.019283,0.2605,0.17931,1,1
5,GO ETHER METABOLIC PROCESS,0.017549,0.26002,0.17596,1,1
5,GO PLACENTA DEVELOPMENT,0.00047456,0.25997,0.20704,1,1
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.035393,0.25991,0.25317,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0081404,0.2597,0.1892,1,1
5,GO SERTOLI CELL DEVELOPMENT,0.0034322,0.25938,0.33394,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0075304,0.25933,0.34888,1,1
5,GO CYTOKINE METABOLIC PROCESS,0.00084609,0.2593,0.24817,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0039469,0.25925,0.33587,1,1
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.041093,0.25903,0.17302,1,1
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.0015653,0.25897,0.26486,1,1
5,GO MANNOSYLATION,0.0010859,0.25887,0.19394,1,1
5,GO INFLAMMATORY RESPONSE,2.7343e-05,0.25875,0.22726,1,1
5,GO CELL CELL ADHESION,1.349e-05,0.25853,0.21376,1,1
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00036427,0.25844,0.20916,1,1
5,GO ENAMEL MINERALIZATION,0.011326,0.25844,0.24156,1,1
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,4.0073e-05,0.2584,0.22327,1,1
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0015189,0.25819,0.21431,1,1
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.104e-05,0.25816,0.26577,1,1
5,GO INTERLEUKIN 6 PRODUCTION,3.1888e-05,0.25816,0.21178,1,1
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,9.3916e-06,0.25803,0.29708,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0053338,0.25784,0.25637,1,1
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0013872,0.25765,0.2739,1,1
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00010845,0.25751,0.23042,1,1
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00017186,0.25748,0.26213,1,1
5,GO GRANULOCYTE DIFFERENTIATION,0.0011199,0.25741,0.20597,1,1
5,GO RESPONSE TO CORTICOSTERONE,0.0094949,0.25739,0.2324,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.7118e-05,0.25716,0.26641,1,1
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.0040578,0.25705,0.3461,1,1
5,GO POSITIVE REGULATION OF GLIOGENESIS,3.8583e-05,0.25697,0.22853,1,1
5,GO MUSCLE ATROPHY,0.027188,0.25671,0.17251,1,1
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0060989,0.25654,0.15681,1,1
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,8.3127e-06,0.25647,0.28115,1,1
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00069957,0.25645,0.21935,1,1
5,GO NEGATIVE REGULATION OF WOUND HEALING,0.0041716,0.25634,0.20454,1,1
5,GO PROGRAMMED NECROTIC CELL DEATH,0.00054072,0.25613,0.26943,1,1
5,GO ALANINE TRANSPORT,0.004408,0.25609,0.18741,1,1
5,GO RESPONSE TO WOUNDING,0.00098941,0.25603,0.1894,1,1
5,GO STEROL TRANSPORT,0.00072223,0.25591,0.18699,1,1
5,GO PROTEIN CONTAINING COMPLEX REMODELING,0.00036427,0.25579,0.23877,1,1
5,GO GLIOGENESIS,0.00010845,0.2556,0.19764,1,1
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,5.2139e-05,0.25556,0.22451,1,1
5,GO CELL MATRIX ADHESION,0.00024286,0.25516,0.20833,1,1
5,GO RESPONSE TO BIOTIC STIMULUS,0.00012074,0.25513,0.19354,1,1
5,GO SKIN EPIDERMIS DEVELOPMENT,0.0018173,0.25489,0.17134,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.2786e-05,0.25476,0.20429,1,1
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.030383,0.25473,0.20825,1,1
5,GO OXALATE TRANSPORT,0.0057817,0.25468,0.17459,1,1
5,GO MESONEPHROS DEVELOPMENT,2.6307e-05,0.25424,0.25632,1,1
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0006154,0.25421,0.21221,1,1
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.00098941,0.25416,0.24294,1,1
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,1.1964e-05,0.2541,0.22507,1,1
5,GO CELL CELL JUNCTION ASSEMBLY,8.4205e-05,0.25396,0.22888,1,1
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,3.1904e-06,0.25386,0.25658,1,1
5,GO NECROTIC CELL DEATH,0.00044439,0.25362,0.26554,1,1
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,8.3127e-06,0.25318,0.24395,1,1
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0071468,0.25286,0.32074,1,1
5,GO CELLULAR GLUCAN METABOLIC PROCESS,3.3132e-05,0.25283,0.23313,1,1
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.011612,0.25282,0.21277,1,1
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0037331,0.25262,0.20095,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00050664,0.2523,0.26375,1,1
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.4712e-06,0.25219,0.21789,1,1
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,8.1192e-05,0.25193,0.32819,1,1
5,GO LYMPHOCYTE ACTIVATION,2.8418e-05,0.25177,0.19625,1,1
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00017186,0.25157,0.30949,1,1
5,GO MYOTUBE CELL DEVELOPMENT,0.0064317,0.25149,0.18614,1,1
5,GO REGULATION OF SYNAPSE MATURATION,0.04854,0.25136,0.2052,1,1
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0010206,0.25122,0.28703,1,1
5,GO POSITIVE REGULATION OF HEMOPOIESIS,9.7346e-05,0.25115,0.20521,1,1
5,GO DISACCHARIDE METABOLIC PROCESS,0.0011199,0.25109,0.24353,1,1
5,GO RENAL SYSTEM PROCESS,9.0551e-05,0.25089,0.20471,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.7323e-05,0.25064,0.27208,1,1
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,6.5149e-05,0.25064,0.19065,1,1
5,GO NEGATIVE REGULATION OF OSSIFICATION,0.00047456,0.25063,0.23862,1,1
5,GO ENDOCRINE HORMONE SECRETION,1.9263e-05,0.25061,0.28364,1,1
5,GO TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING,0.0022332,0.25049,0.21308,1,1
5,GO REGULATION OF ENDOCRINE PROCESS,9.0551e-05,0.25036,0.25676,1,1
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.029068,0.2502,0.19594,1,1
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.024846,0.25003,0.26015,1,1
5,GO NOTCH SIGNALING PATHWAY,5.508e-06,0.24999,0.24072,1,1
5,GO AMELOGENESIS,0.0022332,0.24986,0.26158,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00063551,0.24976,0.18713,1,1
5,GO GRANULOCYTE CHEMOTAXIS,0.00013433,0.24974,0.19615,1,1
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0031536,0.24957,0.23204,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00042998,0.24942,0.21407,1,1
5,GO T CELL MIGRATION,0.0020453,0.24939,0.19028,1,1
5,GO ACTIVATION OF JUN KINASE ACTIVITY,7.013e-05,0.24923,0.22281,1,1
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0047853,0.24898,0.32363,1,1
5,GO SODIUM ION HOMEOSTASIS,5.0226e-05,0.24895,0.23885,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,9.0551e-05,0.24889,0.19965,1,1
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.010245,0.24882,0.21097,1,1
5,GO POSITIVE REGULATION OF COAGULATION,0.0051916,0.24881,0.24594,1,1
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.9532e-05,0.2488,0.18753,1,1
5,GO LYMPHOCYTE MIGRATION,0.00012964,0.24834,0.21109,1,1
5,GO REGULATION OF NATURAL KILLER CELL DIFFERENTIATION,0.0015189,0.24825,0.27028,1,1
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.027803,0.24817,0.18652,1,1
5,GO DIOL BIOSYNTHETIC PROCESS,1.9263e-05,0.2481,0.27041,1,1
5,GO REGULATION OF INNATE IMMUNE RESPONSE,7.2754e-05,0.24807,0.20655,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0022332,0.24797,0.30804,1,1
5,GO TUBE MORPHOGENESIS,0.00031859,0.24777,0.16746,1,1
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00017796,0.24776,0.20434,1,1
5,GO POSITIVE CHEMOTAXIS,0.00042998,0.24776,0.23854,1,1
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0023671,0.24773,0.17282,1,1
5,GO REGULATION OF PEPTIDASE ACTIVITY,7.2754e-05,0.24758,0.24734,1,1
5,GO KIDNEY EPITHELIUM DEVELOPMENT,7.013e-05,0.24745,0.23106,1,1
5,GO KIDNEY MORPHOGENESIS,0.00063551,0.24733,0.20581,1,1
5,GO PROTEIN ADP RIBOSYLATION,0.00022676,0.2473,0.23293,1,1
5,GO RESPONSE TO NUTRIENT,0.00040247,0.24723,0.18971,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0075304,0.24722,0.16928,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,9.7346e-05,0.24718,0.19601,1,1
5,GO ACTIVATION OF MAPK ACTIVITY,4.1112e-06,0.24718,0.24651,1,1
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,5.2139e-05,0.24714,0.27348,1,1
5,GO FIBROBLAST PROLIFERATION,0.0020453,0.247,0.24732,1,1
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,7.547e-05,0.24672,0.28467,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00092958,0.24625,0.21394,1,1
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0047853,0.24619,0.23273,1,1
5,GO REGULATION OF ODONTOGENESIS,0.015203,0.24592,0.28673,1,1
5,GO RESPONSE TO INSECTICIDE,0.0028141,0.24585,0.30196,1,1
5,GO LYTIC VACUOLE ORGANIZATION,2.1663e-05,0.24546,0.20777,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.8301e-05,0.24542,0.20275,1,1
5,GO ANION HOMEOSTASIS,0.0018173,0.24538,0.1796,1,1
5,GO DIGESTIVE SYSTEM DEVELOPMENT,3.7145e-05,0.24533,0.23169,1,1
5,GO RECEPTOR BIOSYNTHETIC PROCESS,0.001872,0.24532,0.18182,1,1
5,GO PLATELET AGGREGATION,0.00050664,0.2451,0.23644,1,1
5,GO GRANULOCYTE MIGRATION,0.00029782,0.24483,0.19702,1,1
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0020453,0.24479,0.24723,1,1
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00013917,0.24478,0.23437,1,1
5,GO REGULATION OF STEM CELL DIVISION,0.012508,0.2444,0.18405,1,1
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.045624,0.24437,0.18843,1,1
5,GO LYMPHOCYTE CHEMOTAXIS,0.00063551,0.24429,0.19858,1,1
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.027188,0.24419,0.14344,1,1
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0071468,0.24385,0.15988,1,1
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.00353,0.24376,0.22666,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00010092,0.2436,0.1969,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,7.2754e-05,0.24352,0.19327,1,1
5,GO LIPID LOCALIZATION,2.0033e-05,0.24345,0.19893,1,1
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.001228,0.24316,0.17416,1,1
5,GO LYMPHOCYTE COSTIMULATION,0.00047456,0.24303,0.2163,1,1
5,GO PROTEIN N LINKED GLYCOSYLATION,4.6597e-05,0.24295,0.23119,1,1
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00013917,0.24292,0.18976,1,1
5,GO BLOOD VESSEL MORPHOGENESIS,0.0013872,0.24273,0.16138,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0017123,0.24265,0.26707,1,1
5,GO WHITE FAT CELL DIFFERENTIATION,0.00057693,0.24254,0.22941,1,1
5,GO KERATINOCYTE DIFFERENTIATION,0.00012964,0.24252,0.22165,1,1
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00081984,0.24241,0.18143,1,1
5,GO REGULATION OF T CELL DIFFERENTIATION,6.0504e-05,0.24208,0.18259,1,1
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.046579,0.24199,0.26953,1,1
5,GO CELLULAR KETONE METABOLIC PROCESS,0.001986,0.24194,0.14264,1,1
5,GO LEUKOCYTE HOMEOSTASIS,0.00050664,0.24181,0.18473,1,1
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.01282,0.24175,0.15811,1,1
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.00069957,0.24172,0.21377,1,1
5,GO TRANSMISSION OF NERVE IMPULSE,0.0036303,0.24156,0.2428,1,1
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0001547,0.24152,0.21217,1,1
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.00014935,0.24086,0.2361,1,1
5,GO PHOSPHOLIPID HOMEOSTASIS,0.0087944,0.24073,0.18685,1,1
5,GO MACROPHAGE CHEMOTAXIS,0.0013872,0.2406,0.2569,1,1
5,GO EATING BEHAVIOR,2.7343e-05,0.24059,0.23948,1,1
5,GO AMINOGLYCAN METABOLIC PROCESS,0.00038934,0.24049,0.20825,1,1
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0011549,0.24046,0.18275,1,1
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.1617e-05,0.24038,0.20832,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.010245,0.24021,0.14477,1,1
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00032948,0.24011,0.18269,1,1
5,GO CARNITINE METABOLIC PROCESS,0.03245,0.2401,0.17851,1,1
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0016129,0.24008,0.25869,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00052342,0.23992,0.18834,1,1
5,GO PROTEIN PROCESSING,0.00019079,0.23977,0.19036,1,1
5,GO B CELL DIFFERENTIATION,1.1493e-05,0.23959,0.19584,1,1
5,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00072223,0.23951,0.18885,1,1
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00014418,0.23943,0.22335,1,1
5,GO NEURONAL ACTION POTENTIAL,0.011047,0.23913,0.29516,1,1
5,GO PROTEIN KINASE B SIGNALING,0.00019753,0.23904,0.18067,1,1
5,GO REGULATION OF GONAD DEVELOPMENT,0.047551,0.23897,0.14858,1,1
5,GO NEGATIVE REGULATION OF GLIOGENESIS,0.00013433,0.23892,0.28844,1,1
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0011199,0.23889,0.17922,1,1
5,GO INACTIVATION OF MAPK ACTIVITY,0.001872,0.23882,0.27265,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.014138,0.23881,0.16715,1,1
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.011326,0.23875,0.2016,1,1
5,GO BILE ACID BIOSYNTHETIC PROCESS,0.00084609,0.23872,0.18086,1,1
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.0010528,0.23864,0.22194,1,1
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00049035,0.23846,0.16781,1,1
5,GO EPIDERMIS DEVELOPMENT,8.7323e-05,0.23846,0.20661,1,1
5,GO REGULATION OF FATTY ACID TRANSPORT,3.1888e-05,0.23846,0.28429,1,1
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0066042,0.23845,0.19732,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.001228,0.23834,0.22588,1,1
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.001986,0.23834,0.17954,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00044439,0.23828,0.18166,1,1
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0079323,0.23789,0.19459,1,1
5,GO BIOLOGICAL ADHESION,9.7346e-05,0.23774,0.19145,1,1
5,GO GLUCOCORTICOID METABOLIC PROCESS,0.0071468,0.23764,0.19781,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.0079323,0.23734,0.14263,1,1
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00072223,0.2373,0.26223,1,1
5,GO ENERGY RESERVE METABOLIC PROCESS,8.1192e-05,0.23724,0.21101,1,1
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.00095906,0.23722,0.18711,1,1
5,GO MYELOID CELL APOPTOTIC PROCESS,0.0040578,0.23675,0.20089,1,1
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00079435,0.23657,0.19176,1,1
5,GO NOTCH RECEPTOR PROCESSING,0.0022332,0.23653,0.35146,1,1
5,GO CELLULAR RESPONSE TO AMYLOID BETA,0.00036427,0.23625,0.22363,1,1
5,GO ERBB SIGNALING PATHWAY,0.0006154,0.23621,0.17896,1,1
5,GO REGULATION OF MAP KINASE ACTIVITY,1.1493e-05,0.23616,0.22183,1,1
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.1888e-05,0.23599,0.18178,1,1
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0011549,0.23592,0.19725,1,1
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00010092,0.23586,0.19012,1,1
5,GO WOUND HEALING,0.0013872,0.23575,0.17687,1,1
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.038561,0.23565,0.2124,1,1
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00012964,0.2356,0.20915,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00057693,0.23559,0.24406,1,1
5,GO GASTRULATION WITH MOUTH FORMING SECOND,0.014841,0.23472,0.18599,1,1
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00028792,0.23466,0.20234,1,1
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0011549,0.23462,0.24585,1,1
5,GO REGULATION OF RESPONSE TO FOOD,0.0014299,0.23456,0.19795,1,1
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.0083534,0.23431,0.19364,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0033369,0.23429,0.24113,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0030654,0.23426,0.19474,1,1
5,GO BILE ACID METABOLIC PROCESS,0.0012662,0.23398,0.18887,1,1
5,GO MUSCLE ADAPTATION,0.00090094,0.2338,0.18155,1,1
5,GO STARTLE RESPONSE,0.0071468,0.2337,0.24128,1,1
5,GO MYELOID CELL HOMEOSTASIS,0.00026903,0.23351,0.16915,1,1
5,GO TISSUE HOMEOSTASIS,0.00010092,0.23309,0.16754,1,1
5,GO REGULATION OF PROTEIN GLYCOSYLATION,0.0013457,0.23308,0.21591,1,1
5,GO REGULATION OF GLIOGENESIS,8.1192e-05,0.23304,0.20328,1,1
5,GO NEPHRON MORPHOGENESIS,0.00065623,0.23303,0.19333,1,1
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.0833e-05,0.23301,0.24675,1,1
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00050664,0.23297,0.18456,1,1
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,5.6174e-05,0.23292,0.19267,1,1
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0017123,0.23292,0.16845,1,1
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0057817,0.23288,0.25042,1,1
5,GO NEUROINFLAMMATORY RESPONSE,0.00092958,0.2328,0.19961,1,1
5,GO REGULATION OF ICOSANOID SECRETION,0.00019753,0.23264,0.25666,1,1
5,GO NEPHRON EPITHELIUM DEVELOPMENT,0.00035231,0.23255,0.20325,1,1
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00042998,0.23247,0.20016,1,1
5,GO REGULATION OF CELL POPULATION PROLIFERATION,3.3132e-05,0.23233,0.16919,1,1
5,GO ENDOTHELIAL CELL MIGRATION,0.00055855,0.23209,0.21266,1,1
5,GO CELLULAR RESPONSE TO VITAMIN,0.024288,0.23206,0.22529,1,1
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0017641,0.23168,0.22689,1,1
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00059588,0.23131,0.17741,1,1
5,GO CHLORIDE ION HOMEOSTASIS,0.0056288,0.23129,0.17306,1,1
5,GO REGULATION OF DENDRITE EXTENSION,0.0071468,0.23128,0.32867,1,1
5,GO CELL CELL JUNCTION ORGANIZATION,0.00032948,0.23113,0.2029,1,1
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0014299,0.23102,0.2637,1,1
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.02268,0.23099,0.13879,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.0062634,0.23095,0.2132,1,1
5,GO TISSUE MIGRATION,0.0014738,0.23088,0.19047,1,1
5,GO PEPTIDYL TYROSINE MODIFICATION,9.0551e-05,0.23088,0.20547,1,1
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,7.6603e-06,0.23087,0.22034,1,1
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,9.389e-05,0.23083,0.17312,1,1
5,GO MOLTING CYCLE,0.001191,0.23081,0.15337,1,1
5,GO NATURAL KILLER CELL DIFFERENTIATION,0.00040247,0.23079,0.20003,1,1
5,GO ORGANELLE MEMBRANE FUSION,0.00098941,0.23061,0.16795,1,1
5,GO REGULATION OF IMMUNE RESPONSE,0.00010462,0.2306,0.18729,1,1
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.013139,0.23053,0.18869,1,1
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.012203,0.23047,0.19998,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0038387,0.23033,0.22408,1,1
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.02843,0.23032,0.21732,1,1
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00022676,0.23002,0.1808,1,1
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.045624,0.22999,0.27248,1,1
5,GO PHOSPHOLIPID TRANSPORT,7.9801e-06,0.22998,0.21818,1,1
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.014841,0.22997,0.20475,1,1
5,GO EPIDERMAL CELL DIFFERENTIATION,0.00012074,0.22966,0.22175,1,1
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,4.4878e-05,0.22964,0.22226,1,1
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0079323,0.22961,0.17996,1,1
5,GO EPIDERMIS MORPHOGENESIS,0.016734,0.22939,0.15204,1,1
5,GO CORNIFICATION,0.0034322,0.22937,0.21935,1,1
5,GO INTEGRIN ACTIVATION,0.00034072,0.22889,0.24674,1,1
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.019283,0.22888,0.18207,1,1
5,GO POSITIVE REGULATION OF TISSUE REMODELING,0.0017641,0.22863,0.21649,1,1
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00026003,0.22857,0.22389,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,4.4878e-05,0.22854,0.2285,1,1
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.0069616,0.22844,0.16508,1,1
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,2.1663e-05,0.22814,0.18733,1,1
5,GO REGULATION OF VASCULATURE DEVELOPMENT,0.00092958,0.22799,0.18151,1,1
5,GO CARDIAC CONDUCTION,0.00042998,0.22773,0.22628,1,1
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00014418,0.22716,0.19629,1,1
5,GO REGULATION OF INFLAMMATORY RESPONSE,3.4421e-05,0.22714,0.21448,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00014418,0.22655,0.22928,1,1
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0066042,0.22654,0.19271,1,1
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0075304,0.22648,0.17025,1,1
5,GO INTESTINAL LIPID ABSORPTION,0.01282,0.22645,0.2393,1,1
5,GO POTASSIUM ION HOMEOSTASIS,0.00013433,0.22641,0.22913,1,1
5,GO MYELOID LEUKOCYTE MIGRATION,0.00021167,0.22638,0.18966,1,1
5,GO TUBE DEVELOPMENT,0.00017796,0.22613,0.1668,1,1
5,GO RESPONSE TO FATTY ACID,0.0022332,0.22591,0.17574,1,1
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0019282,0.2259,0.18388,1,1
5,GO CRANIAL NERVE STRUCTURAL ORGANIZATION,0.035393,0.22588,0.26108,1,1
5,GO POSITIVE REGULATION OF HEART RATE,0.0025817,0.22577,0.28099,1,1
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,3.4421e-05,0.2256,0.23189,1,1
5,GO REGULATION OF RECEPTOR BINDING,0.021165,0.22553,0.18052,1,1
5,GO THYMIC T CELL SELECTION,8.4205e-05,0.22552,0.20014,1,1
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0039469,0.22544,0.2314,1,1
5,GO FIBROBLAST MIGRATION,0.001986,0.22541,0.18233,1,1
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.00021167,0.2254,0.25264,1,1
5,GO UROGENITAL SYSTEM DEVELOPMENT,0.00019079,0.22532,0.18607,1,1
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0059384,0.22531,0.16724,1,1
5,GO EXOCYTOSIS,4.6597e-05,0.22509,0.18928,1,1
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0046564,0.22506,0.19282,1,1
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.001662,0.22506,0.21937,1,1
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.035393,0.22489,0.13633,1,1
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0094949,0.2248,0.21461,1,1
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.00021909,0.22475,0.16321,1,1
5,GO INTERLEUKIN 1 BETA PRODUCTION,0.0023671,0.22454,0.20648,1,1
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.001986,0.22452,0.17827,1,1
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.00026003,0.22442,0.17247,1,1
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.0026572,0.22437,0.19907,1,1
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.025414,0.22357,0.18567,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.00059588,0.22357,0.21941,1,1
5,GO SERINE PHOSPHORYLATION OF STAT PROTEIN,0.0016129,0.22344,0.22943,1,1
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0025083,0.22336,0.18512,1,1
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.013465,0.22301,0.17838,1,1
5,GO CARDIAC CELL DEVELOPMENT,0.00092958,0.22297,0.16961,1,1
5,GO STEROID BIOSYNTHETIC PROCESS,0.00025131,0.22288,0.17941,1,1
5,GO ENDOCRINE PROCESS,0.0030654,0.22283,0.17814,1,1
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,2.9532e-05,0.22279,0.20225,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.02166,0.22279,0.18062,1,1
5,GO RESPONSE TO CAFFEINE,0.012508,0.2227,0.18662,1,1
5,GO VASCULATURE DEVELOPMENT,0.0023671,0.22267,0.14029,1,1
5,GO MACROPHAGE MIGRATION,0.001662,0.22256,0.19915,1,1
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0031536,0.22246,0.19405,1,1
5,GO IMMUNOGLOBULIN PRODUCTION,0.00092958,0.22244,0.14576,1,1
5,GO MUSCLE HYPERTROPHY,0.00065623,0.22226,0.18729,1,1
5,GO LYMPHOCYTE HOMEOSTASIS,0.00019079,0.22214,0.19435,1,1
5,GO QUINONE METABOLIC PROCESS,0.010773,0.22204,0.19392,1,1
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.012203,0.22203,0.33055,1,1
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00045924,0.22194,0.21893,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00018427,0.22192,0.21122,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0042883,0.22183,0.1725,1,1
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00057693,0.22173,0.21307,1,1
5,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00026003,0.22163,0.25328,1,1
5,GO OLIGOPEPTIDE TRANSPORT,0.013139,0.22159,0.16366,1,1
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00012512,0.22156,0.19679,1,1
5,GO BIOMINERALIZATION,0.00017796,0.22147,0.20712,1,1
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.00022676,0.22142,0.15979,1,1
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0066042,0.22139,0.17131,1,1
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.0022992,0.22138,0.22543,1,1
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,6.2786e-05,0.22136,0.16759,1,1
5,GO ACTIVATION OF JNKK ACTIVITY,0.031748,0.22132,0.19539,1,1
5,GO GLAND DEVELOPMENT,1.2962e-05,0.22126,0.19499,1,1
5,GO REGULATION OF FATTY ACID OXIDATION,0.0069616,0.22123,0.18551,1,1
5,GO REGULATION OF OSSIFICATION,0.00014418,0.221,0.24464,1,1
5,GO AMEBOIDAL TYPE CELL MIGRATION,0.0025083,0.22094,0.15819,1,1
5,GO DIENCEPHALON DEVELOPMENT,0.00016595,0.22093,0.2565,1,1
5,GO CELLULAR RESPONSE TO FATTY ACID,0.0011199,0.22081,0.20478,1,1
5,GO PHAGOCYTOSIS,0.0021689,0.22079,0.15853,1,1
5,GO LIPID BIOSYNTHETIC PROCESS,1.0184e-05,0.22056,0.18513,1,1
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.00045924,0.22031,0.25562,1,1
5,GO REGULATION OF EXIT FROM MITOSIS,0.0029794,0.2203,0.14968,1,1
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00069957,0.2203,0.16945,1,1
5,GO COAGULATION,0.0025083,0.22018,0.15387,1,1
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.0013872,0.22014,0.16037,1,1
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0045306,0.21972,0.15904,1,1
5,GO REGULATION OF FERTILIZATION,0.0027346,0.2197,0.18118,1,1
5,GO MONONUCLEAR CELL MIGRATION,0.0013872,0.21948,0.19461,1,1
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00038934,0.21946,0.20941,1,1
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.00031859,0.21928,0.19614,1,1
5,GO MEMBRANE FISSION,0.0040578,0.21917,0.24001,1,1
5,GO BONE MINERALIZATION,0.00069957,0.21916,0.20974,1,1
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.7806e-05,0.21908,0.19125,1,1
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0022992,0.21903,0.23284,1,1
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.015953,0.21892,0.22127,1,1
5,GO ANIMAL ORGAN REGENERATION,0.0053338,0.21886,0.1516,1,1
5,GO TRANSFERRIN TRANSPORT,0.00090094,0.21873,0.15915,1,1
5,GO ENDOCYTIC RECYCLING,0.00026003,0.21858,0.1801,1,1
5,GO CELLULAR RESPONSE TO STEROL,0.0027346,0.21849,0.22155,1,1
5,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00010092,0.21835,0.21242,1,1
5,GO LEUKOCYTE DIFFERENTIATION,1.6455e-05,0.218,0.188,1,1
5,GO NEURON MATURATION,0.00030804,0.21797,0.2472,1,1
5,GO ACTIVATED T CELL PROLIFERATION,4.0073e-05,0.21778,0.21823,1,1
5,GO GPI ANCHOR METABOLIC PROCESS,3.4421e-05,0.21761,0.21272,1,1
5,GO REGULATION OF HEMOPOIESIS,4.8379e-05,0.21759,0.17383,1,1
5,GO SKIN DEVELOPMENT,0.00014418,0.21755,0.20791,1,1
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,4.3218e-05,0.21739,0.19649,1,1
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00012074,0.21738,0.15305,1,1
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.012508,0.21721,0.19556,1,1
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,6.0504e-05,0.21716,0.18922,1,1
5,GO LACTATE METABOLIC PROCESS,0.0099891,0.21685,0.21939,1,1
5,GO DETERMINATION OF ADULT LIFESPAN,0.0036303,0.21684,0.18719,1,1
5,GO DRUG CATABOLIC PROCESS,0.01282,0.21683,0.14551,1,1
5,GO GLYCOPROTEIN METABOLIC PROCESS,1.4039e-05,0.21669,0.2033,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.024846,0.21653,0.2495,1,1
5,GO SENSORY PERCEPTION OF TASTE,0.00026903,0.21639,0.18102,1,1
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.011326,0.21621,0.26527,1,1
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.001228,0.21606,0.24548,1,1
5,GO NEPHRON DEVELOPMENT,0.00037661,0.21603,0.18753,1,1
5,GO NEPHRIC DUCT DEVELOPMENT,0.049546,0.21596,0.17387,1,1
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.037747,0.21591,0.2024,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0022992,0.21584,0.22523,1,1
5,GO POSITIVE REGULATION OF HEART CONTRACTION,0.00054072,0.21583,0.26021,1,1
5,GO DEFENSE RESPONSE TO BACTERIUM,4.1617e-05,0.21535,0.20379,1,1
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,1.7806e-05,0.21522,0.22748,1,1
5,GO VITAMIN CATABOLIC PROCESS,0.046579,0.21503,0.13811,1,1
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00069957,0.21482,0.15339,1,1
5,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0073363,0.21461,0.20034,1,1
5,GO PHOSPHOLIPID CATABOLIC PROCESS,0.0028957,0.21448,0.15369,1,1
5,GO RESPONSE TO AXON INJURY,0.00079435,0.21445,0.21823,1,1
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0057817,0.21431,0.1757,1,1
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,7.2754e-05,0.21429,0.21451,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.0050528,0.21427,0.14783,1,1
5,GO DIGESTIVE TRACT MORPHOGENESIS,0.014841,0.21426,0.15524,1,1
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.0010859,0.21424,0.21185,1,1
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00098941,0.21417,0.17099,1,1
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.017137,0.21399,0.23364,1,1
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,3.1904e-06,0.21396,0.19185,1,1
5,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0047853,0.2139,0.2034,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.036948,0.21384,0.23842,1,1
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,2.6902e-06,0.21377,0.20901,1,1
5,GO PROTEIN LOCALIZATION TO VACUOLE,0.001662,0.21375,0.15419,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0019282,0.21375,0.2007,1,1
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.00054072,0.21364,0.30761,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00084609,0.21357,0.19858,1,1
5,GO BODY MORPHOGENESIS,0.017137,0.21348,0.16506,1,1
5,GO LIPID OXIDATION,0.00084609,0.21337,0.18159,1,1
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0036303,0.21336,0.20654,1,1
5,GO REGULATION OF ANION TRANSPORT,0.00065623,0.21331,0.172,1,1
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.0034322,0.21327,0.16212,1,1
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.023205,0.21313,0.17265,1,1
5,GO L PHENYLALANINE METABOLIC PROCESS,0.017137,0.21307,0.21034,1,1
5,GO REGULATION OF SULFUR METABOLIC PROCESS,0.013465,0.21287,0.1903,1,1
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00040247,0.21275,0.19752,1,1
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,6.7728e-06,0.2125,0.20872,1,1
5,GO PROTEIN PALMITOYLATION,9.0551e-05,0.21247,0.23526,1,1
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.0059384,0.21243,0.2371,1,1
5,GO LYMPHOCYTE DIFFERENTIATION,4.1617e-05,0.2122,0.16709,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0017123,0.21211,0.22857,1,1
5,GO AUTOPHAGY OF NUCLEUS,0.030383,0.21206,0.14064,1,1
5,GO REGULATION OF BODY FLUID LEVELS,0.00042998,0.21194,0.16305,1,1
5,GO OSSIFICATION,0.00026003,0.2119,0.20808,1,1
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00029782,0.21176,0.24224,1,1
5,GO INNATE IMMUNE RESPONSE IN MUCOSA,0.0057817,0.2117,0.14643,1,1
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0042883,0.21165,0.15733,1,1
5,GO MUSCLE CELL DIFFERENTIATION,5.8301e-05,0.2115,0.17478,1,1
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.00021909,0.21147,0.24013,1,1
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0027346,0.21136,0.21935,1,1
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0056288,0.21116,0.16161,1,1
5,GO TERPENOID METABOLIC PROCESS,0.00092958,0.2111,0.17434,1,1
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00021909,0.21093,0.17202,1,1
5,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00054072,0.21056,0.187,1,1
5,GO POSITIVE REGULATION OF SECRETION,3.3287e-06,0.21054,0.20523,1,1
5,GO REGULATION OF KIDNEY DEVELOPMENT,0.01282,0.21034,0.17357,1,1
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0031536,0.21028,0.16243,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.00010845,0.21017,0.16718,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0054795,0.21,0.16953,1,1
5,GO EPITHELIAL CELL DIFFERENTIATION,2.9532e-05,0.20978,0.21446,1,1
5,GO RESPONSE TO AMINE,0.015203,0.20951,0.14995,1,1
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.00074557,0.20946,0.19297,1,1
5,GO POSITIVE REGULATION OF JNK CASCADE,7.547e-05,0.20934,0.1837,1,1
5,GO CELL SUBSTRATE ADHESION,0.0022992,0.20929,0.17695,1,1
5,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00017796,0.20924,0.2238,1,1
5,GO CELL MOTILITY,0.00010092,0.20919,0.17215,1,1
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00069957,0.20914,0.17431,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,5.2139e-05,0.20902,0.17761,1,1
5,GO ERYTHROCYTE HOMEOSTASIS,0.00030804,0.20894,0.16007,1,1
5,GO RESPONSE TO BACTERIUM,0.00050664,0.2089,0.17164,1,1
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.001228,0.2088,0.16973,1,1
5,GO PROTEIN LOCALIZATION TO AXON,0.046579,0.20875,0.29162,1,1
5,GO IMPORT ACROSS PLASMA MEMBRANE,0.00030804,0.20869,0.17955,1,1
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0038387,0.20865,0.1857,1,1
5,GO ADHERENS JUNCTION ASSEMBLY,0.0041716,0.20824,0.2276,1,1
5,GO NUCLEOTIDE TRANSPORT,0.0011199,0.20817,0.16365,1,1
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0060989,0.20807,0.15353,1,1
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00054072,0.20805,0.17061,1,1
5,GO PROTEIN AUTOPROCESSING,0.010506,0.20787,0.17835,1,1
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.0097392,0.20784,0.16084,1,1
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.009256,0.20784,0.23433,1,1
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0028957,0.20782,0.19555,1,1
5,GO PLASMA MEMBRANE ORGANIZATION,0.00054072,0.20765,0.19284,1,1
5,GO LIPID HOMEOSTASIS,6.7596e-05,0.20757,0.17071,1,1
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00079435,0.20748,0.17289,1,1
5,GO RESPONSE TO INTERLEUKIN 6,0.0060989,0.2073,0.1766,1,1
5,GO ACTIVATION OF IMMUNE RESPONSE,0.00037661,0.20701,0.16676,1,1
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.00042998,0.20697,0.18125,1,1
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00045924,0.20681,0.16937,1,1
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0029794,0.20662,0.14603,1,1
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,7.547e-05,0.20644,0.19372,1,1
5,GO ISOPRENOID METABOLIC PROCESS,0.00063551,0.2064,0.17553,1,1
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.016339,0.20636,0.15517,1,1
5,GO T CELL DIFFERENTIATION,5.4121e-05,0.20616,0.17771,1,1
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0029794,0.20595,0.20729,1,1
5,GO SPERM CAPACITATION,0.0013457,0.20595,0.18563,1,1
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0013457,0.20591,0.19235,1,1
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00074557,0.20582,0.17634,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.022165,0.20581,0.13284,1,1
5,GO REGULATION OF B CELL DIFFERENTIATION,0.0026572,0.2058,0.20501,1,1
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.011904,0.20571,0.16722,1,1
5,GO RESPONSE TO DEXAMETHASONE,0.0032441,0.20558,0.16353,1,1
5,GO POSITIVE REGULATION OF CELL SIZE,0.038561,0.20519,0.12923,1,1
5,GO KETONE BIOSYNTHETIC PROCESS,0.007729,0.20513,0.16526,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00055855,0.20457,0.26168,1,1
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0090226,0.20423,0.17692,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0051916,0.20417,0.19045,1,1
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,6.2786e-05,0.20412,0.26469,1,1
5,GO RESPONSE TO VITAMIN,0.014486,0.20409,0.17019,1,1
5,GO REGULATION OF DEFENSE RESPONSE,6.7596e-05,0.20408,0.18414,1,1
5,GO AMINE TRANSPORT,0.0037331,0.20397,0.24988,1,1
5,GO CELLULAR RESPONSE TO CALCIUM ION,0.0012662,0.20389,0.20428,1,1
5,GO REGULATION OF PROTEOLYSIS,0.00045924,0.20386,0.16569,1,1
5,GO ER OVERLOAD RESPONSE,0.013465,0.20358,0.17215,1,1
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00017796,0.20351,0.17173,1,1
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0064317,0.20343,0.21306,1,1
5,GO C21 STEROID HORMONE METABOLIC PROCESS,0.019283,0.20342,0.19602,1,1
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.018836,0.20337,0.17437,1,1
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.010506,0.20321,0.15566,1,1
5,GO MEMBRANE FUSION,6.5149e-05,0.20319,0.19412,1,1
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,2.0033e-05,0.20307,0.26521,1,1
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.029719,0.20301,0.15601,1,1
5,GO CELLULAR RESPONSE TO LIPID,0.0016129,0.20279,0.14199,1,1
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.017137,0.20277,0.16736,1,1
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0013457,0.20274,0.16239,1,1
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,5.508e-06,0.2027,0.18589,1,1
5,GO ORGAN INDUCTION,0.00074557,0.20267,0.20065,1,1
5,GO PSEUDOPODIUM ORGANIZATION,0.014138,0.20266,0.29183,1,1
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0036303,0.20265,0.17288,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0016129,0.20255,0.19346,1,1
5,GO REGULATION OF TUBE SIZE,0.00084609,0.20253,0.15475,1,1
5,GO REGULATION OF CHEMOTAXIS,7.2754e-05,0.20245,0.21067,1,1
5,GO POSITIVE REGULATION OF CELL DEATH,0.00013433,0.20238,0.1561,1,1
5,GO SECRETION BY TISSUE,0.0024367,0.20196,0.20795,1,1
5,GO RESPONSE TO UV C,0.0059384,0.20189,0.14994,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,0.0022992,0.20182,0.24098,1,1
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.0011199,0.20176,0.17019,1,1
5,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0024367,0.20163,0.2038,1,1
5,GO CALCIUM ION IMPORT INTO CYTOSOL,0.042857,0.20157,0.16666,1,1
5,GO TUMOR NECROSIS FACTOR SECRETION,0.001228,0.20135,0.15555,1,1
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00067758,0.2013,0.17203,1,1
5,GO EPITHELIUM DEVELOPMENT,4.3218e-05,0.20116,0.17279,1,1
5,GO MAMMARY GLAND DEVELOPMENT,0.00029782,0.20105,0.1766,1,1
5,GO PEPTIDE SECRETION,2.6902e-06,0.20093,0.20171,1,1
5,GO ACUTE PHASE RESPONSE,0.00074557,0.20065,0.18714,1,1
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00034072,0.20064,0.17224,1,1
5,GO REGULATION OF PEPTIDE SECRETION,1.906e-06,0.2004,0.19827,1,1
5,GO AMINE METABOLIC PROCESS,5.4121e-05,0.19991,0.18936,1,1
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.0028957,0.19991,0.15089,1,1
5,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00017796,0.1997,0.19724,1,1
5,GO REGULATION OF MEMBRANE POTENTIAL,0.0021062,0.19969,0.16446,1,1
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0099891,0.19964,0.26219,1,1
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.024288,0.19955,0.19428,1,1
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0094949,0.19946,0.16788,1,1
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0024367,0.19942,0.16789,1,1
5,GO MESENCHYMAL CELL PROLIFERATION,0.018836,0.19936,0.19919,1,1
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00014935,0.19927,0.14653,1,1
5,GO ACTIVATION OF MAPKKK ACTIVITY,0.011326,0.1991,0.2221,1,1
5,GO RESPONSE TO GONADOTROPIN,0.0079323,0.19897,0.16148,1,1
5,GO TRIGLYCERIDE METABOLIC PROCESS,0.0038387,0.19893,0.15786,1,1
5,GO CALCINEURIN MEDIATED SIGNALING,0.0011199,0.19891,0.16688,1,1
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0081404,0.19881,0.25635,1,1
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.0040578,0.19878,0.1869,1,1
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,2.1663e-05,0.19873,0.16491,1,1
5,GO CELLULAR RESPONSE TO VIRUS,0.0029794,0.1987,0.14343,1,1
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,2.6307e-05,0.19855,0.19761,1,1
5,GO POSITIVE REGULATION OF SIGNALING,1.1964e-05,0.19853,0.15652,1,1
5,GO REGENERATION,0.0045306,0.19852,0.14328,1,1
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.00041602,0.19843,0.14781,1,1
5,GO CELLULAR RESPONSE TO KETONE,0.01282,0.19842,0.13288,1,1
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0011199,0.19821,0.23294,1,1
5,GO POSITIVE REGULATION OF HORMONE SECRETION,7.2754e-05,0.19817,0.22013,1,1
5,GO PROTEIN MATURATION,0.00041602,0.19814,0.14452,1,1
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0023671,0.19814,0.15424,1,1
5,GO REGULATION OF BLOOD CIRCULATION,6.7596e-05,0.19798,0.1988,1,1
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.0016129,0.19796,0.16786,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016339,0.19768,0.21047,1,1
5,GO SUPEROXIDE METABOLIC PROCESS,0.001872,0.19761,0.18541,1,1
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.030383,0.19749,0.20942,1,1
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0038387,0.19746,0.19959,1,1
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00090094,0.19737,0.22369,1,1
5,GO UBIQUINONE METABOLIC PROCESS,0.013465,0.19733,0.10426,1,1
5,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00092958,0.19732,0.13972,1,1
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00023468,0.19717,0.16007,1,1
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.010245,0.197,0.17775,1,1
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00019753,0.19696,0.26875,1,1
5,GO SECRETION,7.6603e-06,0.19689,0.17521,1,1
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.02166,0.19686,0.18098,1,1
5,GO REGULATION OF JUN KINASE ACTIVITY,9.389e-05,0.19669,0.17901,1,1
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.03939,0.1965,0.13084,1,1
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0010206,0.19635,0.1622,1,1
5,GO NATURAL KILLER CELL ACTIVATION,0.00072223,0.19634,0.17896,1,1
5,GO ASTROCYTE DEVELOPMENT,0.010506,0.19632,0.22849,1,1
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00010462,0.19616,0.16714,1,1
5,GO LIPID METABOLIC PROCESS,2.9532e-05,0.196,0.16162,1,1
5,GO REGULATION OF VASCULAR PERMEABILITY,0.00044439,0.19563,0.21282,1,1
5,GO GLUTAMATE METABOLIC PROCESS,0.00038934,0.19556,0.16969,1,1
5,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0006154,0.19549,0.1674,1,1
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0030654,0.19547,0.12653,1,1
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.001872,0.19544,0.22612,1,1
5,GO GLIAL CELL MIGRATION,0.017969,0.19539,0.14177,1,1
5,GO ACYLGLYCEROL HOMEOSTASIS,0.010245,0.19529,0.14717,1,1
5,GO REGULATION OF HISTONE DEACETYLATION,0.0014299,0.19522,0.20165,1,1
5,GO LEFT RIGHT PATTERN FORMATION,0.010506,0.19516,0.16953,1,1
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.1617e-05,0.19502,0.20449,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0051916,0.19499,0.17876,1,1
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00055855,0.1949,0.16915,1,1
5,GO MYELOID CELL DIFFERENTIATION,0.0001547,0.19476,0.15798,1,1
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.001986,0.19474,0.23902,1,1
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0017641,0.19471,0.16763,1,1
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.009256,0.19448,0.2389,1,1
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00059588,0.19441,0.19712,1,1
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.7474e-06,0.19432,0.21444,1,1
5,GO HUMORAL IMMUNE RESPONSE,1.2454e-05,0.19426,0.25163,1,1
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0029794,0.19425,0.15146,1,1
5,GO CELL MATURATION,1.1267e-06,0.19411,0.20013,1,1
5,GO MUSCLE CELL DEVELOPMENT,0.00065623,0.19398,0.17735,1,1
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,9.389e-05,0.19397,0.21475,1,1
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0017641,0.19396,0.15632,1,1
5,GO INNER EAR MORPHOGENESIS,0.0010206,0.1939,0.15433,1,1
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,5.6174e-05,0.19375,0.15052,1,1
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.047551,0.19372,0.097815,1,1
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0010859,0.19372,0.13131,1,1
5,GO REGULATION OF LIPID STORAGE,0.0016129,0.19371,0.17304,1,1
5,GO RESPONSE TO DRUG,0.00054072,0.1937,0.15937,1,1
5,GO RESPONSE TO OSMOTIC STRESS,0.0021689,0.19358,0.14868,1,1
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.027188,0.19343,0.3347,1,1
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.02166,0.19342,0.19312,1,1
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00029782,0.19333,0.21105,1,1
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.010245,0.19315,0.21618,1,1
5,GO RESPONSE TO METAL ION,1.2962e-05,0.19299,0.19484,1,1
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,6.2786e-05,0.19288,0.17309,1,1
5,GO RESPONSE TO BMP,0.00095906,0.19287,0.16761,1,1
5,GO TRANSLESION SYNTHESIS,0.00021909,0.19286,0.17082,1,1
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00029782,0.19285,0.16071,1,1
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.0023671,0.19265,0.1654,1,1
5,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00032948,0.19243,0.19328,1,1
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,4.3218e-05,0.19242,0.16851,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0015653,0.19239,0.18761,1,1
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00034072,0.19219,0.19825,1,1
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00032948,0.19213,0.15533,1,1
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0075304,0.19197,0.11379,1,1
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0090226,0.19188,0.13228,1,1
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00059588,0.19186,0.16314,1,1
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.0015189,0.19168,0.17404,1,1
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.00036427,0.19164,0.18895,1,1
5,GO CYTOPLASM ORGANIZATION,0.014841,0.19149,0.15691,1,1
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,3.8583e-05,0.19141,0.16598,1,1
5,GO NEUTROPHIL MIGRATION,0.00067758,0.19139,0.15134,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0011549,0.19138,0.1505,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00019753,0.19136,0.15195,1,1
5,GO MEMBRANE BIOGENESIS,0.0050528,0.19115,0.21397,1,1
5,GO MUSCLE CELL APOPTOTIC PROCESS,0.0010528,0.19109,0.16583,1,1
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.0010206,0.1906,0.19804,1,1
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00041602,0.19055,0.22885,1,1
5,GO GANGLIOSIDE METABOLIC PROCESS,0.010506,0.19043,0.14944,1,1
5,GO FACIAL NERVE MORPHOGENESIS,0.019739,0.19038,0.27798,1,1
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,7.6603e-06,0.19036,0.19504,1,1
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.0833e-05,0.19029,0.18008,1,1
5,GO STRESS FIBER ASSEMBLY,0.0028141,0.19026,0.17572,1,1
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.022165,0.19022,0.14727,1,1
5,GO FLUID TRANSPORT,0.0064317,0.19017,0.15466,1,1
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.00065623,0.19002,0.19149,1,1
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0010528,0.18986,0.19504,1,1
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0010859,0.18977,0.13629,1,1
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0012662,0.18956,0.16446,1,1
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.00010092,0.18926,0.1555,1,1
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,8.4205e-05,0.18903,0.15578,1,1
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0010859,0.18893,0.15986,1,1
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.00090094,0.1889,0.23459,1,1
5,GO CELLULAR LIPID METABOLIC PROCESS,4.4878e-05,0.18881,0.15969,1,1
5,GO RESPONSE TO ISCHEMIA,0.00074557,0.18878,0.17945,1,1
5,GO APOPTOTIC SIGNALING PATHWAY,0.0001165,0.18866,0.1611,1,1
5,GO VESICLE TARGETING,0.0037331,0.18862,0.12456,1,1
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.037747,0.18851,0.142,1,1
5,GO ERK1 AND ERK2 CASCADE,0.0039469,0.18849,0.20142,1,1
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.0073363,0.18848,0.17363,1,1
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00010462,0.18823,0.17516,1,1
5,GO RESPONSE TO STEROL,0.0040578,0.18797,0.17289,1,1
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.00013433,0.18791,0.16824,1,1
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00022676,0.18785,0.22828,1,1
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.00021167,0.18783,0.13873,1,1
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0057817,0.18777,0.13556,1,1
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.033166,0.1875,0.1321,1,1
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.0029794,0.18743,0.16262,1,1
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0032441,0.1874,0.17418,1,1
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.016339,0.18726,0.12501,1,1
5,GO CARBOHYDRATE TRANSPORT,3.4421e-05,0.18724,0.17385,1,1
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0034322,0.18712,0.16824,1,1
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.042857,0.18709,0.21154,1,1
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.00353,0.18707,0.16362,1,1
5,GO REGULATION OF PHOSPHORYLATION,0.00010845,0.18687,0.14206,1,1
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0041716,0.18683,0.13769,1,1
5,GO REGULATION OF HEART RATE,0.0013054,0.18673,0.20508,1,1
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00059588,0.18672,0.14981,1,1
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.8282e-05,0.18669,0.13902,1,1
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.014841,0.18659,0.13121,1,1
5,GO T CELL APOPTOTIC PROCESS,0.013139,0.18643,0.16518,1,1
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0015189,0.18631,0.19032,1,1
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0030654,0.18631,0.16655,1,1
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00081984,0.1861,0.14439,1,1
5,GO MORPHOGENESIS OF AN EPITHELIUM,0.00059588,0.18605,0.14082,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.017137,0.18584,0.19691,1,1
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00030804,0.18551,0.18242,1,1
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.0053338,0.18544,0.18258,1,1
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.03939,0.18526,0.15214,1,1
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,5.8301e-05,0.18525,0.15889,1,1
5,GO REGULATION OF COLLATERAL SPROUTING,0.050569,0.18507,0.15397,1,1
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00019079,0.18498,0.14308,1,1
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00017186,0.18483,0.1831,1,1
5,GO INORGANIC ANION TRANSPORT,8.4205e-05,0.18477,0.16739,1,1
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,4.3218e-05,0.18423,0.19509,1,1
5,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00036427,0.18408,0.20405,1,1
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.0028957,0.18385,0.12886,1,1
5,GO ER NUCLEUS SIGNALING PATHWAY,0.00074557,0.18384,0.1762,1,1
5,GO ACTION POTENTIAL,0.001228,0.18381,0.188,1,1
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,1.9263e-05,0.18376,0.1531,1,1
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.00074557,0.1836,0.15916,1,1
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.0010206,0.18358,0.1696,1,1
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,4.6597e-05,0.18355,0.1813,1,1
5,GO SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR,0.033166,0.18337,0.24109,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00027832,0.18323,0.15051,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.00036427,0.18297,0.15274,1,1
5,GO EAR DEVELOPMENT,0.00081984,0.18295,0.15136,1,1
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00016595,0.18289,0.1316,1,1
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00037661,0.18276,0.15737,1,1
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.00092958,0.18274,0.15461,1,1
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.019739,0.18274,0.18323,1,1
5,GO CHLORIDE TRANSPORT,0.00024286,0.18273,0.17842,1,1
5,GO ACROSOME REACTION,0.0067808,0.18257,0.15862,1,1
5,GO HORMONE TRANSPORT,1.9263e-05,0.18255,0.20574,1,1
5,GO VESICLE BUDDING FROM MEMBRANE,0.001872,0.18252,0.13397,1,1
5,GO RESPONSE TO CATECHOLAMINE,0.0028957,0.18238,0.15684,1,1
5,GO CELLULAR RESPONSE TO IRON ION,0.012203,0.18226,0.20778,1,1
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.3132e-05,0.18225,0.19868,1,1
5,GO CHONDROCYTE DIFFERENTIATION,0.0099891,0.18217,0.17403,1,1
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00069957,0.18209,0.14571,1,1
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0022332,0.18207,0.18205,1,1
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.0081404,0.18204,0.16504,1,1
5,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00032948,0.18192,0.25738,1,1
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0094949,0.18187,0.1283,1,1
5,GO DIGESTION,0.00065623,0.18182,0.18522,1,1
5,GO DEVELOPMENTAL MATURATION,4.4878e-05,0.18178,0.17908,1,1
5,GO REGULATION OF BIOMINERALIZATION,0.0026572,0.18167,0.16991,1,1
5,GO GLIAL CELL ACTIVATION,0.0049174,0.18164,0.19559,1,1
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00019079,0.18145,0.15888,1,1
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.1964e-05,0.18144,0.18183,1,1
5,GO REGULATION OF MAPK CASCADE,0.00023468,0.18136,0.18341,1,1
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,9.389e-05,0.18135,0.1758,1,1
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0083534,0.18128,0.13285,1,1
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.024846,0.18114,0.14095,1,1
5,GO CELLULAR LIPID CATABOLIC PROCESS,0.00036427,0.18102,0.15496,1,1
5,GO HEART PROCESS,0.00010462,0.18102,0.18994,1,1
5,GO CHOLESTEROL STORAGE,0.001986,0.18064,0.22588,1,1
5,GO POSITIVE REGULATION OF CELL DIVISION,0.00027832,0.18062,0.19561,1,1
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00026903,0.18055,0.1416,1,1
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0011199,0.18035,0.18913,1,1
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.044685,0.18032,0.13178,1,1
5,GO CARBOHYDRATE HOMEOSTASIS,3.0689e-05,0.1803,0.18517,1,1
5,GO REGULATION OF PH,0.0001165,0.18027,0.13197,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.00025131,0.18025,0.13718,1,1
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00063551,0.18011,0.16541,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.01282,0.18008,0.21997,1,1
5,GO REGULATION OF HORMONE LEVELS,4.8612e-06,0.17995,0.19442,1,1
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0001165,0.17988,0.15726,1,1
5,GO REGULATION OF PROTEIN DEACETYLATION,0.00040247,0.17988,0.18724,1,1
5,GO CELL AGGREGATION,0.011612,0.17981,0.17371,1,1
5,GO LIPID CATABOLIC PROCESS,0.0001547,0.17976,0.14807,1,1
5,GO DECIDUALIZATION,0.036164,0.17968,0.17061,1,1
5,GO T CELL RECEPTOR SIGNALING PATHWAY,0.0028957,0.17962,0.1287,1,1
5,GO REGULATION OF LIPID METABOLIC PROCESS,0.00012074,0.17936,0.17197,1,1
5,GO FEMALE GENITALIA DEVELOPMENT,0.0097392,0.17935,0.18121,1,1
5,GO REGULATION OF HORMONE SECRETION,5.8301e-05,0.17927,0.19068,1,1
5,GO RESPONSE TO LIPID,0.0011549,0.17924,0.14562,1,1
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,4.8379e-05,0.17903,0.15435,1,1
5,GO REGULATION OF SPROUTING ANGIOGENESIS,0.015574,0.17873,0.12823,1,1
5,GO HYPOTHALAMUS DEVELOPMENT,0.014841,0.17861,0.1889,1,1
5,GO P38MAPK CASCADE,0.024846,0.1786,0.1327,1,1
5,GO KERATINOCYTE MIGRATION,0.007729,0.1785,0.15622,1,1
5,GO RESPONSE TO INTERLEUKIN 1,0.0045306,0.1784,0.11925,1,1
5,GO MALE SEX DIFFERENTIATION,0.00059588,0.17834,0.15619,1,1
5,GO CIRCULATORY SYSTEM DEVELOPMENT,0.0021689,0.17798,0.1262,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.024846,0.17798,0.13947,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00087311,0.17793,0.176,1,1
5,GO REGULATION OF CHOLESTEROL EFFLUX,0.0022992,0.17724,0.14933,1,1
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.0069616,0.17714,0.23203,1,1
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00010462,0.17711,0.18666,1,1
5,GO RESPONSE TO INORGANIC SUBSTANCE,8.1192e-05,0.17704,0.15716,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.00050664,0.17689,0.14964,1,1
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00016023,0.17686,0.13812,1,1
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.00069957,0.17676,0.18163,1,1
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00074557,0.17657,0.22435,1,1
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.004408,0.17634,0.14795,1,1
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.00012074,0.1761,0.13049,1,1
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.042857,0.17595,0.13101,1,1
5,GO LIPID MODIFICATION,5.2139e-05,0.17584,0.15345,1,1
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00049035,0.17577,0.22044,1,1
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.036164,0.17577,0.14865,1,1
5,GO FATTY ACID METABOLIC PROCESS,0.00028792,0.17542,0.16963,1,1
5,GO REGULATION OF SECRETION,5.7413e-06,0.17536,0.17357,1,1
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.0030654,0.17536,0.13337,1,1
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.013139,0.17522,0.19532,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0079323,0.17481,0.1389,1,1
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.020205,0.17481,0.15512,1,1
5,GO REGULATION OF CELL SHAPE,0.00072223,0.17474,0.1713,1,1
5,GO REGULATION OF KERATINOCYTE MIGRATION,0.0039469,0.17464,0.17464,1,1
5,GO REGULATION OF CELL DIFFERENTIATION,0.00012964,0.17455,0.13595,1,1
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0024367,0.17453,0.14692,1,1
5,GO IMMUNE SYSTEM DEVELOPMENT,6.5149e-05,0.17449,0.14726,1,1
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.03939,0.17439,0.17677,1,1
5,GO REGULATION OF PROSTAGLANDIN SECRETION,0.0073363,0.17439,0.20967,1,1
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.013798,0.17421,0.1884,1,1
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.031059,0.17419,0.13356,1,1
5,GO INTERFERON GAMMA PRODUCTION,0.0022332,0.17401,0.15353,1,1
5,GO REGULATION OF ION TRANSPORT,0.00037661,0.17394,0.1454,1,1
5,GO MEMORY,0.0057817,0.17392,0.14281,1,1
5,GO REGULATION OF LIPID TRANSPORT,0.00067758,0.17375,0.16502,1,1
5,GO REGULATION OF HYDROLASE ACTIVITY,0.00037661,0.17374,0.1277,1,1
5,GO REGULATION OF LIPID LOCALIZATION,0.0027346,0.17373,0.14315,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.001191,0.17362,0.19222,1,1
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.0022992,0.17356,0.15976,1,1
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.018398,0.1735,0.16844,1,1
5,GO CHEMICAL HOMEOSTASIS,8.3127e-06,0.17343,0.15985,1,1
5,GO REGULATION OF FIBROBLAST MIGRATION,0.010773,0.17333,0.15346,1,1
5,GO ACID SECRETION,0.0014299,0.17328,0.17653,1,1
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0017123,0.17292,0.17455,1,1
5,GO PURINE NUCLEOTIDE TRANSPORT,0.0046564,0.17292,0.1445,1,1
5,GO RESPONSE TO CORTICOSTEROID,0.0033369,0.17288,0.15215,1,1
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.0015653,0.17282,0.13379,1,1
5,GO CELL JUNCTION ASSEMBLY,0.00034072,0.1728,0.16382,1,1
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.00072223,0.17278,0.11902,1,1
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0015189,0.17273,0.12119,1,1
5,GO IRON ION TRANSPORT,0.00034072,0.1727,0.1296,1,1
5,GO NEUTROPHIL CHEMOTAXIS,0.00055855,0.17258,0.14215,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.046579,0.17239,0.15314,1,1
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00353,0.17215,0.23555,1,1
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0030654,0.17215,0.16583,1,1
5,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.034637,0.17198,0.14153,1,1
5,GO ORGANIC CATION TRANSPORT,0.0028141,0.17198,0.20283,1,1
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.017137,0.17191,0.13391,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.04854,0.17182,0.16252,1,1
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0011199,0.17149,0.24029,1,1
5,GO CELL GROWTH,0.00054072,0.17138,0.14541,1,1
5,GO REGULATION OF T CELL MIGRATION,0.001986,0.17137,0.19289,1,1
5,GO LYSOSOME LOCALIZATION,0.00021167,0.17113,0.1711,1,1
5,GO ALCOHOL METABOLIC PROCESS,0.00023468,0.17106,0.14708,1,1
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,8.4205e-05,0.17104,0.19083,1,1
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0015189,0.17102,0.131,1,1
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.00067758,0.171,0.18047,1,1
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.0027346,0.17097,0.1805,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.00017796,0.17059,0.12359,1,1
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0034322,0.17059,0.25528,1,1
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.4039e-05,0.1705,0.15598,1,1
5,GO NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.04854,0.17043,0.16603,1,1
5,GO VACUOLAR TRANSPORT,0.001662,0.17028,0.11773,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00054072,0.16999,0.17017,1,1
5,GO RESPONSE TO ANTIBIOTIC,0.00047456,0.16991,0.17914,1,1
5,GO GLOMERULUS DEVELOPMENT,0.0071468,0.16969,0.1883,1,1
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.044685,0.16966,0.16396,1,1
5,GO SECONDARY METABOLIC PROCESS,0.0054795,0.16951,0.17948,1,1
5,GO MONOAMINE TRANSPORT,0.010773,0.1695,0.22958,1,1
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.01282,0.16945,0.20269,1,1
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.0017123,0.16942,0.17563,1,1
5,GO CHOLESTEROL EFFLUX,0.0014299,0.16925,0.14768,1,1
5,GO POSITIVE T CELL SELECTION,0.0022332,0.16918,0.142,1,1
5,GO DNA DEALKYLATION,0.0022332,0.16913,0.17525,1,1
5,GO NEGATIVE REGULATION OF SIGNALING,0.00025131,0.16911,0.12649,1,1
5,GO CELLULAR RESPONSE TO STARVATION,9.0551e-05,0.16911,0.17509,1,1
5,GO RESPONSE TO INSULIN,6.7596e-05,0.1691,0.1519,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0069616,0.16908,0.16638,1,1
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0038387,0.16889,0.11718,1,1
5,GO REGULATION OF BONE MINERALIZATION,0.007729,0.16884,0.18112,1,1
5,GO RESPONSE TO AMYLOID BETA,0.0030654,0.16877,0.17471,1,1
5,GO RESPONSE TO ENDOGENOUS STIMULUS,0.00012074,0.16877,0.13608,1,1
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0097392,0.16874,0.14973,1,1
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00017796,0.16866,0.20928,1,1
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.047551,0.16853,0.1219,1,1
5,GO MULTICELLULAR ORGANISM GROWTH,0.0010859,0.16846,0.11423,1,1
5,GO REGULATION OF MACROPHAGE MIGRATION,0.00087311,0.1684,0.18872,1,1
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0025083,0.16834,0.14674,1,1
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,8.7323e-05,0.16817,0.21307,1,1
5,GO ENDOSOME ORGANIZATION,0.001191,0.1677,0.12429,1,1
5,GO RESPONSE TO RETINOIC ACID,0.011326,0.16763,0.13501,1,1
5,GO LOCOMOTORY BEHAVIOR,0.0066042,0.16757,0.15489,1,1
5,GO NEGATIVE REGULATION OF GROWTH,0.00020448,0.16754,0.15435,1,1
5,GO PIGMENTATION,0.0013054,0.16752,0.1264,1,1
5,GO DETECTION OF STIMULUS,6.7596e-05,0.16735,0.14051,1,1
5,GO AUTOPHAGOSOME ORGANIZATION,0.00036427,0.16729,0.15111,1,1
5,GO PEPTIDE HORMONE SECRETION,0.00016595,0.16724,0.18799,1,1
5,GO SLEEP,0.0015653,0.16715,0.16279,1,1
5,GO DRUG METABOLIC PROCESS,0.0038387,0.16713,0.18783,1,1
5,GO CELL JUNCTION ORGANIZATION,0.0013054,0.16705,0.13822,1,1
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.0034322,0.16698,0.15948,1,1
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.029719,0.1668,0.22562,1,1
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.007729,0.16673,0.19669,1,1
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0090226,0.16671,0.17977,1,1
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00081984,0.16659,0.13528,1,1
5,GO ION HOMEOSTASIS,6.5149e-05,0.1664,0.13466,1,1
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.03939,0.16639,0.11552,1,1
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00016023,0.16629,0.12399,1,1
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.031748,0.16627,0.12986,1,1
5,GO REGULATION OF TRANSPORTER ACTIVITY,0.0059384,0.16625,0.12676,1,1
5,GO RESPONSE TO HYDROGEN PEROXIDE,0.0057817,0.16622,0.13314,1,1
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.00038934,0.16594,0.14423,1,1
5,GO RESPONSE TO FUNGUS,0.0007696,0.16593,0.15837,1,1
5,GO VACUOLE ORGANIZATION,6.2786e-05,0.16593,0.15416,1,1
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.0042883,0.16592,0.12753,1,1
5,GO SARCOMERE ORGANIZATION,0.001986,0.1658,0.16734,1,1
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0042883,0.16579,0.15779,1,1
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.00019753,0.16576,0.13819,1,1
5,GO REGULATION OF MACROPHAGE ACTIVATION,0.011047,0.16566,0.17161,1,1
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.0024367,0.16557,0.16805,1,1
5,GO RELAXATION OF MUSCLE,0.013798,0.16556,0.17423,1,1
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0030654,0.16537,0.27808,1,1
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0050528,0.16534,0.14204,1,1
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.012508,0.16525,0.10492,1,1
5,GO METAL ION HOMEOSTASIS,9.7346e-05,0.16525,0.13596,1,1
5,GO HOMEOSTATIC PROCESS,3.8583e-05,0.16516,0.12745,1,1
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16499,0.14231,1,1
5,GO MONOVALENT INORGANIC CATION TRANSPORT,0.00014418,0.16498,0.16504,1,1
5,GO ENDOCRINE PANCREAS DEVELOPMENT,0.0047853,0.16493,0.17846,1,1
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00010092,0.16482,0.14797,1,1
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0056288,0.16482,0.11619,1,1
5,GO EXECUTION PHASE OF APOPTOSIS,1.2454e-05,0.16479,0.16313,1,1
5,GO REGULATION OF REPRODUCTIVE PROCESS,0.00045924,0.16471,0.12177,1,1
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0028141,0.16468,0.17856,1,1
5,GO DIGESTIVE SYSTEM PROCESS,0.00087311,0.16458,0.18342,1,1
5,GO RETINOIC ACID METABOLIC PROCESS,0.01282,0.16444,0.18434,1,1
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.00034072,0.16413,0.17598,1,1
5,GO RESPONSE TO CALCIUM ION,0.0015189,0.16408,0.15582,1,1
5,GO NIK NF KAPPAB SIGNALING,0.0094949,0.16398,0.10438,1,1
5,GO DETECTION OF MECHANICAL STIMULUS,0.0011199,0.16389,0.17537,1,1
5,GO POSITIVE REGULATION OF TRANSPORT,5.8301e-05,0.16386,0.1383,1,1
5,GO CELLULAR RESPONSE TO PEPTIDE,9.0551e-05,0.16374,0.13587,1,1
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0007696,0.16373,0.12328,1,1
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.00035231,0.1637,0.13807,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00021909,0.16362,0.1439,1,1
5,GO SKELETAL MUSCLE CONTRACTION,0.011612,0.16361,0.14384,1,1
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00029782,0.16357,0.15873,1,1
5,GO DEFINITIVE HEMOPOIESIS,0.044685,0.16351,0.13347,1,1
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0024367,0.16349,0.14134,1,1
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.02268,0.16348,0.095119,1,1
5,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.013798,0.16345,0.10874,1,1
5,GO VESICLE ORGANIZATION,0.00018427,0.1634,0.13696,1,1
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.0027346,0.16322,0.17402,1,1
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00032948,0.16301,0.16266,1,1
5,GO PROTEIN DESTABILIZATION,0.00016595,0.16294,0.17074,1,1
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.018398,0.16291,0.17649,1,1
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00037661,0.16283,0.19859,1,1
5,GO ANATOMICAL STRUCTURE MATURATION,1.2454e-05,0.1628,0.16271,1,1
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.0057817,0.16269,0.16762,1,1
5,GO T CELL SELECTION,0.0011199,0.16268,0.14949,1,1
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00069957,0.16266,0.13855,1,1
5,GO POLYOL BIOSYNTHETIC PROCESS,0.0015653,0.16258,0.12494,1,1
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.0012662,0.16256,0.11994,1,1
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0053338,0.16255,0.14274,1,1
5,GO GLYCOSIDE METABOLIC PROCESS,0.030383,0.16247,0.19925,1,1
5,GO PROTEOLYSIS,0.00026903,0.16243,0.11842,1,1
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00090094,0.16238,0.11411,1,1
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.0025083,0.16229,0.11516,1,1
5,GO SMOOTH MUSCLE CELL PROLIFERATION,0.023741,0.16216,0.12303,1,1
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0001547,0.16214,0.13357,1,1
5,GO REGULATION OF BLOOD PRESSURE,0.0014738,0.16205,0.13948,1,1
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.021165,0.16194,0.13322,1,1
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,2.6307e-05,0.16187,0.14467,1,1
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.0099891,0.16182,0.23346,1,1
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.0067808,0.16169,0.16551,1,1
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,2.2524e-05,0.16167,0.25268,1,1
5,GO ADULT LOCOMOTORY BEHAVIOR,0.0033369,0.16156,0.18939,1,1
5,GO TISSUE MORPHOGENESIS,0.0010206,0.16122,0.13172,1,1
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.017549,0.16121,0.10736,1,1
5,GO CIRCULATORY SYSTEM PROCESS,6.5149e-05,0.1612,0.15631,1,1
5,GO RESPONSE TO STEROID HORMONE,0.001228,0.16115,0.14437,1,1
5,GO VITAMIN BIOSYNTHETIC PROCESS,0.047551,0.16112,0.14606,1,1
5,GO POSITIVE REGULATION OF MAPK CASCADE,0.00023468,0.16106,0.18306,1,1
5,GO RESPONSE TO GROWTH FACTOR,0.0014299,0.16105,0.13591,1,1
5,GO REGULATION OF CHROMATIN BINDING,0.0090226,0.16095,0.14735,1,1
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.001986,0.1609,0.13567,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00067758,0.16089,0.12848,1,1
5,GO NEGATIVE T CELL SELECTION,0.00090094,0.16073,0.22337,1,1
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.046579,0.16073,0.15871,1,1
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00041602,0.16065,0.14314,1,1
5,GO FATTY ACID CATABOLIC PROCESS,0.0033369,0.1605,0.14554,1,1
5,GO REGULATION OF RESPONSE TO STRESS,0.00081984,0.16037,0.11444,1,1
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.00040247,0.1603,0.13185,1,1
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.03245,0.16025,0.14799,1,1
5,GO OSTEOBLAST DIFFERENTIATION,0.0038387,0.16008,0.17365,1,1
5,GO REGULATION OF GLUTAMATE SECRETION,0.041093,0.15997,0.18627,1,1
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.04854,0.1598,0.14108,1,1
5,GO RESPONSE TO HORMONE,0.00037661,0.15957,0.13231,1,1
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0031536,0.15947,0.17548,1,1
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.025994,0.15945,0.10398,1,1
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00074557,0.15932,0.14595,1,1
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,9.7346e-05,0.15903,0.22079,1,1
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.021165,0.15888,0.20217,1,1
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.015953,0.15885,0.13929,1,1
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.052669,0.1588,0.15847,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0012662,0.15854,0.14915,1,1
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.007729,0.15843,0.13328,1,1
5,GO NEUTRAL LIPID METABOLIC PROCESS,0.0037331,0.1584,0.12486,1,1
5,GO RUFFLE ORGANIZATION,0.004408,0.15829,0.16854,1,1
5,GO REGULATION OF TRANSFERASE ACTIVITY,0.00014418,0.15824,0.12783,1,1
5,GO GLUCOSE METABOLIC PROCESS,1.8521e-05,0.15813,0.16586,1,1
5,GO OSTEOCLAST DIFFERENTIATION,0.0039469,0.15805,0.12338,1,1
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.2754e-05,0.15795,0.16681,1,1
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.001872,0.15792,0.14402,1,1
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00027832,0.15788,0.15274,1,1
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0028141,0.15768,0.1507,1,1
5,GO REGULATION OF SYSTEM PROCESS,0.00016023,0.15748,0.14734,1,1
5,GO GOLGI VESICLE BUDDING,0.001872,0.15741,0.11179,1,1
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00019079,0.15728,0.15012,1,1
5,GO SIGNAL PEPTIDE PROCESSING,0.040234,0.1572,0.15403,1,1
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.001872,0.15695,0.12155,1,1
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0013872,0.15673,0.17202,1,1
5,GO POLYAMINE METABOLIC PROCESS,0.03245,0.15662,0.14393,1,1
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0073363,0.15659,0.14235,1,1
5,GO ANIMAL ORGAN MORPHOGENESIS,0.00050664,0.15657,0.13453,1,1
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0010206,0.15632,0.14657,1,1
5,GO CIRCADIAN RHYTHM,2.5774e-06,0.15615,0.16897,1,1
5,GO POSITIVE THYMIC T CELL SELECTION,0.00065623,0.15614,0.25206,1,1
5,GO ENSHEATHMENT OF NEURONS,0.00067758,0.15612,0.17054,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00028792,0.15573,0.15289,1,1
5,GO EXCRETION,0.00025131,0.15568,0.17336,1,1
5,GO EAR MORPHOGENESIS,0.0020453,0.15562,0.12082,1,1
5,GO SPROUTING ANGIOGENESIS,0.019739,0.15559,0.11418,1,1
5,GO STRIATED MUSCLE CONTRACTION,0.0015653,0.15558,0.1451,1,1
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.4878e-05,0.15558,0.16499,1,1
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,6.2786e-05,0.15549,0.16294,1,1
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.040234,0.15545,0.14788,1,1
5,GO NEURON PROJECTION REGENERATION,0.02166,0.15544,0.13338,1,1
5,GO COCHLEA DEVELOPMENT,0.007729,0.15538,0.18654,1,1
5,GO ORGANIC ANION TRANSPORT,4.1617e-05,0.15516,0.13547,1,1
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00026903,0.15502,0.13218,1,1
5,GO REGULATION OF TRANSPORT,4.1617e-05,0.15476,0.13071,1,1
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00020448,0.15465,0.12014,1,1
5,GO RUFFLE ASSEMBLY,0.0064317,0.15461,0.1689,1,1
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0036303,0.15459,0.13381,1,1
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.014138,0.1545,0.10178,1,1
5,GO MODULATION BY VIRUS OF HOST PROCESS,0.0011199,0.15442,0.17531,1,1
5,GO MUSCLE STRUCTURE DEVELOPMENT,0.00028792,0.1542,0.13572,1,1
5,GO EPITHELIAL TUBE MORPHOGENESIS,0.00090094,0.15414,0.13184,1,1
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00017186,0.15394,0.1404,1,1
5,GO REGULATION OF CELLULAR PH,0.00023468,0.15384,0.1181,1,1
5,GO FEEDING BEHAVIOR,0.0030654,0.15381,0.12815,1,1
5,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0020453,0.15376,0.14647,1,1
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.0013872,0.15376,0.15258,1,1
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00095906,0.15363,0.12818,1,1
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.00022676,0.15352,0.14927,1,1
5,GO LYSOSOMAL TRANSPORT,0.011047,0.15332,0.11313,1,1
5,GO VITAMIN TRANSPORT,0.019283,0.15329,0.10766,1,1
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0029794,0.15308,0.16945,1,1
5,GO HORMONE METABOLIC PROCESS,0.00036427,0.15274,0.16249,1,1
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0038387,0.15269,0.15994,1,1
5,GO ANION TRANSPORT,2.3418e-05,0.15257,0.13841,1,1
5,GO CALCIUM ION REGULATED EXOCYTOSIS,0.02068,0.15244,0.24368,1,1
5,GO RESPONSE TO ABIOTIC STIMULUS,0.00035231,0.15237,0.11165,1,1
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0034322,0.15233,0.20284,1,1
5,GO RESPONSE TO KETONE,0.0064317,0.15224,0.12534,1,1
5,GO REGULATION OF CELL DEATH,0.00027832,0.15221,0.12448,1,1
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0028141,0.15219,0.10954,1,1
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0071468,0.15204,0.1332,1,1
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.0050528,0.15204,0.10426,1,1
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02843,0.15199,0.11647,1,1
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.025414,0.15192,0.17228,1,1
5,GO REGULATION OF CATION CHANNEL ACTIVITY,0.02843,0.15192,0.12126,1,1
5,GO TEMPERATURE HOMEOSTASIS,3.4421e-05,0.15183,0.17917,1,1
5,GO CELLULAR PIGMENTATION,0.0034322,0.15179,0.11734,1,1
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0047853,0.15174,0.13012,1,1
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.023205,0.15173,0.17899,1,1
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0042883,0.15171,0.13329,1,1
5,GO RESPONSE TO TOXIC SUBSTANCE,0.0015653,0.1517,0.13587,1,1
5,GO ACTIVATION OF MAPKK ACTIVITY,0.0057817,0.15129,0.17917,1,1
5,GO POLYSACCHARIDE CATABOLIC PROCESS,0.031748,0.15121,0.13184,1,1
5,GO APOPTOTIC PROCESS,0.00018427,0.15097,0.1285,1,1
5,GO IMPORT INTO CELL,0.0025817,0.15085,0.15041,1,1
5,GO ORGANELLE FUSION,0.001662,0.15062,0.12795,1,1
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0047853,0.15062,0.11764,1,1
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.041967,0.15057,0.13012,1,1
5,GO ENDOCYTOSIS,0.0026572,0.1502,0.11055,1,1
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0011199,0.15014,0.12165,1,1
5,GO ZINC ION TRANSPORT,0.020205,0.15,0.11393,1,1
5,GO T CELL DIFFERENTIATION IN THYMUS,0.0039469,0.14993,0.13492,1,1
5,GO REGULATION OF PEPTIDE TRANSPORT,6.2367e-06,0.14979,0.14579,1,1
5,GO POSITIVE REGULATION OF VIRAL PROCESS,0.02068,0.14978,0.091906,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.045624,0.14972,0.14676,1,1
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.029068,0.14958,0.11716,1,1
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0001547,0.14952,0.15532,1,1
5,GO ION TRANSPORT,6.5149e-05,0.14951,0.1389,1,1
5,GO CONNECTIVE TISSUE DEVELOPMENT,0.0028141,0.1495,0.14322,1,1
5,GO JNK CASCADE,0.00032948,0.14949,0.14201,1,1
5,GO ADAPTIVE THERMOGENESIS,2.4346e-05,0.14949,0.18642,1,1
5,GO RESPONSE TO TESTOSTERONE,0.033166,0.14932,0.15641,1,1
5,GO PHOSPHOLIPID METABOLIC PROCESS,0.00017186,0.14904,0.12725,1,1
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0029794,0.14868,0.11947,1,1
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00031859,0.14865,0.12368,1,1
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0021689,0.14862,0.19674,1,1
5,GO POSITIVE REGULATION OF NEURON DEATH,0.00065623,0.14858,0.17081,1,1
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00027832,0.14856,0.12503,1,1
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.0050528,0.1485,0.12536,1,1
5,GO MEMBRANE ORGANIZATION,0.00019753,0.14843,0.12836,1,1
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.014138,0.14838,0.11172,1,1
5,GO SECOND MESSENGER MEDIATED SIGNALING,0.00012074,0.14835,0.1413,1,1
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.007729,0.14803,0.088762,1,1
5,GO COPII COATED VESICLE BUDDING,0.0031536,0.14794,0.094563,1,1
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.010245,0.14775,0.10108,1,1
5,GO RESPONSE TO PEPTIDE,0.00019753,0.14758,0.13166,1,1
5,GO MESENCHYMAL CELL DIFFERENTIATION,0.0049174,0.14735,0.15779,1,1
5,GO REGULATION OF MEIOTIC CELL CYCLE,0.00032948,0.14706,0.14436,1,1
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.00079435,0.14704,0.1181,1,1
5,GO POTASSIUM ION TRANSPORT,0.0031536,0.14698,0.15779,1,1
5,GO REGULATION OF PROTEIN LOCALIZATION,8.7323e-05,0.14695,0.12313,1,1
5,GO METAL ION TRANSPORT,0.00029782,0.1469,0.13104,1,1
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,9.0551e-05,0.14686,0.23108,1,1
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.010506,0.14667,0.12921,1,1
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00019753,0.14647,0.11697,1,1
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00031859,0.14637,0.16535,1,1
5,GO PHAGOSOME MATURATION,0.007729,0.14629,0.1225,1,1
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0039469,0.146,0.13182,1,1
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.0033369,0.14581,0.11103,1,1
5,GO NEGATIVE REGULATION OF SECRETION,0.00019079,0.14555,0.12403,1,1
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.020205,0.14542,0.14374,1,1
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.00353,0.1454,0.16806,1,1
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00054072,0.14523,0.1224,1,1
5,GO POSITIVE REGULATION OF ION TRANSPORT,0.00055855,0.14518,0.13016,1,1
5,GO RESPONSE TO STARVATION,0.00031859,0.14495,0.1613,1,1
5,GO HEART TRABECULA MORPHOGENESIS,0.017137,0.1449,0.13823,1,1
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0025083,0.14485,0.14529,1,1
5,GO DNA CATABOLIC PROCESS,4.4878e-05,0.14474,0.1444,1,1
5,GO REGULATION OF HAIR CYCLE,0.019739,0.14474,0.11765,1,1
5,GO EXPORT ACROSS PLASMA MEMBRANE,0.001986,0.14471,0.23043,1,1
5,GO ION TRANSMEMBRANE TRANSPORT,0.00016023,0.14446,0.13391,1,1
5,GO ACTIN FILAMENT BASED MOVEMENT,0.0073363,0.1443,0.11121,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0029794,0.14428,0.13899,1,1
5,GO RESPONSE TO NITROGEN COMPOUND,0.0001165,0.14383,0.12415,1,1
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00037661,0.14381,0.11832,1,1
5,GO FATTY ACID DERIVATIVE TRANSPORT,0.011047,0.14348,0.10895,1,1
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.012203,0.14348,0.1351,1,1
5,GO CATION TRANSPORT,0.00036427,0.14348,0.12784,1,1
5,GO MAINTENANCE OF LOCATION,0.0015653,0.14345,0.12315,1,1
5,GO SULFATE TRANSPORT,0.029068,0.14344,0.11518,1,1
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.042857,0.14337,0.1289,1,1
5,GO RESPONSE TO MONOSACCHARIDE,0.00065623,0.14325,0.12943,1,1
5,GO LIPID EXPORT FROM CELL,0.019739,0.14322,0.14148,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0020453,0.14309,0.099261,1,1
5,GO FC RECEPTOR SIGNALING PATHWAY,0.012508,0.14306,0.09817,1,1
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0021689,0.14305,0.12033,1,1
5,GO REGULATION OF POTASSIUM ION TRANSPORT,0.015953,0.14303,0.12062,1,1
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.14279,0.12113,1,1
5,GO CELLULAR RESPONSE TO RETINOIC ACID,0.05161,0.14271,0.13336,1,1
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.033894,0.14264,0.095866,1,1
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.00059588,0.14251,0.15184,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.0010528,0.14246,0.12471,1,1
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.047551,0.14234,0.19943,1,1
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.029719,0.14216,0.11196,1,1
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00095906,0.14213,0.16186,1,1
5,GO MICROTUBULE BUNDLE FORMATION,0.015574,0.14192,0.11369,1,1
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0030654,0.14177,0.14362,1,1
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.0041716,0.1416,0.12114,1,1
5,GO RESPONSE TO DSRNA,0.0069616,0.14157,0.12359,1,1
5,GO CATION TRANSMEMBRANE TRANSPORT,0.00074557,0.14143,0.12301,1,1
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.0030654,0.14131,0.12692,1,1
5,GO STEROID CATABOLIC PROCESS,0.025994,0.1413,0.16831,1,1
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.0013054,0.14106,0.11154,1,1
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00028792,0.14101,0.14477,1,1
5,GO DETECTION OF ABIOTIC STIMULUS,0.00072223,0.14096,0.14281,1,1
5,GO RESPONSE TO ESTRADIOL,0.0023671,0.14093,0.13319,1,1
5,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0010206,0.14093,0.12506,1,1
5,GO RESPONSE TO OXYGEN LEVELS,0.0014299,0.14086,0.13435,1,1
5,GO RESPONSE TO ETHANOL,0.0017641,0.1405,0.1326,1,1
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.00023468,0.14047,0.11145,1,1
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.043763,0.14047,0.095348,1,1
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0051916,0.14029,0.11866,1,1
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0011199,0.14002,0.10773,1,1
5,GO DENDRITIC SPINE MAINTENANCE,0.034637,0.14001,0.11755,1,1
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0020453,0.13986,0.12386,1,1
5,GO REPRODUCTION,0.00044439,0.13966,0.10795,1,1
5,GO RESPONSE TO DOPAMINE,0.0073363,0.13965,0.13729,1,1
5,GO SENSORY PERCEPTION OF SMELL,0.0030654,0.13948,0.11785,1,1
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0079323,0.13925,0.15815,1,1
5,GO LENS FIBER CELL DIFFERENTIATION,0.0033369,0.13912,0.19466,1,1
5,GO TRANSMEMBRANE TRANSPORT,0.00012074,0.13898,0.12213,1,1
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00045924,0.13896,0.14,1,1
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.0046564,0.13888,0.11719,1,1
5,GO REGULATION OF PROTEIN STABILITY,0.0050528,0.13887,0.084399,1,1
5,GO REGULATION OF GROWTH,0.00011241,0.13878,0.13858,1,1
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0083534,0.13857,0.16737,1,1
5,GO GLYCEROLIPID METABOLIC PROCESS,0.00026003,0.13849,0.1201,1,1
5,GO ACTIN FILAMENT ORGANIZATION,0.0023671,0.13824,0.11712,1,1
5,GO REGULATION OF MEMBRANE PERMEABILITY,0.00034072,0.13821,0.17619,1,1
5,GO CALCIUM MEDIATED SIGNALING,4.4878e-05,0.13813,0.14218,1,1
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0094949,0.1379,0.1097,1,1
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.016339,0.13784,0.14585,1,1
5,GO TAXIS,0.00035231,0.13778,0.14356,1,1
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0012662,0.13754,0.11887,1,1
5,GO DEMETHYLATION,0.00024286,0.1375,0.14098,1,1
5,GO RESPONSE TO CARBOHYDRATE,0.0010206,0.13741,0.12127,1,1
5,GO POSITIVE REGULATION OF T CELL MIGRATION,0.011326,0.13739,0.13378,1,1
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.00013433,0.13707,0.12663,1,1
5,GO ANION TRANSMEMBRANE TRANSPORT,0.00014935,0.13704,0.13006,1,1
5,GO RESPONSE TO OXIDATIVE STRESS,0.010245,0.13701,0.096748,1,1
5,GO ESTABLISHMENT OF CELL POLARITY,0.019283,0.13701,0.095947,1,1
5,GO RESPONSE TO NICOTINE,0.01282,0.13654,0.16703,1,1
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0040578,0.13647,0.10015,1,1
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.0021689,0.13627,0.12874,1,1
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00081984,0.13625,0.13257,1,1
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.012508,0.13617,0.10258,1,1
5,GO GLYCEROLIPID CATABOLIC PROCESS,0.0032441,0.13614,0.14375,1,1
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00087311,0.13607,0.12997,1,1
5,GO NEUROBLAST PROLIFERATION,0.033166,0.13582,0.10814,1,1
5,GO CARBOHYDRATE METABOLIC PROCESS,7.013e-05,0.1358,0.14042,1,1
5,GO MYELOID DENDRITIC CELL ACTIVATION,0.0026572,0.13569,0.15021,1,1
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.017137,0.13566,0.13804,1,1
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.034637,0.13554,0.10487,1,1
5,GO NEURON DEATH,0.00012964,0.13531,0.13279,1,1
5,GO POSITIVE REGULATION OF CELL GROWTH,0.00079435,0.13528,0.14005,1,1
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.02068,0.13526,0.094622,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0087944,0.13511,0.14042,1,1
5,GO HINDBRAIN DEVELOPMENT,0.0032441,0.13511,0.15474,1,1
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0022332,0.13488,0.093794,1,1
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0073363,0.13485,0.11733,1,1
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0064317,0.13476,0.095138,1,1
5,GO RESPONSE TO PEPTIDE HORMONE,0.00036427,0.13464,0.11788,1,1
5,GO MIDBODY ABSCISSION,0.031748,0.13462,0.15468,1,1
5,GO AGING,0.0034322,0.13457,0.11218,1,1
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.037747,0.13438,0.15391,1,1
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.0022332,0.13435,0.12661,1,1
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0045306,0.13422,0.21592,1,1
5,GO NEUROTROPHIN SIGNALING PATHWAY,0.041093,0.13417,0.12159,1,1
5,GO THYROID HORMONE METABOLIC PROCESS,0.031059,0.13414,0.11773,1,1
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0030654,0.1338,0.16493,1,1
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00013433,0.13367,0.12212,1,1
5,GO GROWTH,0.00045924,0.13364,0.12524,1,1
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.00016023,0.13354,0.13644,1,1
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.011326,0.13352,0.12788,1,1
5,GO OXIDATION REDUCTION PROCESS,0.0029794,0.13341,0.10999,1,1
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.0028957,0.13327,0.11382,1,1
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.02166,0.13317,0.11724,1,1
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0085714,0.13301,0.16472,1,1
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.041967,0.13291,0.07389,1,1
5,GO BEHAVIOR,0.0099891,0.13289,0.10641,1,1
5,GO REGULATION OF PROTEIN BINDING,0.00047456,0.13281,0.13918,1,1
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00098941,0.13275,0.14711,1,1
5,GO NERVOUS SYSTEM PROCESS,0.0013054,0.13274,0.10947,1,1
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0041716,0.13267,0.17523,1,1
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0041716,0.13265,0.12647,1,1
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.014841,0.13255,0.17179,1,1
5,GO SIGNAL RELEASE,0.00014935,0.13255,0.15705,1,1
5,GO MITOTIC CELL CYCLE ARREST,0.049546,0.13226,0.14649,1,1
5,GO STEROL BIOSYNTHETIC PROCESS,0.036164,0.13226,0.089315,1,1
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.0067808,0.13223,0.094754,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.0022332,0.1321,0.17761,1,1
5,GO MONOSACCHARIDE METABOLIC PROCESS,0.00019753,0.1315,0.14187,1,1
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.00044439,0.13109,0.10641,1,1
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00031859,0.13107,0.1279,1,1
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.014486,0.13103,0.13667,1,1
5,GO EXOCYTIC PROCESS,0.0060989,0.13101,0.16182,1,1
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.015203,0.1309,0.099801,1,1
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00072223,0.13064,0.13313,1,1
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.012508,0.13039,0.12586,1,1
5,GO RESPONSE TO TEMPERATURE STIMULUS,0.0059384,0.13034,0.10798,1,1
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.013798,0.13023,0.15219,1,1
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0053338,0.13003,0.15214,1,1
5,GO CELLULAR ION HOMEOSTASIS,0.00026003,0.13001,0.11431,1,1
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0059384,0.13,0.16104,1,1
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00095906,0.12998,0.14755,1,1
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0023671,0.12994,0.13074,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.00092958,0.12993,0.099224,1,1
5,GO REGULATION OF ATP METABOLIC PROCESS,0.02268,0.12989,0.09043,1,1
5,GO NEGATIVE REGULATION OF CELL DEATH,0.0010528,0.12989,0.11524,1,1
5,GO SINGLE FERTILIZATION,0.0020453,0.12967,0.10655,1,1
5,GO REGULATION OF METAL ION TRANSPORT,0.0024367,0.12963,0.1153,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0010528,0.12955,0.1298,1,1
5,GO EMBRYONIC ORGAN DEVELOPMENT,0.00028792,0.12934,0.12901,1,1
5,GO REGULATION OF BMP SIGNALING PATHWAY,0.036164,0.12921,0.12281,1,1
5,GO REGULATION OF AUTOPHAGY,0.00030804,0.12919,0.10882,1,1
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.033894,0.12909,0.11382,1,1
5,GO TRANSITION METAL ION TRANSPORT,0.00036427,0.12873,0.10963,1,1
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0029794,0.12867,0.23004,1,1
5,GO LONG CHAIN FATTY ACID TRANSPORT,0.0057817,0.12859,0.10352,1,1
5,GO PHOSPHATE ION TRANSPORT,0.010245,0.12828,0.12797,1,1
5,GO MUSCLE SYSTEM PROCESS,0.0022992,0.12824,0.11438,1,1
5,GO MACROPHAGE ACTIVATION,0.0022332,0.12824,0.20513,1,1
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.019739,0.12816,0.10909,1,1
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0022992,0.12741,0.12723,1,1
5,GO THIOESTER BIOSYNTHETIC PROCESS,0.0075304,0.12712,0.15124,1,1
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,8.1192e-05,0.12703,0.14306,1,1
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.015574,0.12698,0.087276,1,1
5,GO MONOCARBOXYLIC ACID TRANSPORT,0.0022992,0.12698,0.10258,1,1
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.02843,0.12695,0.11673,1,1
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0056288,0.12693,0.089886,1,1
5,GO MUSCLE FIBER DEVELOPMENT,0.047551,0.12692,0.1125,1,1
5,GO FATTY ACID TRANSPORT,0.0057817,0.12673,0.10819,1,1
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0016129,0.1267,0.15725,1,1
5,GO REGULATION OF LIPID CATABOLIC PROCESS,0.02268,0.1267,0.10236,1,1
5,GO CAMERA TYPE EYE MORPHOGENESIS,0.0067808,0.1266,0.11308,1,1
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0017641,0.12657,0.12062,1,1
5,GO RETINOL METABOLIC PROCESS,0.02268,0.12642,0.13907,1,1
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.0071468,0.12631,0.094623,1,1
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.049546,0.12569,0.071004,1,1
5,GO POSITIVE REGULATION OF TOR SIGNALING,0.011047,0.12568,0.1098,1,1
5,GO SENSORY PERCEPTION,0.00022676,0.1251,0.11237,1,1
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.0066042,0.12507,0.12623,1,1
5,GO MUSCLE CELL PROLIFERATION,0.041093,0.12506,0.094495,1,1
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.001872,0.12487,0.10795,1,1
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0049174,0.12477,0.11657,1,1
5,GO SENSORY ORGAN MORPHOGENESIS,0.001872,0.12472,0.10174,1,1
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.031748,0.12421,0.12074,1,1
5,GO FATTY ACYL COA METABOLIC PROCESS,0.012203,0.12416,0.1547,1,1
5,GO CARDIAC MUSCLE CONTRACTION,0.007729,0.12415,0.12959,1,1
5,GO ASSOCIATIVE LEARNING,0.02268,0.1241,0.11571,1,1
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00087311,0.12392,0.12001,1,1
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.016734,0.12358,0.10245,1,1
5,GO SEX DIFFERENTIATION,0.00095906,0.12322,0.11094,1,1
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.007729,0.12321,0.12356,1,1
5,GO RESPONSE TO ALCOHOL,0.0087944,0.1232,0.10499,1,1
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0083534,0.12313,0.11798,1,1
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0045306,0.12302,0.12051,1,1
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.043763,0.12294,0.11903,1,1
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.018398,0.12285,0.12578,1,1
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.010773,0.12271,0.17281,1,1
5,GO POSTREPLICATION REPAIR,0.0041716,0.12249,0.10994,1,1
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00035231,0.12237,0.13404,1,1
5,GO REGULATION OF VASOCONSTRICTION,0.0075304,0.12218,0.11805,1,1
5,GO GOLGI ORGANIZATION,0.001986,0.12201,0.097043,1,1
5,GO RESPONSE TO ORGANOPHOSPHORUS,0.014138,0.12177,0.092022,1,1
5,GO RECEPTOR METABOLIC PROCESS,0.0057817,0.12174,0.10837,1,1
5,GO ACTIN MEDIATED CELL CONTRACTION,0.024288,0.12148,0.1058,1,1
5,GO TRANSCYTOSIS,0.038561,0.12136,0.11458,1,1
5,GO CELL CELL SIGNALING,0.00098941,0.12133,0.11756,1,1
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.00018427,0.12116,0.10249,1,1
5,GO T CELL LINEAGE COMMITMENT,0.017969,0.12,0.10587,1,1
5,GO PROTEIN AUTOPHOSPHORYLATION,0.0083534,0.11994,0.092807,1,1
5,GO ACTIN FILAMENT BASED PROCESS,0.0015189,0.11989,0.11577,1,1
5,GO CANONICAL WNT SIGNALING PATHWAY,0.0079323,0.11985,0.099369,1,1
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0054795,0.11969,0.099659,1,1
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0049174,0.1194,0.12428,1,1
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0013457,0.11923,0.14106,1,1
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.02268,0.11887,0.1299,1,1
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.014486,0.11886,0.099915,1,1
5,GO CELLULAR HOMEOSTASIS,0.00047456,0.11839,0.10763,1,1
5,GO PROTEIN INSERTION INTO MEMBRANE,0.0013872,0.11835,0.13017,1,1
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0030654,0.11805,0.11574,1,1
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0087944,0.11793,0.0888,1,1
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0021689,0.11768,0.17384,1,1
5,GO CELLULAR RESPONSE TO ALCOHOL,0.033166,0.11743,0.096848,1,1
5,GO RHYTHMIC BEHAVIOR,0.0097392,0.11742,0.12939,1,1
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0011549,0.11738,0.12083,1,1
5,GO RESPONSE TO CHEMOKINE,0.0037331,0.11727,0.11593,1,1
5,GO PROTEIN CATABOLIC PROCESS,0.0024367,0.11726,0.076987,1,1
5,GO PEPTIDYL AMINO ACID MODIFICATION,0.001986,0.11723,0.075691,1,1
5,GO ORGANIC ACID METABOLIC PROCESS,0.0085714,0.11717,0.087633,1,1
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00028792,0.117,0.11946,1,1
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.016339,0.11693,0.083529,1,1
5,GO REGULATION OF CILIUM MOVEMENT,0.0085714,0.11692,0.12051,1,1
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0066042,0.11678,0.10912,1,1
5,GO REGULATION OF MUSCLE CONTRACTION,0.0099891,0.11673,0.10129,1,1
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0075304,0.11597,0.094924,1,1
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0013457,0.11559,0.14403,1,1
5,GO CARDIAC CHAMBER MORPHOGENESIS,0.027803,0.11553,0.09998,1,1
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0017641,0.11551,0.11329,1,1
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.02268,0.11542,0.16119,1,1
5,GO CELL VOLUME HOMEOSTASIS,0.0059384,0.11533,0.10776,1,1
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0099891,0.11526,0.09138,1,1
5,GO STEM CELL PROLIFERATION,0.0050528,0.11521,0.12661,1,1
5,GO RESPONSE TO ACID CHEMICAL,0.0062634,0.11517,0.13123,1,1
5,GO REGULATION OF WNT SIGNALING PATHWAY,0.0071468,0.11472,0.093351,1,1
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.046579,0.11459,0.0947,1,1
5,GO NUCLEAR ENVELOPE ORGANIZATION,0.03939,0.11448,0.068631,1,1
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.030383,0.11419,0.11781,1,1
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.033894,0.11386,0.12094,1,1
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0025083,0.11378,0.12511,1,1
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.031748,0.11367,0.10345,1,1
5,GO CARTILAGE DEVELOPMENT,0.026586,0.11337,0.10927,1,1
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.024846,0.11305,0.094958,1,1
5,GO MESENCHYME DEVELOPMENT,0.013798,0.11302,0.10919,1,1
5,GO POLYOL METABOLIC PROCESS,0.0026572,0.1128,0.097304,1,1
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.0060989,0.11223,0.11669,1,1
5,GO FOCAL ADHESION ASSEMBLY,0.02843,0.11222,0.11942,1,1
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.046579,0.11222,0.09849,1,1
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0033369,0.11221,0.095461,1,1
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0079323,0.11211,0.13578,1,1
5,GO INTRACELLULAR LIPID TRANSPORT,0.019283,0.11158,0.12956,1,1
5,GO SCHWANN CELL DEVELOPMENT,0.041093,0.11149,0.10982,1,1
5,GO NEGATIVE REGULATION OF CELL GROWTH,0.0013872,0.11131,0.14232,1,1
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0017123,0.11116,0.11579,1,1
5,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00353,0.11077,0.099058,1,1
5,GO EYE MORPHOGENESIS,0.0073363,0.11055,0.10066,1,1
5,GO CELLULAR RESPONSE TO CAMP,0.0012662,0.11051,0.15268,1,1
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.017137,0.11043,0.099768,1,1
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.0025817,0.11038,0.18413,1,1
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.11033,0.1385,1,1
5,GO PROTEIN AUTOUBIQUITINATION,0.00074557,0.11023,0.11499,1,1
5,GO IN UTERO EMBRYONIC DEVELOPMENT,0.0042883,0.11018,0.087611,1,1
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.0054795,0.11017,0.11167,1,1
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0014299,0.10999,0.10808,1,1
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.021165,0.10985,0.12084,1,1
5,GO ANDROGEN METABOLIC PROCESS,0.010245,0.1096,0.14781,1,1
5,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0023671,0.10942,0.12727,1,1
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.0097392,0.10913,0.091914,1,1
5,GO REGULATION OF CELL DEVELOPMENT,0.0057817,0.10875,0.10265,1,1
5,GO EMBRYONIC MORPHOGENESIS,0.0015653,0.10867,0.11227,1,1
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.010506,0.10801,0.10372,1,1
5,GO DIVALENT INORGANIC CATION TRANSPORT,0.0026572,0.10766,0.10485,1,1
5,GO REGULATION OF NEURON DIFFERENTIATION,0.025994,0.10764,0.1047,1,1
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.001228,0.10746,0.11188,1,1
5,GO PEPTIDYL SERINE MODIFICATION,0.0059384,0.10737,0.079925,1,1
5,GO DEPHOSPHORYLATION,0.0019282,0.10732,0.082501,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.009256,0.10727,0.099702,1,1
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.02843,0.10703,0.085781,1,1
5,GO NEURAL PRECURSOR CELL PROLIFERATION,0.0040578,0.10702,0.11759,1,1
5,GO DEVELOPMENTAL CELL GROWTH,0.031059,0.10696,0.11228,1,1
5,GO MUSCLE ORGAN MORPHOGENESIS,0.034637,0.10695,0.09267,1,1
5,GO ARACHIDONIC ACID SECRETION,0.031059,0.10686,0.0896,1,1
5,GO ORGANIC ACID TRANSPORT,0.00012964,0.10675,0.10567,1,1
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.0036303,0.10674,0.10763,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00095906,0.10651,0.097767,1,1
5,GO ENDOSOMAL TRANSPORT,0.0033369,0.10628,0.084976,1,1
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.0087944,0.10623,0.073456,1,1
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.041967,0.10607,0.12331,1,1
5,GO MULTI ORGANISM PROCESS,0.0047853,0.10555,0.078655,1,1
5,GO RHYTHMIC PROCESS,0.00012512,0.10521,0.11908,1,1
5,GO DEVELOPMENTAL GROWTH,0.0047853,0.10509,0.10465,1,1
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.010506,0.10508,0.076188,1,1
5,GO REGULATION OF GLIAL CELL MIGRATION,0.014841,0.10504,0.12045,1,1
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.007729,0.10498,0.093384,1,1
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0031536,0.10492,0.081936,1,1
5,GO FEMALE SEX DIFFERENTIATION,0.0045306,0.10453,0.10757,1,1
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.037747,0.10441,0.10092,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.03245,0.10427,0.096175,1,1
5,GO REGULATION OF ENDOCYTOSIS,0.05161,0.10404,0.075255,1,1
5,GO CELLULAR HORMONE METABOLIC PROCESS,0.0090226,0.10391,0.13405,1,1
5,GO REGULATION OF BINDING,0.00087311,0.10318,0.11246,1,1
5,GO TUBE FORMATION,0.0099891,0.10312,0.086683,1,1
5,GO FATTY ACID BETA OXIDATION,0.046579,0.10286,0.084291,1,1
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.011612,0.10252,0.07681,1,1
5,GO REGULATION OF GLUCONEOGENESIS,0.0042883,0.10242,0.1071,1,1
5,GO MIDBRAIN DEVELOPMENT,0.0053338,0.10206,0.1007,1,1
5,GO SMALL MOLECULE CATABOLIC PROCESS,0.013465,0.10164,0.082055,1,1
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.037747,0.10146,0.10577,1,1
5,GO CELL CELL SIGNALING BY WNT,0.0081404,0.10092,0.089439,1,1
5,GO VIRAL BUDDING,0.024846,0.10062,0.1166,1,1
5,GO MEGAKARYOCYTE DIFFERENTIATION,0.00087311,0.099999,0.12412,1,1
5,GO MUSCLE CONTRACTION,0.0051916,0.099934,0.10962,1,1
5,GO CELLULAR EXTRAVASATION,0.031059,0.099706,0.10029,1,1
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0042883,0.099633,0.11536,1,1
5,GO GOLGI LOCALIZATION,0.030383,0.099326,0.12115,1,1
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.023205,0.099199,0.090636,1,1
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.042857,0.099151,0.098815,1,1
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.050569,0.098776,0.07834,1,1
5,GO CELL PROJECTION ASSEMBLY,0.02166,0.0974,0.076557,1,1
5,GO HEART DEVELOPMENT,0.013465,0.09738,0.080618,1,1
5,GO MUSCLE TISSUE DEVELOPMENT,0.017137,0.096275,0.077238,1,1
5,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0073363,0.09613,0.086431,1,1
5,GO POSITIVE REGULATION OF GROWTH,0.0015653,0.095901,0.1141,1,1
5,GO CAMERA TYPE EYE DEVELOPMENT,0.011612,0.095811,0.084163,1,1
5,GO REGULATION OF DNA BINDING,0.015574,0.095747,0.08843,1,1
5,GO EXIT FROM MITOSIS,0.017549,0.095593,0.1013,1,1
5,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0081404,0.09548,0.094472,1,1
5,GO REGULATION OF CELLULAR LOCALIZATION,0.0024367,0.095433,0.083648,1,1
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0053338,0.095258,0.11881,1,1
5,GO REGULATION OF CIRCADIAN RHYTHM,0.0081404,0.095093,0.11118,1,1
5,GO NEGATIVE REGULATION OF NEURON DEATH,0.00065623,0.095057,0.12037,1,1
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.041967,0.094909,0.12672,1,1
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.036948,0.094264,0.078636,1,1
5,GO REGULATION OF CELL MORPHOGENESIS,0.025994,0.093903,0.10203,1,1
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.015203,0.093751,0.079387,1,1
5,GO PROTEIN K48 LINKED UBIQUITINATION,0.010245,0.093389,0.10187,1,1
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.023205,0.093201,0.06733,1,1
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0069616,0.092488,0.1006,1,1
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.031059,0.092416,0.088807,1,1
5,GO ONE CARBON COMPOUND TRANSPORT,0.050569,0.092101,0.12613,1,1
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.050569,0.091793,0.070491,1,1
5,GO REGULATION OF CATABOLIC PROCESS,0.02166,0.091391,0.058011,1,1
5,GO REGULATION OF DEVELOPMENTAL GROWTH,0.0060989,0.091347,0.10805,1,1
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.010245,0.091039,0.072019,1,1
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.0073363,0.090935,0.072165,1,1
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.015953,0.090619,0.094685,1,1
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.05161,0.090424,0.081463,1,1
5,GO NEGATIVE REGULATION OF TRANSPORT,0.0051916,0.090329,0.087101,1,1
5,GO SKELETAL SYSTEM DEVELOPMENT,0.010506,0.090085,0.088798,1,1
5,GO SENSORY ORGAN DEVELOPMENT,0.0021062,0.089969,0.096408,1,1
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00017186,0.089888,0.10031,1,1
5,GO GERM CELL DEVELOPMENT,0.029719,0.089672,0.062838,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.00081984,0.089504,0.081984,1,1
5,GO REGULATION OF INTRACELLULAR TRANSPORT,0.016339,0.089292,0.063667,1,1
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0047853,0.089008,0.076742,1,1
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.01282,0.088521,0.15315,1,1
5,GO PROTEIN COMPLEX OLIGOMERIZATION,0.014841,0.088278,0.076976,1,1
5,GO HEAD DEVELOPMENT,0.0079323,0.087996,0.096564,1,1
5,GO REGULATION OF TOR SIGNALING,0.0017641,0.087951,0.09458,1,1
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.045624,0.087474,0.061077,1,1
5,GO EMBRYO DEVELOPMENT,0.0039469,0.087284,0.083075,1,1
5,GO LEUKOCYTE TETHERING OR ROLLING,0.013139,0.087183,0.10364,1,1
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.027803,0.086999,0.042502,1,1
5,GO REGULATION OF EXOCYTOSIS,0.0062634,0.086981,0.14386,1,1
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.015953,0.086778,0.070064,1,1
5,GO PEROXISOMAL TRANSPORT,0.029719,0.086422,0.12174,1,1
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00087311,0.086231,0.096111,1,1
5,GO PROTEIN DEPHOSPHORYLATION,0.025414,0.086202,0.058046,1,1
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.014138,0.085832,0.083322,1,1
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.0027346,0.085676,0.09416,1,1
5,GO NEURON APOPTOTIC PROCESS,0.0023671,0.08562,0.10507,1,1
5,GO TOR SIGNALING,0.0038387,0.083974,0.070581,1,1
5,GO OVULATION CYCLE,0.041967,0.083103,0.088727,1,1
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00022676,0.082849,0.092875,1,1
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.040234,0.082269,0.054653,1,1
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.013465,0.08205,0.08419,1,1
5,GO NEUROMUSCULAR PROCESS,0.03245,0.081721,0.11759,1,1
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.013465,0.081686,0.087739,1,1
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.01282,0.081412,0.10013,1,1
5,GO MUSCLE ORGAN DEVELOPMENT,0.025414,0.081401,0.064582,1,1
5,GO RESPONSE TO CAMP,0.010773,0.080733,0.10464,1,1
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0020453,0.080609,0.092274,1,1
5,GO POSITIVE REGULATION OF BINDING,0.023741,0.080253,0.081549,1,1
5,GO NEUROGENESIS,0.02068,0.079796,0.085079,1,1
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.015953,0.07946,0.070917,1,1
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.036948,0.079242,0.081777,1,1
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.014138,0.079238,0.089816,1,1
5,GO PEROXISOME ORGANIZATION,0.042857,0.079016,0.10817,1,1
5,GO PROTEIN POLYUBIQUITINATION,0.0056288,0.077992,0.072605,1,1
5,GO REGULATION OF CALCIUM ION TRANSPORT,0.026586,0.077866,0.087621,1,1
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00095906,0.0771,0.076126,1,1
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.02166,0.076789,0.076488,1,1
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0050528,0.075801,0.059256,1,1
5,GO CELL PROJECTION ORGANIZATION,0.018398,0.075551,0.082806,1,1
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.0041716,0.075032,0.064697,1,1
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0014299,0.075003,0.071231,1,1
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.045624,0.074715,0.082297,1,1
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.042857,0.074539,0.081363,1,1
5,GO REGULATION OF PHOSPHATASE ACTIVITY,0.018398,0.074265,0.068271,1,1
5,GO REGULATION OF ACTIN FILAMENT LENGTH,0.031748,0.073719,0.073822,1,1
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.035393,0.073531,0.087579,1,1
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.038561,0.072644,0.053439,1,1
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.0036303,0.072489,0.059806,1,1
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.027188,0.071784,0.057126,1,1
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.014486,0.071713,0.057656,1,1
5,GO CELL FATE COMMITMENT,0.016339,0.071462,0.083146,1,1
5,GO SEXUAL REPRODUCTION,0.009256,0.070116,0.064925,1,1
5,GO FERTILIZATION,0.0099891,0.068929,0.08094,1,1
5,GO MULTICELLULAR ORGANISM REPRODUCTION,0.0069616,0.068666,0.066356,1,1
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.05161,0.068536,0.10782,1,1
5,GO CYTOSKELETON ORGANIZATION,0.015953,0.068387,0.071135,1,1
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.025414,0.066712,0.05941,1,1
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.017969,0.066072,0.11036,1,1
5,GO CARDIAC MUSCLE CELL CONTRACTION,0.041093,0.065888,0.12159,1,1
5,GO CELL MORPHOGENESIS,0.037747,0.063794,0.08073,1,1
5,GO PROTEIN HOMOOLIGOMERIZATION,0.025414,0.063431,0.063469,1,1
5,GO REGULATION OF DEPHOSPHORYLATION,0.023741,0.062626,0.058169,1,1
5,GO MACROMOLECULE DEACYLATION,0.023741,0.061741,0.064271,1,1
5,GO HEART MORPHOGENESIS,0.024846,0.061695,0.0708,1,1
5,GO CELLULAR MACROMOLECULE LOCALIZATION,0.011904,0.061456,0.050852,1,1
5,GO NEGATIVE REGULATION OF BINDING,0.0025817,0.061413,0.11207,1,1
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.016734,0.061295,0.054867,1,1
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.045624,0.057993,0.067129,1,1
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.012508,0.057458,0.077685,1,1
5,GO GAMETE GENERATION,0.027803,0.05744,0.054792,1,1
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.026586,0.055635,0.068779,1,1
5,GO REGULATION OF CELL DIVISION,0.040234,0.055588,0.072944,1,1
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.018398,0.054149,0.045756,1,1
5,GO NEGATIVE REGULATION OF CELL CYCLE,0.05161,0.053786,0.044332,1,1
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.044685,0.047385,0.035662,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE,0.030383,0.03669,0.050373,1,1
6,GO FOREBRAIN NEURON FATE COMMITMENT,3.0576e-06,0.98878,0.99125,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00026903,0.58053,0.47844,1,1
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0013054,0.54973,0.74098,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.0016129,0.54258,0.46878,1,1
6,GO GABAERGIC NEURON DIFFERENTIATION,0.0057817,0.39736,0.47462,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.00021909,0.37869,0.41641,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00035231,0.37288,0.35664,1,1
6,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.00010092,0.33182,0.47085,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0018173,0.32244,0.42684,1,1
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0053338,0.31953,0.31315,1,1
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.0033369,0.30474,0.33375,1,1
6,GO GANGLION DEVELOPMENT,0.010773,0.2964,0.34376,1,1
6,GO OLFACTORY LOBE DEVELOPMENT,0.0025817,0.2798,0.28489,1,1
6,GO SUBPALLIUM DEVELOPMENT,0.0026572,0.27094,0.30187,1,1
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.018836,0.25476,0.27518,1,1
6,GO MRNA SPLICE SITE SELECTION,4.3218e-05,0.25158,0.27561,1,1
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.015203,0.25157,0.19459,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0021062,0.24951,0.22468,1,1
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.02268,0.24689,0.24448,1,1
6,GO V D J RECOMBINATION,0.0045306,0.24638,0.20857,1,1
6,GO SINGLE STRAND BREAK REPAIR,0.00014935,0.24637,0.21682,1,1
6,GO KINETOCHORE ASSEMBLY,0.0016129,0.24464,0.20327,1,1
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0037331,0.24026,0.21647,1,1
6,GO NOSE DEVELOPMENT,0.0066042,0.23606,0.41348,1,1
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.017137,0.22605,0.1794,1,1
6,GO VIRAL LATENCY,0.0062634,0.22526,0.1721,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.00045924,0.22114,0.19978,1,1
6,GO RETROGRADE AXONAL TRANSPORT,0.0028957,0.21995,0.21868,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,5.6174e-05,0.21952,0.23471,1,1
6,GO REGULATION OF HELICASE ACTIVITY,0.016339,0.21849,0.18357,1,1
6,GO KINETOCHORE ORGANIZATION,0.001662,0.21827,0.19721,1,1
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00057693,0.2104,0.18627,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.00012074,0.20797,0.1886,1,1
6,GO CEREBELLAR CORTEX FORMATION,0.004408,0.20385,0.22448,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0036303,0.19711,0.19138,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.016339,0.19681,0.14589,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,3.3132e-05,0.19464,0.21411,1,1
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.017549,0.19322,0.18573,1,1
6,GO GENETIC IMPRINTING,0.00057693,0.19089,0.22916,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00026903,0.18507,0.18746,1,1
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.001872,0.18489,0.20003,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,3.1888e-05,0.18424,0.18917,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00031859,0.1839,0.18276,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00069957,0.17772,0.17136,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00035231,0.16572,0.13189,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0028957,0.1599,0.14792,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0023671,0.15923,0.17049,1,1
6,GO DNA STRAND ELONGATION,0.00030804,0.1562,0.17042,1,1
6,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.047551,0.15426,0.16048,1,1
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.011904,0.15391,0.107,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00044439,0.15106,0.13171,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,5.8301e-05,0.15058,0.15896,1,1
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.029068,0.14833,0.14133,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00087311,0.14749,0.12818,1,1
6,GO MITOTIC DNA REPLICATION CHECKPOINT,0.0094949,0.14606,0.13787,1,1
6,GO RESPIRATORY SYSTEM PROCESS,0.015203,0.14577,0.14181,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00067758,0.14262,0.15863,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.0010859,0.1406,0.18555,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,0.0021689,0.13897,0.18892,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.031059,0.13788,0.10255,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.015953,0.13696,0.10886,1,1
6,GO POSITIVE REGULATION OF MRNA PROCESSING,0.001872,0.13638,0.11401,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0026572,0.13584,0.10492,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.014486,0.13507,0.10539,1,1
6,GO REPLICATION FORK PROCESSING,0.0017641,0.13166,0.12222,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,0.00036427,0.13152,0.14497,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.014486,0.13086,0.118,1,1
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.046579,0.12794,0.065176,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0036303,0.12562,0.12064,1,1
6,GO CELL CYCLE DNA REPLICATION,0.0067808,0.12507,0.095582,1,1
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.027188,0.1239,0.14549,1,1
6,GO MITOTIC DNA REPLICATION,0.025994,0.12369,0.13513,1,1
6,GO HISTONE EXCHANGE,0.0013872,0.12336,0.13257,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0031536,0.1228,0.13621,1,1
6,GO REGULATION OF CILIUM ASSEMBLY,0.014841,0.12004,0.096587,1,1
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.013798,0.11984,0.093438,1,1
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.013798,0.11866,0.2089,1,1
6,GO DNA REPLICATION INITIATION,0.0073363,0.11663,0.11185,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0017641,0.11603,0.099468,1,1
6,GO TRANSPORT ALONG MICROTUBULE,0.0083534,0.11569,0.095753,1,1
6,GO DNA REPLICATION CHECKPOINT,0.011326,0.11568,0.1187,1,1
6,GO HISTONE H4 ACETYLATION,0.00019079,0.1154,0.12172,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0067808,0.11442,0.10907,1,1
6,GO CENTROSOME SEPARATION,0.0099891,0.11394,0.14539,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.02068,0.11285,0.12099,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.011904,0.11097,0.09473,1,1
6,GO MRNA EXPORT FROM NUCLEUS,0.0081404,0.10585,0.086061,1,1
6,GO CHROMOSOME LOCALIZATION,0.007729,0.10428,0.084987,1,1
6,GO MITOTIC SPINDLE ASSEMBLY,0.011904,0.10342,0.096323,1,1
6,GO NUCLEOSOME ORGANIZATION,0.0010859,0.10203,0.11582,1,1
6,GO DNA DEPENDENT DNA REPLICATION,0.0066042,0.10161,0.083307,1,1
6,GO HISTONE H3 K4 METHYLATION,0.0087944,0.1009,0.11518,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00059588,0.09998,0.098875,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,0.0020453,0.099231,0.093849,1,1
6,GO DNA GEOMETRIC CHANGE,0.033894,0.098822,0.061153,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,0.010773,0.098429,0.087364,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.001986,0.095807,0.11022,1,1
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.038561,0.095458,0.080167,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0066042,0.092912,0.079044,1,1
6,GO REGULATION OF MRNA PROCESSING,0.018398,0.091774,0.07923,1,1
6,GO RNA EXPORT FROM NUCLEUS,0.038561,0.091709,0.065445,1,1
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.017969,0.091324,0.092756,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0026572,0.090921,0.10507,1,1
6,GO NCRNA TRANSCRIPTION,0.029068,0.088617,0.054293,1,1
6,GO REGULATION OF CENTROSOME CYCLE,0.0073363,0.088416,0.10505,1,1
6,GO HISTONE MONOUBIQUITINATION,0.01282,0.087175,0.10365,1,1
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.007729,0.086217,0.07496,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,0.013465,0.085304,0.1036,1,1
6,GO RNA SPLICING,0.0087944,0.083108,0.069885,1,1
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.015953,0.082754,0.087849,1,1
6,GO RECOMBINATIONAL REPAIR,0.0046564,0.079864,0.077808,1,1
6,GO MICROTUBULE BASED TRANSPORT,0.042857,0.077316,0.077854,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.049546,0.076883,0.059084,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0027346,0.074724,0.094324,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.0025817,0.073418,0.098168,1,1
6,GO SNRNA TRANSCRIPTION,0.0059384,0.072347,0.057945,1,1
6,GO PEPTIDYL LYSINE METHYLATION,0.036948,0.070762,0.062537,1,1
6,GO DNA CONFORMATION CHANGE,0.018836,0.070499,0.060525,1,1
6,GO CHROMOSOME SEGREGATION,0.017137,0.069977,0.060049,1,1
6,GO PROTEIN ACETYLATION,0.0056288,0.069468,0.05945,1,1
6,GO DNA RECOMBINATION,0.02068,0.065687,0.049044,1,1
6,GO MRNA PROCESSING,0.013798,0.065163,0.061273,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.01282,0.062736,0.069795,1,1
6,GO DNA REPAIR,0.0094949,0.061001,0.045533,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,0.009256,0.058153,0.090754,1,1
6,GO DOUBLE STRAND BREAK REPAIR,0.015953,0.056257,0.054584,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,0.012203,0.055082,0.045141,1,1
6,GO NUCLEAR CHROMOSOME SEGREGATION,0.02843,0.054375,0.056813,1,1
6,GO CHROMATIN REMODELING,0.029068,0.049453,0.067825,1,1
6,GO REGULATION OF RNA SPLICING,0.036948,0.046168,0.05361,1,1
6,GO CHROMOSOME ORGANIZATION,0.025994,0.036852,0.036348,1,1
